Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Dirk Schadendorf

Institut für Dermatologie der Medizinischen Fakultät am Universitätsklinikum Essen

Anschrift
Hufelandstraße 55
45122 Essen
Telefon
+49 201 723 2460
Webseite
http://www.uk-essen.de/index.php?id=hautklinik

Funktionen

  • Direktor/in, Klinik für Dermatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Amaral, Teresa; Nanz, Lena; Higuita, Lina Maria Serna; Ascierto, Paolo; Berking, Carola; Couselo, Eva Muñoz; Donia, Marco; Dummer, Reinhard; Gutzmer, Ralf; Haushild, Axel; Jalving, Mathilde; Lee, Rebecca; Lorigan, Paul; Marquez-Rodas, Ivan; Michelin, Olivier; Nathan, Paul; Robert, Caroline; Schadendorf, Dirk; Sobczuk, Pawel; Flatz, Lukas; Leiter, Ulrike; Garbe, Claus
    A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma : Results of systematic literature research
    In: European Journal of Cancer (EJC) , Jg. 215 2025, 115160
    DOI (Open Access)
  • Hughes, Brett G.M.; Guminski, Alexander; Bowyer, Samantha; Migden, Michael R.; Schmults, Chrysalyne D.; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Grob, Jean-Jacques; Lewis, Karl D.; Ansstas, George; Day, Fiona; Ladwa, Rahul; Stein, Brian N.; Muñoz Couselo, Eva; Meier, Friedegund; Hauschild, Axel; Schadendorf, Dirk; Basset-Seguin, Nicole; Modi, Badri; Dalac-Rat, Sophie; Dunn, Lara A.; Flatz, Lukas; Mortier, Laurent; Guégan, Sarah; Heinzerling, Lucie M.; Mehnert, Janice M.; Trabelsi, Sabiha; Soria-Rivas, Ainara; Stratigos, Alexander J.; Ulrich, Claas; Wong, Deborah J.; Beylot-Barry, Marie; Bossi, Paolo; Bugés Sánchez, Cristina; Chandra, Sunandana; Robert, Caroline; Russell, Jeffery S.; Silk, Ann W.; Booth, Jocelyn; Yoo, Suk-Young; Seebach, Frank; Lowy, Israel; Fury, Matthew G.; Rischin, Danny
    A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1) : Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
    In: Journal of the American Academy of Dermatology: JAAD , Jg. 92 2025, Nr. 1, S. 68 – 77
    DOI
  • Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Liszkay; Loquai, Carmen; Mandalà, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A
    A plain language summary of the 7-year update from part 1 of the COLUMBUS study : encorafenib and binimetinib for people with BRAF V600-mutant melanoma
    In: Future Oncology , Jg. 21 2025, Nr. 5, S. 523 – 531
    DOI (Open Access)
  • Braun, Lukas M.; Giesler, Sophie; Andrieux, Geoffroy; Riemer, Roxane; Talvard-Balland, Nana; Duquesne, Sandra; Rückert, Tamina; Unger, Susanne; Kreutmair, Stefanie; Zwick, Melissa; Follo, Marie; Hartmann, Alina; Osswald, Natascha; Melchinger, Wolfgang; Chapman, Stefanie; Hutchinson, James A.; Haferkamp, Sebastian; Torster, Leopold; Kött, Julian; Gebhardt, Christoffer; Hellwig, Dirk; Karantzelis, Nikolaos; Wallrabenstein, Till; Lowinus, Theresa; Yücel, Mehtap; Brehm, Niklas; Rawluk, Justyna; Pfeifer, Dietmar; Bronsert, Peter; Rogg, Manuel; Mattern, Sven; Heikenwälder, Mathias; Fusco, Stefano; Malek, Nisar P.; Singer, Stephan; Schmitt-Graeff, Annette; Ceteci, Fatih; Greten, Florian R.; Blazar, Bruce R.; Boerries, Melanie; Köhler, Natalie; Duyster, Justus; Ihorst, Gabriele; Lassmann, Silke; Keye, Philip; Minguet, Susana; Schadendorf, Dirk; Ugurel, Selma; Rafei-Shamsabadi, David; Thimme, Robert; Hasselblatt, Peter; Bengsch, Bertram; Schell, Christoph; Pearce, Erika L.; Meiss, Frank; Becher, Burkhard; Funke-Lorenz, Carolin; Placke, Jan-Malte; Apostolova, Petya; Zeiser, Robert
    Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
    In: Cancer Cell , Jg. 43 2025, Nr. 2, S. 269 – 291.e19
    DOI (Open Access)
  • Yoon, Charles H.; Ross, Merrick I.; Gastman, Brian R.; Luke, Jason J.; Ascierto, Paolo A.; Long, Georgina V.; Rutkowski, Piotr; Khattak, Muhammad; Del Vecchio, Michele; de la Cruz Merino, Luis; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Schadendorf, Dirk; Carlino, Matteo S.; Zhao, Yujie; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M. M.; Gershenwald, Jeffrey E.; Sondak, Vernon K.
    Adjuvant Pembrolizumab in Stage II Melanoma : Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial
    In: Annals of Surgical Oncology , Jg. 32 2025, Nr. 4, S. 2756 – 2764
    DOI
  • Lodde, Georg; Albrecht, Jessica Lea; Schadendorf, Dirk
    Behandlung des metastasierten Melanoms : Update 2025
    In: Deutsche Medizinische Wochenschrift - DMW , Jg. 150 2025, Nr. 10, S. 562 – 569
    DOI
  • Syeda, Mahrukh M; Long, Georgina V; Garrett, James; Atkinson, Victoria; Santinami, Mario; Schadendorf, Dirk; Hauschild, Axel; Millward, Michael; Mandala, Mario; Chiarion-Sileni, Vanna; Smylie, Michael; Manikhas, Georgy M; Dummer, Reinhard; Wiggins, Jennifer M; Ali, Saim; Adnaik, Sachin Bajirao; Tan, Monique; Dajee, Maya; Polsky, David
    Clinical validation of droplet digital PCR assays in detecting BRAFV⁶⁰⁰-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD) : A biomarker analysis from a double-blind, randomised phase 3 trial
    In: The Lancet Oncology , Jg. 26 2025, Nr. 5, S. 641 – 653
    DOI
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Correction : Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine , Jg. 23 2025, Nr. 1, 596
    DOI (Open Access)
  • Amaral, T.; Ottaviano, M.; Arance, A.; Blank, C.; Chiarion-Sileni, V.; Donia, M.; Dummer, R.; Garbe, C.; Gershenwald, J.E.; Gogas, H.; Guckenberger, M.; Haanen, J.; Hamid, O.; Hauschild, A.; Höller, C.; Lebbé, C.; Lee, R.J.; Long, G.V.; Lorigan, P.; Muñoz Couselo, E.; Nathan, P.; Robert, C.; Romano, E.; Schadendorf, Dirk; Sondak, V.; Suijkerbuijk, K.P.M.; van Akkooi, A.C.J.; Michelin, O.; Ascierto, P.A.; Michielin, O.
    Cutaneous melanoma : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    In: Annals of Oncology , Jg. 36 2025, Nr. 1, S. 10 – 30
    DOI
  • Tasdogan, Alpaslan; Sullivan, Ryan J.; Katalinic, Alexander; Lebbe, Celeste; Whitaker, Dagmar; Puig, Susana; van de Poll-Franse, Lonneke V.; Massi, Daniela; Schadendorf, Dirk
    Cutaneous melanoma
    In: Nature Reviews Disease Primers , Jg. 11 2025, Nr. 1, 23
    DOI
  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer , Jg. 6 2025, Nr. 2, S. 307 – 322
    DOI (Open Access)
  • Haggenmüller, Sarah; Wies, Christoph; Abels, Julia; Winterstein, Jana T.; Heinlein, Lukas; Nogueira Garcia, Carina; Utikal, Jochen S.; Wohlfeil, Sebastian A.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Sarfert, Cosimo; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Drexler, Konstantin; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob Nikolas; Fröhling, Stefan; Llamas-Velasco, Mar; Requena, Luis C.; Ferrara, Gerardo; Fernandez-Figueras, Maite; Fraitag, Sylvie; Müller, Cornelia S. L.; Starz, Hans; Kutzner, Heinz; Barnhill, Raymond; Carr, Richard; Resnik, Kenneth S.; Braun, Stephan Alexander; Holland-Letz, Tim; Brinker, Titus J.
    Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumors
    In: Nature Communications , Jg. 16 2025, Nr. 1, 789
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.J.; Kandolf, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Gaudy-Marqueste, C.; Kiecker, F.; Utikal, J.; Hartmann, M.; Miethe, S.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in with targeted to immunotherapy in advanced BRAFV⁶⁰⁰-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
    In: ESMO Open , Jg. 10 2025, Nr. 5, 105053
    DOI (Open Access)
  • Tomsitz, Dirk; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike; Schilling, Bastian; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk; Berking, Carola; Ugurel, Selma; Heinzerling, Lucie
    Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
    In: Journal of the European Academy of Dermatology and Venereology 2025 , in press
    DOI (Open Access)
  • Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Cowey, C. Lance; Schadendorf, Dirk; Wagstaff, John; Queirolo, Paola; Dummer, Reinhard; Butler, Marcus O.; Hill, Andrew G.; Postow, Michael A.; Gaudy-Marqueste, Caroline; Medina, Theresa; Lao, Christopher D.; Walker, John; Márquez-Rodas, Iván; Haanen, John B. A. G.; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S.; Sandhu, Shahneen; Lebbé, Céleste; Ascierto, Paolo A.; Long, Georgina V.; Ritchings, Corey; Nassar, Ayman; Askelson, Margarita; Benito, Melanie Pe; Wang, Wenjia; Hodi, F. Stephen; Larkin, James; CheckMate 067 Investigators
    Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
    In: The New England Journal of Medicine , Jg. 392 2025, Nr. 1, S. 11 – 22
    DOI (Open Access)
  • Reinhard, Sören; Utikal, Jochen Sven; Zaremba, Anne; Lodde, Georg; von Wasielewski, Imke; Klespe, Kai Christian; Meier, Friedegund; Haferkamp, Sebastian; Kähler, Katharina C.; Herbst, Rudolf; Gebhardt, Christoffer; Sindrilaru, Anca; Dippel, Edgar; Angela, Yenny; Mohr, Peter; Pfoehler, Claudia; Forschner, Andrea; Kaatz, Martin; Schell, Beatrice; Gesierich, Anja; Loquai, Carmen; Hassel, Jessica C.; Ulrich, Jens; Meiss, Frank; Schley, Gaston; Heinzerling, Lucie M.; Sachse, Michael; Welzel, Julia; Weishaupt, Carsten; Sunderkötter, Cord; Michl, Christiane; Lindhof, Harm-Henning; Kreuter, Alexander; Heppt, Markus V.; Wenk, Saskia; Mauch, Cornelia; Berking, Carola; Nedwed, Annekathrin Silvia; Gutzmer, Ralf; Leiter, Ulrike; Schadendorf, Dirk; Ugurel, Selma; Weichenthal, Michael; Haist, Maximilian; Fleischer, Maria Isabel; Lang, Berenice; Grabbe, Stephan; Stege, Henner
    First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma : A multicenter study from the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) , Jg. 220 2025, 115356
    DOI (Open Access)
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine , Jg. 23 2025, Nr. 1, 532
    DOI (Open Access)
  • Mughal, Sadaf S.; Reiss, Yvonne; Felsberg, Jörg; Meyer, Lasse; Macas, Jadranka; Schlue, Silja; Starzetz, Tatjana; Köhrer, Karl; Fehm, Tanja; Müller, Volkmar; Lamszus, Katrin; Schadendorf, Dirk; Helfrich, Iris; Wikman, Harriet; Berghoff, Anna; Brors, Benedikt; Plate, Karl H.; Reifenberger, Guido
    Identification and characterization of tertiary lymphoid structures in brain metastases
    In: Acta Neuropathologica Communications , Jg. 13 2025, Nr. 1, 91
    DOI (Open Access)
  • Weichenthal, Michael; Ellebaek, Eva; Mangana, Joanna; Asher, Nethanel; Gavrilova, Iva; Kandolf, Lidija; Ugurel, Selma; Hausschild, Axel; Meier, Friedegund; Leiter, Ulrike; Livingstone, Elisabeth; Gebhardt, Christoffer; Gutzmer, Ralf; Ruhlmann, Christina H.; Mahncke-Guldbrandt, Louise; Haslund, Charlotte A.; Kopec, Sylwia; Teterycz, Paweł; Bender, Marc; Poudroux, Wilfried; Muñoz-Couselo, Eva; Berciano-Guerrero, Miguel-Angel; Shalamanova, Gergana; DePalo, Danielle K.; Brozić, Jasmina Marić; Chiarion-Sileni, Vanna; Arance, Anna; Ziogas, Dimitrios; Robert, Caroline; van de Velde, Anthonie Obik; Gassama, Awa Aminata; Shapira, Ronnie; BenBetzalel, Guy; Grynberg, Shirly; Ramelyte, Egle; Bertoldo, Fabio; DelPrete, Valerio; Gaudy-Marqueste, Caroline; Mohr, Peter; Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen; Espinosa, Enrique; Lebbé, Celeste; Rutkowski, Piotr; Haanen, John; Schadendorf, Dirk; Svane, Inge Marie
    Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment : A EUMelaReg real-world evidence study
    In: European Journal of Cancer (EJC) , Jg. 220 2025, 115339
    DOI
  • Kött, Julian; Zell, Tim; Zimmermann, Noah; Rünger, Alessandra; Smit, Daniel J.; Abeck, Finn; Geidel, Glenn; Hansen-Abeck, Inga; Heidrich, Isabel; Weichenthal, Michael; Ugurel, Selma; Leiter, Ulrike; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth; von Wasielewski, Imke; Mohr, Peter; Meier, Friedegund; Haferkamp, Sebastian; Drexler, Konstantin; Herbst, Rudolf; Kellner, Ivonne; Utikal, Jochen; Wohlfeil, Sebastian A.; Pföhler, Claudia; Adam, Leonie; Terheyden, Patrick; Ulrich, Jens; Meiss, Frank; Möbes, Monica; Welzel, Julia; Schilling, Bastian; Ziller, Fabian; Kaatz, Martin; Kreuter, Alexander; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Weishaupt, Carsten; Hüning, Svea; Heinzerling, Lucie; Loquai, Carmen; Schley, Gaston; Gambichler, Thilo; Löffler, Harald; Grabbe, Stephan; Schultz, Erwin; Devereux, Nina; Hassel, Jesscia C.; Simon, Jan-Ch.; Raap, Ulrike; Assaf, Chalid; Klemke, Claus-Detlev; Sunderkötter, Cord; Hofmann, Silke C.; Wenk, Saskia; Tronnier, Michael; Thies, Silke; Heppt, Markus V.; Eggermont, Alexander; Schulze, Hans-Joachim; Zouboulis, Christos C.; Tüting, Thomas; Bauer, Alexander T.; Schneider, Stefan W.; Gebhardt, Christoffer
    Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy : A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
    In: European Journal of Cancer (EJC) , Jg. 214 2025, 115159
    DOI (Open Access)
  • Robert, C.; Long, G.V.; Larkin, J.; Wolchok, J.D.; Hassel, J.C.; Schadendorf, Dirk; Hodi, F.S.; Lebbé, C.; Grob, J.-J.; Hyngstrom, J.R.; Wagstaff, J.; Chesney, J.; Butler, M.O.; Bechter, O.; Márquez-Rodas, I.; Pavlick, A.C.; Durani, P.; Pe Benito, M.; Wang, P.; Postow, M.A.; Ascierto, P.A.
    Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy : A pooled analysis in 935 patients
    In: European Journal of Cancer (EJC) , Jg. 214 2025, 115119
    DOI (Open Access)
  • Hauschild, Axel; Garbe, Claus; Ascierto, Paolo Antonio; Demidov, Lev; Dreno, Brigitte; Dummer, Reinhard; Eggermont, Alexander; Forsea, Ana-Maria; Gebhardt, Christoffer; Gershenwald, Jeffrey E; Hamid, Omid; Hoeller, Christoph; Kandolf, Lidija; Kaufmann, Roland; Kirkwood, John M; Lebbé, Celeste; Long, Georgina V; Malvehy, Josep; Martin-Algarra, Salvador; McArthur, Grant; Neyns, Bart; Richtig, Erika; Robert, Caroline; Schadendorf, Dirk; Scolyer, Richard; Sondak, Vernon K; Wainstein, Alberto; Weichenthal, Michael; Nuti, Paolo; Melanoma World Society Study Group
    Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice : An international survey
    In: The Lancet Oncology , Jg. 26 2025, Nr. 1, S. 12 – 14
    DOI
  • Krawutschke, Marvin; Teufel, Martin; Schmidt, Kira; Pasche, Saskia; Schweig, Theresa; Bialek, Anna; Kowalski, Axel; Tewes, Mitra; Schuler, Martin; Schadendorf, Dirk; Scherbaum, Norbert; Skoda, Eva-Maria; Fink, Madeleine; Müller, Bernhard W.
    Neurofeedback Reduces P300 Amplitudes to Intensely Emotive Pictures in Depressed Cancer Patients
    In: Clinical EEG and Neuroscience , Jg. 56 2025, Nr. 3, S. 217 – 229
    DOI (Open Access)
  • Luke, Jason J.; Ascierto, Paolo A.; Khattak, Muhammad A.; Rutkowski, Piotr; Del Vecchio, Michele; Spagnolo, Francesco; Mackiewicz, Jacek; Merino, Luis de la Cruz; Chiarion-Sileni, Vanna; Kirkwood, John M.; Robert, Caroline; Schadendorf, Dirk; de Galitiis, Federica; Carlino, Matteo S.; Dummer, Reinhard; Mohr, Peter; Odeleye-Ajakaye, Amos; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M.M.; Long, Georgina V.
    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma : Long-term follow-up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study
    In: European Journal of Cancer (EJC) , Jg. 220 2025, 115381
    DOI
  • Placke, Jan-Malte; Rajcsanyi, Luisa Sophie; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Weichenthal, Michael; Meier, Friedegund; Berking, Carola; Leiter, Ulrike; Seier, Johanna; Krefting, Frederik; Tasdogan, Alpaslan; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
    In: Frontiers in Immunology , Jg. 16 2025, 1536642
    DOI (Open Access)
  • von Bubnoff, Dagmar; Schmitt, Christina; Goldinger, Simone M.; Schadendorf, Dirk; Kähler, Katharina C.; Hafner, Christian; Kramer, Nora; Fröhlich, Waltraud; Dummer, Reinhard; Berking, Carola; Schliep, Stefan; Kirchberger, Michael C.; Heinzerling, Lucie
    Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab
    In: PLoS ONE , Jg. 20 2025, Nr. 5, e0321937
    DOI (Open Access)
  • Küper, Alisa; Lodde, Georg Christian; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Psychological Factors Influencing Appropriate Reliance on AI-enabled Clinical Decision Support Systems : Experimental Web-Based Study Among Dermatologists
    In: Journal of Medical Internet Research (JMIR) , Jg. 27 2025, e58660
    DOI (Open Access)
  • Sauer, Christina; Ullerich, Cathrin; Livingstone, Elisabeth; Tagay, Sefik; Bugaj, Till J.; Skoda, Eva-Maria; Teufel, Martin; Schadendorf, Dirk; Friederich, Hans-Christoph
    Psychosocial distress and psychosocial resources in couples facing non-melanoma skin cancers and malignant melanoma
    In: Journal of Psychosocial Oncology , Jg. 43 2025, Nr. 2, S. 173 – 188
    DOI
  • Egea‐Rodriguez, Sara; Váraljai, Renáta; Nordmann, Thierry M.; Lubis, Restuan; Philip, Manuel; Rambow, Florian; Rösch, Alexander; Flaig, Michael; Horn, Susanne; Stoll, Raphael; Zhao, Fang; Paschen, Annette; Klebl, Bert; Hickson, Ian D.; Schadendorf, Dirk; Mann, Matthias; Helfrich, Iris
    RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
    In: Clinical and Translational Medicine , Jg. 15 2025, Nr. 1, e70094
    DOI (Open Access)
  • Melo, Luiza Martins Nascentes; Sabatier, Marie; Ramesh, Vijayashree; Szylo, Krystina J.; Fraser, Cameron S.; Pon, Alex; Mitchell, Evann C.; Servage, Kelly A.; Allies, Gabriele; Westedt, Isa V.; Cansiz, Feyza; Krystkiewicz, Jonathan; Kutritz, Andrea; Schadendorf, Dirk; Morrison, Sean J.; Ubellacker, Jessalyn M.; Sreelatha, Anju; Tasdogan, Alpaslan
    Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II Activity
    In: Cancer Research , Jg. 85 2025, Nr. 5, S. 942 – 955
    DOI (Open Access)
  • Placke, Jan-Malte; Bottek, Jenny; Váraljai, Renata; Shannan, Batool; Scharfenberg, Sarah; Krisp, Christoph; Spangenberg, Philippa; Soun, Camille; Siemes, Devon; Borgards, Lars; Hoffmann, Franziska; Zhao, Fang; Paschen, Anette; Schlueter, Hartmut; von Eggeling, Ferdinand; Helfrich, Iris; Rambow, Florian; Ugurel, Selma; Tasdogan, Alpaslan; Schadendorf, Dirk; Engel, Daniel R.; Rösch, Alexander
    Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
    In: British Journal of Dermatology: BJD , Jg. 192 2025, Nr. 3, S. 481 – 491
    DOI
  • Tawbi, Hussein A.; Hodi, F. Stephen; Lipson, Evan J.; Schadendorf, Dirk; Ascierto, Paolo A.; Matamala, Luis; Castillo Gutiérrez, Erika; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Janoski De Menezes, Juliana; Dalle, Stéphane; Arance, Ana Maria; Grob, Jean-Jacques; Ratto, Barbara; Rodriguez, Saima; Mazzei, Antonella; Dolfi, Sonia; Long, Georgina V.
    Three-Year Overall Survival with Nivolumab Plus Relatlimab in Advanced Melanoma from RELATIVITY-047
    In: Journal of Clinical Oncology (JCO) , Jg. 43 2025, Nr. 13, S. 1546 – 1552
    DOI (Open Access)
  • Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma
    In: JAAD Case Reports , Jg. 55 2025, S. 123 – 125
    DOI (Open Access)
  • Forschner, Andrea; Kähler, Katharina C.; Gschnell, Martin; Langan, Ewan A.; Weishaupt, Carsten; Meiss, Frank; Thoms, Kai-Martin; Wahl, Renate U.; Göppner, Daniela; Garzarolli, Marlene; Sachse, Michael; Schlaak, Max; Reitmajer, Markus; Kellner, Ivonne; Gesierich, Anja; Mohr, Peter; Meier, Friedegund; von Wasielewski, Imke; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Terheyden, Patrick; Kaatz, Martin; Haferkamp, Sebastian; Leiter, Ulrike; Ugurel, Selma; Weichenthal, Michael; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Nanz, Lena; Loquai, Carmen
    Treatment at the end of life in patients with advanced melanoma : A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg
    In: Frontiers in Immunology , Jg. 16 2025, 1509886
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, Wolfgang; Thielmann, Carl Maximilian; Murali, Rajmohan; Zaremba-Montenari, Anne; Standl, Fabian; Lodde, Georg; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Stang, Andreas; Griewank, Klaus
    pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
    In: European Journal of Cancer (EJC) , Jg. 220 2025, 115337
    DOI (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    A Systematic Comparison of Task Adaptation Techniques for Digital Histopathology
    In: Bioengineering , Jg. 11 2024, Nr. 1, 19
    DOI (Open Access)
  • Weichenthal, Michael; Mangana, Joanna; Gavrilova, Iva; Lugowska, Iwona; Shalamanova, Gergana Krumova; Kandolf, Lidija; Chiarion-Sileni, Vanna; Mohr, Peter; Karanikolova, Teodora Sotirova; Teterycz, Pawel; Espinosa, Enrique; Schnecko, Philipp; Cheng, Phil; Bender, Marc; Jiang, Shan; Burke, Thomas; Ascierto, Paolo Antonio; Gogas, Helen; Rodas, Ivan Marquez; Rutkowski, Piotr; Schadendorf, Dirk; Dummer, Reinhard
    Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe
    In: Cancers , Jg. 16 2024, Nr. 21, 3558
    DOI (Open Access)
  • Bührer, Emanuel; Kicinski, Michal; Mandala, Mario; Pe, Madeline; Long, Georgina V; Atkinson, Victoria; Blank, Christian U; Haydon, Andrew; Dalle, Stéphane; Khattak, Adnan; Carlino, Matteo S; Meshcheryakov, Andrey; Sandhu, Shahneen; Puig, Susana; Schadendorf, Dirk; Jamal, Rahima; Rutkowski, Piotr; van den Eertwegh, Alfonsus J M; Coens, Corneel; Grebennik, Dmitri; Krepler, Clemens; Robert, Caroline; Eggermont, Alexander M M
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : Long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
    In: The Lancet Oncology , Jg. 25 2024, Nr. 9, S. 1202 – 1212
    DOI
  • Albrecht, Jessica Lea; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Váraljai, Renáta; Lodde, Georg; Placke, Jan-Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Rösch, Alexander; Schulz, Carsten; Berking, Carola; Pöttgen, Christoph; Menzies, Alexander M.; Long, Georgina V.; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 202 2024, 113976
    DOI (Open Access)
  • Pires da Silva, Ines; Li, Isabel; Ugurel, Selma; Serra-Bellver, Patricio; Andhale, Avanti; Burnette, Hannah; Aya, Francisco; Conway, Jordan W.; Braden, Jorja; Carlino, Matteo S.; Menzies, Alexander M.; Weichenthal, Michael; Mohr, Peter; Gutzmer, Ralf; Arance, Ana M.; Johnson, Douglas B.; Lorigan, Paul; Schadendorf, Dirk; Lo, Serigne N.; Long, Georgina V.
    Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
    In: European Journal of Cancer (EJC) , Jg. 205 2024, 114101
    DOI
  • Chorti, Eleftheria; Kowall, Bernd; Hassel, Jessica C.; Schilling, Bastian; Sachse, Michael; Gutzmer, Ralf; Loquai, Carmen; Kähler, Katharina C.; Hüsing, Anika; Gilde, Catharina; Thielmann, Carl Maximilian; Zaremba-Montenari, Anne; Placke, Jan-Malte; Gratsias, Emmanouil; Martaki, Anna; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Stang, Andreas; Zimmer, Lisa
    Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
    In: European Journal of Cancer (EJC) , Jg. 200 2024, 113536
    DOI (Open Access)
  • Schäfer, Henning; Idrissi-Yaghir, Ahmad; Arzideh, Kamyar; Damm, Hendrik; Pakull, Tabea M.G.; Schmidt, Cynthia S.; Bahn, Mikel; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Nensa, Felix; Horn, Peter; Friedrich, Christoph M.
    BioKGrapher : Initial evaluation of automated knowledge graph construction from biomedical literature
    In: Computational and Structural Biotechnology Journal , Jg. 24 2024, S. 639 – 660
    DOI (Open Access)
  • Robbrecht, Debbie; Grob, Jean-Jacques; Bechter, Oliver; Simonelli, Matteo; Doger, Bernard; Borbath, Ivan; Butler, Marcus O.; Cheng, Tina; Romano, Patricia Martin; Pons-Tostivint, Elvire; Di Nicola, Massimo; Curigliano, Giuseppe; Ryu, Min-Hee; Rodriguez-Vida, Alejo; Schadendorf, Dirk; Garralda, Elena; Abbadessa, Giovanni; Demers, Brigitte; Amrate, Amele; Wang, Hong; Lee, Joon Sang; Pomponio, Robert; Wang, Rui
    Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors
    In: Clinical and Translational Science (CTS) , Jg. 17 2024, Nr. 2, e13736
    DOI (Open Access)
  • Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandalà, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A.
    COLUMBUS 7-year update : A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma
    In: European Journal of Cancer (EJC) , Jg. 204 2024, 114073
    DOI (Open Access)
  • Krueger, Oskar; Eisenburger, Robin; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Theurer, Sarah; Brodin, Berthold; Schadendorf, Dirk; Ugurel, Selma
    Case report: : Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab
    In: Frontiers in Immunology , Jg. 15 2024, 1369190
    DOI, Online Volltext (Open Access)
  • Matull, Johanna; Placke, Jan-Malte; Lodde, Georg; Zaremba-Montenari, Anne; Utikal, Jochen; Terheyden, Patrick; Pföhler, Claudia; Herbst, Rudolf; Kreuter, Alexander; Welzel, Julia; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Thielmann, Carl Maximilian; Griewank, Klaus
    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
    In: Frontiers in Immunology , Jg. 15 2024, 1383125
    DOI (Open Access)
  • Krefting, Frederik; Moelleken, Maurice; Hölsken, Stefanie; Placke, Jan-Malte; Eisenburger, Robin Tamara; Albrecht, Jessica Lea; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma; Dissemond, Joachim; Sondermann, Wiebke
    Comparison of visual diagnostic accuracy of dermatologists practicing in Germany in patients with light skin and skin of color
    In: Scientific Reports , Jg. 14 2024, Nr. 1, 8740
    DOI, Online Volltext (Open Access)
  • Jansen, Philipp; Arrastia, Jean Le'Clerc; Baguer, Daniel Otero; Schmidt, Maximilian; Landsberg, Jennifer; Wenzel, Jörg; Emberger, Michael; Schadendorf, Dirk; Hadaschik, Eva; Maass, Peter; Griewank, Klaus Georg
    Deep learning based histological classification of adnex tumors
    In: European Journal of Cancer (EJC) , Jg. 196 2024, 113431
    DOI
  • Heinzelmann, Anna; Tewes, Mitra; Müller, Sandy; Sure, Ulrich; Herrmann, Ken; Schadendorf, Dirk; Warnecke, Eva; Rausch, Raya; Skoda, Eva-Maria; Salvador Comino, Maria Rosa
    Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient’s subjective need for palliative support and symptom burden in inpatients with advanced cancer
    In: Journal of Cancer Research and Clinical Oncology , Jg. 150 2024, Nr. 7, 360
    DOI (Open Access)
  • Rudolph, Victoria; Leven, Anna-Sophia; Eisenburger, Robin; Schadendorf, Dirk; Wiegand, Susanne
    Die interdisziplinäre Behandlung von Hautkrebs
    In: Laryngo-Rhino-Otologie , Jg. 103 2024, Nr. S 01, S. S100 – S124
    DOI (Open Access)
  • Nurtsch, Angelina; Teufel, Martin; Jahre, Lisa Maria; Esber, André; Rausch, Raya; Tewes, Mitra; Schöbel, Christoph; Palm, Stefan; Schuler, Martin; Schadendorf, Dirk; Skoda, Eva-Maria; Bäuerle, Alexander
    Drivers and barriers of patients’ acceptance of video consultation in cancer care
    In: Digital Health , Jg. 10 2024
    DOI, Online Volltext (Open Access)
  • Lodde, Georg; Zhao, Fang; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Jansen, Philipp; Kowall, Bernd; Galetzka, Wolfgang; Hörst, Fabian; Kleesiek, Jens; Hellwig, Birte; Rahnenführer, Jörg; Rajcsanyi, Luisa; Peters, Triinu; Hinney, Anke; Placke, Jan-Malte; Sucker, Antje; Paschen, Annette; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Tasdogan, Alpaslan; Rösch, Alexander; Hadaschik, Eva; Schadendorf, Dirk; Griewank, Klaus; Ugurel, Selma
    Early versus late response to PD-1-based immunotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 210 2024, 114295
    DOI (Open Access)
  • Haggenmüller, Sarah; Schmitt, Max; Krieghoff-Henning, Eva; Hekler, Achim; Maron, Roman C.; Wies, Christoph; Utikal, Jochen S.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Drexler, Konstantin; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Brinker, Titus J.
    Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics
    In: JAMA Dermatology , Jg. 160 2024, Nr. 3, S. 303 – 311
    DOI (Open Access)
  • Long, Georgina V.; Hauschild, Axel; Santinami, Mario; Kirkwood, John M.; Atkinson, Victoria; Mandala, Mario; Merelli, Barbara; Sileni, Vanna Chiarion; Nyakas, Marta; Haydon, Andrew; Dutriaux, Caroline; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Schadendorf, Dirk; Lesimple, Thierry; Plummer, Ruth; Larkin, James; Tan, Monique; Adnaik, Sachin Bajirao; Burgess, Paul; Jandoo, Tarveen; Dummer, Reinhard
    Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
    In: The New England Journal of Medicine , Jg. 7 2024, Nr. 391, S. 1709 – 1720
    DOI
  • Khushalani, Nikhil I.; Ott, Patrick A.; Ferris, Robert L.; Cascone, Tina; Schadendorf, Dirk; Le, Dung T.; Sharma, Manish R.; Barlesi, Fabrice; Sharfman, William; Luke, Jason J.; Melero, Ignacio; Lathers, Deanne; Neely, Jaclyn; Suryawanshi, Satyendra; Sanyal, Abanti; Holloway, James L.; Suryawanshi, Rasika; Ely, Scott; Segal, Neil H.
    Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
    In: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 3, e007364
    DOI (Open Access)
  • Long, Georgina V.; Lipson, Evan J.; Hodi, F. Stephen; Ascierto, Paolo A.; Larkin, James; Lao, Christopher; Grob, Jean-Jacques; Ejzykowicz, Flavia; Moshyk, Andriy; Garcia-Horton, Viviana; Zhou, Zheng-Yi; Xin, Yiqiao; Palaia, Jennell; McDonald, Laura; Keidel, Sarah; Salvatore, Anthony; Patel, Divya; Sakkal, Leon A.; Tawbi, Hussein; Schadendorf, Dirk
    First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma : An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 33, S. 3926 – 3934
    DOI (Open Access)
  • Dudnichenko, Oleksandr; Penkov, Konstantin; McKean, Meredith; Mandalà, Mario; Kukushkina, Mariia; Panella, Timothy; Csőszi, Tibor; Gerletti, Paola; Thakur, Mahgull; Polli, Anna; di Pietro, Alessandra; Schadendorf, Dirk
    First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma : Safety lead-in results from the randomized phase III STARBOARD study
    In: European Journal of Cancer (EJC) , Jg. 213 2024, 115070
    DOI (Open Access)
  • Tarantino, Giuseppe; Ricker, Cora A.; Wang, Annette; Ge, William; Aprati, Tyler J.; Huang, Amy Y.; Madha, Shariq; Chen, Jiajia; Shi, Yingxiao; Glettig, Marc; Feng, Catherine H.; Frederick, Dennie T.; Freeman, Samuel; Holovatska, Marta M.; Manos, Michael P.; Zimmer, Lisa; Rösch, Alexander; Zaremba, Anne; Livingstone, Elisabeth; Jameson, Jacob C.; Saghafian, Soroush; Lee, Andrew; Zhao, Karena; Morris, Luc G.T.; Reardon, Brendan; Park, Jihye; Elmarakeby, Haitham A.; Schilling, Bastian; Giobbie-Hurder, Anita; Vokes, Natalie I.; Buchbinder, Elizabeth I.; Flaherty, Keith T.; Haq, Rizwan; Wu, Catherine J.; Boland, Genevieve M.; Hodi, F. Stephen; Van Allen, Eliezer M.; Schadendorf, Dirk; Liu, David
    Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    In: Science Advances , Jg. 10 2024, Nr. 48, eadp4670
    DOI (Open Access)
  • Rischin, Danny; Hughes, Brett G M; Basset-Séguin, Nicole; Schadendorf, Dirk; Bowyer, Samantha; Trabelsi Messai, Sabiha; Meier, Friedegund; Eigentler, Thomas K; Casado Echarren, Victoria; Stein, Brian; Beylot-Barry, Marie; Dalac, Sophie; Dréno, Brigitte; Migden, Michael R; Hausschild, Axel; Schmults, Chrysalyne D; Lim, Annette M; Yoo, Suk-Young; Paccaly, Anne J; Papachristos, Apostolos; Nguyen, Jenny-Hoa; Okoye, Emmanuel; Seebach, Frank; Booth, Jocelyn; Lowy, Israel; Fury, Matthew G; Guminski, Alexander
    High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 3, e008325
    DOI (Open Access)
  • Wohlfeil, Sebastian A.; Kranzmann, Leonie; Weiß, Christel; von Wasielewski, Imke; Klespe, Kai C.; Kähler, Katharina C.; Weichenthal, Michael; Schadendorf, Dirk; Zimmer, Lisa; Mohr, Peter; Meier, Friedegund; Pfoehler, Claudia; Berking, Carola; Heppt, Markus V.; Herbst, Rudolf; Kreuter, Alexander; Gutzmer, Ralf; Ulrich, Jens; Meiss, Frank; Gebhardt, Christoffer; Dippel, Edgar; Leiter, Ulrike; Schilling, Bastian; Ugurel, Selma; Utikal, Jochen
    Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma : A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg
    In: International Journal of Cancer , Jg. 155 2024, Nr. 10, S. 1808 – 1823
    DOI (Open Access)
  • Rogava, Meri; Aprati, Tyler J.; Chi, Wei-Yu; Melms, Johannes C.; Hug, Clemens; Davis, Stephanie H.; Earlie, Ethan M.; Chung, Charlie; Deshmukh, Sachin K.; Wu, Sharon; Sledge, George; Tang, Stephen; Ho, Patricia; Amin, Amit Dipak; Caprio, Lindsay; Gurjao, Carino; Tagore, Somnath; Ngo, Bryan; Lee, Michael J.; Zanetti, Giorgia; Wang, Yiping; Chen, Sean; Ge, William; Melo, Luiza Martins Nascentes; Allies, Gabriele; Rösler, Jonas; Gibney, Goeffrey T.; Schmitz, Oliver J.; Sykes, Megan; Creusot, Rémi J.; Tüting, Thomas; Schadendorf, Dirk; Röcken, Martin; Eigentler, Thomas K.; Molotkov, Andrei; Mintz, Akiva; Bakhoum, Samuel F.; Beyaz, Semir; Cantley, Lewis C.; Sorger, Peter K.; Meckelmann, Sven; Tasdogan, Alpaslan; Liu, David; Laughney, Ashley M.; Izar, Benjamin
    Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation
    In: Nature Cancer , Jg. 5 2024, Nr. 3, S. 433 – 447
    DOI (Open Access)
  • Wohlfarth, Jonas; Kosnopfel, Corinna; Faber, Dominic; Berthold, Marion; Siedel, Claudia; Bernhardt, Melissa; Schlosser, Andreas; Aprati, Tyler; Liu, David; Schrama, David; Houben, Roland; Schadendorf, Dirk; Goebeler, Matthias; Meierjohann, Svenja; Schilling, Bastian
    Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density
    In: Molecular Oncology , Jg. 18 2024, Nr. 10, S. 2449 – 2470
    DOI (Open Access)
  • Lugowska, I.; Becker, Jürgen; Ascierto, P.A.; Veness, M.; Blom, A.; Lebbe, C.; Migliano, E.; Hamming-Vrieze, O.; Goebeler, M.; Kneitz, H.; Nathan, P.; Rutkowski, P.; Slowinska, M.; Schadendorf, Dirk; Piulats, J.M.; Petrelli, F.; van Akkooi, A.C.J.; Berruti, A.
    Merkel-cell carcinoma : ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
    In: ESMO Open , Jg. 9 2024, Nr. 5, 102977
    DOI (Open Access)
  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Mitigating cognitive bias with clinical decision support systems : An experimental study
    In: Journal of Decision Systems , Jg. 33 2024, Nr. 3, S. 439 – 458
    DOI
  • Uzuner, Hamdiye; Paschen, Annette; Schadendorf, Dirk; Köster, Johannes
    Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing
    In: BMC Bioinformatics , Jg. 25 2024, Nr. 1, 240
    DOI (Open Access)
  • Shelton, Spencer D.; House, Sara; Martins Nascentes Melo, Luiza; Ramesh, Vijayashree; Chen, Zhenkang; Wei, Tao; Wang, Xun; Llamas, Claire B.; Venigalla, Siva Sai Krishna; Menezes, Cameron J.; Allies, Gabriele; Krystkiewicz, Jonathan; Rösler, Jonas; Meckelmann, Sven W.; Zhao, Peihua; Rambow, Florian; Schadendorf, Dirk; Zhao, Zhiyu; Gill, Jennifer G.; DeBerardinis, Ralph J.; Morrison, Sean J.; Tasdogan, Alpaslan; Mishra, Prashant
    Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
    In: Science Advances , Jg. 10 2024, Nr. 44, eadk8801
    DOI (Open Access)
  • Haggenmüller, Sarah; Maron, Roman C.; Hekler, Achim; Krieghoff-Henning, Eva; Utikal, Jochen S.; Gaiser, Maria; Müller, Verena; Fabian, Sascha; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; Weichenthal, Michael; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Drexler, Konstantin; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Kaminski, Katharina; Doppler, Astrid; Bucher, Tabea; Brinker, Titus J.; Garcia, Carina Nogueira; Thamm, Janis; Schuh, Sandra; Welzel, Julia; Maul-Duwendag, Lara Valeska; Georg, Paul; Feldmeyer, Laurence; Bechara, Falk; Steininger, Julian; Lehr, Sophia; Rauschenberg, Ricarda; Eberle, Anna-Lisa; Hartmann, Sören Manfred; Hasler, Helena; Bender-Säbelkampf, Sophia; Bauerschmitz, Jürgen P.; Kaufmann, Matthias; Erfurt-Berge, Cornelia; Peitsch, Wiebke Katharina; Wehkamp, Ulrike; Jost, Marion; Franklin, Cindy; Holzgruber, Julia; Haist, Maximilian; Giulini, Mario; Wohlfeil, Sebastian; Faihs, Valentina; Sattler, Elke; Stürmer, Suzan; Krammer, Sebastian; Kendziora, Benjamin; Akcetin, Semra Larissa; Mitwalli, Mohammed; Avci, Pinar; Fiocco, Zeno; Hartmann, Daniela; Fernandes Lobo Pereira, Manuel Pedro; Thiem, Alexander; Aebischer, Valentin; Forchhammer, Stephan; Wolff, Isabel
    Patients’ and dermatologists’ preferences in artificial intelligence–driven skin cancer diagnostics : A prospective multicentric survey study
    In: Journal of the American Academy of Dermatology: JAAD , Jg. 91 2024, Nr. 2, S. 366 – 370
    DOI (Open Access)
  • Luke, Jason J.; Ascierto, Paolo A.; Khattak, Muhammad A.; De La Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M.; Robert, Caroline; Grob, Jean-Jacques; De Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo S.; Wu, Xi Lawrence; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M.M.; Long, Georgina V.
    Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma : Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 14, S. 1619 – 1624
    DOI (Open Access)
  • Schadendorf, Dirk; Luke, Jason John; Ascierto, Paolo A; Long, Georgina V; Rutkowski, Piotr; Khattak, Adnan; Del Vecchio, Michele; De La Cruz-Merino, Luis; Mackiewicz, Jacek; Sileni, Vanna Chiarion; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; Dummer, Reinhard; Carlino, Matteo S; Zhao, Yujie; Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander; Scolyer, Richard A
    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma : Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
    In: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 3, e007501
    DOI (Open Access)
  • Long, Georgina V.; Larkin, James; Schadendorf, Dirk; Grob, Jean-Jacques; Lao, Christopher D.; Márquez-Rodas, Iván; Wagstaff, John; Lebbé, Céleste; Pigozzo, Jacopo; Robert, Caroline; Ascierto, Paolo A.; Atkinson, Victoria; Postow, Michael A.; Atkins, Michael B.; Sznol, Mario; Callahan, Margaret K.; Topalian, Suzanne L.; Sosman, Jeffrey A.; Kotapati, Srividya; Thakkar, Pratik K.; Ritchings, Corey; Pe Benito, Melanie; Re, Sandra; Soleymani, Samira; Hodi, F. Stephen
    Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 43 2024, Nr. 8, S. 938 – 948
    DOI (Open Access)
  • Kennedy, Oliver John; Glassee, Nina; Kicinski, Michal; Blank, Christian U.; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Giacomo, Anna Maria Di; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C.J.; Gandini, Sara; Buhrer, Emanuel; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M.M.; Mandala, Mario; Lorigan, Paul; Valpione, Sara
    Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer (EJC) , Jg. 201 2024, 113585
    DOI
  • Schadendorf, Dirk; Lord-Bessen, Jennifer; Ejzykowicz, Flavia; Shi, Ling; Yu, Peiwen; Srinivasan, Swetha
    Prognostic value of patient-reported outcomes in advanced or metastatic melanoma patients treated with immunotherapy : Findings from the CheckMate-067 study
    In: European Journal of Cancer (EJC) , Jg. 213 2024, 115099
    DOI (Open Access)
  • Heinlein, Lukas; Maron, Roman C.; Hekler, Achim; Haggenmüller, Sarah; Wies, Christoph; Utikal, Jochen S.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Drexler, Konstantin; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Krieghoff-Henning, Eva; Brinker, Titus J.
    Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care
    In: Communications Medicine , Jg. 4 2024, Nr. 1, 177
    DOI (Open Access)
  • Hartmann, Eva Maria; Küper, Alisa; Swoboda, Jessica; Lodde, Georg; Livingstone, Elisabeth; Beckmann, Catharina Lena; Schadendorf, Dirk; Sachweh, Sabine
    Requirements for a dashboard optimized for melanoma patient care through user-centered context exploration
    In: Scientific Reports , Jg. 14 2024, Nr. 1, 17471
    DOI (Open Access)
  • Phan, Julia; Chen, Brandon; Zhao, Zhiyu; Allies, Gabriele; Iannaccone, Antonella; Paul, Animesh; Cansiz, Feyza; Spina, Alberto; Leven, Anna-Sophia; Gellhaus, Alexandra; Schadendorf, Dirk; Kimmig, Rainer; Mettlen, Marcel; Tasdogan, Alpaslan; Morrison, Sean J.
    Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis
    In: Science , Jg. 386 2024, Nr. 6722, eado6836
    DOI
  • Baranda, Joaquina C.; Robbrecht, Debbie; Sullivan, Ryan; Doger, Bernard; Santoro, Armando; Barve, Minal; Grob, Jean-Jacques; Bechter, Oliver; Vieito, Maria; de Miguel, Maria Jose; Schadendorf, Dirk; Johnson, Melissa; Pouzin, Clemence; Cantalloube, Cathy; Wang, Rui; Lee, Jooyun; Chen, Xiaofei; Demers, Brigitte; Amrate, Amele; Abbadessa, Giovanni; Hodi, F. Stephen
    Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors : Findings from a phase 1/1b study
    In: Clinical and Translational Science (CTS) , Jg. 17 2024, Nr. 6, e13854
    DOI (Open Access)
  • Kött, Julian; Zimmermann, Noah; Zell, Tim; Rünger, Alessandra; Heidrich, Isabel; Geidel, Glenn; Smit, Daniel J.; Hansen, Inga; Abeck, Finn; Schadendorf, Dirk; Eggermont, Alexander; Puig, Susana; Hauschild, Axel; Gebhardt, Christoffer
    Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy
    In: European Journal of Cancer (EJC) , Jg. 202 2024, 113989
    DOI (Open Access)
  • Eggermont, Alexander MM; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus JM; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C.J.; Lorigan, Paul; Grebennik, Dmitri; Kreplere, Clemens; Marreaud, Sandrine; Suciu, Stefan; Robert, Caroline
    Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
    In: European Journal of Cancer (EJC) , Jg. 211 2024, 114327
    DOI
  • Jansen, Philipp; Galetzka, Wolfgang; Lodde, Georg; Standl, Fabian; Zaremba-Montenari, Anne; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Placke, Jan-Malte; Landsberg, Jennifer; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
    In: European Journal of Cancer (EJC) , Jg. 208 2024, 114208
    DOI (Open Access)
  • Garbe, Claus; Forsea, Ana-Maria; Amaral, Teresa; Arenberger, Petr; Autier, Philippe; Berwick, Marianne; Boonen, Brigitta; Bylaite, Matilda; del Marmol, Veronique; Dreno, Brigitte; Fargnoli, Maria Concetta; Geller, Alan C.; Green, Adele C.; Greinert, Rüdiger; Hauschild, Axel; Harwood, Catherine A.; Hoorens, Isabelle; Kandolf, Lidija; Kaufmann, Roland; Kelleners-Smeets, Nicole; Lallas, Aimilios; Lebbé, Celeste; Leiter, Ulrike; Lim, Henry W.; Longo, Caterina; Malvehy, Joseph; Moreno, David; Pellacani, Giovanni; Peris, Ketty; Robert, Caroline; Saiag, Philippe; Schadendorf, Dirk; Peter Soyer, H.; Stockfleth, Eggert; Stratigos, Alex; Uhara, Hisashi; Vieira, Ricardo; Volkmer, Beate; Weinstock, Martin A.; Whitaker, Dagmar; Zalaudek, Iris; Whiteman, David C.; Brochez, Lieve
    Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them
    In: European Journal of Cancer (EJC) , Jg. 204 2024, 114074
    DOI (Open Access)
  • Messmer, Julia M.; Thommek, Calvin; Piechutta, Manuel; Venkataramani, Varun; Wehner, Rebekka; Westphal, Dana; Schubert, Marc; Mayer, Chanté D.; Effern, Maike; Berghoff, Anna S.; Hinze, Daniel; Helfrich, Iris; Schadendorf, Dirk; Wick, Wolfgang; Hölzel, Michael; Karreman, Matthia A.; Winkler, Frank
    T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels
    In: Immunity , Jg. 57 2024, Nr. 11, S. 2688 – 2703.e11
    DOI (Open Access)
  • Mavarani, Laven; Reinsch, Nico; Albayrak-Rena, Sarah; Potthoff, Anja; Hower, Martin; Dolff, Sebastian; Schadendorf, Dirk; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    The Association of HIV-Specific Risk Factors with Cardiovascular Events in Addition to Traditional Risk Factors in People Living with HIV
    In: AIDS Research and Human Retroviruses , Jg. 40 2024, Nr. 4, S. 235 – 245
    DOI
  • Swoboda, Jessica; Albert, Moritz; Beckmann, Catharina Lena; Lodde, Georg; Livingstone, Elisabeth; Nensa, Felix; Schadendorf, Dirk; Böckmann, Britta
    The Mappability of Clinical Real-World Data of Patients with Melanoma to Oncological Fast Healthcare Interoperability Resources (FHIR) Profiles : A Single-Center Interoperability Study
    In: Informatics , Jg. 11 2024, Nr. 3, 42
    DOI, Online Volltext (Open Access)
  • Schaper-Gerhardt, Katrin; Gutzmer, Ralf; Angela, Yenny; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Hassel, Jessica C.; Weishaupt, Carsten; Remes, Bernhard; Kubat, Linda; Spassova, Ivelina; Becker, Jürgen
    The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
    In: European Journal of Cancer (EJC) , Jg. 202 2024, 113984
    DOI (Open Access)
  • Ertl, Carolin; Ruf, Theresa; Mentzer, Dirk; Kong, Mingzi; Kramer, Rafaela; Bergwelt-Baildon, Michael von; Subklewe, Marion; Tomsitz, Dirk; Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen; Lebbé, Celeste; Long, Georgina V.; McArthur, Grant; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Zimmer, Lisa; Eigentler, Thomas; Grabbe, Stephan; Forschner, Andrea; Kähler, Katharina C.; Milani, Valeria; Pföhler, Claudia; Hassel, Jessica; Gutzmer, Ralf; Loquai, Carmen; Routy, Bertrand; Furness, Andrew J.S.; Blank, Christian; Wolchok, Jedd D.; French, Lars E.; Hauschild, Axel; Heinzerling, Lucie
    The side effect registry immuno-oncology (SERIO) : A tool for systematic analysis of immunotherapy-induced side effects
    In: European Journal of Cancer (EJC) , Jg. 199 2024, 113505
    DOI
  • Krefting, Frederik; Livingstone, Elisabeth; Sondermann, Wiebke; Thielmann, Carl M.; Placke, Jan-Malte; Schadendorf, Dirk; Polan, Christina; Rath, Peter-Michael; Scharmann, Ulrike; Uhrlaß, Silke; Nenoff, Pietro
    Tinea capitis due to Trichophyton soudanense and Microsporum audouinii : A surprising finding
    In: JEADV Clinical Practice , Jg. 3 2024, Nr. 3, Skin Diversity, S. 887 – 890
    DOI, Online Volltext (Open Access)
  • Hekler, Achim; Maron, Roman C.; Haggenmüller, Sarah; Schmitt, Max; Wies, Christoph; Utikal, Jochen S.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Drexler, Konstantin; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Krieghoff-Henning, Eva; Brinker, Titus J.
    Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning
    In: Journal of the American Academy of Dermatology: JAAD , Jg. 90 2024, Nr. 5, S. 1028 – 1031
    DOI (Open Access)
  • Karreman, Matthia A.; Bauer, Alexander T.; Solecki, Gergely; Berghoff, Anna S.; Mayer, Chanté D; Frey, Katharina; Hebach, Nils; Feinauer, Manuel J.; Schieber, Nicole L.; Tehranian, Cedric; Mercier, Luc; Singhal, Mahak; Venkataramani, Varun; Schubert, Marc C.; Hinze, Daniel; Hölzel, Michael; Helfrich, Iris; Schadendorf, Dirk; Schneider, Stefan W.; Westphal, Dana; Augustin, Hellmut G.; Goetz, Jacky G.; Schwab, Yannick; Wick, Wolfgang; Winkler, Frank
    Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization
    In: Cancer Research , Jg. 83 2023, Nr. 8, S. 1299 – 1314
    DOI (Open Access)
  • Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stéphane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, Matteo S.; Di Giacomo, Anna Maria; Butler, Marcus O.; Muñoz-Couselo, Eva; Brown, Michael P.; Rutkowski, Piotr; Haydon, Andrew; Grob, Jean-Jacques; Schachter, Jacob; Queirolo, Paola; De La Cruz-Merino, Luis; Van Der Westhuizen, Andre; Menzies, Alexander M.; Re, Sandra; Bas, Tuba; De Pril, Veerle; Braverman, Julia; Tenney, Daniel J.; Tang, Hao; Long, Georgina V.
    Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 3, S. 517 – 527
    DOI (Open Access)
  • Becker, Jürgen; Ugurel, Selma; Leiter, Ulrike; Meier, Friedegund; Gutzmer, Ralf; Haferkamp, Sebastian; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, Thomas K; Hauschild, Axel; Kiecker, Felix; Hassel, Jessica C; Mohr, Peter; Fluck, Michael; Thomas, Ioannis; Garzarolli, Marlene; Grimmelmann, Imke; Drexler, Konstantin; Spillner, Alexandra N; Eckhardt, Sebastian; Schadendorf, Dirk; van Akkoi, Alexander; van Houdt, Winan; Wilhelm, Tabea; Farmer, Kimberly; Ulrich, Claas; Gambichler, Thilo; Bluhm, Leonie; Schinagl, Heidemarie; Kellner, Ivonne; Herbst, Rudolf; Meiß, Frank; Rafei-Shamsabadi, David; Sell, Sabine; Kaatz, Martin; Wulfken, Lena; Hartmann, Martin; Kähler, Katharina; Ziemer, Mirjana; Simon, Jan; Terheyden, Patrick; Thaci, Diamant; Loquai, Carmen; Mitzel-Rink, Heidrun; Grabbe, Stephan; Stege, Henner; Gaiser, Maria; Utikal, Jochen; Berking, Carola; Heinzerling, Lucie; Schlaak, Max; Tomsitz, Dirk; Dyballa, Jörg; Magnolo, Nina; Weishaupt, Carsten; Berneburg, Mark; Garbe, Claus; Flatz, Lukas; Gesierich, Anja; Schilling, Bastian
    Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trial
    In: Lancet , Jg. 402 2023, Nr. 10404, S. 798 – 808
    DOI
  • Lodde, Georg; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Hauschild, Axel; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Beckmann, Catharina L.; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth
    Adjuvant treatment and outcome of stage III melanoma patients : Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
    In: European Journal of Cancer (EJC) , Jg. 191 2023, 112957
    DOI
  • Nascentes Melo, Luiza Martins; Kumar, Suresh; Riess, Valeria; Szylo, Krystina J.; Eisenburger, Robin; Schadendorf, Dirk; Ubellacker, Jessalyn M.; Tasdogan, Alpaslan
    Advancements in melanoma cancer metastasis models
    In: Pigment Cell and Melanoma Research , Jg. 36 2023, Nr. 2, S. 206 – 223
    DOI (Open Access)
  • van Akkooi, Alexander C.J.; Schadendorf, Dirk; Eggermont, Alexander M.M.
    Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma
    In: European Journal of Cancer (EJC) , Jg. 182 2023, S. 163 – 169
    DOI
  • Weischenfeldt, Joachim; Beroukhim, Rameen; Campbell, Peter J.; Küppers, Ralf; Schadendorf, Dirk
    Author Correction : Patterns of somatic structural variation in human cancer genomes
    In: Nature , Jg. 614 2023, Nr. 7948, S. E38
    DOI (Open Access)
  • Gerstung, Moritz; Jolly, Clemency; Leshchiner, Ignaty; Küppers, Ralf; Schadendorf, Dirk
    Author Correction : The evolutionary history of 2,658 cancers
    In: Nature , Jg. 614 2023, E42
    DOI (Open Access)
  • Yakneen, Sergei; M. Waszak, Sebastian; Korbel, Jan O.; Küppers, Ralf; Schadendorf, Dirk
    Author Correction : Butler enables rapid cloud-based analysis of thousands of human genomes
    In: Nature Biotechnology , Jg. 41 2023, Nr. 4, S. 577
    DOI (Open Access)
  • Calabrese, Claudia; Brazma, Alvis; Brooks, Angela N.; Rätsch, Gunnar; Küppers, Ralf; Schadendorf, Dirk
    Author Correction : Genomic basis for RNA alterations in cancer
    In: Nature , Jg. 614 2023, Nr. 7948, S. E37
    DOI (Open Access)
  • Alexandrov, Ludmil B.; Kim, Jaegil; Haradhvala, Nicholas J.; Rozen, Steven G.; Stratton, Michael R.; Küppers, Ralf; Schadendorf, Dirk
    Author Correction: : The repertoire of mutational signatures in human cancer
    In: Nature , Jg. 614 2023, S. E41
    DOI (Open Access)
  • Cortés-Ciriano, Isidro; Küppers, Ralf; Schadendorf, Dirk; Park, Peter J.
    Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
    In: Nature Genetics , Jg. 55 2023, Nr. 6, 1076
    DOI (Open Access)
  • Yuan, Yuan; Küppers, Ralf; Schadendorf, Dirk; Park, Keunchil; Campbell, Peter J.; Liang, Han
    Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
    In: Nature Genetics , Jg. 55 2023, Nr. 6, S. 1078
    DOI (Open Access)
  • Akdemir, Kadir C.; Küppers, Ralf; Schadendorf, Dirk; Futreal, P. Andrew
    Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
    In: Nature Genetics , Jg. 55 2023, Nr. 6, S. 1079
    DOI (Open Access)
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan M.; Klose, Jasmin M.; Fendler, Wolfgang P.; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer , Jg. 4 2023, Nr. 9, S. 1395
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Author Correction: Pan-cancer analysis of whole genomes
    In: Nature , Jg. 614 2023, Nr. 7948, S. E39
    DOI (Open Access)
  • Rodriguez-Martin, Bernardo; Schadendorf, Dirk; Küppers, Ralf; Campbell, Peter J.
    Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
    In: Nature Genetics , Jg. 55 2023, Nr. 6, 1080
    DOI (Open Access)
  • Zapatka, Marc; Schadendorf, Dirk; Lichter, Peter
    Author Correction: The landscape of viral associations in human cancers
    In: Nature Genetics , Jg. 55 2023, Nr. 6, S. 1077
    DOI (Open Access)
  • Fan, Kaiji; Srinivas, Nalini; Kubat, Linda; Gravemeyer, Jan; Sucker, Antje; Schadendorf, Dirk; Gambichler, Thilo; Becker, Jürgen
    B-cell lymphoma extra-large (Bcl-xL) is a promising drug target in Merkel cell carcinoma
    In: British Journal of Dermatology: BJD 2023
    DOI
  • Lee, Joanna; Ahmed, Tasnia; Maurichi, Andrea; Di Guardo, Lorenzo; Stagno, Anna M.; Warburton, Lydia; Taylor, Amelia. M.; Livingstone, Elisabeth; Rehman, Saba; Khattak, Adnan; Kahler, Katharina C.; Vanella, Vito; Atkinson, Victoria; Millward, Michael; Schadendorf, Dirk; Johnson, Douglas B.; Ascierto, Paolo A.; Hauschild, Axel; Lo, Serigne N.; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Di Guardo, Lorenza
    BRAF inhibitor cessation prior to disease progression in metastatic melanoma : Long-term outcomes
    In: European Journal of Cancer (EJC) , Jg. 179 2023, S. 87 – 97
    DOI
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, Fabian; Meiss, Frank; Ulrich, Jens; Kreuter, Alexander; Gebhardt, Christoffer; Welzel, Julia; Schilling, Bastian; Kaatz, Martin; Scharfetter-Kochanek, Karin; Dippel, Edgar; Nashan, Dorothee; Sachse, Michael; Weishaupt, Carsten; Löffler, Harald; Gambichler, Thilo; Loquai, Carmen; Heinzerling, Lucie; Grabbe, Stephan; Debus, Dirk; Schley, Gaston; Hassel, Jessica C.; Weyandt, Gerhard; Trommer, Maike; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen Christian; Horn, Susanne; Schadendorf, Dirk; Ugurel, Selma
    Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 11 2023, Nr. 4
    DOI (Open Access)
  • Dummer, Reinhard; Flaherty, Keith T; Robert, Caroline; Arance, Ana; B de Groot, Jan Willem; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandalà, Mario; Schadendorf, Dirk; Yamazaki, Naoya; Pietro, Alessandra di; Cantey-Kiser, Jean; Edwards, Michelle; Ascierto, Paolo A
    COLUMBUS 5-year update : a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF
    In: Future Oncology , Jg. 19 2023, Nr. 16, S. 1091 – 1098
    DOI (Open Access)
  • Berking, Carola; Livingstone, Elisabeth; Debus, Dirk; Loquai, Carmen; Weichenthal, Michael; Leiter, Ulrike; Kiecker, Felix; Mohr, Peter; Eigentler, Thomas K.; Remy, Janina; Schober, Katharina; Heppt, Markus V.; von Wasielewski, Imke; Schadendorf, Dirk; Gutzmer, Ralf
    COMBI-r : A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma
    In: Cancers , Jg. 15 2023, Nr. 18, 4436
    DOI (Open Access)
  • Lodde, Georg; Krefting, Frederik; Placke, Jan-Malte; Schneider, Lea; Fiedler, Melanie; Dittmer, Ulf; Becker, Jürgen; Hölsken, Stefanie; Schadendorf, Dirk; Ugurel, Selma; Sondermann, Wiebke
    COVID-19 vaccination in psoriasis patients receiving systemic treatment : A prospective single-center study
    In: Frontiers in Immunology , Jg. 14 2023, S. 1107438
    DOI (Open Access)
  • Schmidt, Kira; Krawutschke, Marvin; Kowalski, Axel; Pasche, Saskia; Bialek, Anna; Schweig, Theresa; Weismüller, Benjamin; Tewes, Mitra; Schuler, Martin; Hamacher, Rainer; Müller, Bernhard W.; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin; Fink, Madeleine
    Cancer Patients’ Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy : A Clinical Waitlist Control Study
    In: Applied Psychophysiology Biofeedback , Jg. 48 2023, Nr. 2, S. 217 – 227
    DOI (Open Access)
  • Arndt, Volker; Doege, Daniela; Fröhling, Stefan; Albers, Peter; Algül, Hana; Bargou, Ralf; Bokemeyer, Carsten; Bornhäuser, Martin; Brandts, Christian H.; Brossart, Peter; Brucker, Sara Yvonne; Brümmendorf, Tim H.; Döhner, Hartmut; Gattermann, Norbert; Hallek, Michael; Heinemann, Volker; Keilholz, Ulrich; Kindler, Thomas; von Levetzow, Cornelia; Lordick, Florian; Neumann, Ulf Peter; Peters, Christoph; Schadendorf, Dirk; Stilgenbauer, Stephan; Zander, Thomas; Zips, Daniel; Braun, Delia; Seufferlein, Thomas; Nettekoven, Gerd; Baumann, Michael
    Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 2, S. 913 – 919
    DOI (Open Access)
  • Mavarani, Laven; Albayrak-Rena, Sarah; Potthoff, Anja; Hower, Martin; Dolff, Sebastian; Sammet, Stefanie; Maischack, Felix; Schadendorf, Dirk; Schmidt, Börge; Esser, Stefan; HIV HEART AGING Study
    Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population
    In: Infection - A Journal of Infectious Disease , Jg. 51 2023, Nr. 4, S. 1081 – 1091
    DOI (Open Access)
  • Lodde, Georg C.; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Sucker, Antje; Placke, Jan-Malte; Zaremba, Anne; Albrecht, Lea Jessica; Kowall, Bernd; Galetzka, Wolfgang; Becker, Jürgen C.; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma; Griewank, Klaus
    Characterisation and outcome of RAC1 mutated melanoma
    In: European Journal of Cancer (EJC) , Jg. 183 2023, S. 1 – 10
    DOI
  • Hench, Juergen; Mihic-Probst, Daniela; Agaimy, Abbas; Frank, Stephan; Meyer, Peter; Hultschig, Claus; Simi, Sara; Alos, Lucia; Balamurugan, Thiagarajah; Blokx, Willeke; Bosisio, Francesca; Cappellesso, Rocco; Griewank, Klaus; Hadaschik, Eva; van Kempen, Leon C.; Kempf, Werner; Lentini, Maria; Mazzucchelli, Luca; Rinaldi, Gaetana; Rutkowski, Piotr; Schadendorf, Dirk; Schilling, Bastian; Szumera-Cieckiewicz, Anna; van den Oord, Joost; Mandalà, Mario; Massi, Daniela
    Clinical, histopathological and molecular features of dedifferentiated melanomas : An EORTC Melanoma Group Retrospective Analysis
    In: European Journal of Cancer (EJC) , Jg. 187 2023, S. 7 – 14
    DOI (Open Access)
  • Leven, Anna-Sophia; Becker, Jürgen C.; Pöttgen, Christoph; Schadendorf, Dirk; Ugurel, Selma; Tasdogan, Alpaslan
    Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma : a case report
    In: International Journal of Dermatology , Jg. 63 2023, Nr. 2, S. e69 – e71
    DOI
  • Cortés-Ciriano, Isidro; Küppers, Ralf; Schadendorf, Dirk; Park, Peter J.
    Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
    In: Nature Genetics , Jg. 52 2023, S. 331 – 341
    DOI (Open Access)
  • Yuan, Yuan; Küppers, Ralf; Schadendorf, Dirk; Park, Keunchil; Campbell, Peter J.; Liang, Han
    Comprehensive molecular characterization of mitochondrial genomes in human cancers
    In: Nature Genetics , Jg. 52 2023, S. 342 – 352
    DOI (Open Access)
  • Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Robert, Caroline; Flaherty, Keith T.
    Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma : Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 29, S. 4621 – 4631
    DOI (Open Access)
  • Placke, Jan-Malte; Kimmig, Mona; Griewank, Klaus; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Welzel, Julia; Engel, Daniel Robert; Kreft, Sophia; Sucker, Antje; Lodde, Georg; Krefting, Frederik; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen; Weichenthal, Michael; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort study
    In: eBioMedicine , Jg. 96 2023, 104774
    DOI (Open Access)
  • Philip, Manuel; Puppel, Sven Holger; Stiller, Mathias; Paschen, Annette; Rösch, Alexander; Zaremba, Anne; Schadendorf, Dirk; Horn, Susanne
    Database for queries of melanoma cohorts with molecular and clinical data
    In: Pigment Cell and Melanoma Research , Jg. 36 2023, Nr. 2, S. 252 – 258
    DOI (Open Access)
  • Jansen, Philipp; Baguer, Daniel Otero; Duschner, Nicole; Arrastia, Jean Le'Clerc; Schmidt, Maximilian; Landsberg, Jennifer; Wenzel, Jörg; Schadendorf, Dirk; Hadaschik, Eva; Maass, Peter; Schaller, Jörg; Griewank, Klaus
    Deep learning detection of melanoma metastases in lymph nodes
    In: European Journal of Cancer (EJC) , Jg. 188 2023, S. 161 – 170
    DOI
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    Deep learning in computational dermatopathology of melanoma : A technical systematic literature review
    In: Computers in Biology and Medicine , Jg. 163 2023, 107083
    DOI (Open Access)
  • Akdemir, Kadir C.; Küppers, Ralf; Schadendorf, Dirk; Futreal, P. Andrew
    Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
    In: Nature Genetics , Jg. 52 2023, Nr. 3, S. 294 – 305
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.; Kandolf-Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.A.M.; Gesierich, A.H.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijuskovic, Z.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Grob, J.J.; Kiecker, F.; Utikal, J.; Windemuth-Kieselbach, C.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma : The ImmunoCobiVem phase 2 randomised trial
    In: European Journal of Cancer (EJC) , Jg. 190 2023, 112941
    DOI
  • Wong, Selina K.; Blum, Steven M.; Sun, Xiaopeng; Da Silva, Inês P.; Zubiri, Leyre; Ye, Fei; Bai, Kun; Zhang, Kevin; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Serra-Bellver, Patricio; Muñoz-Couselo, Eva; Ortiz, Carolina; Lostes, Julia; Huertas, Roberto M.; Arance, Ana; Pickering, Lisa; Long, Georgina V.; Carlino, Matteo S.; Buchbinder, Elizabeth I.; Vázquez-Cortés, Leticia; Jara-Casas, Diego; Márquez-Rodas, Iván; González-Espinoza, Iván R.; Balko, Justin M.; Menzies, Alexander M.; Sullivan, Ryan J.; Johnson, Douglas B.
    Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 181 2023, S. 188 – 197
    DOI
  • Rausch, Raya; Bäuerle, Alexander; Rentrop, Vanessa; Jansen, Christoph; Nensa, Felix; Palm, Stefan; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    Falling off the screening grid : Predictors for postponed utilization of psycho-oncological support in cancer patients and its implications for distress assessment and management
    In: Psycho-Oncology , Jg. 32 2023, Nr. 11, S. 1727 – 1735
    DOI (Open Access)
  • Martins Nascentes Melo, Luiza; Herrera-Rios, Dayana; Hinze, Daniel; Löffek, Stefanie; Oezel, Irem; Turiello, Roberta; Klein, Juliane; Leonardelli, Sonia; Westedt, Isa-Vanessa; Al-Matary, Yahya; Egea-Rodriguez, Sara; Brenzel, Alexandra; Bau, Maja; Sucker, Antje; Hadaschik, Eva; Wirsdörfer, Florian; Hanenberg, Helmut; Uhlenbrock, Niklas; Rauh, Daniel; Poźniak, Joanna; Rambow, Florian; Marine, Jean-Christophe; Effern, Maike; Glodde, Nicole; Schadendorf, Dirk; Jablonska, Jadwiga; Hölzel, Michael; Helfrich, Iris
    Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 11 2023, Nr. 4, e004150
    DOI (Open Access)
  • Stupia, Simone; Heeke, Christina; Brüggemann, Alicia; Zaremba-Montenari, Anne; Thier, Beatrice; Kretz, Julia; Sucker, Antje; Philip, Manuel; Zelinskyy, Gennadiy; Ferrone, Soldano; Rösch, Alexander; Horn, Susanne; Hadaschik, Eva; Schadendorf, Dirk; Trilling, Mirko; Dittmer, Ulf; Griewank, Klaus; Zhao, Fang; Paschen, Annette
    HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance
    In: Clinical Cancer Research , Jg. 29 2023, Nr. 15, S. 2894 – 2907
    DOI
  • Hoffmann, Julia; Steeb, Theresa; Weber, Christiane; Doppler, Astrid; Schmitt, Jochen; Schadendorf, Dirk; Berking, Carola; Meier, Friedegund
    Health literacy and information needs among German skin cancer patients in comparison to people without skin cancer : A survey
    In: JEADV Clinical Practice , Jg. 2 2023, Nr. 4, S. 830 – 838
    DOI (Open Access)
  • Schadendorf, Dirk; Tawbi, Hussein; Lipson, Evan J.; Stephen Hodi, F.; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Grob, Jean-Jacques; Moshyk, Andriy; Lord-Bessen, Jennifer; Hamilton, Melissa; Guo, Shien; Shi, Ling; Keidel, Sarah; Long, Georgina V.
    Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma : RELATIVITY-047 trial
    In: European Journal of Cancer (EJC) , Jg. 187 2023, S. 164 – 173
    DOI (Open Access)
  • Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pföhler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Löffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma : a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) , Jg. 188 2023, S. 140 – 151
    DOI, Online Volltext (Open Access)
  • Nuñez, Nicolas Gonzalo; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; Martinez Gomez, Julia; Purde, Mette-Triin; Niederer, Rebekka; Porsch, Maximilian; Lichtensteiger, Christa; Kramer, Rafaela; Erdmann, Michael; Schmitt, Christina; Heinzerling, Lucie; Abdou, Marie-Therese; Karbach, Julia; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma; Klümper, Niklas; Hölzel, Michael; Power, Laura; Kreutmair, Stefanie; Capone, Mariaelena; Madonna, Gabriele; Cevhertas, Lacin; Heider, Anja; Amaral, Teresa; Hasan Ali, Omar; Bomze, David; Dimitriou, Florentia; Diem, Stefan; Ascierto, Paolo Antonio; Dummer, Reinhard; Jäger, Elke; Driessen, Christoph; Levesque, Mitchell Paul; van de Veen, Willem; Joerger, Markus; Früh, Martin; Becher, Burkhard; Flatz, Lukas
    Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    In: Med , Jg. 4 2023, Nr. 2, S. 113 – 129.e7
    DOI (Open Access)
  • de Braud, Filippo; Dooms, Christophe; Heist, Rebecca S.; Lebbe, Celeste; Wermke, Martin; Gazzah, Anas; Schadendorf, Dirk; Rutkowski, Piotr; Wolf, Jürgen; Ascierto, Paolo A.; Gil-Bazo, Ignacio; Kato, Shumei; Wolodarski, Maria; McKean, Meredith; Muñoz Couselo, Eva; Sebastian, Martin; Santoro, Armando; Cooke, Vesselina; Manganelli, Luca; Wan, Kitty; Gaur, Anil; Kim, Jaeyeon; Caponigro, Giordano; Couillebault, Xuân-Mai; Evans, Helen; Campbell, Catarina D.; Basu, Sumit; Moschetta, Michele; Daud, Adil
    Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma : Results From the Expansion Arm of a Phase Ib, Open-Label Study
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 14, S. 2651 – 2660
    DOI
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan-Malte; Klose, Jasmin M.; Fendler, Wolfgang; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer , Jg. 4 2023, Nr. 9, S. 1292 – 1308
    DOI (Open Access)
  • Le Rhun, E.; Weller, M.; van den Bent, M.; Brandsma, D.; Furtner, J.; Rudà, R.; Schadendorf, Dirk; Seoane, J.; Tonn, J.-C.; Wesseling, P.; Wick, W.; Minniti, G.; Peters, S.; Curigliano, G.; Preusser, M.; ESMO Guidelines Committee
    Leptomeningeal metastasis from solid tumours : EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    In: ESMO Open , Jg. 8 2023, Nr. 5, 101624
    DOI (Open Access)
  • Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Eckstein, Markus; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schlaak, Max; Thoms, Kai-Martin; Ugurel, Selma; Utikal, Jochen; Weichenthal, Michael; Schuler-Thurner, Beatrice; Berking, Carola; Heppt, Markus V.
    Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoms : results from a retrospective multicenter trial
    In: Frontiers of Medicine , Jg. 17 2023, Nr. 5, S. 878 – 888
    DOI (Open Access)
  • Goodman, Rachel S.; Di Guardo, Lorenza; Maurichi, Andrea; Kirwin, Brendan; Khattak, Adnan; Vanella, Vito; Lee, Joanna; Lawless, Aleigha; Czapla, Juliane; Spagnoletti, Andrea; Ambrosini, Margherita; Livingstone, Elisabeth; Long, Georgina V.; Sullivan, Ryan J.; Carlino, Matteo S.; Atkinson, Victoria; Trojanello, Claudia; Ascierto, Paolo A.; Schadendorf, Dirk; Warburton, Lydia; Menzies, Alexander M.; Santinami, Mario; Johnson, Douglas B.
    Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 194 2023, 113354
    DOI
  • Lodde, Georg; Leven, Anna-Sophia; Schadendorf, Dirk; Gutzmer, Ralf
    Medikamentöse Therapie des inoperablen Melanoms
    In: Die Onkologie , Jg. 29 2023, Nr. 8, S. 680 – 686
    DOI (Open Access)
  • Schneider, Lucas; Wies, Christoph; Krieghoff-Henning, Eva I.; Bucher, Tabea-Clara; Utikal, Jochen S.; Schadendorf, Dirk; Brinker, Titus J.
    Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma
    In: European Journal of Cancer (EJC) , Jg. 183 2023, S. 131 – 138
    DOI (Open Access)
  • Placke, Jan-Malte; Mertens, Delphine; Tasdogan, Alpaslan; Chorti, Eleftheria; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Stoffels, Ingo; Klode, Joachim
    Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 37 2023, Nr. 5: Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, S. 907 – 913
    DOI (Open Access)
  • Gross, Neil D; Miller, David M; Khushalani, Nikhil I; Divi, Vasu; Ruiz, Emily S; Lipson, Evan J; Meier, Friedegund; Su, Yungpo Bernard; Swiecicki, Paul L; Atlas, Jennifer; Geiger, Jessica L; Hauschild, Axel; Choe, Jennifer H; Hughes, Brett G M; Schadendorf, Dirk; Patel, Vishal A; Homsi, Jade; Taube, Janis M; Lim, Annette M; Ferrarotto, Renata; Yoo, Suk-Young; Mathias, Melissa; Han, Hyunsil; Seebach, Frank; Lowy, Israel; Fury, Matthew G; Rischin, Danny
    Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma : follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
    In: The Lancet Oncology , Jg. 24 2023, Nr. 11, S. 1196 – 1205
    DOI
  • Garbe, Claus; Dummer, Reinhard; Amaral, Teresa; Amaria, Rodabe N.; Ascierto, Paolo A.; Burton, Elizabeth M.; Dreno, Brigitte; Eggermont, Alexander M. M.; Hauschild, Axel; Hoeller, Christoph; Kaufmann, Roland; Lebbe, Celeste; Mandala, Mario; Menzies, Alexander M.; Moreno, David; Michielin, Olivier; Nathan, Paul; Patel, Sapna P.; Robert, Caroline; Schadendorf, Dirk; Lorigan, Paul C.; Scolyer, Richard A.; Tawbi, Hussein A.; van de Wiel, Bart A.; Blank, Christian; Long, Georgina V.
    Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
    In: Nature Medicine , Jg. 29 2023, Nr. 6, S. 1310 – 1312
    DOI
  • Fink, Madeleine; Pasche, Saskia; Schmidt, Kira; Tewes, Mitra; Schuler, Martin; Mülley, Bernhard W.; Schadendorf, Dirk; Scherbaum, Norbert; Kowalski, Axel; Skoda, Eva-Maria; Teufel, Martin
    Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients : Results of an Explorative Randomized Controlled Trial
    In: Integrative Cancer Therapies , Jg. 22 2023
    DOI, Online Volltext (Open Access)
  • Ascierto, Paolo Antonio; Lipson, Evan J.; Dummer, Reinhard; Larkin, James; Long, Georgina V.; Sanborn, Rachel E.; Chiarion-Sileni, Vanna; Dréno, Brigitte; Dalle, Stéphane; Schadendorf, Dirk; Callahan, Margaret K.; Nyakas, Marta; Atkinson, Victoria; Gomez-Roca, Carlos Alberto; Yamazaki, Naoya; Tawbi, Hussein A.; Sarkis, Naomey; Warad, Deepti; Dolfi, Sonia; Mitra, Priyam; Suryawanshi, Satyendra; Grob, Jean-Jacques
    Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy : Results From the Phase I/IIa RELATIVITY-020 Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 15, S. 2724 – 2735
    DOI (Open Access)
  • Steeb, Theresa; Brütting, Julia; Reinhardt, Lydia; Hoffmann, Julia; Weiler, Nina; Heppt, Markus V.; Erdmann, Michael; Doppler, Astrid; Weber, Christiane; Schadendorf, Dirk; Meier, Friedegund; Berking, Carola
    One Website to Gather them All : Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website - A Mixed-methods Approach
    In: Journal of Cancer Education , Jg. 38 2023, Nr. 4, S. 1264 – 1270
    DOI (Open Access)
  • Rodriguez-Martin, Bernardo; Schadendorf, Dirk; Küppers, Ralf; Campbell, Peter J.
    Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
    In: Nature Genetics , Jg. 52 2023, Nr. 3, S. 306 – 319
    DOI (Open Access)
  • Hassel, Jessica C.; Berking, Carola; Forschner, Andrea; Gebhardt, Christoffer; Heinzerling, Lucie; Meier, Friedegund; Ochsenreither, Sebastian; Siveke, Jens; Hauschild, Axel; Schadendorf, Dirk
    Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
    In: European Journal of Cancer (EJC) , Jg. 191 2023, 112986
    DOI (Open Access)
  • Kennedy, Oliver John; Kicinski, Michal; Valpione, Sara; Gandini, Sara; Suciu, Stefan; Blank, Christian U.; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C.J.; Robert, Caroline; Eggermont, Alexander M.M.; Lorigan, Paul; Mandala, Mario
    Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer (EJC) , Jg. 189 2023, 112900
    DOI (Open Access)
  • Placke, Jan-Malte; Zahn, Maximilian; Zillikens, Hannah; Krefting, Frederik; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Sucker, Antje; Roesch, Alexander; Tasdogan, Alpaslan; Srinivas, Nalini K.; Schadendorf, Dirk; Becker, Jürgen C.; Ugurel, Selma
    Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centre
    In: JEADV Clinical Practice , Jg. 2 2023, Nr. 4, S. 810 – 818
    DOI, Online Volltext (Open Access)
  • Cammann, Clemens; Kulla, Jonas; Wiebusch, Lüder; Walz, Christian; Zhao, Fang; Lowinus, Theresa; Topfstedt, Eylin; Mishra, Neha; Henklein, Petra; Bommhardt, Ursula; Bossaller, Lukas; Hagemeier, Christian; Schadendorf, Dirk; Schmidt, Boris; Paschen, Annette; Seifert, Ulrike
    Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells
    In: Biomedicine & Pharmacotherapy , Jg. 168 2023, 115635
    DOI (Open Access)
  • Kehrmann, Jan; Koch, Fiona; Zumdick, Skrollan; Höwner, Anna; Best, Lara; Masshöfer, Lars; Scharfenberg, Sarah; Zeschnigk, Michael; Becker, Jürgen C.; Schadendorf, Dirk; Buer, Jan; Rösch, Alexander
    Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies
    In: Microbiology Spectrum , Jg. 11 2023, Nr. 3, e04401-22
    DOI (Open Access)
  • Hoefsmit, Esmee P.; Völlmy, Franziska; Rozeman, Elisa A.; Reijers, Irene L.M.; Versluis, Judith M.; Hoekman, Liesbeth; van Akkooi, Alexander C.J.; Long, Georgina V.; Schadendorf, Dirk; Dummer, Reinhard; Altelaar, Maarten; Blank, Christian U.
    Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
    In: Cancer Research Communications , Jg. 3 2023, Nr. 4, S. 672 – 683
    DOI (Open Access)
  • Kuhn, Christina Katharina; Meister, Jaroslawna; Kreft, Sophia; Stiller, Mathias; Puppel, Sven-Holger; Zaremba, Anne; Scheffler, Björn; Ullrich, Vivien; Schöneberg, Torsten; Schadendorf, Dirk; Horn, Susanne
    TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities
    In: PLoS ONE , Jg. 18 2023, Nr. 7, e0281487
    DOI (Open Access)
  • Sondermann, Wiebke; Wies, Christoph; Esser, Stefan; Utikal, Jochen S.; Schadendorf, Dirk; Brinker, Titus J.
    The "Intimarzt" (intimate doctor) Model Project : Anonymous Remote Diagnosis of Sexually Transmitted Diseases
    In: Deutsches Ärzteblatt international , Jg. 120 2023, Nr. 6, S. 94 – 95
    DOI (Open Access)
  • Ho, Patricia; Melms, Johannes C.; Rogava, Meri; Frangieh, Chris J.; Poźniak, Joanna; Shah, Shivem B.; Walsh, Zachary; Kyrysyuk, Oleksandr; Amin, Amit Dipak; Caprio, Lindsay; Fullerton, Benjamin T.; Soni, Rajesh Kumar; Ager, Casey R.; Biermann, Jana; Wang, Yiping; Khosravi-Maharlooei, Mohsen; Zanetti, Giorgia; Mu, Michael; Fatima, Hijab; Moore, Emily K.; Vasan, Neil; Bakhoum, Samuel F.; Reiner, Steven L.; Bernatchez, Chantale; Sykes, Megan; Mace, Emily M.; Wucherpfennig, Kai W.; Schadendorf, Dirk; Bechter, Oliver; Shah, Parin; Schwartz, Gary K.; Marine, Jean-Christophe; Izar, Benjamin
    The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
    In: Cancer Cell , Jg. 41 2023, Nr. 7, S. 1207 – 1221.e12
    DOI (Open Access)
  • Illert, A.L.; Stenzinger, A.; Bitzer, M.; Horak, P.; Gaidzik, V.I.; Möller, Y.; Beha, J.; Öner, Ö.; Schmitt, F.; Laßmann, S.; Ossowski, S.; Schaaf, C.P.; Hallek, M.; Brümmendorf, T.H.; Albers, P.; Fehm, T.; Brossart, P.; Glimm, H.; Schadendorf, Dirk; Bleckmann, A.; Brandts, C.H.; Esposito, I.; Mack, E.; Peters, C.; Bokemeyer, C.; Fröhling, S.; Kindler, T.; Algül, H.; Heinemann, V.; Döhner, H.; Bargou, R.; Ellenrieder, V.; Hillemanns, P.; Lordick, F.; Hochhaus, A.; Beckmann, M.W.; Pukrop, T.; Trepel, M.; Sundmacher, L.; Wesselmann, S.; Nettekoven, G.; Kohlhuber, F.; Heinze, O.; Budczies, J.; Werner, M.; Nikolaou, K.; Beer, A.J.; Tabatabai, G.; Weichert, W.; Keilholz, U.; Boerries, M.; Kohlbacher, O.; Duyster, J.; Thimme, R.; Seufferlein, T.; Schirmacher, P.; Malek, N.P.
    The German Network for Personalized Medicine to enhance patient care and translational research
    In: Nature Medicine , Jg. 29 2023, Nr. 6, S. 1298 – 1301
    DOI
  • Albrecht, Lea Jessica; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk
    The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
    In: Current Oncology Reports , Jg. 25 2023, Nr. 6 , :647-657
    DOI (Open Access)
  • Zapatka, Marc; Küppers, Ralf; Schadendorf, Dirk; Lichter, Peter
    The landscape of viral associations in human cancers
    In: Nature Genetics 2023, Nr. 52, S. 320 – 330
    DOI (Open Access)
  • Alexandrov, Ludmil B.; Kim, Jaegil; Haradhvala, Nicholas J.; Rozen, Steven G.; Stratton, Michael R.; Küppers, Ralf; Schadendorf, Dirk
    The repertoire of mutational signatures in human cancer
    In: Nature , Jg. 578 2023, Nr. 7793, S. 94 – 101
    DOI (Open Access)
  • Mallardo, Domenico; Woodford, Rachel; Menzies, Alexander M.; Zimmer, Lisa; williamson, Andrew; Ramelyte, Egle; Dimitriou, Florentia; Wicky, Alexandre; Wallace, Roslyn; Mallardo, Mario; Cortellini, Alessio; Budillon, Alfredo; Atkinson, Victoria; Sandhu, Shahneen; Olivier, Michielin; Dummer, Reinhard; Lorigan, Paul; Schadendorf, Dirk; Long, Georgina V.; Simeone, Ester; Ascierto, Paolo A.
    The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
    In: Journal of Translational Medicine , Jg. 21 2023, Nr. 1, 753
    DOI (Open Access)
  • Haist, Maximilian; Stege, Henner; Rogall, Friederike; Tan, Yuqi; von Wasielewski, Imke; Klespe, Kai Christian; Meier, Friedegund; Mohr, Peter; Kähler, Katharina C.; Weichenthal, Michael; Hauschild, Axel; Schadendorf, Dirk; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Gutzmer, Ralf; Debus, Dirk; Schilling, Bastian; Kreuter, Alexander; Ulrich, Jens; Meiss, Frank; Herbst, Rudolf; Forschner, Andrea; Leiter, Ulrike; Pfoehler, Claudia; Kaatz, Martin; Ziller, Fabian; Hassel, Jessica C.; Tronnier, Michael; Sachse, Michael; Dippel, Edgar; Terheyden, Patrick; Berking, Carola; Heppt, Markus V.; Kiecker, Felix; Haferkamp, Sebastian; Gebhardt, Christoffer; Simon, Jan Christoph; Grabbe, Stephan; Loquai, Carmen
    Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy : A multicenter study from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 11 2023, Nr. 9, e007630
    DOI (Open Access)
  • Bayerl, Felix; Meiser, Philippa; Donakonda, Sainitin; Hirschberger, Anna; Lacher, Sebastian B.; Pedde, Anna-Marie; Hermann, Chris D.; Elewaut, Anais; Knolle, Moritz; Ramsauer, Lukas; Rudolph, Thomas J.; Grassmann, Simon; Öllinger, Rupert; Kirchhammer, Nicole; Trefny, Marcel; Anton, Martina; Wohlleber, Dirk; Höchst, Bastian; Zaremba-Montenari, Anne; Krüger, Achim; Rad, Roland; Obenauf, Anna C.; Schadendorf, Dirk; Zippelius, Alfred; Buchholz, Veit R.; Schraml, Barbara U.; Böttcher, Jan P.
    Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
    In: Immunity , Jg. 56 2023, Nr. 6, S. 1341 – 1358.e11
    DOI (Open Access)
  • Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas K.; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Rösch, Alexander; Ziemer, Mirjana; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Simon, Jan-Christoph; Herbst, Rudolf A.; Berking, Carola; Utikal, Jochen; Sell, Sabine; Martens, Uwe M.; Terheyden, Patrick; Stadler, Rudolf
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trial
    In: Lancet , Jg. 400 2022, Nr. 10358, S. 1117 – 1129
    DOI
  • Khattak, Muhammad A.; Luke, Jason J.; Long, Georgina V.; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Robert, Caroline; Grob, Jean-Jacques; de la Cruz Merino, Luis; Del Vecchio, Michele; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Carlino, Matteo S.; Mohr, Peter; De Galitiis, Federica; Ross, Merrick I.; Eroglu, Zeynep; Chen, Ke; Jiang, Ruixuan; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M.M.; Kirkwood, John M.
    Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma : Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
    In: European Journal of Cancer (EJC) 2022 , in press
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Bristow, Robert G.; Boutros, Paul C.; PCAWG Consortium
    Author Correction : Divergent mutational processes distinguish hypoxic and normoxic tumours
    In: Nature Communications , Jg. 13 2022, 7569
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Author Correction : Integrative pathway enrichment analysis of multivariate omics data
    In: Nature Communications , Jg. 13 2022, 7570
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Feuerbach, Lars; PCAWG Consortium
    Author Correction : Genomic footprints of activated telomere maintenance mechanisms in cancer
    In: Nature Communications , Jg. 13 2022, 7574
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Creighton, Chad J.; PCAWG Consortium
    Author Correction : High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    In: Nature Communications , Jg. 13 2022, 7572
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Macintyre, Geoff; PCAWG Consortium
    Author Correction : Inferring structural variant cancer cell fraction
    In: Nature Communications , Jg. 13 2022, 7568
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Stein, Lincoln D.; PCAWG Consortium
    Author Correction : A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
    In: Nature Communications , Jg. 13 2022, 7573
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Morris, Quaid D.; PCAWG Consortium
    Author Correction : Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
    In: Nature Communications , Jg. 13 2022, 7567
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Shuai, Shimin; Stein, Lincoln D.; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Author Correction : Combined burden and functional impact tests for cancer driver discovery using DriverPower
    In: Nature Communications , Jg. 13 2022, 7571
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Consortium
    Author Correction : Pathway and network analysis of more than 2500 whole cancer genomes
    In: Nature Communications , Jg. 13 2022, 7566
    DOI (Open Access)
  • Wendlinger, Simone; Wohlfarth, Jonas; Kreft, Sophia; Siedel, Claudia; Kilian, Teresa; Dischinger, Ulrich; Heppt, Markus V.; Wistuba-Hamprecht, Kilian; Meier, Friedegund; Goebeler, Matthias; Schadendorf, Dirk; Gesierich, Anja; Kosnopfel, Corinna; Schilling, Bastian
    Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma
    In: Cancers , Jg. 14 2022, Nr. 9, 2294
    DOI (Open Access)
  • Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; De Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandalà, Mario; Schadendorf, Dirk; Yamazaki, Naoya; Di Pietro, Alessandra; Cantey-Kiser, Jean; Edwards, Michelle; Ascierto, Paolo A.
    COLUMBUS 5-Year Update : A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 36, S. 4178 – 4188
    DOI (Open Access)
  • Lodde, Georg; Fiedler, Melanie; Dittmer, Ulf; Placke, Jan-Malte; Jansen, Philipp; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Sondermann, Wiebke; Ugurel, Selma
    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment : A prospective singlecenter study investigating seroconversion rates
    In: Frontiers in Oncology , Jg. 12 2022, 879876
    DOI, Online Volltext (Open Access)
  • Menzies, Alexander M.; da Silva, Ines Pires; Trojaniello, Claudia; Vieu, Elisabeth; Amaria, Rodabe N.; Zimmer, Lisa; Lo, Serigne N.; Burton, Elizabeth M.; Tawbi, Hussein A.; Schadendorf, Dirk; Grob, Jean J.; Ascierto, Paolo A.; Long, Georgina V.; Pires da Silva, Ines
    CTLA-4 Blockade Resistance after Relatlimab and Nivolumab
    In: The New England Journal of Medicine , Jg. 386 2022, Nr. 17, S. 1668 – 1669
    DOI (Open Access)
  • Jansen, Philipp; Lodde, Georg; Wetter, Axel; Welt, Anja; Stuschke, Martin; Dührsen, U.; Stoffels, Ingo; Klode, Joachim; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitors
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 36 2022, Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 – 44
    DOI (Open Access)
  • Goldinger, Simone M.; Buder-Bakhaya, Kristina; Lo, Serigne N.; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I.; Ascierto, Paolo A.; Gutzmer, Ralf; Rozeman, Elisa A.; Hoeller, Christoph; Johnson, Douglas B.; Gesierich, Anja; Kölblinger, Peter; Bennannoune, Naima; Cohen, Justine V.; Kähler, Katharina C.; Wilson, Melissa A.; Cebon, Jonathan; Atkinson, Victoria; Smith, Jessica L.; Michielin, Olivier; Long, Georgina V.; Hassel, Jessica C.; Weide, Benjamin; Haydu, Lauren E.; Schadendorf, Dirk; McArthur, Grant; Ott, Patrick A.; Blank, Christian; Robert, Caroline; Sullivan, Ryan; Hauschild, Axel; Carlino, Matteo S.; Garbe, Claus; Davies, Michael A.; Menzies, Alexander M.
    Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma : a retrospective multicentre analysis
    In: European Journal of Cancer (EJC) , Jg. 162 2022, S. 22 – 33
    DOI
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens; Schadendorf, Dirk; Váraljai, Renáta; Rösch, Alexander
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine , Jg. 12 2022, Nr. 11, e1090
    DOI, Online Volltext (Open Access)
  • da Silva, Ines Pires; Ahmed, Tasnia; McQuade, Jennifer L.; Nebhan, Caroline A.; Park, John J.; Versluis, Judith M.; Serra-Bellver, Patricio; Khan, Yasir; Slattery, Tim; Oberoi, Honey K.; Ugurel, Selma; Haydu, Lauren E.; Herbst, Rudolf; Utikal, Jochen; Pfohler, Claudia; Terheyden, Patrick; Weichenthal, Michael; Gutzmer, Ralf; Mohr, Peter; Rai, Rajat; Smith, Jessica L.; Scolyer, Richard A.; Arance, Ana M.; Pickering, Lisa; Larkin, James; Lorigan, Paul; Blank, Christian U.; Schadendorf, Dirk; Davies, Michael A.; Carlino, Matteo S.; Johnson, Douglas B.; Long, Georgina V.; Lo, Serigne N.; Menzies, Alexander M.
    Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 10, S. 1068 – 1080
    DOI (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Björn Andtback, Hannah; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lucie; Gutzmer, Ralf; Utikal, Jochen S.; Horny, Kai; Schildhaus, Hans-Ulrich; Habermann, Daniel; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Jürgen
    Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 1, e003198
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Meier, Friedegund; Schlein, Christian; Jansen, Philipp; Lodde, Georg; Song, Mingxia; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus
    Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
    In: Pigment Cell and Melanoma Research , Jg. 35 2022, Nr. 6, S. 573 – 586
    DOI (Open Access)
  • Gambichler, Thilo; Rohrmoser, E.-M.; Horny, Kai; Sucker, Antje; Schadendorf, Dirk; Skrygan, Marina; Susok, Laura; Stücker, Markus; Becker, Jürgen
    Comparison of mutation profiles in primary melanomas and corresponding nodal naevi using next-generation sequencing
    In: Clinical and Experimental Dermatology (CED) , Jg. 47 2022, Nr. 2, S. 373 – 380
    DOI (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot J.; Sellier, Abir T.; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.
    Corrigendum to ‘Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)’
    In: European Journal of Cancer (EJC) , Jg. 160 2022, S. 287 – 288
    DOI
  • Westphalen, C. Benedikt; Bokemeyer, Carsten; Büttner, Reinhard; Fröhling, Stefan; Gaidzik, Verena I.; Glimm, Hanno; Hacker, Ulrich T.; Heinemann, Volker; Illert, Anna L.; Keilholz, Ulrich; Kindler, Thomas; Kirschner, Martin; Schilling, Bastian; Siveke, Jens; Schroeder, Thomas; Tischler, Verena; Wagner, Sebastian; Weichert, Wilko; Zips, Daniel; Loges, Sonja; Schadendorf, Dirk; Schildhaus, Hans-Ulrich; Working Group Molecular Diagnostics and Therapy
    Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group Molecular Diagnostics and Therapy”
    In: European Journal of Cancer (EJC) , Jg. 162 2022, S. 245 – 246
    DOI
  • Jansen, Philipp; Creosteanu, Adelaida; Matyas, Viktor; Dilling, Amrei; Pina, Ana; Saggini, Andrea; Schimming, Tobias; Landsberg, Jennifer; Burgdorf, Birte; Giaquinta, Sylvia; Müller, Hansgeorg; Emberger, Michael; Rose, Christian; Schmitz, Lutz; Geraud, Cyrill; Schadendorf, Dirk; Schaller, Jörg; Alber, Maximilian; Klauschen, Frederick; Griewank, Klaus G.
    Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide Images
    In: Journal of Fungi , Jg. 8 2022, Nr. 9, 912
    DOI, Online Volltext (Open Access)
  • Kaatz, Martin; Mohr, Peter; Livingstone, Elisabeth; Weichenthal, Michael; Kreuter, Alexander; Pföhler, Claudia; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen Sven; Gutzmer, Ralf; Herbst, Rudolf; Schadendorf, Dirk
    Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions : Non-interventional Cohort Study JONAS
    In: Acta Dermato-Venereologica , Jg. 102 2022, adv00695
    DOI (Open Access)
  • Jansen, Philipp; Baguer, Daniel Otero; Duschner, Nicole; Le’Clerc Arrastia, Jean; Schmidt, Maximilian; Wiepjes, Bettina; Schadendorf, Dirk; Hadaschik, Eva; Maass, Peter; Schaller, Jörg; Griewank, Klaus Georg
    Evaluation of a Deep Learning Approach to Differentiate Bowen’s Disease and Seborrheic Keratosis
    In: Cancers , Jg. 14 2022, Nr. 14, 3518
    DOI (Open Access)
  • Hauser, Katja; Kurz, Alexander; Haggenmüller, Sarah; Maron, Roman C.; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Kutzner, Heinz; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Hekler, Achim; Krieghoff-Henning, Eva; Brinker, Titus J.
    Explainable artificial intelligence in skin cancer recognition : A systematic review
    In: European Journal of Cancer (EJC) , Jg. 167 2022, S. 54 – 69
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Roth, Sebastian; Placke, Jan-Malte; Chorti, Eleftheria; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Krefting, Frederik; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
    In: Cancers , Jg. 14 2022, Nr. 9, 2090
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Krahl, Dieter; Burkhardt, Hans; John, Stefan; Géraud, Cyrill; Philip, Manuel; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Sucker, Antje; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Susanne; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
    In: Cancers , Jg. 14 2022, Nr. 17, 4066
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Philip, Manuel; Rose, Christian; Schaller, Jörg; Müller, Hansgeorg; Kutzner, Heinz; Möller, Inga; Stadtler, Nadine; Kretz, Julia; Sucker, Antje; Bankfalvi, Agnes; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Paschen, Annette; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
    In: International Journal of Cancer , Jg. 151 2022, Nr. 9, S. 1542 – 1554
    DOI (Open Access)
  • Lodde, Georg; Jansen, Philipp; Möller, Inga; Sucker, Antje; Hassel, Jessica C.; Forschner, Andrea; Eckardt, Julia; Meier, Friedegund; Reinhardt, Lydia; Kähler, Katharina C.; Ziemer, Mirjana; Schlaak, Max; Rahimi, Farnaz; Schatton, Kerstin; Meiss, Frank; Gutzmer, Ralf; Pföhler, Claudia; Terheyden, Patrick; Schilling, Bastian; Sachse, Michael; Heppt, Markus V.; Sindrilaru, Anca; Leiter, Ulrike; Zaremba, Anne; Thielmann, Carl Maximilian; Ugurel, Selma; Zimmer, Lisa; Hadaschik, Eva; Bechrakis, Nikolaos E.; Schadendorf, Dirk; Westekemper, Henrike; Livingstone, Elisabeth; Griewank, Klaus G.; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma)
    Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
    In: European Journal of Cancer (EJC) , Jg. 166 2022, S. 60 – 72
    DOI
  • Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Kähler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola; Heppt, Markus V.
    Immune Checkpoint Blockade for Metastatic Uveal Melanoma : Re-Induction following Resistance or Toxicity
    In: Cancers , Jg. 14 2022, Nr. 3, 518
    DOI (Open Access)
  • Rünger, Alessandra; Schadendorf, Dirk; Hauschild, Axel; Gebhardt, Christoffer
    Immune checkpoint blockade for organ-transplant recipients with cancer : A review
    In: European Journal of Cancer (EJC) , Jg. 175 2022, S. 326 – 335
    DOI
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike; Helfrich, Iris; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne; Ugurel, Selma
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 6, e004509
    DOI (Open Access)
  • Thier, Beatrice; Zhao, Fang; Stupia, Simone; Brüggemann, Alicia; Koch, Johannes; Schulze, Nina; Horn, Susanne; Coch, Christoph; Hartmann, Gunther; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette
    Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 6, e003863
    DOI (Open Access)
  • Glutsch, Valerie; Schummer, Patrick; Kneitz, Hermann; Gesierich, Anja; Goebeler, Matthias; Klein, Detlef; Posch, Christian; Gebhardt, Christoffer; Haferkamp, Sebastian; Zimmer, Lisa; Becker, Jürgen; Leiter, Ulrike; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian
    Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma : A multicenter study of the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 11, e005930
    DOI (Open Access)
  • Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O.; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S.; Lebbé, Céleste; McArthur, Grant; Ascierto, Paolo A.; Daniels, Gregory A.; Long, Georgina V.; Bas, Tuba; Ritchings, Corey; Larkin, James; Hodi, F Stephen
    Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 2, S. 127 – 137
    DOI (Open Access)
  • Kreft, Sophia; Glutsch, Valerie; Zaremba-Montenari, Anne; Schummer, Patrick; Mohr, Peter; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Pföhler, Claudia; Sachse, Michael Max; Meiss, Frank; Forschner, Andrea; Haferkamp, Sebastian; Welzel, Julia; Terheyden, Patrick; Herbst, Rudolf; Utikal, Jochen; Kaatz, Martin; Weishaupt, Carsten; Kreuter, Alexander; Debus, Dirk; Duecker, Pia; Sindrilaru, Anca; Löffler, Harald; Schley, Gaston; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Gesierich, Anja; Schilling, Bastian
    MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma : An evaluation of the multicenter prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) , Jg. 167 2022, S. 32 – 41
    DOI (Open Access)
  • Salzmann, Martin; Pawlowski, Johannes; Loquai, Carmen; Rafei-Shamsabadi, David A.; Meiss, Frank; Ugurel, Selma; Schadendorf, Dirk; Meier, Friedegund; Enk, Alexander H.; Hassel, Jessica C.
    MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma : A multi-centre, retrospective study
    In: European Journal of Cancer (EJC) , Jg. 166 2022, S. 24 – 32
    DOI
  • Jansen, Philipp; Lodde, Georg; Griewank, Klaus; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk
    Management of partial and non-responding cutaneous squamous cell carcinoma
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 36 2022, Nr. S1, S. 29 – 34
    DOI (Open Access)
  • Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    In: Cancer Imaging , Jg. 22 2022, Nr. 1
    DOI, Online Volltext (Open Access)
  • Maron, Roman C.; Hekler, Achim; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Müller, Verena; Gaiser, Maria; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Krieghoff-Henning, Eva; Brinker, Titus J.
    Model soups improve performance of dermoscopic skin cancer classifiers
    In: European Journal of Cancer (EJC) , Jg. 173 2022, S. 307 – 316
    DOI (Open Access)
  • Gross, Neil D.; Miller, David M.; Khushalani, Nikhil I.; Divi, Vasu; Ruiz, Emily S.; Lipson, Evan J.; Meier, Friedegund; Su, Yungpo B.; Swiecicki, Paul L.; Atlas, Jennifer; Geiger, Jessica L.; Hauschild, Axel; Choe, Jennifer H.; Hughes, Brett G.M.; Schadendorf, Dirk; Patel, Vishal A.; Homsi, Jade; Taube, Janis M.; Lim, Annette M.; Ferrarotto, Renata; Kaufman, Howard L.; Seebach, Frank; Lowy, Israel; Yoo, Suk-Young; Mathias, Melissa; Fenech, Keilah; Han, Hyunsil; Fury, Matthew G.; Rischin, Danny
    Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
    In: The New England Journal of Medicine , Jg. 387 2022, Nr. 17, S. 1557 – 1568
    DOI (Open Access)
  • Eggermont, Alexander Mm; Ascierto, Paolo A.; Khushalani, Nikhil I.; Schadendorf, Dirk; Boland, Genevieve; Weber, Jeffrey; Lewis, Karl D.; Johnson, Daniel; Rivalland, Gareth; Khattak, Adnan; Majem, Margarita; Gogas, Helen; Long, Georgina V.; Currie, Sue L.; Chien, David; Tagliaferri, Mary A.; Carlino, Matteo S.; Diab, Adi
    PIVOT-12 : A Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
    In: Future Oncology , Jg. 18 2022, Nr. 8, S. 903 – 913
    DOI (Open Access)
  • Luke, Jason J.; Rutkowski, Piotr; Queirolo, Paola; Del Vecchio, Michele; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; de la Cruz Merino, Luis; Khattak, Muhammad A.; Schadendorf, Dirk; Long, Georgina V.; Ascierto, Paolo A.; Mandala, Mario; De Galitiis, Federica; Haydon, Andrew; Dummer, Reinhard; Grob, Jean-Jacques; Robert, Caroline; Carlino, Matteo S.; Mohr, Peter; Poklepovic, Andrew; Sondak, Vernon K.; Scolyer, Richard A.; Kirkwood, John M.; Chen, Ke; Diede, Scott J.; Ahsan, Sama; Ibrahim, Nageatte; Eggermont, Alexander M. M.
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
    In: Lancet , Jg. 399 2022, Nr. 10336, S. 1718 – 1729
    DOI
  • Long, Georgina V; Luke, Jason J; Khattak, Muhammad A; de la Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; de Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo S; Mohr, Peter; Dummer, Reinhard; Gershenwald, Jeffrey E; Yoon, Charles H; Wu, Xi Lawrence; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Ascierto, Paolo A
    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716) : distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 23 2022, Nr. 11, S. 1378 – 1388
    DOI
  • Chauvistré, Heike; Shannan, Batool; Daignault-Mill, Sheena M.; Ju, Robert J.; Picard, Daniel; Egetemaier, Stefanie; Váraljai, Renáta; Gibhardt, Christine S.; Sechi, Antonio; Kaschani, Farnusch; Keminer, Oliver; Stehbens, Samantha J.; Liu, Qin; Yin, Xiangfan; Jeyakumar, Kirujan; Vogel, Felix C. E.; Krepler, Clemens; Rebecca, Vito W.; Kubat, Linda; Lueong, Smiths S.; Forster, Jan; Horn, Susanne; Remke, Marc; Ehrmann, Michael; Paschen, Annette; Becker, Jürgen; Helfrich, Iris; Rauh, Daniel; Kaiser, Markus; Gul, Sheraz; Herlyn, Meenhard; Bogeski, Ivan; Rodríguez-López, José Neptuno; Haass, Nikolas K.; Schadendorf, Dirk; Rösch, Alexander
    Persister state-directed transitioning and vulnerability in melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Nature Communications , Jg. 13 2022, Nr. 1, S. 35 – 36
    DOI, Online Volltext (Open Access)
  • Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K.; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C.; Ascierto, Paolo A.; Eggermont, Alexander M.M.; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina V.; Luke, Jason J.; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M.; Lorigan, Paul C.
    Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts : Implications for Adjuvant Treatment
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 32, S. 3741 – 3749
    DOI (Open Access)
  • Kennedy, Oliver J.; Kicinski, Michal; Valpione, Sara; Gandini, Sara; Suciu, Stefan; Blank, Christian U.; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna M.; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C.J.; Robert, Caroline; Eggermont, Alexander M.M.; Lorigan, Paul; Mandala, Mario
    Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer (EJC) , Jg. 165 2022, S. 97 – 112
    DOI (Open Access)
  • Dummer, Reinhard; Long, Georgina V.; Robert, Caroline; Tawbi, Hussein A.; Flaherty, Keith T.; Ascierto, Paolo A.; Nathan, Paul D.; Rutkowski, Piotr; Leonov, Oleg; Dutriaux, Caroline; Mandalà, Mario; Lorigan, Paul; Ferrucci, Pier Francesco; Grob, Jean Jacques; Meyer, Nicolas; Gogas, Helen; Stroyakovskiy, Daniil; Arance, Ana; Brase, Jan C.; Green, Steven; Haas, Tomas; Masood, Aisha; Gasal, Eduard; Ribas, Antoni; Schadendorf, Dirk
    Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 13, S. 1428 – 1438
    DOI (Open Access)
  • Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kähler, Katharina C.; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pföhler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael
    Real-World Therapy with Pembrolizumab : Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
    In: Cancers , Jg. 14 2022, Nr. 7, 1804
    DOI (Open Access)
  • Tawbi, Hussein A.; Schadendorf, Dirk; Lipson, Evan J.; Ascierto, Paolo A.; Matamala, Luis; Castillo Gutiérrez, Erika; Rutkowski, Piotr; Gogas, Helen J.; Lao, Christopher D.; De Menezes, Juliana Janoski; Dalle, Stéphane; Arance, Ana; Grob, Jean-Jacques; Srivastava, Shivani; Abaskharoun, Mena; Hamilton, Melissa; Keidel, Sarah; Simonsen, Katy L.; Sobiesk, Anne Marie; Li, Bin; Hodi, F. Stephen; Long, Georgina V.
    Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
    In: The New England Journal of Medicine , Jg. 386 2022, Nr. 1, S. 24 – 34
    DOI (Open Access)
  • Schadendorf, Dirk
    Reply to: Letter comments on: Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers
    In: European Journal of Cancer (EJC) , Jg. 162 2022, S. 243 – 244
    DOI
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM) , Jg. 63 2022, Nr. 3, S. 396 – 398
    DOI (Open Access)
  • Haist, Maximilian; Stege, Henner; Lang, Berenice Mareen; Tsochataridou, Aikaterini; Salzmann, Martin; Mohr, Peter; Schadendorf, Dirk; Ugurel, Selma; Placke, Jan-Malte; Weichenthal, Michael; Gutzmer, Ralf; Leiter, Ulrike; Kaatz, Martin; Haferkamp, Sebastian; Berking, Carola; Heppt, Markus; Tschechne, Barbara; Schummer, Patrick; Gebhardt, Christoffer; Grabbe, Stephan; Loquai, Carmen
    Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma : A Multicenter, Retrospective Analysis from the German ADOReg Registry
    In: Cancers , Jg. 14 2022, Nr. 22, 5543
    DOI (Open Access)
  • Bordbari, Sharareh; Mörchen, Britta; Pylaeva, Ekaterina; Siakaeva, Elena; Spyra, Ilona; Domnich, Maksim; Droege, Freya; Kanaan, Oliver; Lang, Karl S.; Schadendorf, Dirk; Lang, Stephan; Helfrich, Iris; Jablonska, Jadwiga
    SIRT1‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophils
    In: International Journal of Cancer , Jg. 150 2022, Nr. 7, S. 1198 – 1211
    DOI (Open Access)
  • Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Ribas, Antoni; Sullivan, Ryan J.; Panella, Timothy; McKean, Meredith; Santos, Edgardo S.; Brill, Kimberli; Polli, Anna; Pietro, Alessandra di; Ascierto, Paolo A.
    STARBOARD : encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma
    In: Future Oncology , Jg. 18 2022, Nr. 17, S. 2041 – 2051
    DOI (Open Access)
  • Tawbi, Hussein A; Robert, Caroline; Brase, Jan C; Gusenleitner, Daniel; Gasal, Eduard; Garrett, James; Savchenko, Alexander; Görgün, Güllü; Flaherty, Keith T; Ribas, Antoni; Dummer, Reinhard; Schadendorf, Dirk; Long, Georgina V; Nathan, Paul D; Ascierto, Paolo A
    Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma : exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 6, e004226
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus G.
    TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
    In: European Journal of Cancer (EJC) , Jg. 161 2022, S. 99 – 107
    DOI (Open Access)
  • Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush
    Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
    In: European Heart Journal , Jg. 43 2022, Nr. 4, S. 316 – 329
    DOI
  • Hegedüs, Luca; Livingstone, Elisabeth; Bankfalvi, Agnes; Viehof, Jan; Enyedi, Ágnes; Bilecz, Ágnes; Győrffy, Balázs; Baranyi, Marcell; Tőkés, Anna-Mária; Gil, Jeovanis; Marko-Varga, György; Griewank, Klaus; Zimmer, Lisa; Váraljai, Renáta; Sucker, Antje; Zaremba, Anne; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    The Prognostic Relevance of PMCA4 Expression in Melanoma : Gender Specificity and Implications for Immune Checkpoint Inhibition
    In: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 6, 3324
    DOI, Online Volltext (Open Access)
  • Ascierto, Paolo A.; Schadendorf, Dirk
    Update in the treatment of non-melanoma skin cancers : the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 12, e005082
    DOI (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    Validating Automatic Concept-Based Explanations for AI-Based Digital Histopathology
    In: Sensors , Jg. 22 2022, Nr. 14, 5346
    DOI, Online Volltext (Open Access)
  • Bäuerle, Alexander; Martus, Peter; Erim, Yesim; Schug, Caterina; Heinen, Jana; Krakowczyk, Julia Barbara; Steinbach, Jasmin; Damerau, Mirjam; Bethge, Wolfgang; Dinkel, Andreas; Dries, Sebastian; Mehnert-Theuerkauf, Anja; Neumann, Anja; Schadendorf, Dirk; Tewes, Mitra; Wiltink, Jörg; Wünsch, Alexander; Zipfel, Stephan; Graf, Johanna; Teufel, Martin
    Web-based mindfulness and skills-based distress reduction for patients with cancer : study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct
    In: BMJ Open , Jg. 12 2022, Nr. 6, e056973
    DOI (Open Access)
  • Maron, Roman C.; Schlager, Justin G.; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hobelsberger, Sarah; Hauschild, Axel; French, Lars; Heinzerling, Lucie; Schlaak, Max; Ghoreschi, Kamran; Hilke, Franz J.; Poch, Gabriela; Heppt, Markus V.; Berking, Carola; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Goebeler, Matthias; Krieghoff-Henning, Eva; Hekler, Achim; Fröhling, Stefan; Lipka, Daniel B.; Kather, Jakob N.; Brinker, Titus J.
    A benchmark for neural network robustness in skin cancer classification
    In: European Journal of Cancer (EJC) , Jg. 155 2021, S. 191 – 199
    DOI (Open Access)
  • Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Lorigan, Paul C; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M M; Lesimple, Thierry; Maio, Michele; Linette, Gerald; Mortier, Laurent; Svane, Inge Marie; Schachter, Jacob; Brown, Michael; Hersey, Peter; Barrow, Catherine; Kudchadkar, Ragini; Dutriaux, Caroline; Song, Xinni; Quaglino, Pietro; Queirolo, Paola; Meier, Friedegund; Stroyakovskiy, Daniil; Guillot, Bernard; Romero, Pablo Luis Ortiz; Bastholt, Lars; Garbe, Claus; Grange, Florent; Mohr, Peter; Algazi, Alain; Bechter, Oliver; Hernberg, Micaela; Loquai, Carmen; Meiss, Frank; Chiarion Sileni, Vanna; Bar-Sela, Gil; Fitzharris, Bernard; Saiag, Philippe; Arnault, Jean-Philippe; Simon, Jan-Christoph; Stephens, Rosalie; Baurain, Jean-Francois; Lebbe, Célèste; Combemale, Patrick; Dummer, Reinhard; Hauschild, Axel; Parente, Phillip; Yamazaki, Naoya; Milhem, Mohammed; Leccia, Marie-Thérèse; Geoffrois, Lionel; Kretschmer, Lutz; Dunwoodie, Elaine; Walker, John; Lotem, Michal; Hendler, Daniel; Mackiewicz, Andrzej; Sekulovic, Lidija; Dzienis, Marcin; Hospers, Geke A.P.; Siano, Marco; Hassel, Jessica; Corrie, Philippa; Passos, Maria-Jose; Levin, Max; Hoeller, Christoph; Machet, Laurent; Hallmeyer, Sigrun; Waterston, Ashita; Descamps, Vincent; Kiecker, Felix; Aarts, Maureen; Schmidt, Henrik; Raimundo, Ana; Nyakas, Marta; Lacour, Jean-Philippe; Berking, Carola; Ferrucci, Pier Francesco; Jameson, Michael; Kim, Kevin; Yokota, Kenji; Kerger, Joseph; Aubin, François; Groenewegen, Gerard; Kapiteijn, Helena; Boehncke, Wolf-Henning; Utikal, Jochen; Casasola, Richard; Marshall, Ernest; Ferraresi, Virginia; Richtig, Erika; Matkovic, Suzana; Inozume, Takashi; Crook, Timothy; McNeil, Catriona; Kiyohara, Yoshio; Avril, Marie-Francoise; Hein, Rüdiger; Terheyden, Patrick; Nathan, Paul; Aoi, Jun; Skytta, Tanja; Jouary, Thomas; Takenouchi, Tatsuya; Straume, Oddbjorn; Martins, César; Mukhametshina, Guzel
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
    In: The Lancet Oncology , Jg. 22 2021, Nr. 5, S. 655 – 664
    DOI (Open Access)
  • Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline; Menzies, Alex; Lesimple, Thierry; Maio, Michele; Linette, Gerald; Brown, Michael; Hersey, Peter; Svane, Inge Marie; Mortier, Laurent; Schachter, Jacob; Barrow, Catherine; Kudchadkar, Ragini; Song, Xinni; Dutriaux, Caroline; Quaglino, Pietro; Meier, Friedegund; Queirolo, Paola; Stroyakovskiy, Daniil; Bastholt, Lars; Guillot, Bernard; Garbe, Claus; Ortiz Romero, Pablo Luis; Grange, Florent; Mohr, Peter; Algazi, Alain; Bechter, Oliver; Hernberg, Micaela; Arnault, Jean-Philippe; Saiag, Philippe; Loquai, Carmen; Meiss, Frank; Simon, Jan-Christoph; Bar-Sela, Gil; Chiarion Sileni, Vanna; Fitzharris, Bernard; McCrystal, Mike; Parente, Phillip; Baurain, Jean-Francois; Combemale, Patrick; Lebbe, Célèste; Hauschild, Axel; Yamazaki, Naoya; Dummer, Reinhard; Milhem, Mohammed; Dzienis, Marcin; Walker, John; Geoffrois, Lionel; Leccia, Marie-Thérèse; Kretschmer, Lutz; Hendler, Daniel; Lotem, Michal; Mackiewicz, Andrzej; Sekulovic, Lidija; Dunwoodie, Elaine; Hoeller, Christoph; Machet, Laurent; Hassel, Jessica; Hospers, Geke A.P.; Passos, Maria-Jose; Levin, Max; Fehr, Martin; Corrie, Philippa; Waterston, Ashita; Hallmeyer, Sigrun; Schmidt, Henrik; Descamps, Vincent; Lacour, Jean-Philippe; Berking, Carola; Kiecker, Felix; Ferrucci, Pier Francesco; Yokota, Kenji; Aarts, Maureen; Jameson, Michael; Winge-Main, Anna Katharina; Ferreira, Paula; Kim, Kevin; McNeil, Catriona; Hofmann-Wellenhof, Reiner; Kerger, Joseph; Aubin, François; Utikal, Jochen; Ferraresi, Virginia; Inozume, Takashi; Kiyohara, Yoshio; Groenewegen, Gerard; Kapiteijn, Helena; Matkovic, Suzana; Boehncke, Wolf-Henning; Casasola, Richard; Crook, Timothy; Marshall, Ernest; Skytta, Tanja; Avril, Marie-Francoise; Jouary, Thomas; Hein, Rüdiger; Terheyden, Patrick; Aoi, Jun; Takenouchi, Tatsuya; Straume, Oddbjorn; Martins, César; Mukhametshina, Guzel; Nathan, Paul
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
    In: The Lancet Oncology , Jg. 22 2021, Nr. 5, S. 643 – 654
    DOI
  • Hegedüs, Luca; Okumus, Özlem; Livingstone, Elisabeth; Baranyi, Marcell; Kovács, Ildikó; Döme, Balázs; Tóvári, József; Bankfalvi, Agnes; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    Allosteric and ATP-competitive MEK-inhibition in a novel spitzoid melanoma model with a raf-and phosphorylation-independent mutation
    In: Cancers , Jg. 13 2021, Nr. 4, S. 829
    DOI, Online Volltext (Open Access)
  • De Santis, Francesca; Fucà, Giovanni; Schadendorf, Dirk; Mantovani, Alberto; Magnani, Luca; Lisanti, Michael; Pettitt, Stephen; Bellone, Matteo; Del Sal, Giannino; Minucci, Saverio; Eggermont, Alexander; Bruzzi, Paolo; Bicciato, Silvio; Conte, Pierfranco; Noberini, Roberta; Hiscott, John; De Braud, Filippo; Del Vecchio, Michele; Di Nicola, Massimo
    Anticancer innovative therapy congress : Highlights from the 10th anniversary edition
    In: Cytokine & Growth Factor Reviews , Jg. 59 2021, S. 1 – 8
    DOI (Open Access)
  • Placke, Jan-Malte; Rawitzer, Josefine; Reis, Henning; Rashidi-Alavijeh, Jassin; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Griewank, Klaus; Schmid, Kurt Werner; Schadendorf, Dirk; Rösch, Alexander; Zimmer, Lisa
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
    In: Frontiers in Oncology , Jg. 11 2021, 725549
    DOI, Online Volltext (Open Access)
  • Gutzmer, Ralf; Robert, Caroline; Loquai, Carmen; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Dummer, Reinhard
    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib : results from a preplanned sensitivity analysis
    In: BMC Cancer , Jg. 21 2021, Nr. 1, 1244
    DOI (Open Access)
  • Pfeiffer, Lukas; Farahpour, Farnoush; Sriram, Ashwin; Spassova, Ivelina; Hoffmann, Daniel; Kubat, Linda; Stoitzner, Patrizia; Gambichler, Thilo; Sucker, Antje; Ugurel, Selma; Schadendorf, Dirk; Becker, Jürgen C.
    BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
    In: Cancer Immunology, Immunotherapy , Jg. 70 2021, Nr. 6, S. 1635 – 1647
    DOI (Open Access)
  • Syeda, Mahrukh M.; Wiggins, Jennifer M.; Corless, Broderick C; Long, Georgina V.; Flaherty, Keith T.; Schadendorf, Dirk; Nathan, Paul D.; Robert, Caroline; Ribas, Antoni; Davies, Michael A.; Grob, Jean Jacques; Gasal, Eduard; Squires, Matthew; Marker, Mahtab; Garrett, James; Brase, Jan C.; Polsky, David
    Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib : A clinical validation study
    In: The Lancet Oncology , Jg. 22 2021, Nr. 3, S. 370 – 380
    DOI (Open Access)
  • Gravemeyer, Jan; Lange, Anja; Ritter, Cathrin; Spassova, Ivelina; Song, Lina; Picard, Daniel; Remke, Marc; Horny, Kai; Sriram, Ashwin; Gambichler, Thilo; Schadendorf, Dirk; Hoffmann, Daniel; Becker, Jürgen
    Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition
    In: Journal of Investigative Dermatology , Jg. 141 2021, Nr. 7, S. 1675 – 1686.e4
    DOI (Open Access)
  • Zaremba, Anne; Philip, Manuel; Hassel, Jessica C.; Glutsch, Valerie; Fiocco, Zeno; Loquai, Carmen; Rafei-Shamsabadi, David; Gutzmer, Ralf; Utikal, Jochen; Haferkamp, Sebastian; Reinhardt, Lydia; Kähler, Katharina C.; Weishaupt, Carsten; Moreira, Alvaro; Thoms, Kai-Martin; Wilhelm, Tabea; Pföhler, Claudia; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Stadtler, Nadine; Sucker, Antje; Kiecker, Felix; Heinzerling, Lucie; Meier, Friedegund; Meiss, Frank; Schlaak, Max; Schilling, Bastian; Horn, Susanne; Schadendorf, Dirk; Livingstone, Elisabeth
    Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
    In: European Journal of Cancer (EJC) , Jg. 152 2021, S. 139 – 154
    DOI
  • Rogiers, Aljosja; Da Silva, Ines Pires; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M.; Trager, Megan H.; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A.N.; Borgers, Jessica S.W.; Roy, Severine; Mangana, Joanna; Pimentel Muniz, Thiago; Cooksley, Tim; Lupu, Jeremy; Vaisman, Alon; Saibil, Samuel D.; Butler, Marcus O.; Menzies, Alexander M.; Carlino, Matteo S.; Erdmann, Michael; Berking, Carola; Zimmer, Lisa; Schadendorf, Dirk; Pala, Laura; Queirolo, Paola; Posch, Christian; Hauschild, Axel; Dummer, Reinhard; Haanen, John; Blank, Christian U.; Robert, Caroline; Sullivan, Ryan J.; Ascierto, Paolo Antonio; Miller, Wilson H; Stephen Hodi, F.; Suijkerbuijk, Karijn P.M.; Reynolds, Kerry L.; Rahma, Osama E.; Lorigan, Paul C.; Carvajal, Richard D.; Lo, Serigne; Mandala, Mario; Long, Georgina V.
    Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
    In: Journal for ImmunoTherapy of Cancer , Jg. 9 2021, Nr. 1, e001931
    DOI (Open Access)
  • Höhn, Julia; Krieghoff-Henning, Eva; Jutzi, Tanja B.; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hobelsberger, Sarah; Hauschild, Axel; Schlager, Justin G.; French, Lars; Heinzerling, Lucie; Schlaak, Max; Ghoreschi, Kamran; Hilke, Franz J.; Poch, Gabriela; Kutzner, Heinz; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Goebeler, Matthias; Hekler, Achim; Fröhling, Stefan; Lipka, Daniel B.; Kather, Jakob N.; Krahl, Dieter; Ferrara, Gerardo; Haggenmüller, Sarah; Brinker, Titus J.
    Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification
    In: European Journal of Cancer (EJC) , Jg. 149 2021, S. 94 – 101
    DOI (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Theysohn, Jens; Haubold, Johannes; Cosgarea, Ioana; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Stoffels, Ingo; Klode, Joachim; Lodde, Georg; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer : A retrospective analysis of 47 cases
    In: European Journal of Cancer (EJC) , Jg. 150 2021, S. 119 – 129
    DOI
  • Placke, Jan-Malte; Reis, Henning; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Stoffels, Ingo; Klode, Joachim
    Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up : A monocentre study
    In: European Journal of Cancer (EJC) , Jg. 154 2021, S. 167 – 174
    DOI (Open Access)
  • Brinker, Titus J.; Kiehl, Lennard; Schmitt, Max; Jutzi, Tanja B.; Krieghoff-Henning, Eva I.; Krahl, Dieter; Kutzner, Heinz; Gholam, Patrick; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Hekler, Achim; Fröhling, Stefan; Kather, Jakob N.; Haggenmüller, Sarah; von Kalle, Christof; Heppt, Markus; Hilke, Franz; Ghoreschi, Kamran; Tiemann, Markus; Wehkamp, Ulrike; Hauschild, Axel; Weichenthal, Michael; Utikal, Jochen S.
    Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumours
    In: European Journal of Cancer (EJC) , Jg. 154 2021, S. 227 – 234
    DOI (Open Access)
  • Gangaev, Anastasia; Rozeman, Elisa A.; Rohaan, Maartje W.; Isaeva, Olga I.; Philips, Daisy; Patiwael, Sanne; van den Berg, Joost H.; Ribas, Antoni; Schadendorf, Dirk; Schilling, Bastian; Schumacher, Ton N.; Blank, Christian U.; Haanen, John B. A. G.; Kvistborg, Pia
    Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 118 2021, Nr. 43, e2102849118
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Christiane; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
    In: Frontiers in Oncology , Jg. 11 2021, 741993
    DOI, Online Volltext (Open Access)
  • Stege, Henner; Haist, Maximilian; Schultheis, Michael; Fleischer, Maria Isabel; Mohr, Peter; Meier, Friedegund; Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Herbst, Rudolf; Pföhler, Claudia; Kähler, Katharina; Weichenthal, Michael; Terheyden, Patrick; Nashan, Dorothée; Debus, Dirk; Kaatz, Martin; Ziller, Fabian; Haferkamp, Sebastian; Forschner, Andrea; Leiter, Ulrike; Kreuter, Alexander; Ulrich, Jens; Kleemann, Johannes; Bradfisch, Fabienne; Grabbe, Stephan; Loquai, Carmen
    Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study
    In: Cancers , Jg. 13 2021, Nr. 10, S. 2312
    DOI (Open Access)
  • Le Rhun, E.; Guckenberger, M.; Smits, M.; Dummer, R.; Bachelot, T.; Sahm, F.; Galldiks, N.; de Azambuja, E.; Berghoff, A.S.; Metellus, P.; Peters, S.; Hong, Y.-K.; Winkler, F.; Schadendorf, Dirk; van den Bent, M.; Seoane, J.; Stahel, R.; Minniti, G.; Wesseling, P.; Weller, M.; Preusser, M.
    EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
    In: Annals of Oncology , Jg. 32 2021, Nr. 11, S. 1332 – 1347
    DOI (Open Access)
  • Kähler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund; Zimmer, Lisa; Heppt, Markus; Gesierich, Anja; Thoms, Kai-Martin; Utikal, Jochen; Hassel, Jessica C.; Loquai, Carmen; Pföhler, Claudia; Heinzerling, Lucie; Kaatz, Martin; Göppner, Daniela; Pflugfelder, Annette; Bohne, Ann-Sophie; Satzger, Imke; Reinhardt, Lydia; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma : A Retrospective Multicenter DeCOG Study
    In: Frontiers in Oncology , Jg. 11 2021, 672172
    DOI (Open Access)
  • Gutzmer, Ralf; Schulze, Hans Joachim; Hauschild, Axel; Leiter, Ulrike; Meier, Friedegund E.; Haferkamp, Sebastian; Ulrich, Claas; Wahl, Renate Ursula; Berking, Carola; Herbst, Rudolf A.; Häckl, Manuel; Schadendorf, Dirk
    Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany : The non-interventional study NIELS
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 35 2021, Nr. 8, S. 1678 – 1685
    DOI (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Krackhardt, Angela; Schultz, Erwin S.; Göppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Stelter, Kai; Windemuth-Kieselbach, Christine; Ugurel, Selma; Schadendorf, Dirk
    Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV⁶⁰⁰ mutant melanoma : safety and tolerability results from the phase I IMMU-TARGET trial
    In: European Journal of Cancer (EJC) , Jg. 158 2021, S. 72 – 84
    DOI
  • Yang, Yongjie; Ma, Yanfang; Lu, Jingli; Zhang, Qiwen; Guan, Kelei; Liu, Kefeng; Kang, Jian; Du, Shuzhang; Tang, Shu; Liu, Xuehui; Zhang, Ailing; Schadendorf, Dirk; Agarwala, Sanjiv S.; Zhang, Xiaojian
    Evaluation of the reporting quality of clinical practice guidelines on melanoma using the RIGHT checklist
    In: Annals of Translational Medicine , Jg. 9 2021, Nr. 14, 1172
    DOI (Open Access)
  • Lodde, Georg; Forschner, Andrea; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Schatton, Kerstin; Gebhardt, Christoffer; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Factors influencing the adjuvant therapy decision : Results of a real-world multicenter data analysis of 904 melanoma patients
    In: Cancers , Jg. 13 2021, Nr. 10, S. 2319
    DOI, Online Volltext (Open Access)
  • Jansen, Philipp; Müller, Hansgeorg; Lodde, Georg C.; Zaremba, Anne; Möller, Inga; Sucker, Antje; Paschen, Annette; Esser, Stefan; Schaller, Jörg; Gunzer, Matthias; Standl, Fabian; Bauer, Sebastian; Schadendorf, Dirk; Mentzel, Thomas; Hadaschik, Eva; Griewank, Klaus G.
    GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
    In: Frontiers in Genetics , Jg. 12 2021, 663272
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Kramer, Rafaela; De Temple, Viola; Bertram, Stefanie; Salzmann, Martin; Gesierich, Anja; Reinhardt, Lydia; Baroudjian, Barouyr; Sachse, Michael M.; Mechtersheimer, Gunhild; Johnson, Douglas B.; Weppler, Alison M.; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pföhler, Claudia; Hepner, Adriana; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Lebbé, Céleste; Enokida, Tomohiro; Tahara, Makoto; Bröckelmann, Paul J.; Eigentler, Thomas; Kähler, Katharina C.; Gutzmer, Ralf; Berking, Carola; Ugurel, Selma; Stadtler, Nadine; Sucker, Antje; Becker, Jürgen; Livingstone, Elisabeth; Meier, Friedegund; Hassel, Jessica C.; Schadendorf, Dirk; Hanoun, Maher; Heinzerling, Lucie; Zimmer, Lisa
    Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition : A Descriptive Observational Retrospective Multicenter Analysis
    In: Frontiers in Oncology , Jg. 11 2021, 765608
    DOI, Online Volltext (Open Access)
  • Merz, Simon F.; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    High-resolution three-dimensional imaging for precise staging in melanoma
    In: European Journal of Cancer (EJC) , Jg. 159 2021, S. 182 – 193
    DOI (Open Access)
  • Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Hohberger, Bettina; Kähler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola; Heppt, Markus V.
    Immune checkpoint blockade for metastatic uveal melanoma : Patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
    In: Cancers , Jg. 13 2021, Nr. 13, 3359
    DOI (Open Access)
  • Weber, Jeffrey S.; Ascierto, Paolo A.; Middleton, Mark R.; Hennicken, Delphine; Zoffoli, Roberto; Pieters, Anne; Amadi, Adenike; Kupas, Katrin; Kotapati, Srividya; Moshyk, Andriy; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma
    In: European Journal of Cancer (EJC) , Jg. 158 2021, S. 225 – 233
    DOI (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I; Schmults, Chrysalyne D; Guminski, Alexander; Chang, Anne Lynn S; Lewis, Karl D; Lim, Annette M; Hernandez-Aya, Leonel; Hughes, Brett G M; Schadendorf, Dirk; Hauschild, Axel; Thai, Alesha A; Stankevich, Elizabeth; Booth, Jocelyn; Yoo, Suk-Young; Li, Siyu; Chen, Zhen; Okoye, Emmanuel; Chen, Chieh-I; Mastey, Vera; Sasane, Medha; Lowy, Israel; Fury, Matthew G; Migden, Michael R
    Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma : Extended follow-up of outcomes and quality of life analysis
    In: Journal for ImmunoTherapy of Cancer , Jg. 9 2021, Nr. 8, e002757
    DOI (Open Access)
  • Höhn, Julia; Hekler, Achim; Krieghoff-Henning, Eva; Kather, Jakob Nikolas; Utikal, Jochen Sven; Meier, Friedegund; Gellrich, Frank Friedrich; Hauschild, Axel; French, Lars; Schlager, Justin Gabriel; Ghoreschi, Kamran; Wilhelm, Tabea; Kutzner, Heinz; Heppt, Markus; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Maron, Roman C.; Schmitt, Max; Jutzi, Tanja; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus Josef
    Integrating patient data into skin cancer classification using convolutional neural networks : Systematic review
    In: Journal of Medical Internet Research (JMIR) , Jg. 23 2021, Nr. 7, e20708
    DOI (Open Access)
  • Váraljai, Renáta; Horn, Susanne; Sucker, Antje; Pierscianek, Daniela; Schmitt, Verena; Carpinteiro, Alexander; Becker, Katrin; Reifenberger, Julia; Rösch, Alexander; Felsberg, Joerg; Reifenberger, Guido; Sure, Ulrich; Schadendorf, Dirk; Helfrich, Iris
    Integrative genomic analyses of patient-matched intracranial and extracranial metastases reveal a novel brain-specific landscape of genetic variants in driver genes of malignant melanoma
    In: Cancers , Jg. 13 2021, Nr. 4, S. 731
    DOI, Online Volltext (Open Access)
  • Albrecht, Margarete; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Hamacher, Rainer; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Kutanes Angiosarkom mit klinischem Bild eines Quincke-Ödems
    In: Der Hautarzt , Jg. 72 2021, Nr. 9, S. 801 – 804
    DOI (Open Access)
  • Chorti, Eleftheria; Kebir, Sied; Ahmed, Misbah S.; Keyvani, Kathy; Umutlu, Lale; Kanaki, Theodora; Zaremba, Anne; Reinboldt-Jockenhöfer, Finja; Knispel, Sarah; Gratsias, Emmanouil; Rösch, Alexander; Ugurel, Selma; Scheffler, Björn; Schadendorf, Dirk; Livingstone, Elisabeth; Meier, Friedegund; Glas, Martin; Zimmer, Lisa
    Leptomeningeal disease from melanoma : Poor prognosis despite new therapeutic modalities
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 395 – 404
    DOI
  • Salzmann, Martin; Tosev, Georgi; Heck, Melanie; Schadendorf, Dirk; Maatouk, Imad; Enk, Alexander H.; Hartmann, Martin; Hassel, Jessica C.
    Male fertility during and after immune checkpoint inhibitor therapy : A cross-sectional pilot study
    In: European Journal of Cancer (EJC) , Jg. 152 2021, S. 41 – 48
    DOI
  • Harbers, Franziska Noelle; Thier, Beatrice; Stupia, Simone; Zhu, Si; Schwamborn, Marion; Peller, Vicky; Chauvistré, Heike; Crivello, Pietro; Fleischhauer, Katharina; Rösch, Alexander; Sucker, Antje; Schadendorf, Dirk; Chen, Yong; Paschen, Annette; Zhao, Fang
    Melanoma Differentiation Trajectories Determine Sensitivity Toward Pre-Existing CD8⁺ Tumor-Infiltrating Lymphocytes
    In: Journal of Investigative Dermatology , Jg. 141 2021, Nr. 10, S. 2480 – 2489
    DOI (Open Access)
  • Bhave, Prachi; Pallan, Lalit; Long, Georgina V.; Menzies, Alexander M.; Atkinson, Victoria; Cohen, Justine V.; Sullivan, Ryan J.; Chiarion-Sileni, Vanna; Nyakas, Marta; Kähler, Katharina; Hauschild, Axel; Plummer, Ruth; Trojaniello, Claudia; Ascierto, Paolo A.; Zimmer, Lisa; Schadendorf, Dirk; Allayous, Clara; Lebbe, Celeste; Maurichi, Andrea; Santinami, Mario; Roy, Severine; Robert, Caroline; Lesimple, Thierry; Patel, Sapna; Versluis, Judith M.; Blank, Christian U.; Khattak, Adnan; Van der Westhuizen, Andre; Carlino, Matteo S.; Shackleton, Mark; Haydon, Andrew
    Melanoma recurrence patterns and management after adjuvant targeted therapy : A multicentre analysis
    In: British Journal of Cancer (BJC) , Jg. 124 2021, Nr. 3, S. 574 – 580
    DOI (Open Access)
  • Bäuerle, Alexander; Musche, Venja; Schmidt, Kira; Schweda, Adam; Fink, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairment
    In: International Journal of Environmental Research and Public Health = IJERPH , Jg. 18 2021, Nr. 5, 2318
    DOI, Online Volltext (Open Access)
  • Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Lange, Anja; Gambichler, Thilo; Ødum, Niels; Schrama, David; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen
    Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53
    In: Oncogene , Jg. 40 2021, Nr. 5, S. 980 – 996
    DOI (Open Access)
  • Gutzmer, Ralf; Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkel-Zell-Karzinom
    In: Der Onkologe , Jg. 27 2021, Nr. 6, S. 569 – 578
    DOI
  • Thielmann, Carl Maximilian; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Paredes, Bruno E.; Brinkmeier, Thomas; Griewank, Klaus; Schadendorf, Dirk; Klode, Joachim; Stoffels, Ingo; Hadaschik, Eva
    Metastatic pigmented epithelioid melanocytoma in a 7-year-old female
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. 8, S. 1217 – 1219
    DOI (Open Access)
  • Zaremba, Anne; Lodde, Georg; Murali, Rajmohan; Philip, Manuel; Cosgarea, Ioana; Jansen, Philipp; Chorti, Eleftheria; Rose, Christian; Hemmerlein, Bernhard; Matull, Johanna; Thielmann, Carl Maximilian; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 340 – 347
    DOI (Open Access)
  • Frangieh, Chris J.; Melms, Johannes C.; Thakore, Pratiksha I.; Geiger-Schuller, Kathryn R.; Ho, Patricia; Luoma, Adrienne M.; Cleary, Brian; Jerby-Arnon, Livnat; Malu, Shruti; Cuoco, Michael S.; Zhao, Maryann; Ager, Casey R.; Rogava, Meri; Hovey, Lila; Rotem, Asaf; Bernatchez, Chantale; Wucherpfennig, Kai W.; Johnson, Bruce E.; Rozenblatt-Rosen, Orit; Schadendorf, Dirk; Regev, Aviv; Izar, Benjamin
    Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
    In: Nature Genetics , Jg. 53 2021, Nr. 3, S. 332 – 341
    DOI (Open Access)
  • Nguyen, Tan-Trieu; Ramsay, Lee Ann; Ahanfeshar-Adams, Mozhdeh; Lajoie, Mathieu; Schadendorf, Dirk; Alain, Tommy; Watson, Ian R.
    Mutations in the IFNγ-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatment
    In: Clinical Cancer Research , Jg. 27 2021, Nr. 12, S. 3432 – 3442
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba-Montenari, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Hadaschik, Eva; Ugurel, Selma; Griewank, Klaus
    NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 159 2021, S. 113 – 124
    DOI
  • de Semir, David; Bezrookove, Vladimir; Nosrati, Mehdi; Dar, Altaf A.; Miller, James R.; Leong, Stanley P.; Kim, Kevin B.; Liao, Wilson; Soroceanu, Liliana; McAllister, Sean; Debs, Robert J.; Schadendorf, Dirk; Leachman, Sancy A.; Cleaver, James E.; Kashani-Sabet, Mohammed
    Nuclear receptor coactivator NCOA3 regulates UV radiation⇓induced DNA damage and melanoma susceptibility
    In: Cancer Research , Jg. 81 2021, Nr. 11, S. 2956 – 2969
    DOI (Open Access)
  • Knispel, Sarah; Gassenmaier, Maximilian; Menzies, Alexander M.; Loquai, Carmen; Johnson, Douglas B.; Franklin, Cindy; Gutzmer, Ralf; Hassel, Jessica C.; Weishaupt, Carsten; Eigentler, Thomas; Schilling, Bastian; Schummer, Patrick; Sirokay, Judith; Kiecker, Felix; Owen, Carina N.; Fleischer, Maria I.; Cann, Christopher; Kähler, Katharina C.; Mohr, Peter; Bluhm, Leonie; Niebel, Dennis; Thoms, Kai-Martin; Goldinger, Simone M.; Reinhardt, Lydia; Meier, Friedegund; Berking, Carola; Reinhard, Raphael; Susok, Laura; Ascierto, Paolo A.; Drexler, Konstantin; Pföhler, Claudia; Tietze, Julia; Heinzerling, Lucie; Livingstone, Elisabeth; Ugurel, Selma; Long, Georgina V.; Stang, Andreas; Schadendorf, Dirk; Zimmer, Lisa
    Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 61 – 75
    DOI
  • Steeb, Theresa; Wessely, Anja; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K. C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan. C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus; Berking, Carola; Schlaak, Max; Heppt, Markus V.
    Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries : A multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
    In: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021, Nr. 6, S. 1763 – 1771
    DOI (Open Access)
  • Schadendorf, Dirk; Robert, Caroline; Dummer, Reinhard; Flaherty, Keith T.; Tawbi, Hussein A.; Menzies, Alexander M.; Banerjee, Hiya; Lau, Mike; Long, Georgina V.
    Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers
    In: European Journal of Cancer (EJC) , Jg. 153 2021, S. 234 – 241
    DOI (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; Jan de Willem, Groot; Sellier, Abir Tadmouri; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.
    Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib : Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
    In: European Journal of Cancer (EJC) , Jg. 152 2021, S. 116 – 128
    DOI
  • Jansen, Philipp; Lodde, Georg; Zaremba, Anne; Thielmann, Carl Maximilian; Matull, Johanna; Müller, Hansgeorg; Möller, Inga; Sucker, Antje; Esser, Stefan; Schaller, Jörg; Schadendorf, Dirk; Mentzel, Thomas; Hadaschik, Eva; Griewank, Klaus
    Rare TERT Promoter Mutations Present in Benign and Malignant Cutaneous Vascular Tumors
    In: Dermato , Jg. 1 2021, Nr. 1, S. 18 – 25
    DOI (Open Access)
  • Eggermont, Alexander M M; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline
    Reply to E. Hindié
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 8, S. 944 – 946
    DOI (Open Access)
  • Zaremba, Anne; Hadaschik, Eva; Schadendorf, Dirk; Griewank, Klaus
    Response to comment : Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer (EJC) , Jg. 157 2021, S. 514 – 515
    DOI
  • Maron, Roman C.; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hauschild, Axel; French, Lars E.; Schlaak, Max; Ghoreschi, Kamran; Kutzner, Heinz; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Hekler, Achim; Krieghoff-Henning, Eva; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus J.
    Robustness of convolutional neural networks in recognition of pigmented skin lesions
    In: European Journal of Cancer (EJC) , Jg. 145 2021, S. 81 – 91
    DOI (Open Access)
  • Brase, Jan C.; Walter, Robert F.H.; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V.; Nathan, Paul D.; Ribas, Antoni; Flaherty, Keith T.; Karaszewska, Boguslawa; Schachter, Jacob; Sucker, Antje; Schmid, Kurt Werner; Zimmer, Lisa; Livingstone, Elisabeth; Gasal, Eduard; Schadendorf, Dirk; Rösch, Alexander
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
    In: Clinical Cancer Research , Jg. 27 2021, Nr. 16, S. 4500 – 4510
    DOI (Open Access)
  • Haggenmüller, Sarah; Maron, Roman C.; Hekler, Achim; Utikal, Jochen S.; Barata, Catarina; Barnhill, Raymond L.; Beltraminelli, Helmut; Berking, Carola; Betz-Stablein, Brigid; Blum, Andreas; Braun, Stephan A.; Carr, Richard; Combalia, Marc; Fernandez-Figueras, Maria-Teresa; Ferrara, Gerardo; Fraitag, Sylvie; French, Lars E.; Gellrich, Frank F.; Ghoreschi, Kamran; Goebeler, Matthias; Guitera, Pascale; Haenssle, Holger A.; Haferkamp, Sebastian; Heinzerling, Lucie; Heppt, Markus V.; Hilke, Franz J.; Hobelsberger, Sarah; Krahl, Dieter; Kutzner, Heinz; Lallas, Aimilios; Liopyris, Konstantinos; Llamas-Velasco, Mar; Malvehy, Josep; Meier, Friedegund; Müller, Cornelia S.L.; Navarini, Alexander A.; Navarrete-Dechent, Cristián; Perasole, Antonio; Poch, Gabriela; Podlipnik, Sebastian; Requena, Luis; Rotemberg, Veronica M.; Saggini, Andrea; Sangueza, Omar P.; Santonja, Carlos; Schadendorf, Dirk; Schilling, Bastian; Schlaak, Max; Schlager, Justin G.; Sergon, Mildred; Sondermann, Wiebke; Soyer, H. Peter; Starz, Hans; Stolz, Wilhelm; Vale, Esmeralda; Weyers, Wolfgang; Zink, Alexander; Krieghoff-Henning, Eva; Kather, Jakob N.; von Kalle, Christof; Lipka, Daniel B.; Fröhling, Stefan; Hauschild, Axel; Kittler, Harald; Brinker, Titus J.
    Skin cancer classification via convolutional neural networks : Systematic review of studies involving human experts
    In: European Journal of Cancer (EJC) , Jg. 156 2021, S. 202 – 216
    DOI (Open Access)
  • Wessely, Anja; Steeb, Theresa; Berking, Carola; Schlaak, Max; Heppt, Markus V.; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K.C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus
    Surveillance of patients with conjunctival melanoma in German-speaking countries : A multinational survey of the German dermatologic cooperative oncology group
    In: European Journal of Cancer (EJC) , Jg. 143 2021, S. 43 – 45
    DOI
  • Hodi, F Stephen; Wolchok, Jedd D.; Schadendorf, Dirk; Larkin, James; Long, Georgina V.; Qian, Xiaozhong; Saci, Abdel; Young, Tina C.; Srinivasan, Sujaya; Chang, Han; Tang, Hao; Wind-Rotolo, Megan; Rizzo, Jasmine I.; Jackson, Donald G.; Ascierto, Paolo A.
    TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
    In: Cancer Immunology Research , Jg. 9 2021, Nr. 10, S. 1202 – 1213
    DOI (Open Access)
  • Malvehy, Josep; Samoylenko, Igor; Schadendorf, Dirk; Gutzmer, Ralf; Grob, Jean-Jacques; Sacco, Joseph J.; Gorski, Kevin S.; Anderson, Abraham; Pickett, Cheryl A.; Liu, Kate; Gogas, Helen
    Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions : Findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 9 2021, Nr. 3, S. e001621
    DOI (Open Access)
  • Hu, Hai; Khodadadi-Jamayran, Alireza; Dolgalev, Igor; Cho, Hyunwoo; Badri, Sana; Chiriboga, Luis A.; Zeck, Briana; de Rodas Gregorio, MiguelLopez; Dowling, Catríona M.; Labbe, Kristen; Deng, Jiehui; Chen, Ting; Zhang, Hua; Zappile, Paul; Chen, Ze; Ueberheide, Beatrix; Karatza, Angeliki; Han, Han; Ranieri, Michela; Tang, Sittinon; Jour, George; Osman, Iman; Sucker, Antje; Schadendorf, Dirk; Tsirigos, Aristotelis; Schalper, Kurt A.; Velcheti, Vamsidhar; Huang, Hsin-Yi; Jin, Yujuan; Ji, Hongbin; Poirier, John T.; Li, Fei; Wong, Kwok-Kin
    Targeting the Atf7ip–Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity
    In: Cancer Immunology Research , Jg. 9 2021, Nr. 11, S. 1298 – 1315
    DOI (Open Access)
  • Zaremba, Anne; Eggermont, Alexander M.M.; Robert, Caroline; Dummer, Reinhardt; Ugurel, Selma; Livingstone, Elisabeth; Ascierto, Paolo A.; Long, Georgina V.; Schadendorf, Dirk; Zimmer, Lisa
    The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
    In: European Journal of Cancer (EJC) , Jg. 155 2021, S. 268 – 280
    DOI
  • Váraljai, Renáta; Elouali, S.; Lueong, Smiths S.; Wistuba-Hamprecht, Kilian; Seremet, Teofila C.; Siveke, Jens; Becker, Jürgen; Sucker, Antje; Paschen, Annette; Horn, Peter; Neyns, Bart; Weide, Benjamin M.; Schadendorf, Dirk; Rösch, Alexander
    The predictive and prognostic significance of cell-free DNA concentration in melanoma
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 35 2021, Nr. 2, S. 387 – 395
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Stein, Lincoln D.; PCAWG Consortium
    A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
    In: Nature Communications , Jg. 11 2020, 728
    DOI (Open Access)
  • Dummer, Reinhard; Brase, Jan C.; Garrett, James; Campbell, Catarina D.; Gasal, Eduard; Squires, Matthew; Gusenleitner, Daniel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Flaherty, Keith; Larkin, James; Robert, Caroline; Kefford, Richard; Kirkwood, John M.; Hauschild, Axel; Schadendorf, Dirk; Long, Georgina V.
    Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV⁶⁰⁰-mutant, stage III melanoma (COMBI-AD) : Exploratory biomarker analyses from a randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 21 2020, Nr. 3, S. 358 – 372
    DOI (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A.; Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick; Utikal, Jochen
    Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trial
    In: Lancet , Jg. 395 2020, Nr. 10236, S. 1558 – 1568
    DOI
  • Eggermont, Alexander M.M.; Rutkowski, Piotr; Dutriaux, Caroline; Hofman-Wellenhof, Rainer; Dziewulski, Peter; Marples, Maria; Grange, Floren; Lok, Catherine; Pennachioli, Elisabetta; Robert, Caroline; van Akkooi, Alexander C.J.; Bastholt, Lars; Minisini, Alessandro; Marshall, Ernest; Salès, François; Grob, Jean-Jacques; Bechter, Oliver; Schadendorf, Dirk; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Testori, Alessandro A.E.
    Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary : Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial
    In: European Journal of Cancer (EJC) , Jg. 133 2020, S. 94 – 103
    DOI
  • Bhat, Hilal; Zaun, Gregor; Hamdan, Thamer A.; Lang, Judith; Adomati, Tom; Schmitz, Rosa; Friedrich, Sarah-Kim; Bergerhausen, Michael; Cham, Lamin B.; Li, Fanghui; Ali, Murtaza; Zhou, Fan; Khairnar, Vishal; Duhan, Vikas; Brandenburg, Tim; Machlah, Yara Maria; Schiller, Maximilian; Berry, Arshia; Xu, Haifeng; Vollmer, Jörg; Häussinger, Dieter; Thier, Beatrice; Pandyra, Aleksandra A.; Schadendorf, Dirk; Paschen, Annette; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
    In: Frontiers in Immunology , Jg. 11 2020, S. 1849
    DOI, Online Volltext (Open Access)
  • Jutzi, Tanja B.; Krieghoff-Henning, Eva I.; Holland-Letz, Tim; Utikal, Jochen Sven; Hauschild, Axel; Schadendorf, Dirk; Sondermann, Wiebke; Fröhling, Stefan; Hekler, Achim; Schmitt, Max; Maron, Roman C.; Brinker, Titus J.
    Artificial Intelligence in Skin Cancer Diagnostics : The Patients' Perspective
    In: Frontiers in Medicine , Jg. 7 2020, S. 233
    DOI (Open Access)
  • Eggermont, Alexander M. M.; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander; Robert, Caroline; Suciu, Stefan
    Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical Trial
    In: JAMA Oncology , Jg. 6 2020, Nr. 4, S. 519 – 527
    DOI (Open Access)
  • Puzanov, Igor; Ribas, Antoni; Robert, Caroline; Schachter, Jacob; Nyakas, Marta; Daud, Adil; Arance, Ana; Carlino, Matteo S.; O'Day, Steven J.; Long, Georgina V.; Margolin, Kim A.; Dummer, Reinhard; Schadendorf, Dirk; Lutzky, Jose; Ascierto, Paolo A.; Tarhini, Ahmad; Lin, Jianxin; Mogg, Robin; Homet Moreno, Blanca; Ibrahim, Nageatte; Hamid, Omid
    Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma : Pooled Analysis of 3 Clinical Trials
    In: JAMA Oncology , Jg. 6 2020, Nr. 8, S. 1256 – 1264
    DOI
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Arnon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; von Bubnoff, Dagmar; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Van Allen, Eliezer M.; Schadendorf, Dirk
    Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine , Jg. 26 2020, Nr. 7, S. 1147
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
    In: Nature Communications , Jg. 11 2020, Nr. 1, S. 6232
    DOI (Open Access)
  • Cabrita, Rita; Lauss, Martin; Sanna, Adriana; Donia, Marco; Skaarup Larsen, Mathilde; Mitra, Shamik; Johansson, Iva; Phung, Bengt; Harbst, Katja; Vallon-Christersson, Johan; van Schoiack, Alison; Lövgren, Kristina; Warren, Sarah; Jirström, Karin; Olsson, Håkan; Pietras, Kristian; Ingvar, Christian; Isaksson, Karolin; Schadendorf, Dirk; Schmidt, Henrik; Bastholt, Lars; Carneiro, Ana; Wargo, Jennifer A.; Svane, Inge Marie; Jönsson, Göran
    Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma
    In: Nature , Jg. 580 2020, Nr. 7801, S. E1
    DOI (Open Access)
  • Musche, Venja; Bäuerle, Alexander; Steinbach, Jasmin; Schweda, Adam; Hetkamp, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Beckmann, Mingo; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
    In: Frontiers in Psychology , Jg. 11 2020, S. 1984
    DOI (Open Access)
  • Brenner, Ellen; Schörg, Barbara F.; Ahmetlić, Fatima; Wieder, Thomas; Hilke, Franz Joachim; Simon, Nadine; Schroeder, Christopher; Demidov, German; Riedel, Tanja; Fehrenbacher, Birgit; Schaller, Martin; Forschner, Andrea; Eigentler, Thomas; Niessner, Heike; Sinnberg, Tobias; Böhm, Katharina S.; Hömberg, Nadine; Braumüller, Heidi; Dauch, Daniel; Zwirner, Stefan; Zender, Lars; Sonanini, Dominik; Geishauser, Albert; Bauer, Jürgen; Eichner, Martin; Jarick, Katja J.; Beilhack, Andreas; Biskup, Saskia; Döcker, Dennis; Schadendorf, Dirk; Quintanilla-Martinez, Leticia; Pichler, Bernd J.; Kneilling, Manfred; Mocikat, Ralph; Röcken, Martin
    Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours
    In: Nature Communications , Jg. 11 2020, Nr. 1, S. 1335
    DOI (Open Access)
  • Migden, Michael R.; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Lewis, Karl D.; Schmults, Chrysalyne D.; Hernandez-Aya, Leonel; Meier, Friedegund; Schadendorf, Dirk; Guminski, Alexander; Hauschild, Axel; Wong, Deborah J.; Daniels, Gregory A.; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Weinreich, David M.; Yancopoulos, George D.; Lowy, Israel; Fury, Matthew G.; Rischin, Danny
    Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trial
    In: The Lancet Oncology , Jg. 21 2020, Nr. 2, S. 294 – 305
    DOI (Open Access)
  • Sun, Wei; Zhao, Fang; Xu, Yu; Huang, Kai; Guo, Xianling; Zheng, Biqiang; Liu, Xin; Luo, Zhiguo; Kong, Yunyi; Xu, Midie; Schadendorf, Dirk; Chen, Yong
    Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1
    In: Cell Death and Disease , Jg. 11 2020, Nr. 7, 496
    DOI (Open Access)
  • David, Paul; Drabczyk-Pluta, Malgorzata; Pastille, Eva; Knuschke, Torben; Werner, Tanja; Honke, Nadine; Megger, Dominik A.; Akhmetzyanova, Ilseyar; Shaabani, Namir; Eyking-Singer, Annette; Cario, Elke; Kershaw, Olivia; Gruber, Achim D.; Tenbusch, Matthias; Dietze, Kirsten; Trilling, Mirko; Liu, Jia; Schadendorf, Dirk; Streeck, Hendrik; Lang, Karl S.; Xie, Youhua; Zimmer, Lisa; Sitek, Barbara; Paschen, Annette; Westendorf, Astrid; Dittmer, Ulf; Zelinskyy, Gennadiy
    Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
    In: PLoS Pathogens , Jg. 16 2020, Nr. 3, e1008340
    DOI (Open Access)
  • Dummer, Reinhard; Lebbé, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein A.; Ascierto, Paolo A.; Ribas, Antoni; Flaherty, Keith T.; Pakhle, Neha; Campbell, Catarina D.; Gusenleitner, Daniel; Masood, Aisha; Brase, Jan C.; Gasal, Eduard; Long, Georgina V.
    Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma : safety run-in and biomarker cohorts of COMBI-i
    In: Nature Medicine , Jg. 26 2020, Nr. 10, S. 1557 – 1563
    DOI
  • Küppers, Ralf; Schadendorf, Dirk; Shuai, Shimin; Stein, Lincoln D.
    Combined burden and functional impact tests for cancer driver discovery using DriverPower
    In: Nature Communications , Jg. 11 2020, 734
    DOI (Open Access)
  • Massi, Daniela; Mihic-Probst, Daniela; Schadendorf, Dirk; Dummer, Reinhard; Mandalà, Mario
    Dedifferentiated melanomas : Morpho-phenotypic profile, genetic reprogramming and clinical implications
    In: Cancer Treatment Reviews , Jg. 88 2020, S. 102060
    DOI
  • Küppers, Ralf; Schadendorf, Dirk; Bristow, Robert G.; Boutros, Paul C.; PCAWG Consortium
    Divergent mutational processes distinguish hypoxic and normoxic tumours
    In: Nature Communications , Jg. 11 2020, 737
    DOI (Open Access)
  • Chorti, Eleftheria; Kanaki, Theodora; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Gratsias, Emmanouil; Rösch, Alexander; Bonella, Francesco; Wessendorf, Thomas; Wälscher, Julia; Theegarten, Dirk; Schadendorf, Dirk; Livingstone, Elisabeth
    Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasis
    In: European Journal of Cancer (EJC) , Jg. 131 2020, S. 18 – 26
    DOI
  • Matull, Johanna; Livingstone, Elisabeth; Wetter, Axel; Zimmer, Lisa; Zaremba, Anne; Lahner, Harald; Schadendorf, Dirk; Ugurel, Selma
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade : A Case Report
    In: Frontiers in Oncology , Jg. 10 2020, S. 592609
    DOI, Online Volltext (Open Access)
  • Pohl, Julia; Mincu, Raluca-Ileana; Mrotzek, Simone Maria; Hinrichs, Lena; Michel, Lars; Livingstone, Elisabeth; Zimmer, Lisa; Wakili, Reza; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR Registry
    In: Journal of Clinical Medicine (JCM) , Jg. 9 2020, Nr. 7, 2060
    DOI, Online Volltext (Open Access)
  • Textoris-Taube, Kathrin; Cammann, Clemens; Henklein, Petra; Topfstedt, Eylin; Ebstein, Frédéric; Henze, Sarah; Liepe, Juliane; Zhao, Fang; Schadendorf, Dirk; Dahlmann, Burkhardt; Uckert, Wolfgang; Paschen, Annette; Mishto, Michele; Seifert, Ulrike
    ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope
    In: European Journal of Immunology , Jg. 50 2020, Nr. 2, S. 270 – 283
    DOI (Open Access)
  • Brinker, Titus J.; Faria, Bianca Lisa; De Faria, Olber Moreira; Klode, Joachim; Schadendorf, Dirk; Utikal, Jochen S.; Mons, Ute; Krieghoff-Henning, Eva; Lisboa, Oscar Campos; Oliveira, Ana Carla Cruz; Lino, Henrique Augusto; Bernardes-Souza, Breno
    Effect of a Face-Aging Mobile App-Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil : A Cluster-Randomized Clinical Trial
    In: JAMA Dermatology , Jg. 156 2020, Nr. 7, S. 737 – 745
    DOI (Open Access)
  • Hekler, Achim; Kather, Jakob N.; Krieghoff-Henning, Eva; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Upmeier zu Belzen, Julius; French, Lars; Schlager, Justin G.; Ghoreschi, Kamran; Wilhelm, Tabea; Kutzner, Heinz; Berking, Carola; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Izar, Benjamin; Maron, Roman; Schmitt, Max; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus J.
    Effects of Label Noise on Deep Learning-Based Skin Cancer Classification
    In: Frontiers in Medicine , Jg. 7 2020, S. 177
    DOI (Open Access)
  • Koch, F.; Salva, Katrin Agnes; Wirtz, M.; Hadaschik, Eva; Varaljai, Renáta; Schadendorf, Dirk; Rösch, Alexander
    Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses : A prospective, randomized and rater-blinded study (ACTICAP)
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 34 2020, Nr. 12, S. E844 – E846
    DOI
  • Ugurel, Selma; Schadendorf, Dirk; Horny, K.; Sucker, Antje; Schramm, Sabine; Utikal, Jochen; Pföhler, Claudia; Herbst, Rudolf A.; Schilling, B.; Blank, Christian U.; Becker, Jürgen; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
    In: Annals of Oncology , Jg. 31 2020, Nr. 1, S. 144 – 152
    DOI (Open Access)
  • Sondermann, Wiebke; von Kalle, Christof; Utikal, Jochen S.; Schadendorf, Dirk; Esser, Stefan; Durani, Benjamin; Durani, Hendrike; Jansen, Martin; Brinker, Titus J.
    Externe wissenschaftliche Evaluation der ersten Teledermatologie-App ohne direkten Patientenkontakt in Deutschland („Online Hautarzt – AppDoc“)
    In: Der Hautarzt , Jg. 71 2020, Nr. 11, S. 887 – 897
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Chorti, Eleftheria; Reissig, Timm M.; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Hadaschik, Eva; Griewank, Klaus; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 10, S. 1165 – 1168
    DOI (Open Access)
  • Dummer, R.; Hauschild, A.; Santinami, M.; Atkinson, V.; MandalÃ, M.; Kirkwood, J.M.; Sileni, V. Chiarion; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Robert, C.; Mortier, L.; Schachter, J.; Lesimple, T.; Plummer, R.; Dasgupta, K.; Gasal, E.; Tan, M.; Long, G.V.; Schadendorf, Dirk
    Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
    In: The New England Journal of Medicine , Jg. 383 2020, Nr. 12, S. 1139 – 1148
    DOI (Open Access)
  • Robert, Caroline; Long, Georgina V.; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Rutkowski, Piotr; Hassel, Jessica C.; McNeil, Catriona M.; Kalinka, Ewa Anna; Lebbé, Céleste; Charles, Julie; Hernberg, Micaela M.; Savage, Kerry J.; Chiarion-Sileni, Vanna; Mihalcioiu, Catalin; Mauch, Cornelia; Arance, Ana; Cognetti, Francesco; Ny, Lars; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Zoco, Jesús; Re, Sandra; Ascierto, Paolo A.; Atkinson, Victoria
    Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 33, S. 3937 – 3946
    DOI (Open Access)
  • Livingstone, Elisabeth; Zaremba, Anne; Horn, Susanne; Ugurel, Selma; Casalini, Belén; Schlaak, Max; Hassel, Jessica Cecile; Herbst, Rudolf A.; Utikal, Jochen; Weide, Benjamin M.; Gutzmer, Ralf; Meier, Friedegund E.; Koelsche, Christian; Hadaschik, Eva; Sucker, Antje; Reis, Henning; Merkelbach-Bruse, Sabine; Siewert, Martina M.; Sahm, Felix; von Deimling, Andreas; Cosgarea, Ioana; Zimmer, Lisa; Schadendorf, Dirk; Schilling, Bastian; Griewank, Klaus
    GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanoma
    In: British Journal of Dermatology: BJD , Jg. 183 2020, Nr. 5, S. 928 – 939
    DOI (Open Access)
  • Landi, Maria Teresa; Bishop, D. Timothy; MacGregor, Stuart; Machiela, Mitchell J.; Stratigos, Alexander J.; Ghiorzo, Paola; Brossard, Myriam; Calista, Donato; Choi, Jiyeon; Fargnoli, Maria Concetta; Zhang, Tongwu; Rodolfo, Monica; Trower, Adam J.; Menin, Chiara; Martinez, Jacobo; Hadjisavvas, Andreas; Song, Lei; Stefanaki, Irene; Scolyer, Richard; Yang, Rose; Goldstein, Alisa M.; Potrony, Miriam; Kypreou, Katerina P.; Pastorino, Lorenza; Queirolo, Paola; Pellegrini, Cristina; Cattaneo, Laura; Zawistowski, Matthew; Gimenez-Xavier, Pol; Rodriguez, Arantxa; Elefanti, Lisa; Manoukian, Siranoush; Rivoltini, Licia; Smith, Blair H.; Loizidou, Maria A.; Del Regno, Laura; Massi, Daniela; Mandala, Mario; Khosrotehrani, Kiarash; Akslen, Lars A.; Amos, Christopher I.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Soyer, H. Peter; Bataille, Veronique; Dalmasso, Bruna; Bowdler, Lisa M.; Burdon, Kathryn P.; Chen, Wei V.; Codd, Veryan; Craig, Jamie E.; Dębniak, Tadeusz; Falchi, Mario; Fang, Shenying; Friedman, Eitan; Simi, Sarah; Galan, Pilar; Garcia-Casado, Zaida; Gillanders, Elizabeth M.; Gordon, Scott; Green, Adele; Gruis, Nelleke A.; Hansson, Johan; Harland, Mark; Harris, Jessica; Helsing, Per; Henders, Anjali; Hočevar, Marko; Höiom, Veronica; Hunter, David; Ingvar, Christian; Kumar, Rajiv; Lang, Julie; Lathrop, G. Mark; Lee, Jeffrey E.; Li, Xin; Lubiński, Jan; Mackie, Rona M.; Malt, Maryrose; Malvehy, Josep; McAloney, Kerrie; Mohamdi, Hamida; Molven, Anders; Moses, Eric K.; Neale, Rachel E.; Novaković, Srdjan; Nyholt, Dale R.; Olsson, Håkan; Orr, Nicholas; Fritsche, Lars G.; Puig-Butille, Joan Anton; Qureshi, Abrar A.; Radford-Smith, Graham L.; Randerson-Moor, Juliette; Requena, Celia; Rowe, Casey; Samani, Nilesh J.; Sanna, Marianna; Schadendorf, Dirk; Schulze, Hans-Joachim; Simms, Lisa A.; Smithers, Mark; Song, Fengju; Swerdlow, Anthony J.; van der Stoep, Nienke; Kukutsch, Nicole A.; Visconti, Alessia; Wallace, Leanne; Ward, Sarah V.; Wheeler, Lawrie; Sturm, Richard A.; Hutchinson, Amy; Jones, Kristine; Malasky, Michael; Vogt, Aurelie; Zhou, Weiyin; Pooley, Karen A.; Elder, David E.; Han, Jiali; Hicks, Belynda; Hayward, Nicholas K.; Kanetsky, Peter A.; Brummett, Chad; Montgomery, Grant W.; Olsen, Catherine M.; Hayward, Caroline; Dunning, Alison M.; Martin, Nicholas G.; Evangelou, Evangelos; Mann, Graham J.; Long, Georgina; Pharoah, Paul D. P.; Easton, Douglas F.; Barrett, Jennifer H.; Cust, Anne E.; Abecasis, Goncalo; Duffy, David L.; Whiteman, David C.; Gogas, Helen; De Nicolo, Arcangela; Tucker, Margaret A.; Newton-Bishop, Julia A.; Peris, Ketty; Chanock, Stephen J.; Demenais, Florence; Brown, Kevin M.; Puig, Susana; Nagore, Eduardo; Shi, Jianxin; Iles, Mark M.; Law, Matthew H.
    Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
    In: Nature Genetics , Jg. 52 2020, Nr. 5, S. 494 – 504
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Feuerbach, Lars; PCAWG Consortium
    Genomic footprints of activated telomere maintenance mechanisms in cancer
    In: Nature Communications , Jg. 11 2020, 733
    DOI (Open Access)
  • Mandala, M.; Arance, A.; Dummer, R.; Ascierto, P.A.; Gogas, H.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsová, I.; Gutzmer, R.; Chiarion Sileni, V.; Dutriaux, C.; Loquai, C.; Tadmouri, A.; Pickard, M.D.; Gollerkeri, A.; Robert, C.; Flaherty, K.T.
    Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma : DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma
    In: Value in Health , Jg. 23 2020, Nr. Suppl. 2, S. 428
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Creighton, Chad J.; PCAWG Consortium
    High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    In: Nature Communications , Jg. 11 2020, 736
    DOI (Open Access)
  • Leiter, Ulrike; Loquai, Carmen; Reinhardt, Lydia; Rafei-Shamsabadi, David; Gutzmer, Ralf; Kaehler, Katharina; Heinzerling, Lucie; Hassel, Jessica C.; Glutsch, Valerie; Sirokay, Judith; Schlecht, Nora; Rübben, Albert; Gambichler, Thilo; Schatton, Kerstin; Pfoehler, Claudia; Franklin, Cindy; Terheyden, Patrick; Haferkamp, Sebastian; Mohr, Peter; Bischof, Lena; Livingstone, Elisabeth; Zimmer, Lisa; Weichenthal, Michael; Schadendorf, Dirk; Meiwes, Andreas; Keim, Ulrike; Garbe, Claus; Becker, Jürgen; Ugurel, Selma
    Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy : A retrospective multicenter DeCOG study of 84 patients
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 2, S. e000897
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Immuntherapie beim malignen Melanom
    In: Der Internist , Jg. 61 2020, Nr. 7, S. 669 – 675
    DOI (Open Access)
  • Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pföhler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk; Ugurel, Selma
    Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma : A multicenter retrospective cohort study of the DeCOG
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 1, S. e000395
    DOI (Open Access)
  • Hemstock, Matthew; Amadi, Adenike; Kupas, Katrin; Roskell, Neil; Kotapati, Srividya; Gooden, Kyna; Middleton, Mark R.; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
    In: European Journal of Cancer (EJC) , Jg. 132 2020, S. 176 – 186
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Cmero, Marek; Macintyre, Geoff; PCAWG Consortium
    Inferring structural variant cancer cell fraction
    In: Nature Communications , Jg. 11 2020, 730
    DOI (Open Access)
  • Melms, Johannes C.; Vallabhaneni, Sreeram; Mills, Caitlin E.; Yapp, Clarence; Chen, Jia-Yun; Morelli, Eugenio; Waszyk, Patricia; Kumar, Sushil; Deming, Derrick; Moret, Nienke; Rodriguez, Steven; Subramanian, Kartik; Rogava, Meri; Cartwright, Adam N.R.; Luoma, Adrienne; Mei, Shaolin; Brinker, Titus J.; Miller, David M.; Spektor, Alexander; Schadendorf, Dirk; Riggi, Nicolo; Wucherpfennig, Kai W.; Sorger, Peter K.; Izar, Benjamin
    Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity
    In: Cancer Research , Jg. 80 2020, Nr. 4, S. 798 – 810
    DOI (Open Access)
  • Conway, Jake R.; Dietlein, Felix; Taylor-Weiner, Amaro; AlDubayan, Saud; Vokes, Natalie; Keenan, Tanya; Reardon, Brendan; He, Meng Xiao; Margolis, Claire A.; Weirather, Jason L.; Haq, Rizwan; Schilling, Bastian; Stephen Hodi, F.; Schadendorf, Dirk; Liu, David; Van Allen, Eliezer M.
    Integrated molecular drivers coordinate biological and clinical states in melanoma
    In: Nature Genetics , Jg. 52 2020, Nr. 12, S. 1373 – 1383
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Integrative pathway enrichment analysis of multivariate omics data
    In: Nature Communications , Jg. 11 2020, 735
    DOI (Open Access)
  • Hauschild, Axel; Ascierto, Paolo A.; Schadendorf, Dirk; Grob, Jean Jacques; Ribas, Antoni; Kiecker, Felix; Dutriaux, Caroline; Demidov, Lev V.; Lebbé, Céleste; Rutkowski, Piotr; Blank, Christian U.; Gutzmer, Ralf; Millward, Michael; Kefford, Richard; Haas, Tomas; D'Amelio, Anthony; Gasal, Eduard; Mookerjee, Bijoyesh; Chapman, Paul B.
    Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy : Analysis from phase 2 and 3 clinical trials
    In: European Journal of Cancer (EJC) , Jg. 125 2020, S. 114 – 120
    DOI (Open Access)
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; van Akkooi, Alexander C.J.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline
    Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma : Updated results from the EORTC 1325-MG/KEYNOTE-054 trial
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 33, S. 3925 – 3936
    DOI (Open Access)
  • Herrera-Rios, Dayana; Mughal, Sadaf S.; Teuber-Hanselmann, Sarah; Pierscianek, Daniela; Sucker, Antje; Jansen, Philipp; Schimming, Tobias; Klode, Joachim; Reifenberger, Julia; Felsberg, Jörg; Keyvani, Kathy; Brors, Benedikt; Sure, Ulrich; Reifenberger, Guido; Schadendorf, Dirk; Helfrich, Iris
    Macrophages/microglia represent the major source of indolamine 2,3-dioxygenase expression in melanoma metastases of the brain
    In: Frontiers in Immunology , Jg. 11 2020 , Article-No: 120
    DOI, Online Volltext (Open Access)
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Pathologe , Jg. 41 2020, Nr. 3, S. 281 – 292
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Hautarzt , Jg. 71 2020, S. 63 – 77
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Onkologe , Jg. 26 2020, Nr. 1, S. 75 – 87
    DOI
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen Melanom
    In: Der Onkologe , Jg. 26 2020, Nr. 8, S. 713 – 720
    DOI
  • Gutzmer, Ralf; Vordermark, Dirk; Hassel, Jessica C.; Krex, Dietmar; Wendl, Christina; Schadendorf, Dirk; Sickmann, Thomas; Rieken, Stefan; Pukrop, Tobias; Höller, Christoph; Eigentler, Thomas K.; Meier, Friedegund
    Melanoma brain metastases – Interdisciplinary management recommendations 2020
    In: Cancer Treatment Reviews , Jg. 89 2020, S. 102083
    DOI
  • Tasdogan, Alpaslan; Faubert, Brandon; Ramesh, Vijayashree; Ubellacker, Jessalyn M.; Shen, Bo; Solmonson, Ashley; Murphy, Malea M.; Gu, Zhimin; Gu, Wen; Martin, Misty; Kasitinon, Stacy Y.; Vandergriff, Travis; Mathews, Thomas P.; Zhao, Zhiyu; Schadendorf, Dirk; DeBerardinis, Ralph J.; Morrison, Sean J.
    Metabolic heterogeneity confers differences in melanoma metastatic potential
    In: Nature , Jg. 577 2020, Nr. 7788, S. 115 – 120
    DOI (Open Access)
  • Michel, Lars; Schadendorf, Dirk; Rassaf, Tienush
    Onkokardiologie : Neue Herausforderungen, neue Möglichkeiten
    In: Herz: Cardiovascular Diseases , Jg. 45 2020, S. 619 – 625
    DOI (Open Access)
  • Ascierto, Paolo Antonio; Del Vecchio, Michelle; Mackiewicz, Andrzej; Robert, Caroline; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Svane, Inge Marie; Mcneil, Catriona; Rutkowski, Piotr; Loquai, Carmen; Mortier, Laurent; Hamid, Omid; Bastholt, Lars; Dreno, Brigitte; Schadendorf, Dirk; Garbe, Claus; Nyakas, Marta; Grob, Jean-Jacques; Thomas, Luc; Liszkay, Gabriella; Smylie, Michael; Hoeller, Christoph; Ferraresi, Virginia; Grange, Florent; Gutzmer, Ralf; Pikiel, Joanna; Hosein, Fareeda; Simsek, Burcin; Maio, Michele
    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 1
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium; et al.
    Pan-cancer analysis of whole genomes
    In: Nature , Jg. 578 2020, Nr. 7793, S. 82 – 93
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Pathway and network analysis of more than 2500 whole cancer genomes
    In: Nature Communications , Jg. 11 2020, 729
    DOI (Open Access)
  • Rischin, Danny; Migden, Michael R.; Lim, Annette M.; Schmults, Chrysalyne D.; Khushalani, Nikhil I.; Hughes, Brett G.M.; Schadendorf, Dirk; Dunn, Lara A.; Hernandez-Aya, Leonel; Chang, Anne Lynn S.; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C.; Geiger, Jessica L.; Gutzmer, Ralf; Alam, Murad; Okoye, Emmanuel; Mathias, Melissa; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Guminski, Alexander
    Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma : Primary analysis of fixed-dosing, long-term outcome of weight-based dosing
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 1, S. e000775
    DOI (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Terheyden, Patrick; Sucker, Antje; Hassel, Jessica C.; Ritter, Cathrin; Kubat, Linda; Habermann, Daniel; Farahpour, Farnoush; Saeedghalati, Mohammadkarim; Peiffer, Lukas; Kumar, Rajiv; Schrama, David; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Jürgen C.
    Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
    In: Clinical Cancer Research , Jg. 26 2020, Nr. 9, S. 2257 – 2267
    DOI (Open Access)
  • Garbe, Claus; Keim, Ulrike; Suciu, Stefan; Amaral, Teresa; Eigentler, Thomas K.; Gesierich, Anja; Hauschild, Axel; Heinzerling, Lucie; Kiecker, Felix; Schadendorf, Dirk; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zouboulis, Christos C.; Keilholz, Ulrich; Testori, Alessandro; Martus, Peter; Leiter, Ulrike; Eggermont, Alexander M.M.
    Prognosis of patients with stage III melanoma according to American joint committee on cancer version 8 : A reassessment on the basis of 3 independent stage III melanoma cohorts
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 22, S. 2543 – 2551
    DOI (Open Access)
  • Ascierto, P.A.; Lewis, K.D.; Di Giacomo, A.M.; Demidov, L.; Mandalà, M.; Bondarenko, I.; Herbert, C.; Mackiewicz, A.; Rutkowski, P.; Guminski, A.; Simmons, B.; Ye, C.; Hooper, G.; Wongchenko, M.J.; Goodman, G.R.; Yan, Y.; Schadendorf, Dirk
    Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenib
    In: Annals of Oncology , Jg. 31 2020, Nr. 1, S. 153 – 159
    DOI (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Fosko, Scott W.; Zloty, David M.; Labeille, Bruno; Grob, Jean Jacques; Puig, Susana; Makrutzki, Martina; Gilberg, Frank; Hong, A.; Dréno, Brigitte; Rogers, Gary S.; Kunstfeld, Rainer
    Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas : Patient‐reported outcomes from the MIKIE study
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 34 2020, Nr. 9, S. e526 – e529
    DOI
  • Dummer, Reinhard; Ascierto, Paolo A.; Nathan, Paul; Robert, Caroline; Schadendorf, Dirk
    Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A Review
    In: JAMA Oncology , Jg. 6 2020, Nr. 12, S. 1957 – 1966
    DOI
  • Küppers, Ralf; Schadendorf, Dirk; Morris, Quaid D.; PCAWG Consortium
    Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
    In: Nature Communications , Jg. 11 2020, 731
    DOI (Open Access)
  • Hekler, Achim; Utikal, Jochen S.; Solass, Wiebke; Schmitt, Max; Klode, Joachim; Schadendorf, Dirk; Sondermann, Wiebke; Franklin, Cindy; Bestvater, Felix; Krahl, Dieter; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus J.
    Reply to the letter to the editor: ‘Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images’
    In: European Journal of Cancer (EJC) , Jg. 130 2020, S. 262 – 264
    DOI (Open Access)
  • Bazhin, Alexandr V.; Tambor, Vojtech; Dikov, Boyan; Philippov, Pavel P.; Schadendorf, Dirk; Eichmüller, Stefan B.
    Retraction Note to : cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells
    In: Cellular and Molecular Life Sciences - CMLS , Jg. 77 2020, Nr. 5, 963
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
    In: Nature Communications , Jg. 11 2020, Nr. 1, S. 4748
    DOI (Open Access)
  • Eigentler, Thomas K.; Augustin, Matthias; Beer, Ambros J.; Bendel, Martin; Berking, Carola; Bölükbas, Servet; Dippel, Egdar; Fehm, Tanja; Feyer, Petra; Foilman, Markus; Forschner, Andrea; Frerich, Bernhard; Gärtner, Jan; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Heinzerling, Lucie; Heppt, Markus; Hübner, Jutta; Kähler, Katharina; Kiehl, Martina; Kölbl, Oliver; Krause-Bergmann, Albrecht; Lang, Stephan; Langer, Thomas; Leiter, Ulrike; Loquai, Carmen; Löser, Christoph; Mehlhorn, Grit; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Müller, Cornelia; Nehls, Wiebke; Noah, Ernst Magnus; Rösch, Alexander; Schilling, Bastian; Schmid-Wendtner, Monika; Tietze, Julia; Vogt, Thomas; Wehrmann, Jochen; Weichenthal, Michael; Weide, Benjamin; Wick, Wolfgang; Ziemer, Mirjana; Zimmer, Lisa; Garbe, Claus; Schadendorf, Dirk
    S3 Guideline for the Diagnosis, Therapy and Follow‐Up of Malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 10, S. 1079 – 1208
    DOI (Open Access)
  • Jansen, Philipp; Stoffels, Ingo; Müseler, Anne-Christine; Petri, Maximilian; Brinker, Titus J.; Schedlowski, Manfred; Schadendorf, Dirk; Engler, Harald; Klode, Joachim
    Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia : A prospective study
    In: World Journal of Surgical Oncology , Jg. 18 2020, Nr. 1, S. 53
    DOI, Online Volltext (Open Access)
  • Turiello, Roberta; Capone, Mariaelena; Giannarelli, Diana; Morretta, Elva; Monti, Maria Chiara; Madonna, Gabriele; Mallardo, Domenico; Festino, Lucia; Azzaro, Rosa; Levesque, Mitchell P.; Imhof, Laurence; Weide, Benjamin; Amaral, Teresa; Chevrier, Marc; Sucker, Antje; Rutkowski, Piotr; Schadendorf, Dirk; Lebbe, Celeste; Luke, Jason John; Wistuba-Hamprecht, Kilian; Dummer, Reinhard; Pinto, Aldo; Morello, Silvana; Ascierto, Paolo A.
    Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 2, S. e001689
    DOI (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; PCAWG Tumour Subtypes and Clinical Translation; PCAWG Consortium
    Sex differences in oncogenic mutational processes
    In: Nature Communications , Jg. 11 2020, Nr. 1, S. 4330
    DOI (Open Access)
  • Dummer, Reinhard G.; Ascierto, Paolo A.; Basset-Seguin, Nicole; Dréno, Brigitte; Garbe, Claus; Gutzmer, Ralf; Hauschild, Axel; Krattinger, Regina; Lear, John T.; Malvehy, Josep; Schadendorf, Dirk; Grob, Jean Jacques
    Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma : A joint expert opinion
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 34 2020, Nr. 9, S. 1944 – 1956
    DOI (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Becker, Jürgen C.; Flaherty, Keith T.; Grob, Jean J.; Hauschild, Axel; Larkin, James; Livingstone, Elisabeth; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
    In: European Journal of Cancer (EJC) , Jg. 130 2020, S. 126 – 138
    DOI
  • Farah, Maya; Reuben, Alexandre; Spassova, Ivelina; Yang, Richard K.; Kubat, Linda; Nagarajan, Priyadharsini; Ning, Jing; Li, Wen; Aung, Phyu P.; Curry, Jonathan L.; Torres-Cabala, Carlos A.; Hudgens, Courtney W.; Ugurel, Selma; Schadendorf, Dirk; Gumbs, Curtis; Little, Latasha D.; Futreal, Andrew; Wistuba, Ignacio I.; Prieto, Victor G.; Wang, Linghua; Wong, Michael K.; Wargo, Jennifer A.; Becker, Jürgen; Tetzlaff, Michael T.
    T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
    In: Journal of Investigative Dermatology , Jg. 140 2020, Nr. 11, S. 2146 – 2156.e4
    DOI (Open Access)
  • Such, Lina; Zhao, Fang; Liu, Derek; Thier, Beatrice; Le-Trilling, Vu Thuy Khanh; Sucker, Antje; Coch, Christoph; Pieper, Natalia; Howe, Sebastian; Bhat, Hilal; Kalkavan, Halime; Ritter, Cathrin; Brinkhaus, Robin; Ugurel, Selma; Köster, Johannes; Seifert, Ulrike; Dittmer, Ulf; Schuler, Martin; Lang, Karl S.; Kufer, Thomas A.; Hartmann, Gunther; Becker, Jürgen; Horn, Susanne; Ferrone, Soldano; Liu, David; Van Allen, Eliezer M.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Paschen, Annette
    Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
    In: The Journal of Clinical Investigation (JCI) , Jg. 130 2020, Nr. 8, S. 4266 – 4281
    DOI (Open Access)
  • Cabrita, Rita; Lauss, Martin; Sanna, Adriana; Donia, Marco; Larsen, Mathilde; Schadendorf, Dirk
    Tertiary lymphoid structures improve immunotherapy and survival in melanoma
    In: Nature , Jg. 577 2020, Nr. 7791, S. 561 – 565
    DOI
  • Gebhardt, Christoffer; Ascierto, Paolo; Atkinson, Victoria; Corrie, Pippa; Dummer, Reinhard; Schadendorf, Dirk
    The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions
    In: European Journal of Cancer (EJC) , Jg. 138 2020, S. 68 – 76
    DOI
  • Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline
    Update on tolerability and overall survival in COLUMBUS : landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
    In: European Journal of Cancer (EJC) , Jg. 126 2020, S. 33 – 44
    DOI (Open Access)
  • Matsuya, Taisuke; Nakamura, Yasuhiro; Matsushita, Shigeto; Tanaka, Ryota; Teramoto, Yukiko; Asami, Yuri; Uehara, Jiro; Aoki, Megumi; Yamamura, Kentaro; Nakamura, Yoshiyuki; Fujisawa, Yasuhiro; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Kagamu, Hiroshi; Fujimoto, Manabu; Honma, Masaru; Ishida-Yamamoto, Akemi; Araki, Ryuichiro; Yamamoto, Akifumi
    Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma : A multi-institutional retrospective study
    In: The Journal of Dermatology , Jg. 47 2020, Nr. 6, S. 629 – 635
    DOI
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Klode, Joachim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Schadendorf, Dirk; Fröhling, Stefan; von Kalle, Christof; Ludwig-Peitsch, Wiebke; Sirokay, Judith; Heinzerling, Lucie; Albrecht, Magarete; Baratella, Katharina; Bischof, Lena; Chorti, Eleftheria; Dith, Anna; Drusio, Christina; Giese, Nina; Gratsias, Emmanouil; Griewank, Klaus; Hallasch, Sandra; Hanhart, Zdenka; Herz, Saskia; Hohaus, Katja; Jansen, Philipp; Jockenhöfer, Finja; Kanaki, Theodora; Knispel, Sarah; Leonhard, Katja; Martaki, Anna; Matei, Liliana; Matull, Johanna; Olischewski, Alexandra; Petri, Maximilian; Placke, Jan-Malte; Raub, Simon; Salva, Katrin; Schlott, Swantje; Sody, Elsa; Steingrube, Nadine; Stoffels, Ingo; Ugurel, Selma; Sondermann, Wiebke; Zaremba, Anne; Gebhardt, Christoffer; Booken, Nina; Christolouka, Maria; Buder-Bakhaya, Kristina; Bokor-Billmann, Therezia; Gholam, Patrick; Hänßle, Holger; Salzmann, Martin; Schäfer, Sarah; Schäkel, Knut; Schank, Timo; Bohne, Ann-Sophie; Deffaa, Sophia; Drerup, Katharina; Egberts, Friederike; Erkens, Anna-Sophie; Ewald, Benjamin; Falkvoll, Sandra; Gerdes, Sascha; Harde, Viola; Jost, Marion; Kosova, Katja; Messinger, Laetitia; Metzner, Malte; Morrison, Kirsten; Motamedi, Rogina; Pinczker, Anja; Rosenthal, Anne; Scheller, Natalie; Schwarz, Thomas; Stölzl, Dora; Thielking, Federieke; Tomaschewski, Elena; Wehkamp, Ulrike; Weichenthal, Michael; Wiedow, Oliver; Bär, Claudia Maria; Bender-Säbelkampf, Sophia; Horbrügger, Marc; Karoglan, Ante; Kraas, Luise; Faulhaber, Jörg; Geraud, Cyrill; Guo, Ze; Koch, Philipp; Linke, Miriam; Maurier, Nolwenn; Müller, Verena; Thomas, Benjamin; Utikal, Jochen Sven; Alamri, Ali Saeed M.; Baczako, Andrea; Betke, Matthias; Haas, Carolin; Hartmann, Daniela; Heppt, Markus V.; Kilian, Katharina; Krammer, Sebastian; Lapczynski, Natalie Lidia; Mastnik, Sebastian; Nasifoglu, Suzan; Ruini, Cristel; Sattler, Elke; Schlaak, Max; Wolff, Hans; Achatz, Birgit; Bergbreiter, Astrid; Drexler, Konstantin; Ettinger, Monika; Halupczok, Anna; Hegemann, Marie; Dinauer, Verena; Maagk, Maria; Mickler, Marion; Philipp, Biance; Wilm, Anna; Wittmann, Constanze; Gesierich, Anja; Glutsch, Valerie; Kahlert, Katrin; Kerstan, Andreas; Schrüfer, Philipp
    A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task
    In: European Journal of Cancer (EJC) , Jg. 111 2019, S. 148 – 154
    DOI (Open Access)
  • Heinzerling, Lucie; Ascierto, Paolo Antonio; Dummer, Reinhard; Gogas, Helen; Lebbé, Celeste; Long, Georgina V.; McArthur, Grant A .; Moslehi, Javad; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D.; Hauschild, Axel
    Adverse events 2.0—Let us get SERIOs : New reporting for adverse event outcomes needed in the era of immunooncology
    In: European Journal of Cancer (EJC) , Jg. 112 2019, S. 29 – 31
    DOI
  • Gogas, Helen J.; Flaherty, Keith T.; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline
    Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study : incidence, course and management
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 97 – 106
    DOI (Open Access)
  • Cosgarea, Ioana; Koelsch, Bernd; Fischer, Christine; Griewank, Klaus; van den Berg, Linda; Kutritz, Anja; Schadendorf, Dirk; Kindler-Röhrborn, Andrea
    An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)
    In: Journal of Investigative Dermatology , Jg. 139 2019, Nr. 10, S. 2235 – 2238.e5
    DOI (Open Access)
  • Storim, Julian; Verheyen, Jens; Wolff, Eva; Wohlschläger, Jeremias; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    Antiretroviral therapy suppresses rectal HIV-RNA shedding despite inflammation in MSM with rectal C. trachomatis and N. gonorrhoeae infections - A cross-sectional, single-center study
    In: Sexually Transmitted Infections , Jg. 95 2019, Nr. 2, S. 95 – 98
    DOI (Open Access)
  • Váraljai, Renáta; Wistuba-Hamprecht, Kilian; Seremet, Teofila; Diaz, Joey Mark S.; Nsengimana, Jérémie; Sucker, Antje; Griewank, Klaus; Placke, Jan-Malte; Horn, Peter A.; Neuhoff, Nils von; Shannan, Batool; Chauvistré, Heike; Vogel, Felix C.E.; Horn, Susanne; Becker, Jürgen; Newton-Bishop, Julia; Stang, Andreas; Neyns, Bart; Weide, Benjamin; Schadendorf, Dirk; Rösch, Alexander
    Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma
    In: JCO Precision Oncology , Jg. 3 2019
    DOI (Open Access)
  • Stoffels, Ingo; Jansen, Philipp; Petri, Maximilian; Goerdt, Lukas; Brinker, Titus J.; Griewank, Klaus; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in Melanoma
    In: JAMA Network Open , Jg. 2 2019, Nr. 8, S. e199020
    DOI (Open Access)
  • Reinsch, Nico; Streeck, Hendrik; Holzendorf, Volker; Schulze, Christina; Neumann, Till; Brockmeyer, Norbert H.; Kehrmann, Jan; Schadendorf, Dirk; Esser, Stefan
    B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV : Results from the HIV-HEART study
    In: International Journal of Cardiology , Jg. 281 2019, S. 127 – 132
    DOI
  • van Herpen, Carla M.L.; Agarwala, Sanjiv S.; Hauschild, Axel; Berking, Carola; Beck, J. Thaddeus; Schadendorf, Dirk; Jansen, Rob; Queirolo, Paola; Ascierto, Paolo A.; Blank, Christian U.; Heinrich, Michael C.; Pal, Rupam R.; Derti, Adnan; Antona, Victor; Nauwelaerts, Heidi; Zubel, Angela; Dummer, Reinhard
    Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma
    In: OncoTarget , Jg. 10 2019, Nr. 19, S. 1850 – 1859
    DOI (Open Access)
  • Mincu, Raluca I.; Mahabadi, Amir Abbas; Michel, Lars; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    Cardiovascular Adverse Events Associated with BRAF and MEK Inhibitors : A Systematic Review and Meta-analysis
    In: JAMA Network Open , Jg. 2 2019, Nr. 8, S. e198890
    DOI (Open Access)
  • Syeda, Mahrukh M; WIGGINS, JENNIFER M; Corless, Broderick; Long, Georgina V.; Flaherty, Keith; Schadendorf, Dirk; Nathan, Paul D.; Robert, Caroline; Ribas, Antoni; Davies, Michael A.; Grob, Jean Jacques; Gasal, Eduard; Squires, Matthew; Marker, Mahtab; Brase, Jan C.; Polsky, David
    Circulating tumor DNA (ctDNA) kinetics to predict survival in patients (pts) with unresectable or metastatic melanoma treated with dabrafenib (D) or D + trametinib (T)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15_suppl, S. 9510
    DOI
  • Zaremba, Anne; Murali, Rajmohan; Jansen, Philipp; Möller, Inga; Sucker, Antje; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Brinker, Titus J.; Hadaschik, Eva; Franklin, Cindy; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus; Cosgarea, Ioana
    Clinical and genetic analysis of melanomas arising in acral sites
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 66 – 76
    DOI (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Enk, Alexander H.; Haferkamp, Sebastian; Karoglan, Ante; von Kalle, Christof; Weichenthal, Michael; Sattler, Elke; Schadendorf, Dirk; Gaiser, Maria R.; Klode, Joachim; Utikal, Jochen S.
    Comparing artificial intelligence algorithms to 157 German dermatologists : the melanoma classification benchmark
    In: European Journal of Cancer (EJC) , Jg. 111 2019, S. 30 – 37
    DOI (Open Access)
  • Kappelmann-Fenzl, Melanie; Kuphal, Silke; Krupar, Rosemarie; Schadendorf, Dirk; Umansky, Viktor; Vardimon, Lily; Hellerbrand, Claus; Bosserhoff, Anja-Katrin
    Complex formation with monomeric α-tubulin and importin 13 fosters c-jun protein stability and is required for c-jun’s nuclear translocation and activity
    In: Cancers , Jg. 11 2019, Nr. 11, S. 1806
    DOI (Open Access)
  • Sekulic, Aleksandar; Migden, Michael R.; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher D.; Miller, Chris; Mortier, Laurent; Murrell, Dédée F.; Hamid, Omid; Quevedo, Jorge F.; Hou, Jeannie; Mckenna, Edward; Dimier, Natalie; Williams, Sarah; Schadendorf, Dirk; Hauschild, Axel
    Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : final update of the pivotal ERIVANCE BCC study
    In: BMC Cancer , Jg. 19 2019, S. 366
    DOI (Open Access)
  • Hekler, Achim; Utikal, Jochen S.; Enk, Alexander H.; Solass, Wiebke; Schmitt, Max; Klode, Joachim; Schadendorf, Dirk; Sondermann, Wiebke; Franklin, Cindy; Bestvater, Felix; Flaig, Michael J.; Krahl, Dieter; Kalle, Christof von; Fröhling, Stefan; Brinker, Titus J.
    Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images
    In: European Journal of Cancer (EJC) , Jg. 118 2019, S. 91 – 96
    DOI (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Klode, Joachim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Schadendorf, Dirk; Holland-Letz, Tim; von Kalle, Christof; Ludwig-Peitsch, Wiebke; Sirokay, Judith; Heinzerling, Lucie; Albrecht, Magarete; Baratella, Katharina; Bischof, Lena; Chorti, Eleftheria; Dith, Anna; Drusio, Christina; Giese, Nina; Gratsias, Emmanouil; Griewank, Klaus; Hallasch, Sandra; Hanhart, Zdenka; Herz, Saskia; Hohaus, Katja; Jansen, Philipp; Jockenhöfer, Finja; Kanaki, Theodora; Knispel, Sarah; Leonhard, Katja; Martaki, Anna; Matei, Liliana; Matull, Johanna; Olischewski, Alexandra; Petri, Maximilian; Placke, Jan-Malte; Raub, Simon; Salva, Katrin; Schlott, Swantje; Sody, Elsa; Steingrube, Nadine; Stoffels, Ingo; Ugurel, Selma; Zaremba, Anne; Gebhardt, Christoffer; Booken, Nina; Christolouka, Maria; Buder-Bakhaya, Kristina; Bokor-Billmann, Therezia; Gholam, Patrick; Hänßle, Holger; Salzmann, Martin; Schäfer, Sarah; Schäkel, Knut; Schank, Timo; Bohne, Ann-Sophie; Deffaa, Sophia; Drerup, Katharina; Egberts, Friederike; Erkens, Anna-Sophie; Ewald, Benjamin; Falkvoll, Sandra; Gerdes, Sascha; Harde, Viola; Jost, Marion; Kosova, Katja; Messinger, Laetitia; Metzner, Malte; Morrison, Kirsten; Motamedi, Rogina; Pinczker, Anja; Rosenthal, Anne; Scheller, Natalie; Schwarz, Thomas; Stölzl, Dora; Thielking, Federieke; Tomaschewski, Elena; Wehkamp, Ulrike; Weichenthal, Michael; Wiedow, Oliver; Bär, Claudia Maria; Bender-Säbelkampf, Sophia; Horbrügger, Marc; Karoglan, Ante; Kraas, Luise; Faulhaber, Jörg; Geraud, Cyrill; Guo, Ze; Koch, Philipp; Linke, Miriam; Maurier, Nolwenn; Müller, Verena; Thomas, Benjamin; Utikal, Jochen Sven; Alamri, Ali Saeed M.; Baczako, Andrea; Betke, Matthias; Haas, Carolin; Hartmann, Daniela; Heppt, Markus V.; Kilian, Katharina; Krammer, Sebastian; Lapczynski, Natalie Lidia; Mastnik, Sebastian; Nasifoglu, Suzan; Ruini, Cristel; Sattler, Elke; Schlaak, Max; Wolff, Hans; Achatz, Birgit; Bergbreiter, Astrid; Drexler, Konstantin; Ettinger, Monika; Halupczok, Anna; Hegemann, Marie; Dinauer, Verena; Maagk, Maria; Mickler, Marion; Philipp, Biance; Wilm, Anna; Wittmann, Constanze; Gesierich, Anja; Glutsch, Valerie; Kahlert, Katrin; Kerstan, Andreas; Schrüfer, Philipp
    Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
    In: European Journal of Cancer (EJC) , Jg. 113 2019, S. 47 – 54
    DOI (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Berking, Carola; Haferkamp, Sebastian; Hauschild, Axel; Weichenthal, Michael; Klode, Joachim; Schadendorf, Dirk; Holland-Letz, Tim; Kalle, Christof von; Fröhling, Stefan; Schilling, Bastian; Utikal, Jochen S.
    Deep neural networks are superior to dermatologists in melanoma image classification
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 11 – 17
    DOI (Open Access)
  • Vokes, Natalie; Margolis, Claire; Liu, David; Schilling, Bastian; Schadendorf, Dirk; Van Allen, Eliezer Mendel
    Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15_Suppl, S. 2515 – 2515
    DOI
  • Kreft, Sophia; Gesierich, Anja; Eigentler, Thomas; Franklin, Cindy; Valpione, Sara; Ugurel, Selma; Utikal, Jochen; Haferkamp, Sebastian; Blank, Christian; Larkin, James; Garbe, Claus; Schadendorf, Dirk; Lorigan, Paul; Schilling, Bastian
    Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
    In: European Journal of Cancer (EJC) , Jg. 116 2019, S. 207 – 215
    DOI
  • Lebbé, Celeste; Meyer, Nicolas; Mortier, Laurent; Marquez-Rodas, Ivan; Robert, Caroline; Rutkowski, Piotr; Menzies, Alexander M.; Eigentler, Thomas; Ascierto, Paolo A.; Smylie, Michael; Schadendorf, Dirk; Ajaz, Mazhar; Svane, Inge Marie; Gonzalez, Rene; Rollin, Linda; Lord-Bessen, Jennifer; Saci, Abdel; Grigoryeva, Elena; Pigozzo, Jacopo
    Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma : Results From the Phase IIIb/IV CheckMate 511 Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 11, S. 867 – 875
    DOI (Open Access)
  • Schilling, Bastian; Martens, Alexander; Geukes Foppen, Marnix H.; Gebhardt, Christoffer; Hassel, Jessica C.; Rozeman, Elisa A.; Gesierich, Anja; Gutzmer, Ralf; Kähler, Katharina C.; Livingstone, Elisabeth; Diamantopoulos, Panagiotis T.; Gogas, Helen; Madonna, Gabriele; Ascierto, Paolo A.; Goldinger, Simone M.; Mangana, Johanna; Garbe, Claus; Schadendorf, Dirk; Blank, Christian; Weide, Benjamin
    First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
    In: Cancer Immunology, Immunotherapy , Jg. 68 2019, Nr. 5, S. 765 – 772
    DOI (Open Access)
  • Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier F.; Smylie, Michael; Hogg, David; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S.; Lebbé, Céleste; McArthur, Grant; Ascierto, Paolo A.; Daniels, Gregory A.; Long, Georgina V.; Bastholt, Lars; Rizzo, Jasmine I.; Balogh, Agnes; Moshyk, Andriy; Hodi, F Stephen; Wolchok, Jedd D.
    Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
    In: The New England Journal of Medicine , Jg. 381 2019, Nr. 16, S. 1535 – 1546
    DOI (Open Access)
  • Robert, Caroline; Flaherty, Keith; Nathan, Paul; Hersey, Peter; Garbe, Claus; Milhem, Mohammed; Demidov, Lev; Mohr, Peter; Hassel, Jessica C.; Rutkowski, Piotr; Dummer, Reinhard; Utikal, Jochen; Kiecker, Felix; Larkin, James; D'Amelio, Anthony; Mookerjee, Bijoyesh; Schadendorf, Dirk
    Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 109 2019, S. 61 – 69
    DOI (Open Access)
  • Robert, C.; Grob, J.J.; Stroyakovskiy, D.; Karaszewska, B.; Hauschild, A.; Levchenko, E.; Chiarion Sileni, V.; Schachter, J.; Garbe, C.; Bondarenko, I.; Gogas, H.; Mandalá, M.; Haanen, J.B.A.G.; Lebbé, C.; MacKiewicz, A.; Rutkowski, P.; Nathan, P.D.; Ribas, A.; Davies, M.A.; Flaherty, K.T.; Burgess, P.; Tan, M.; Gasal, E.; Voi, M.; Schadendorf, Dirk; Long, G.V.; Grob, Jean J.; Haanen, John B.A.G.; Nathan, Paul D.; Davies, Michael A.; Flaherty, Keith T.; Long, Georgina V.
    Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma
    In: The New England Journal of Medicine , Jg. 381 2019, Nr. 7, S. 626 – 636
    DOI (Open Access)
  • Jansen, Philipp; Cosgarea, Ioana; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Franklin, Cindy; Paschen, Annette; Zaremba, Anne; Brinker, Titus Josef; Stoffels, Ingo; Schadendorf, Dirk; Klode, Joachim; Hadaschik, Eva; Griewank, Klaus
    Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi
    In: Cancers , Jg. 11 2019, Nr. 4, S. 546
    DOI, Online Volltext (Open Access)
  • Emmons, Michael F.; Faião-Flores, Fernanda; Sharma, Ritin; Thapa, Ram; Messina, Jane L.; Becker, Jürgen; Schadendorf, Dirk; Seto, Edward; Sondak, Vernon K.; Koomen, John M.; Chen, Yian A.; Lau, Eric K.; Wan, Lixin; Licht, Jonathan D.; Smalley, Keiran S. M.
    HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy
    In: Cancer Research , Jg. 79 2019, Nr. 11, S. 2947 – 2961
    DOI (Open Access)
  • Schadendorf, Dirk; Di Giacomo, Anna Maria; Demidov, Lev; Merelli, Barbara; Bondarenko, Igor; Ascierto, Paolo A.; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant R.; Simmons, Brian; Ye, Chenglin; Hong, Agnes; Lewis, Karl
    Health-related quality of life in patients with fully resected BRAFV⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenib
    In: European Journal of Cancer (EJC) , Jg. 123 2019, S. 155 – 161
    DOI (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Sucker, A.; Schramm, Sara; Utikal, J.; Pfohler, C.; Herbst, R.; Schilling, Bastian; Blank, C.; Becker, J. C.; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    High PD-1 or PD-L1 Concentrations in the Serum of Melanoma Patients are predictive for reduced Therapeutic Success of PD-1 Inhibition
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 17 2019, Nr. Suppl. 5, S. 7 – 7
  • Ascierto, Paolo Antonio; Schadendorf, Dirk
    Immunotherapy in non-melanoma skin cancer : Updates and new perspectives
    In: Drugs in Context , Jg. 8 2019, S. 212583
    DOI (Open Access)
  • Kanaki, Theodora; Stang, Andreas; Gutzmer, Ralf; Zimmer, Lisa; Chorti, Eleftheria; Sucker, Antje; Ugurel, Selma; Hadaschik, Eva; Gräger, Nikolai S.; Satzger, Imke; Schadendorf, Dirk; Livingstone, Elisabeth
    Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 18 – 29
    DOI
  • Brütting, Julia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang G.; Berking, Carola; Meier, Friedegund E.; im Auftrag der NVKH
    Informations- und Hilfsangebote für Melanompatienten : Präferenzielle Unterschiede zwischen Patienten und Ärzten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 17 2019, Nr. 6, S. 652 – 654
    DOI
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Amon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; Bubnoff, Dagmar von; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Allen, Eliezer M. van; Schadendorf, Dirk
    Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine , Jg. 25 2019, Nr. 12, S. 1916 – 1927
    DOI (Open Access)
  • Ugurel, Selma; Spassova, Ivelina; Wohlfarth, Jonas; Drusio, Christina; Cherouny, Angela; Melior, Anita; Sucker, Antje; Zimmer, Lisa; Ritter, Cathrin; Schadendorf, Dirk; Becker, Jürgen
    MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition : a case series
    In: Cancer Immunology, Immunotherapy , Jg. 68 2019, Nr. 6, S. 983 – 990
    DOI (Open Access)
  • Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Best Practice Onkologie , Jg. 14 2019, Nr. 7/8, S. 312 – 323
    DOI
  • Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Der Hautarzt , Jg. 70 2019, Nr. 3, S. 215 – 227
    DOI
  • Zaremba, Anne; Chorti, Eleftheria; Jockenhöfer, Finja; Bolz, Saskia; Sirin, Selma; Glas, Martin; Becker, Jürgen C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Hagenacker, Tim; Zimmer, Lisa
    Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?
    In: Journal for ImmunoTherapy of Cancer , Jg. 7 2019, Nr. 1, S. 141
    DOI, Online Volltext (Open Access)
  • Pylaeva, Ekaterina; Harati, Mozhgan Dehghan; Spyra, Ilona; Bordbari, Sharareh; Strachan, Sarah; Thakur, Basant Kumar; Höing, Benedikt; Franklin, Cindy; Skokowa, Julia; Welte, Karl; Schadendorf, Dirk; Bankfalvi, Agnes; Brandau, Sven; Lang, Stephan; Jablonska, Jadwiga
    NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils
    In: International Journal of Cancer , Jg. 144 2019, Nr. 1, S. 136 – 149
    DOI
  • Urbonas, Vincas; Schadendorf, Dirk; Zimmer, Lisa; Danson, Sarah J.; Marshall, Ernest; Corrie, Pippa G.; Wheater, Matthew J.; Plummer, E.; Mauch, Cornelia; Scudder, Claire; Goff, Matthew; Love, Sharon B.; Mohammed, S.B.; Middleton, Mark R.
    Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trial
    In: Annals of Oncology , Jg. 30 2019, Nr. 2, S. 317 – 324
    DOI (Open Access)
  • Hekler, Achim; Utikal, Jochen Sven; Enk, Alexander H.; Berking, Carola; Klode, Joachim; Schadendorf, Dirk; Jansen, Philipp; Franklin, Cindy; Holland-Letz, Tim; Krahl, Dieter; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus Josef
    Pathologist-level classification of histopathological melanoma images with deep neural networks
    In: European Journal of Cancer (EJC) , Jg. 115 2019, S. 79 – 83
    DOI (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Lesimple, Thierry; Plummer, Ruth; Schachter, Jacob; Dasgupta, Kohinoor; Manson, Stephanie; Koruth, Roy; Mookerjee, Bijoyesh; Kefford, Richard; Dummer, Reinhard; Kirkwood, John M.; Long, Georgina V.
    Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD) : a randomised, placebo-controlled, phase 3 trial
    In: The Lancet Oncology , Jg. 20 2019, Nr. 5, S. 701 – 710
    DOI
  • Sondermann, Wiebke; Utikal, Jochen Sven; Enk, Alexander H.; Schadendorf, Dirk; Klode, Joachim; Hauschild, Axel; Weichenthal, Michael; French, Lars E.; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Fröhling, Stefan; Kalle, Christof von; Brinker, Titus J.
    Prediction of melanoma evolution in melanocytic nevi via artificial intelligence : A call for prospective data
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 30 – 34
    DOI (Open Access)
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus JM.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Lupinacci, Robert; Krepler, Clemens; Ibrahim, Nageatte; Kicinski, Michal; Marreaud, Sandrine; van Akkooi, Alexander C.; Suciu, Stefan; Robert, Caroline
    Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer (EJC) , Jg. 116 2019, S. 148 – 157
    DOI
  • Viehof, Jan; Livingstone, Elisabeth; Loscha, Elena; Stockhammer, Paul; Bankfalvi, Agnes; Plönes, Till; Mardanzai, Khaled; Zimmer, Lisa; Sucker, Antje; Schadendorf, Dirk; Hegedüs, Balazs; Aigner, Clemens
    Prognostic factors for pulmonary metastasectomy in malignant melanoma : Size matters
    In: European Journal of Cardio-Thoracic Surgery , Jg. 56 2019, Nr. 6, S. 1104 – 1109
    DOI (Open Access)
  • Schadendorf, Dirk; Melanoma GWAS Consortium
    Publisher Correction : Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications , Jg. 10 2019, Nr. 1, S. 299
    DOI (Open Access)
  • Duffy, David L.; Zhu, Gu; Li, Xin; Sanna, Marianna; Jacobs, Leonie C.; Evans, David M.; Yazar, Seyhan; Beesley, Jonathan; Lawrence, Matthew H.; Kraft, Peter; Visconti, Alessia; Taylor, John C.; Lui, Fan; Wright, Margaret J.; Henders, Anjali K.; Bowdler, Lisa; Glass, Dan; Ikram, Arfan M.; Uitterlinden, André G.; Madden, Pamela A.; Heath, Andrew C.; Nelson, Elliot C.; Green, Adele C.; Chanock, Stephen; Barrett, Jennifer H.; Brown, Matthew A.; Hayward, Nicholas K.; MacGregor, Stuart; Sturm, Richard A.; Hewitt, Alex W.; Leenhardt, Jeffrey E.; Brossard, Myriam; Moses, Eric K.; Song, Fengju; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Novaković, Srdjan; Olsson, Håkan; Puig, Susana; Puig-Butille, Joan Anton; Radford-Smith, Graham L.; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nicholas; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Schulze, Hans-Joachim; Dunning, Alison M.; Demenais, Florence; Amos, Christopher I.; Kayser, Manfred; Hunter, David J.; Newton Bishop, Julia A.; Spector, Timothy D.; Montgomery, Grant W.; Mackey, David A.; Smith, George Davey; Nijsten, Tamar E.; Bishop, D. Timothy; Bataille, Veronique; Falchi, Mario; Han, Jiali; Martin, Nicholas G.
    Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications , Jg. 10 2019, Nr. 1, S. 299
    DOI (Open Access)
  • Taylor, Fiona; Regan, Meredith M.; Schadendorf, Dirk; Atkins, Michael B.; Lawrance, Rachael; Moreno-Koehler, Alejandro; Moshyk, Andriy; Rao, Sumati; Ritchings, Corey; KOTAPATI, SRIVIDYA; Lord-Bessen, Jennifer; Rizzo, Jasmine I.; McDermott, David F.; Middleton, Mark R.
    Quality of life (QoL) and symptom burden in patients (pts) with advanced melanoma during the treatment-free interval (TFI) after discontinuation of nivolumab (NIVO) or NIVO plus ipilimumab (IPI)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15_Suppl, S. 9568
    DOI
  • Brütting, Julia; Reinhardt, Lydia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang; Berking, Carola; Meier, Friedegund
    Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients
    In: Journal of Cancer Education , Jg. 34 2019, Nr. 4, S. 760 – 767
    DOI
  • Long, Georgina V.; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Hauschild, Axel
    Reply to E. Hindié and K.R. Hess
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 1356 – 1358
    DOI (Open Access)
  • Schadendorf, Dirk; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C.; Nathan, Paul
    Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment : A single-arm, open-label, phase II study (CheckMate 172)
    In: European Journal of Cancer (EJC) , Jg. 121 2019, S. 144 – 153
    DOI
  • Nathan, Paul; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C.; Schadendorf, Dirk
    Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment : a single-arm, open-label, phase II study (CheckMate 172)
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 168 – 178
    DOI (Open Access)
  • Weichenthal, Michael; Ugurel, Selma; Leiter, Ulrike M.; Satzger, Imke; Kähler, Katharina C.; Welzel, Julia; Pföhler, Claudia; Feldmann-Böddeker, Ingrid; Meier, Friedegund Elke; Terheyden, Patrick; Haferkamp, Sebastian; Herbst, Rudolf; Ulrich, Jens; Utikal, Jochen; Kreuter, Alexander; Gutzmer, Ralf; Schadendorf, Dirk; Mohr, Peter
    Salvage therapy after failure from anti-PD-1 single agent treatment : A Study by the German ADOReg melanoma registry
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15_Suppl, S. 9505
    DOI
  • Stoffels, Ingo; Herrmann, Ken; Rekowski, Jan; Jansen, Philipp; Schadendorf, Dirk; Stang, Andreas; Klode, Joachim
    Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trial
    In: Trials , Jg. 20 2019, Nr. 1, S. 99
    DOI (Open Access)
  • Shannan, B.; Matschke, Johann; Chauvistré, Heike; Vogel, F.; Klein, Diana; Meier, Friedegund; Westphal, Dana; Bruns, Johannes; Rauschenberg, Ricarda; Utikal, Jochen; Forschner, Andrea; Berking, Carola; Terheyden, Patrick; Dabrowski, Evelyn; Gutzmer, Ralf; Rafei-Shamsabadi, David Ali; Meiss, Frank; Heinzerling, Lucie M.; Zimmer, Lisa; Livingstone, Elisabeth; Váraljai, Renáta; Hoewner, A.; Horn, Susanne; Klode, Joachim; Stuschke, Martin; Scheffler, Björn; Marchetto, Aruna; Sannino, Giuseppina; Grünewald, Thomas Georg Philipp; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander
    Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanoma
    In: European Journal of Cancer (EJC) , Jg. 109 2019, S. 137 – 153
    DOI
  • Brütting, Julia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang; Berking, Carola; Meier, Friedegund; on behalf of the NVKH
    Sources of information and support for melanoma patients : differences between patients' and clinicians' preferences, Clinical letter
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 17 2019, Nr. 6, S. 652 – 654
    DOI
  • Hekler, Achim; Utikal, Jochen S.; Enk, Alexander H.; Hauschild, Axel; Weichenthal, Michael; Maron, Roman C.; Berking, Carola; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Schilling, Bastian; Holland-Letz, Tim; Izar, Benjamin; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus J.
    Superior skin cancer classification by the combination of human and artificial intelligence
    In: European Journal of Cancer (EJC) , Jg. 120 2019, S. 114 – 121
    DOI (Open Access)
  • Ascierto, Paolo A.; Long, Georgina V.; Robert, Caroline; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Ny, Lars; Arance, Ana; Svane, Inge Marie; Schadendorf, Dirk; Gogas, Helen; Saci, Abdel; Jiang, Joel; Rizzo, Jasmine; Atkinson, Victoria
    Survival Outcomes in Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma Treated with Nivolumab Therapy : Three-Year Follow-up of a Randomized Phase 3 Trial
    In: JAMA Oncology , Jg. 5 2019, Nr. 2, S. 187 – 194
    DOI
  • Jacquelot, Nicolas; Yamazaki, Takahiro; Roberti, Maria P.; Duong, Connie P. M.; Andrews, Miles C.; Verlingue, Loic; Ferrere, Gladys; Becharef, Sonia; Vétizou, Marie; Daillère, Romain; Messaoudene, Meriem; Enot, David P.; Stoll, Gautier; Ugel, Stefano; Marigo, Ilaria; Foong Ngiow, Shin; Marabelle, Aurélien; Prevost-Blondel, Armelle; Gaudreau, Pierre-Olivier; Gopalakrishnan, Vancheswaran; Eggermont, Alexander M.; Opolon, Paule; Klein, Christophe; Madonna, Gabriele; Ascierto, Paolo A.; Sucker, Antje; Schadendorf, Dirk; Smyth, Mark J.; Soria, Jean-Charles; Kroemer, Guido; Bronte, Vincenzo; Wargo, Jennifer; Zitvogel, Laurence
    Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
    In: Cell Research , Jg. 29 2019, Nr. 10, S. 846 – 861
    DOI (Open Access)
  • Maron, Roman C.; Weichenthal, Michael; Utikal, Jochen S.; Hekler, A.; Berking, Carola; Hauschild, Axel; Enk, Alexander H.; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Jansen, Philipp; Holland-Letz, Tim; Schilling, Bastian; von Kalle, Christof; Fröhling, Stefan; Gaiser, Maria R.; Hartmann, Daniela; Gesierich, Anja; Kähler, Katharina C.; Wehkamp, Ulrike; Karoglan, Ante; Bär, Claudia; Brinker, Titus J.; Schmitt, Laurenz; Peitsch, Wiebke K.; Hoffmann, Friederike; Becker, Jürgen; Drusio, Christina; Lodde, G.; Sammet, Stefanie; Sondermann, Wiebke; Ugurel, Selma; Zader, Jeannine; Salzmann, Martin; Schäfer, S.; Schäkel, Knut; Winkler, J.; Wölbing, Priscilla; Asper, Hiba; Bohne, Ann-Sophie; Brown, Victoria; Burba, Bianca; Deffaa, Sophia; Dietrich, Cecilia; Dietrich, Matthias; Drerup, Katharina Antonia; Egberts, Friederike; Erkens, Anna-Sophie; Greven, S.; Harde, V.; Jost, Marion; Kaeding, M.; Kosova, Katharina; Lischner, Stephan; Maagk, M.; Messinger, Anna Laetitia; Metzner, M.; Motamedi, Rogina; Rosenthal, Ann-Christine; Seidl, Ulrich; Stemmermann, Jana; Torz, Kaspar; Velez, Juliana Giraldo; Haiduk, Jennifer; Alter, Mareike; Bergenthal, Paul; Gerlach, Anne; Holtorf, Christian; Kindermann, Sophie; Kraas, L.; Felcht, Moritz; Klemke, Claus-Detlev; Kurzen, Hjalmar; Leibing, Thomas; Müller, Verena; Reinhard, Raphael R.; Winter, Franziska; Eicher, Laurie; Heppt, Markus; Kilian, Katharina; Krammer, Sebastian; Lill, D.; Niesert, Anne-Charlotte; Oppel, Eva; Sattler, Elke; Senner, S.; Wallmichrath, Jens; Wolff, Hans; Giner, Tina; Glutsch, Valerie; Kerstan, Andreas; Presser, Dagmar; Schrüfer, Philipp; Schummer, Patrick; Stolze, Ina; Weber, Judith; Drexler, Konstantin; Mickler, Marion; Stauner, Camila Toledo; Thiem, Alexander
    Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 57 – 65
    DOI (Open Access)
  • Vogel, Felix C. E.; Bordag, Natalie; Zügner, E.; Trajkovic-Arsic, Marija; Chauvistré, Heike; Shannan, Batool; Váraljai, Renáta; Horn, Susanne; Magnes, Christoph; Siveke, Jens; Schadendorf, Dirk; Rösch, Alexander
    Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
    In: Journal of Investigative Dermatology , Jg. 139 2019, Nr. 12, S. 2506 – 2516.e10
    DOI (Open Access)
  • Phung, Bengt; Cieśla, Maciej; Sanna, Adriana; Guzzi, Nicola; Beneventi, Giulia; Cao Thi Ngoc, Phuong; Lauss, Martin; Cabrita, Rita; Cordero, Eugenia; Bosch, Ana; Rosengren, Frida; Häkkinen, Jari; Griewank, Klaus; Paschen, Annette; Harbst, Katja; Olsson, Håkan; Ingvar, Christian; Carneiro, Ana; Tsao, Hensin; Schadendorf, Dirk; Pietras, Kristian; Bellodi, Cristian; Jönsson, Göran
    The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
    In: Cell Reports , Jg. 27 2019, Nr. 12, S. 3573 – 3586.e7
    DOI (Open Access)
  • Jansen, Philipp; Petri, Maximilian; Merz, Simon F.; Brinker, Titus J.; Schadendorf, Dirk; Stang, Andreas; Stoffels, Ingo; Klode, Joachim
    The prognostic value of sentinel lymph nodes on distant metastasis–free survival in patients with high-risk squamous cell carcinoma
    In: European Journal of Cancer (EJC) , Jg. 111 2019, S. 107 – 115
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Treatment in metastatic melanoma : Time to re-think
    In: Annals of Oncology , Jg. 30 2019, Nr. 4, S. 501 – 503
    DOI (Open Access)
  • Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer
    Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
    In: Journal for ImmunoTherapy of Cancer , Jg. 7 2019, Nr. 1, S. 343
    DOI (Open Access)
  • Brütting, Julia; Bergmann, Maike; Garzarolli, Marlene; Rauschenberg, Ricarda; Weber, Christiane; Berking, Carola; Tilgen, Wolfgang; Schadendorf, Dirk; Meier, Friedegund
    Unmet information needs of patients with melanoma in Germany
    In: Melanoma Research , Jg. 29 2019, Nr. 2, S. 196 – 204
    DOI
  • Varaljai, R.; Wistuba-Hamprecht, K.; Seremet, T.; Diaz, JMS; Nsengimana, J.; Sucker, A.; Griewank, Klaus; Horn, Peter; von Neuhoff, N.; Shannan, B.; Chauvistre, H.; Vogel, FCE; Horn, S.; Becker, J. C.; Newton-Bishop, J.; Stang, Andreas; Neyns, B.; Weide, B.; Schadendorf, Dirk; Rösch, Alexander
    ctDNA as a noninvasive monitoring tool in metastatic melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. Suppl. 15, S. 9548
    DOI
  • Jerby-Arnon, Livnat; Shah, Parin; Cuoco, Michael S.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Rabasha, Bokang; Liu, David; Zhang, Gao; Margolais, Claire; Ashenberg, Orr; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Rizwan; Hodi, F. Stephen; Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie T.; Miao, Benchun; Moll, Tabea; Flaherty, Keith T.; Herlyn, Meenhard; Jenkins, Russell W.; Thummalapalli, Rohit; Kowalczyk, Monika S.; Cañadas, Israel; Schilling, Bastian; Cartwright, Adam N.R.; Luoma, Adrienne M.; Malu, Shruti; Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andrée; Barbie, David A.; Shalek, Alex K.; Tirosh, Itay; Sorger, Peter K.; Wucherpfennig, Kai; Van Allen, Eliezer M.; Schadendorf, Dirk; Johnson, Bruce E.; Rotem, Asaf; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin; Regev, Aviv
    A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
    In: Cell , Jg. 175 2018, Nr. 4, S. 984 – 997.e24
    DOI (Open Access)
  • Brinker, Titus Josef; Brieske, Christian Martin; Esser, Stefan; Klode, Joachim; Mons, Ute; Batra, Anil; Rüther, Tobias; Seeger, Werner; Enk, Alexander H.; von Kalle, Christof; Berking, Carola; Heppt, Markus V.; Gatzka, Martina V.; Bernardes-Souza, Breno; Schlenk, Richard F.; Schadendorf, Dirk
    A Face-Aging App for Smoking Cessation in a Waiting Room Setting : Pilot Study in an HIV Outpatient Clinic
    In: Journal of Medical Internet Research (JMIR) , Jg. 20 2018, Nr. 8, S. e10976
    DOI (Open Access)
  • D’Angelo, Sandra P.; Hamid, Omid A.; Tarhini, Ahmad; Schadendorf, Dirk; Chmielowski, Bartosz; Collichio, Frances A.; Pavlick, Anna C.; Lewis, Karl D.; Weil, Susan C.; Heyburn, John; Schweizer, Charles; O’Shannessy, Daniel J.; Carvajal, Richard D.
    A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma
    In: Investigational New Drugs: The Journal of New Anticancer Agents , Jg. 36 2018, Nr. 1, S. 103 – 113
    DOI (Open Access)
  • Brinker, Titus Josef; Heckl, Marlene; Gatzka, Martina; Heppt, Markus V.; Rodrigues, Henrique Resende; Schneider, Sven; Sondermann, Wiebke; E Silva, Carolina de Almeida; Kirchberger, Michael C.; Klode, Joachim; Enk, Alexander H.; Knispel, Sarah; von Kalle, Christof; Stoffels, Ingo; Schadendorf, Dirk; Nakamura, Yasuhiro; Esser, Stefan; Assis, Aisllan; Bernardes-Souza, Breno
    A skin cancer prevention facial-aging mobile app for secondary schools in Brazil : Appearance-focused interventional study
    In: JMIR mhealth and uhealth , Jg. 6 2018, Nr. 3, e60
    DOI (Open Access)
  • Brinker, Titus Josef; Faria, Bianca Lisa; Gatzka, Martina; de Faria, Olber Moreira; Heppt, Markus V.; Kirchberger, Michael C.; Schadendorf, Dirk; Nakamura, Yasuhiro; Buslaff, Fabian; Lisboa, Oscar Campos; Oliveira, Ana Carla Cruz; Lino, Henrique Augusto; Bernardes-Souza, Breno
    A skin cancer prevention photoageing intervention for secondary schools in Brazil delivered by medical students : protocol for a randomised controlled trial
    In: BMJ Open , Jg. 8 2018, Nr. 3, S. e018299
    DOI (Open Access)
  • Wirtz, M.; Stoffels, Ingo; Dissemond, Joachim; Schadendorf, Dirk; Rösch, Alexander
    Actinic keratoses treated with cold atmospheric plasma
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 32 2018, Nr. 1, S. e37 – e39
    DOI
  • Grob, Jean Jacques; Garbe, Claus; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Schadendorf, Dirk
    Adjuvant melanoma therapy with new drugs : Should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?
    In: The Lancet Oncology , Jg. 19 2018, Nr. 12, S. e720 – e725
    DOI
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander C. J.; Suciu, Stefan; Robert, Caroline
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma
    In: The New England Journal of Medicine , Jg. 378 2018, Nr. 19, S. 1789 – 1801
    DOI (Open Access)
  • Maio, Michele; Lewis, Karl; Demidov, Lev; Mandalà, Mario; Bondarenko, Igor; Ascierto, Paolo A; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant R; Simmons, Brian; Ye, Chenglin; Yan, Yibing; Schadendorf, Dirk; BRIM8 Investigators
    Adjuvant vemurafenib in resected, BRAF mutation-positive melanoma (BRIM8) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
    In: The Lancet Oncology , Jg. 19 2018, Nr. 4, S. 510 – 520
    DOI
  • Hillen, Uwe; Leiter, Ulrike; Haase, Sylvie; Kaufmann, Roland; Becker, Jürgen; Gutzmer, Ralf; Terheyden, Patrick; Krause-Bergmann, Albrecht; Schulze, Hans-Joachim; Hassel, Jessica; Lahner, Nina; Wollina, Uwe; Ziller, Fabian; Utikal, Jochen; Hafner, Christine; Ulrich, Jens; Machens, Hans-Günther; Weishaupt, Carsten; Hauschild, Axel; Mohr, Peter; Pföhler, Claudia; Maurer, Jan; Wolff, Patrick; Windemuth-Kieselbach, Christine; Schadendorf, Dirk; Livingstone, Elisabeth; Dermatologic Cooperative Oncology Group (DeCOG)
    Advanced cutaneous squamous cell carcinoma : A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG
    In: European Journal of Cancer (EJC) , Jg. 96 2018, S. 34 – 43
    DOI
  • Atkinson, Victoria G.; Hauschild, Axel; Santinami, Mario; Mandala, Mario; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta S.; Dutriaux, Caroline; Haydon, Andrew M. M.; Mortier, Laurent; Robert, Caroline; Schachter, Jacob M.; Schadendorf, Dirk; Feng, X.; Jong, Egbert de; Mookerjee, Bijoyesh P.; Kefford, Rick F.; Dummer, Reinhard G.; Kirkwood, John M.; Long, Georgina V.
    Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii446
    DOI (Open Access)
  • Kugel, Curtis H.; Douglass, Stephen M.; Webster, Marie R.; Kaur, Amanpreet; Liu, Qin; Yin, Xiangfan; Weiss, Sarah A.; Darvishian, Farbod; Al-Rohil, Rami N.; Ndoye, Abibatou; Behera, Reeti; Alicea, Gretchen M.; Ecker, Brett L.; Fane, Mitchell; Allegrezza, Michael J.; Svoronos, Nikolaos; Kumar, Vinit; Wang, Daniel Y.; Somasundaram, Rajasekharan; Hu-Lieskovan, Siwen; Ozgun, Alpaslan; Herlyn, Meenhard; Conejo-Garcia, Jose R.; Gabrilovich, Dmitry; Stone, Erica L.; Nowicki, Theodore S.; Sosman, Jeffrey; Rai, Rajat; Carlino, Matteo S.; Long, Georgina V.; Marais, Richard; Ribas, Antoni; Eroglu, Zeynep; Davies, Michael A.; Schilling, Bastian; Schadendorf, Dirk; Xu, Wei; Amaravadi, Ravi K.; Menzies, Alexander M.; McQuade, Jennifer L.; Johnson, Douglas B.; Osman, Iman; Weeraratna, Ashani T.
    Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-Cell populations
    In: Clinical Cancer Research , Jg. 24 2018, Nr. 21, S. 5347 – 5356
    DOI (Open Access)
  • McQuade, Jennifer L; Daniel, Carrie R; Hess, Kenneth R; Mak, Carmen; Wang, Daniel Y; Rai, Rajat R; Park, John J; Haydu, Lauren E; Spencer, Christine; Wongchenko, Matthew; Lane, Stephen; Lee, Dung-Yang; Kaper, Mathilde; McKean, Meredith; Beckermann, Kathryn E; Rubinstein, Samuel M; Rooney, Isabelle; Musib, Luna; Budha, Nageshwar; Hsu, Jessie; Nowicki, Theodore S; Avila, Alexandre; Haas, Tomas; Puligandla, Maneka; Lee, Sandra; Fang, Shenying; Wargo, Jennifer A; Gershenwald, Jeffrey E; Lee, Jeffrey E; Hwu, Patrick; Chapman, Paul B; Sosman, Jeffrey A; Schadendorf, Dirk; Grob, Jean-Jacques; Flaherty, Keith T; Walker, Dana; Yan, Yibing; McKenna, Edward; Legos, Jeffrey J; Carlino, Matteo S; Ribas, Antoni; Kirkwood, John M; Long, Georgina V; Johnson, Douglas B; Menzies, Alexander M; Davies, Michael A
    Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy : a retrospective, multicohort analysis
    In: The Lancet Oncology , Jg. 19 2018, Nr. 3, S. 310 – 322
    DOI (Open Access)
  • Griewank, Klaus; Wiesner, Thomas; Murali, Rajmohan; Pischler, Carina; Müller, Hansgeorg; Koelsche, Christian; Möller, Inga; Franklin, Cindy; Cosgarea, Ioana; Sucker, Antje; Schadendorf, Dirk; Schaller, Jörg; Horn, Susanne; Brenn, Thomas; Mentzel, Thomas
    Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles
    In: Modern Pathology , Jg. 31 2018, Nr. 3, S. 418 – 428
    DOI (Open Access)
  • Schaarschmidt, Benedikt Michael; Grueneisen, Johannes; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, Philipp; Antoch, Gerald; Pöppel, Thorsten
    Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 45 2018, Nr. 12, S. 2093 – 2102
    DOI
  • Shukla, Sachet A.; Bachireddy, Pavan; Schilling, Bastian; Galonska, Christina; Zhan, Qian; Bango, Clyde; Langer, Rupert; Lee, Patrick C.; Gusenleitner, Daniel; Keskin, Derin B.; Babadi, Mehrtash; Mohammad, Arman; Gnirke, Andreas; Clement, Kendell; Cartun, Zachary J.; Van Allen, Eliezer M.; Miao, Diana; Huang, Ying; Snyder, Alexandra; Merghoub, Taha; Wolchok, Jedd D.; Garraway, Levi A.; Meissner, Alexander; Weber, Jeffrey S.; Hacohen, Nir; Neuberg, Donna; Potts, Patrick R.; Murphy, George F.; Lian, Christine G.; Schadendorf, Dirk; Hodi, F. Stephen; Wu, Catherine J.
    Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
    In: Cell , Jg. 173 2018, Nr. 3, S. 624 – 633.e8
    DOI (Open Access)
  • Totzeck, Matthias; Mincu, Raluca-Ileana; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush
    Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity : A meta-analysis of approximately 29,000 cancer patients
    In: European Journal of Preventive Cardiology , Jg. 25 2018, Nr. 5, S. 482 – 494
    DOI
  • Fan, Kaiji; Ritter, Cathrin; Nghiem, Paul; Blom, Astrid; Verhaegen, Monique E.; Dlugosz, Andrzej; Ødum, Niels; Woetmann, Anders; Tothill, Richard W.; Hicks, Rodney J.; Sand, Michael; Schrama, David; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen C.
    Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma
    In: Clinical Cancer Research , Jg. 24 2018, Nr. 23, S. 5873 – 5882
    DOI (Open Access)
  • Hecht, Markus; Meier, Friedegund; Zimmer, Lisa; Polat, Bülent; Loquai, Carmen; Weishaupt, Carsten; Forschner, Andrea; Gutzmer, Ralf; Utikal, Jochen S.; Goldinger, Simone M.; Geier, Michael; Hassel, Jessica C.; Balermpas, Panagiotis; Kiecker, Felix; Rauschenberg, Ricarda; Dietrich, Ursula; Clemens, Patrick; Berking, Carola; Grabenbauer, Gerhard; Schadendorf, Dirk; Grabbe, Stephan; Schuler, Gerold; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
    In: British Journal of Cancer (BJC) , Jg. 118 2018, Nr. 6, S. 785 – 792
    DOI (Open Access)
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Giacomo, AnnaMaria Di; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma : A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]
    In: European Journal of Cancer (EJC) , Jg. 93 2018, S. 158
    DOI
  • Olischewsky, Alexandra; De Schrijver, Sofie; Bankfalvi, Agnes; Wetter, Axel; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Dose-dependent toxicity of ipilimumab in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 95 2018, S. 104 – 108
    DOI
  • Grob, Jean Jacques; Schadendorf, Dirk; Lorigan, Paul; Ascierto, Paolo; Larkin, James; Nathan, Paul; Robert, Caroline; Hauschild, Axel; Weber, Jeffrey; Daud, Adil; Hamid, Omid; Dummer, Reinhard; Hansson, Johan; Hoeller, Christoph; Schachter, Jacob; Van Akkooi, Alexander C. J.; Garbe, Claus
    Eighth American Joint Committee on Cancer (AJCC) melanoma classification : Let us reconsider stage III
    In: European Journal of Cancer (EJC) , Jg. 91 2018, S. 168 – 170
    DOI
  • Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A; Pickard, Michael D; Sandor, Victor; Robert, Caroline; Flaherty, Keith T
    Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS) : a multicentre, open-label, randomised phase 3 trial
    In: The Lancet Oncology , Jg. 19 2018, Nr. 5, S. 603 – 615
    DOI (Open Access)
  • Dummer, Reinhard G.; Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria G.; Mandala, Mario; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta S.; Dutriaux, Caroline; Haydon, Andrew M. M.; Mortier, Laurent; Robert, Caroline; Schachter, Jacob M.; Feng, X.; Jong, Egbert de; Mookerjee, Bijoyesh P.; Kefford, Rick F.; Kirkwood, John M.; Long, Georgina V.
    Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii445
    DOI (Open Access)
  • Pieper, Natalia; Zaremba, Anne; Leonardelli, Sonia; Harbers, Franziska Noelle; Schwamborn, Marion; Lübcke, Silke; Schrörs, Barbara; Baingo, Jolanthe; Schramm, Alexander; Haferkamp, Sebastian; Seifert, Ulrike; Sucker, Antje; Lennerz, Volker; Wölfel, Thomas; Schadendorf, Dirk; Schilling, Bastian; Paschen, Annette; Zhao, Fang
    Evolution of melanoma cross-resistance to CD8⁺ T cells and MAPK inhibition in the course of BRAFi treatment
    In: OncoImmunology , Jg. 7 2018, Nr. 8, e1450127
    DOI (Open Access)
  • Schaarschmidt, B. M.; Grueneisen, J.; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, P.; Antoch, G.; Pöppel, Thorsten
    F-18-FDG PET/MR including DWI in initial N-Staging in patients with malignant melanoma : Is it a possible replacement for sentinel lymph node biopsy?
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 45 2018, Nr. Suppl. 1, S. 38
  • Brinker, Titus J.; Klode, Joachim; Esser, Stefan; Schadendorf, Dirk
    Facial-aging app availability in waiting rooms as a potential opportunity for skin cancer prevention
    In: JAMA Dermatology , Jg. 154 2018, Nr. 9, S. 1085 – 1086
    DOI (Open Access)
  • Wagner, Tobias; Augustin, Matthias; Blome, Christine; Forschner, Andrea; Garbe, Claus; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Terheyden, Patrick; Mueller-Brenne, Tina; Kähler, Katharina C.
    Fear of cancer progression in patients with stage IA malignant melanoma
    In: European Journal of Cancer Care , Jg. 27 2018, Nr. 5, e12901
    DOI
  • Miao, Diana; Margolis, Claire A.; Vokes, Natalie I.; Liu, David; Taylor-Weiner, Amaro; Wankowicz, Stephanie M.; Adeegbe, Dennis; Keliher, Daniel; Schilling, Bastian; Tracy, Adam; Manos, Michael; Chau, Nicole G.; Hanna, Glenn J.; Polak, Paz; Rodig, Scott J.; Signoretti, Sabina; Sholl, Lynette M.; Engelman, Jeffrey A.; Getz, Gad; Jänne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David A.; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter; Van Allen, Eliezer M.
    Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
    In: Nature Genetics , Jg. 50 2018, Nr. 9, S. 1271 – 1281
    DOI (Open Access)
  • Brütting, Julia; Bergmann, Maike; Garzarolli, Marlene; Rauschenberg, Ricarda; Weber, Christiane; Berking, Carola; Tilgen, Wolfgang; Schadendorf, Dirk; Meier, Friedegund; NVKH Supporting Group
    Information-seeking and use of information resources among melanoma patients of German skin cancer centers
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. 9, S. 1093 – 1101
    DOI
  • Brütting, Julia; Bergmann, M.; Weber, C.; Berking, C.; Tilgen, W.; Schadendorf, Dirk; Meier, F.
    Informationsangebote für Melanompatienten und ihre Bekanntheit unter Betroffenen
    In: Der Hautarzt , Jg. 69 2018, Nr. 4, S. 335 – 339
    DOI
  • Griewank, Klaus G.; Koelsche, Christian; van de Nes, Johannes A. P.; Schrimpf, Daniel; Gessi, Marco; Möller, Inga; Sucker, Antje; Scolyer, Richard A.; Buckland, Michael E.; Murali, Rajmohan; Pietsch, Torsten; Deimling, Andreas von; Schadendorf, Dirk
    Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profiling
    In: Clinical Cancer Research , Jg. 24 2018, Nr. 18, S. 4494 – 4504
    DOI (Open Access)
  • Teramoto, Yukiko; Nakamura, Yasuhiro; Asami, Yuri; Matsuya, Taisuke; Brinker, Titus J.; Jansen, Philipp; Schulz, Andrea; Stoffels, Ingo; Klode, Joachim; Schadendorf, Dirk; Yamamoto, Akifumi
    Intraoperative use of LIGHTVISION : a novel fluorescence navigation system using indocyanine green for sentinel lymph node biopsy in skin cancer patients
    In: European Journal of Dermatology (EJD) , Jg. 28 2018, Nr. 4, S. 532 – 534
    DOI
  • Knappe, Ulrich J.; Tischoff, Iris; Tannapfel, Andrea; Reinbold, Wolf-Dieter; Möller, Inga; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus; van de Nes, Johannes
    Intraventricular melanocytoma diagnosis confirmed by gene mutation profile
    In: Neuropathology , Jg. 38 2018, Nr. 3, S. 288 – 292
    DOI
  • Haselmann, Verena; Gebhardt, Christoffer; Brechtel, Ingrid; Duda, Angelika; Czerwinski, Claudia; Sucker, Antje; Holland-Letz, Tim; Utikal, Jochen; Schadendorf, Dirk; Neumaier, Michael
    Liquid profiling of circulating tumor DNA in plasma of melanoma patients for companion diagnostics and monitoring of BRAF inhibitor therapy
    In: Clinical Chemistry , Jg. 64 2018, Nr. 5, S. 830 – 842
    DOI
  • Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 35, S. 3441 – 3449
    DOI (Open Access)
  • Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie
    MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients
    In: European Journal of Cancer (EJC) , Jg. 98 2018, S. 10 – 16
    DOI
  • Schadendorf, Dirk; Van Akkooi, Alexander; Berking, Carola; Griewank, Klaus; Gutzmer, Ralf; Hauschild, Axel; Stang, Andreas; Rösch, Alexander; Ugurel, Selma
    Melanoma
    In: Lancet , Jg. 392 2018, Nr. 10151, S. 971 – 984
    DOI
  • Drusio, Christina; Becker, Jürgen C.; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Der Onkologe , Jg. 24 2018, Nr. 12, S. 1037 – 1049
    DOI
  • Drusio, Christina; Schadendorf, Dirk; Ugurel, Selma
    Mit Nivolumab und Pembrolizumab gegen das Melanom : Wirkprinzip und Umgang mit immunvermittelten Nebenwirkungen der Anti-PD1-Therapie
    In: Deutsche Apotheker Zeitung , Jg. 158 2018, Nr. 30
  • Scholz, S.L.; Cosgarea, I.; Süßkind, D.; Murali, R.; Möller, I.; Reis, Henning; Leonardelli, S.; Schilling, Bastian; Schimming, T.; Hadaschik, Eva; Franklin, Cindy; Paschen, Annette; Sucker, A.; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    NF1 mutations in conjunctival melanoma
    In: British Journal of Cancer (BJC) , Jg. 118 2018, Nr. 9, S. 1243 – 1247
    DOI (Open Access)
  • Hodi, Frank Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Cowey, Charles Lance; Lao, Christopher D; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Hill, Andrew; Hogg, David; Marquez-Rodas, Ivan; Jiang, Joel; Rizzo, Jasmine; Larkin, James; Wolchok, Jedd D
    Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067) : 4-year outcomes of a multicentre, randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 19 2018, Nr. 11, S. 1480 – 1492
    DOI
  • Duffy, David L.; Zhu, Gu; Li, Xin; Sanna, Marianna; Iles, Mark M.; Jacobs, Leonie C.; Evans, David M.; Yazar, Seyhan; Beesley, Jonathan; Law, Matthew H.; Kraft, Peter; Visconti, Alessia; Taylor, John C.; Lui, Fan; Wright, Margaret J.; Henders, Anjali K.; Bowdler, Lisa; Glass, Dan; Ikram, Arfan M.; Uitterlinden, André G.; Madden, Pamela A.; Heath, Andrew C.; Nelson, Elliot C.; Green, Adele C.; Chanock, Stephen; Barrett, Jennifer H.; Brown, Matthew A.; Hayward, Nicholas K.; MacGregor, Stuart; Sturm, Richard A.; Hewitt, Alex W.; Lee, Jeffrey E.; Brossard, Myriam; Moses, Eric K.; Song, Fengju; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Novaković, Srdjan; Olsson, Håkan; Puig, Susana; Puig-Butille, Joan Anton; Radford-Smith, Graham L.; van der Stoep, Nienke; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nicholas; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Schulze, Hans-Joachim; Dunning, Alison M.; Demenais, Florence; Amos, Christopher I.; Kayser, Manfred; Hunter, David J.; Newton Bishop, Julia A.; Spector, Timothy D.; Montgomery, Grant W.; Mackey, David A.; Smith, George Davey; Nijsten, Tamar E.; Bishop, D. Timothy; Bataille, Veronique; Falchi, Mario; Han, Jiali; Martin, Nicholas G.
    Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications , Jg. 9 2018, Nr. 1, S. 4774
    DOI (Open Access)
  • Carlino, Matteo S.; Long, Georgina V.; Schadendorf, Dirk; Robert, Caroline; Ribas, Antoni; Richtig, Erika; Nyakas, Marta; Caglevic, Christian; Tarhini, Ahmed; Blank, Christian; Hoeller, Christoph; Bar-Sela, Gil; Barrow, Catherine; Wolter, Pascal; Zhou, Honghong; Emancipator, Kenneth; Jensen, Erin H.; Ebbinghaus, Scot; Ibrahim, Nageatte; Daud, Adil
    Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006 : A randomised clinical trial
    In: European Journal of Cancer (EJC) , Jg. 101 2018, S. 236 – 243
    DOI (Open Access)
  • Hodi, Frank S.; Chiarion-Sileni, Vanna; Gonzalez, René C.; Grob, Jean J.; Rutkowski, Piotr; Cowey, Charles L.; Lao, Christopher D.; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard G.; Ferrucci, Pier F.; Smylie, Michael; Hill, A. G.; Hogg, David; Márquez-Rodas, Iván; Jiang, Joel; Rizzo, Jasmine I.; Larkin, James M. G.; Wolchok, J.
    Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii735
    DOI (Open Access)
  • Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen J.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A.; Pickard, Michael D.; Sandor, Victor; Robert, Caroline; Flaherty, Keith T.
    Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS) : A multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 19 2018, Nr. 10, S. 1315 – 1327
    DOI
  • Larkin, James; Minor, David; D'Angelo, Sandra; Neyns, Bart; Smylie, Michael; Miller, Wilson H.; Gutzmer, Ralf; Linette, Gerald; Chmielowski, Bartosz; Lao, Christopher D.; Lorigan, Paul; Grossmann, Kenneth; Hassel, Jessica C.; Sznol, Mario; Daud, Adil; Sosman, Jeffrey; Khushalani, Nikhil; Schadendorf, Dirk; Hoeller, Christoph; Walker, Dana; Kong, George; Horak, Christine; Weber, Jeffrey
    Overall survival in patients with advanced melanoma who received nivolumab versus investigator's choice chemotherapy in CheckMate 037 : A Randomized, Controlled, Open-Label Phase III Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 4, S. 383 – 390
    DOI (Open Access)
  • Petri, Maximilian; Stoffels, Ingo; Griewank, Klaus; Jose, Jithin; Engels, Peter; Schulz, Andrea; Pötzschke, Harald; Jansen, Philipp; Schadendorf, Dirk; Dissemond, Joachim; Klode, Joachim
    Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy
    In: Molecular Imaging and Biology , Jg. 20 2018, Nr. 1, S. 124 – 130
    DOI
  • Migden, Michael R.; Rischin, Danny; Schmults, Chrysalyne D.; Guminski, Alexander; Hauschild, Axel; Lewis, Karl D.; Chung, Christine H.; Hernandez-Aya, Leonel; Lim, Annette M.; Chang, Anne Lynn S.; Rabinowits, Guilherme; Thai, Alesha A.; Dunn, Lara A.; Hughes, Brett G.M.; Khushalani, Nikhil I.; Modi, Badri; Schadendorf, Dirk; Gao, Bo; Seebach, Frank; Li, Siyu; Li, Jingjin; Mathias, Melissa; Booth, Jocelyn; Mohan, Kosalai; Stankevich, Elizabeth; Babiker, Hani M.; Brana, Irene; Gil-Martin, Marta; Homsi, Jade; Johnson, Melissa L.; Moreno, Victor; Niu, Jiaxin; Owonikoko, Taofeek K.; Papadopoulos, Kyriakos P.; Yancopoulos, George D.; Lowy, Israel; Fury, Matthew G.
    PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma
    In: The New England Journal of Medicine , Jg. 379 2018, Nr. 4, S. 341 – 351
    DOI (Open Access)
  • Schaper-Gerhardt, Katrin; Okoye, Steven; Herbst, Rudolf; Ulrich, Jens; Terheyden, Patrick; Pföhler, Claudia; Utikal, Jochen S.; Kreuter, Alexander; Mohr, Peter; Dippel, Edgar; Satzger, Imke; Sucker, Antje; Schadendorf, Dirk; Ugurel, Selma; Gutzmer, Ralf
    PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 88 2018, S. 67 – 76
    DOI
  • De Semir, David; Bezrookove, Vladimir; Nosrati, Mehdi; Dar, Altaf A.; Wu, Clayton; Shen, Julia; Rieken, Christopher; Venkatasubramanian, Meenakshi; Miller, James R.; Desprez, Pierre-Yves; McAllister, Sean; Soroceanu, Liliana; Debs, Robert J.; Salomonis, Nathan; Schadendorf, Dirk; Cleaver, James E.; Kashani-Sabet, Mohammed
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 115 2018, Nr. 25, S. E5766 – E5775
    DOI (Open Access)
  • Tykodi, Scott S.; Schadendorf, Dirk; Cella, David; Reck, Martin; Harrington, Kevin; Wagner, Samuel; Shaw, James W.
    Patient-reported outcomes with nivolumab in advanced solid cancers
    In: Cancer Treatment Reviews , Jg. 70 2018, S. 75 – 87
    DOI (Open Access)
  • Milsch, Laura; Gesierich, Anja; Kreft, Sophia; Livingstone, Elisabeth; Zimmer, Lisa; Goebeler, Matthias; Schadendorf, Dirk; Schilling, Bastian
    Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade
    In: European Journal of Cancer (EJC) , Jg. 99 2018, S. 58 – 65
    DOI
  • Dummer, Reinhard; Michielin, Olivier; Nägeli, Mirjam Chantal; Goldinger, Simone M.; Campigotto, Federico; Kriemler-Krahn, Ulrike; Schmid, Herbert; Pedroncelli, Alberto; Micaletto, Sara; Schadendorf, Dirk
    Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma
    In: ESMO Open , Jg. 3 2018, Nr. 5, S. e000388
    DOI (Open Access)
  • Jansen, Philipp; Stoffels, Ingo; Klode, Joachim; Jockenhöfer, Finja; Augustin, Matthias; Schadendorf, Dirk; Dissemond, Joachim
    Postsurgical treatment of split skin graft donor sites in dermatological departments
    In: The International Journal of Lower Extremity Wounds , Jg. 17 2018, Nr. 1, S. 22 – 29
    DOI
  • Krajewski, Christin; Benson, Sven; Elsenbruch-Harnish, Sigrid; Schadendorf, Dirk; Livingstone, Elisabeth
    Predictors of quality of life in melanoma patients 4 years after diagnosis : Results of a nationwide cohort study in Germany
    In: Journal of Psychosocial Oncology , Jg. 36 2018, Nr. 6, S. 734 – 753
    DOI
  • Scholz, Simone L.; Murali, Rajmohan; Westekemper, Henrike; Schadendorf, Dirk; Griewank, Klaus G.
    Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912)
    In: Ophthalmology , Jg. 125 2018, Nr. 11, S. e78 – e79
    DOI
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Di Giacomo, AnnaMaria; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
    In: European Journal of Cancer (EJC) , Jg. 91 2018, S. 116 – 124
    DOI (Open Access)
  • Schadendorf, Dirk; Jiang, Joel; Kelleher, Thomas; Postow, Michael A.
    Reply to M. Horiguchi et al [Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab as a Result of Adverse Events Lived Significantly Longer Than Patients Who Continued Treatment]
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 7, S. 721
    DOI (Open Access)
  • Bezrookove, Vladimir; Nosrati, Mehdi; Miller, James R.; De Semir, David; Dar, Altaf A.; Vosoughi, Elham; Vaquero, Edith; Sucker, Antje; Lazar, Alexander J.; Gershenwald, Jeffrey E.; Davies, Michael A.; Schadendorf, Dirk; Kashani-Sabet, Mohammed
    Role of elevated PHIP copy number as a prognostic and progression marker for cutaneous melanoma
    In: Clinical Cancer Research , Jg. 24 2018, Nr. 17, S. 4119 – 4125
    DOI (Open Access)
  • Machiraju, Devayani; Moll, Iris; Gebhardt, Christoffer; Sucker, Antje; Buder-Bakhaya, Kristina; Schadendorf, Dirk; Hassel, Jessica C.
    STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α
    In: Melanoma Research , Jg. 28 2018, Nr. 3, S. 204 – 210
    DOI
  • Jockenhöfer, Finja; Schimming, Tobias T.; Schaller, Jörg; Moege, Jürgen; Livingstone, Elisabeth; Salva, Katrin A.; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander
    Sebaceous tumours: more than skin deep
    In: Gut , Jg. 67 2018, Nr. 11, S. 2045 – 2053
    DOI
  • Brinker, Titus Josef; Hekler, Achim; Utikal, Jochen Sven; Grabe, Niels; Schadendorf, Dirk; Klode, Joachim; Berking, Carola; Steeb, Theresa; Enk, Alexander H.; von Kalle, Christof
    Skin Cancer Classification using Convolutional Neural Networks : Systematic Review
    In: Journal of Medical Internet Research (JMIR) , Jg. 20 2018, Nr. 10, S. e11936
    DOI (Open Access)
  • Brinker, Titus Josef; Hekler, Achim; von Kalle, Christof; Schadendorf, Dirk; Esser, Stefan; Berking, Carola; Zacher, Martina T.; Sondermann, Wiebke; Grabe, Niels; Steeb, Theresa; Utikal, Jochen Sven; French, Lars E.; Enk, Alexander H.
    Teledermatology : Comparison of Store-and-Forward Versus Live Interactive Video Conferencing
    In: Journal of Medical Internet Research (JMIR) , Jg. 20 2018, Nr. 10, e11871
    DOI (Open Access)
  • Rachakonda, Sivaramakrishna; Kong, Haiying; Srinivas, Nalini; Garcia-Casado, Zaida; Requena, Celia; Fallah, Mahdi; Heidenreich, Barbara; Planelles, Dolores; Traves, Victor; Schadendorf, Dirk; Nagore, Eduardo; Kumar, Rajiv
    Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
    In: Genes, Chromosomes and Cancer , Jg. 57 2018, Nr. 11, S. 564 – 572
    DOI
  • Kähler, Katharina C.; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Müller-Brenne, Tina; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Augustin, Matthias
    The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy : A survey in German melanoma patients and their treating physicians
    In: OncoTarget , Jg. 9 2018, Nr. 40, S. 26217 – 26225
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Kanaki, Theodora; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth
    The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma
    In: Expert Opinion on Drug Safety , Jg. 17 2018, Nr. 1, S. 73 – 87
    DOI
  • Horn, Susanne; Leonardelli, Sonia; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance
    In: Journal of the National Cancer Institute (JNCI) , Jg. 110 2018, Nr. 6, S. 677 – 681
    DOI (Open Access)
  • Long, Georgina V.; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria G.; Mandala, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Robert, Caroline; Schadendorf, Dirk; Dasgupta, Kohinoor; Shilkrut, Mark; Garrett, James; Brase, Jan C.; Kefford, Rick F.; Kirkwood, John M.; Dummer, Reinhard G.
    Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii734 – viii735
    DOI (Open Access)
  • Schadendorf, Dirk; et.al.
    Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8
  • Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, Sophia; Kähler, Katharina C.
    Willingness to pay for a cure of low-risk melanoma patients in Germany
    In: PLoS ONE , Jg. 13 2018, Nr. 5, S. e0197780
    DOI (Open Access)
  • Brinker, Titus Josef; Enk, Alexander; Gatzka, Martina; Nakamura, Yasuhiro; Sondermann, Wiebke; Omlor, Albert Joachim; Petri, Maximilian Philip; Karoglan, Ante; Seeger, Werner; Klode, Joachim; Kalle, Christof von; Schadendorf, Dirk
    A Dermatologist's ammunition in the war against smoking : a photoaging app
    In: Journal of Medical Internet Research (JMIR) , Jg. 19 2017, Nr. 9, S. e326
    DOI (Open Access)
  • Brinker, Titus Josef; Owczarek, Andreas Dawid; Seeger, Werner; Groneberg, David Alexander; Brieske, Christian Martin; Jansen, Philipp; Klode, Joachim; Stoffels, Ingo; Schadendorf, Dirk; Izar, Benjamin; Fries, Fabian Norbert; Hofmann, Felix Johannes
    A medical student-delivered smoking prevention program, education against tobacco, for secondary schools in Germany : Randomized controlled trial
    In: Journal of Medical Internet Research (JMIR) , Jg. 19 2017, Nr. 6, S. e199
    DOI (Open Access)
  • Faria, Bianca Lisa; Brieske, Christian M; Cosgarea, Ioana; Omlor, Albert J; Fries, Fabian N; Moreira de Faria, Christian Olber; Lino, Henrique Augusto; Oliveira, Ana Carla Cruz; Lisboa, Oscar Campos; Klode, Joachim; Schadendorf, Dirk; Bernardes-Souza, Breno; Brinker, Titus J
    A smoking prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised trial.
    In: BMJ Open , Jg. 7 2017, S. e018589
    DOI (Open Access)
  • Sucker, Antje; Zhao, Fang; Pieper, Natalia; Heeke, Christina; Maltaner, Raffaela; Stadtler, Nadine; Real, Birgit; Bielefeld, Nicola; Howe, Sebastian; Weide, Benjamin; Gutzmer, Ralf; Utikal, Jochen; Loquai, Carmen; Gogas, Helen; Klein-Hitpaß, Ludger; Zeschnigk, Michael; Westendorf, Astrid; Trilling, Mirko; Horn, Susanne; Schilling, Bastian; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Acquired IFNγ 3 resistance impairs anti-Tumor immunity and gives rise to T-cell-resistant melanoma lesions
    In: Nature Communications , Jg. 8 2017, 15440
    DOI (Open Access)
  • van de Nes, Johannes; Koelsche, Christian; Gessi, Marco; Möller, Inga; Sucker, Antje; Scolyer, Richard A.; Buckland, Michael E.; Pietsch, Torsten; Murali, Rajmohan; Schadendorf, Dirk; Griewank, Klaus
    Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors
    In: Journal of Investigative Dermatology , Jg. 137 2017, Nr. 9, S. 2033 – 2035
    DOI
  • Möller, Inga; Murali, Rajmohan; Müller, Hansgeorg; Wiesner, Thomas; Jackett, Louise A.; Scholz, Simone L.; Cosgarea, Ioana; van de Nes, Johannes; Sucker, Antje; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Kutzner, Heinz; Rütten, Arno; Böckers, Martin; Scolyer, Richard A.; Schadendorf, Dirk; Griewank, Klaus
    Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi
    In: Modern Pathology , Jg. 30 2017, Nr. 3, S. 350 – 356
    DOI (Open Access)
  • Long, G.V.; Hauschild, A.; Santinami, M.; Atkinson, V.; Mandal, M.; Chiarion-Sileni, V.; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Robert, C.; Mortier, L.; Schachter, J.; Schadendorf, Dirk; Lesimple, T.; Plummer, R.; Ji, R.; Zhang, P.; Mookerjee, B.; Legos, J.; Kefford, R.; Dummer, R.; Kirkwood, J.M.
    Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma
    In: The New England Journal of Medicine , Jg. 377 2017, Nr. 19, S. 1813 – 1823
    DOI (Open Access)
  • Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Ford, James; Weill, Marine; Sirulnik, L Andres; Jehl, Valentine; Bozón, Viviana; Long, Georgina V; Flaherty, Keith
    Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 18 2017, Nr. 4, S. 435 – 445
    DOI
  • Schadendorf, Dirk; Schuler, Martin
    Checkpointinhibitoren
    In: Der Onkologe , Jg. 23 2017, Nr. 8, S. 619 – 625
    DOI
  • Ugurel, Selma; Loquai, Carmen; Terheyden, Patrick; Schadendorf, Dirk; Richtig, Erika; Utikal, Jochen; Gutzmer, Ralf; Rass, Knuth; Sunderkötter, Cord; Stein, Annette; Fluck, Michael; Kaatz, Martin; Trefzer, Uwe; Kähler, Katharina; Stadler, Rudolf; Berking, Carola; Höller, Christoph; Kerschke, Laura; Edler, Lutz; Kopp-Schneider, Annette; Becker, Jürgen
    Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma : a multicenter randomized phase-3 DeCOG trial
    In: OncoTarget , Jg. 8 2017, Nr. 44, S. 76029 – 76043
    DOI (Open Access)
  • Franklin, Cindy; Rooms, Isabelle; Fiedler, Melanie; Reis, Henning; Milsch, Laura; Herz, Saskia; Livingstone, Elisabeth; Zimmer, Lisa; Schmid, Kurt Werner; Dittmer, Ulf; Schadendorf, Dirk; Schilling, Bastian
    Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
    In: European Journal of Cancer (EJC) , Jg. 86 2017, S. 248 – 256
    DOI
  • Long, G.V.; Flaherty, K.T.; Stroyakovskiy, D.; Gogas, H.; Levchenko, E.; de Braud, F.; Larkin, J.; Garbe, C.; Jouary, T.; Hauschild, A.; Chiarion-Sileni, V.; Lebbe, C.; Mandalà, M.; Millward, M.; Arance, A.; Bondarenko, I.; Haanen, J.B.A.G.; Hansson, J.; Utikal, J.; Ferraresi, V.; Mohr, P.; Probachai, V.; Schadendorf, Dirk; Nathan, P.; Robert, C.; Ribas, A.; Davies, M.A.; Lane, S.R.; Legos, J.J.; Mookerjee, B.; Grob, J-J
    Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma : long-term survival and safety analysis of a phase 3 study
    In: Annals of Oncology , Jg. 28 2017, Nr. 7, S. 1631 – 1639
    DOI (Open Access)
  • Guo, Jun; Carvajal, Richard D.; Dummer, Reinhard G.; Hauschild, Axel; Daud, Adil I.; Bastian, Boris C.; Markovic, Svetomir N.; Queirolo, Paola; Arance, Ana Maria; Berking, Carola; Camargo, Veridiana P.; Herchenhorn, Daniel; Petrella, Teresa M.; Schadendorf, Dirk; Sharfman, William H.; Testori, Alessandro; Novick, Steven C.; Hertle, Sabine; Nourry, C.; Chen, Q.; Hodi, Frank Stephen
    Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma : Final results from the global, single-arm, phase ii team trial
    In: Annals of Oncology , Jg. 28 2017, Nr. 6, S. 1380 – 1387
    DOI (Open Access)
  • Schadendorf, Dirk; Wolchok, Jedd D.; Stephen Hodi, F.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Rutkowski, Piotr; Grob, Jean-Jacques; Lance Cowey, C.; Lao, Christopher D.; Chesney, Jason; Robert, Caroline; Grossmann, Kenneth; McDermott, David; Walker, Dana; Bhore, Rafia; Larkin, James; Postow, Michael A.
    Efficacy and safety outcomes in patients with advanced melanoma who discontinued treatment with nivolumab and ipilimumab because of adverse events : a pooled analysis of randomized phase II and III trials
    In: Journal of Clinical Oncology (JCO) , Jg. 35 2017, Nr. 34, S. 3807 – 3814
    DOI (Open Access)
  • Becker, Jürgen; Lorenz, Eva; Ugurel, Selma; Eigentler, Thomas K.; Kiecker, Felix; Pföhler, Claudia; Kellner, Ivonne; Meier, Friedegund; Kähler, Katharina; Mohr, Peter; Berking, Carola; Haas, Gabriele; Helwig, Christoph; Oksen, Dina; Schadendorf, Dirk; Mahnke, Lisa; Bharmal, Murtuza
    Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
    In: OncoTarget , Jg. 8 2017, Nr. 45, S. 79731 – 79741
    DOI (Open Access)
  • Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D.; Robert, Caroline; Pavlick, Anna C.; Gonzalez, Rene; Hodi, F. Stephen; Ascierto, Paolo A.; Salama, April K. S.; Margolin, Kim A.; Gangadhar, Tara C.; Wei, Ziwen; Ebbinghaus, Scot; Ibrahim, Nageatte; Ribas, Antoni
    Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 86 2017, S. 37 – 45
    DOI
  • Scholz, Simone L.; Möller, Inga; Reis, Henning; Süßkind, Daniela; van de Nes, Johannes; Leonardelli, Sonia; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Paschen, Annette; Sucker, Antje; Murali, Rajmohan; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma
    In: Investigative Ophthalmology & Visual Science, IOVS , Jg. 58 2017, Nr. 9, S. 3464 – 3470
    DOI (Open Access)
  • Ugurel, Selma; Kiecker, Felix; Fröhling, Stefan; Wetter, Axel; Bankfalvi, Agnes; Sucker, Antje; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Becker, Jürgen; Schadendorf, Dirk
    Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 83 2017, S. 142 – 145
    DOI
  • Schrörs, Barbara; Lübcke, Silke; Lennerz, Volker; Fatho, Martina; Bicker, Anne; Wölfel, Catherine; Derigs, Patrick; Hankeln, Thomas; Schadendorf, Dirk; Paschen, Annette; Wölfel, Thomas
    HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
    In: OncoTarget , Jg. 8 2017, Nr. 17, S. 28312 – 28327
    DOI (Open Access)
  • Schadendorf, Dirk; Larkin, James; Wolchok, Jedd; Hodi, F. Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Rutkowski, Piotr; Grob, Jean-Jacques; Cowey, C. Lance; Lao, Christopher; Wagstaff, John; Callahan, Margaret K.; Postow, Michael A.; Smylie, Michael; Ferrucci, Pier Francesco; Dummer, Reinhard; Hill, Andrew; Taylor, Fiona; Sabater, Javier; Walker, Dana; Kotapati, Srividya; Abernethy, Amy; Long, Georgina V.
    Health-related quality of life results from the phase III CheckMate 067 study
    In: European Journal of Cancer (EJC) , Jg. 82 2017, S. 80 – 91
    DOI (Open Access)
  • Potrony, Miriam; Rebollo-Morell, Aida; Giménez-Xavier, Pol; Zimmer, Lisa; Puig-Butille, Joan Anton; Tell-Marti, Gemma; Sucker, Antje; Badenas, Celia; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana
    IRF4 rs12203592 functional variant and melanoma survival
    In: International Journal of Cancer , Jg. 140 2017, Nr. 8, S. 1845 – 1849
    DOI
  • Schadendorf, Dirk; Nghiem, Paul; Bhatia, Shailender; Hauschild, Axel; Saiag, Philippe; Mahnke, Lisa; Hariharan, Subramanian; Kaufman, Howard L.
    Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma
    In: OncoImmunology , Jg. 6 2017, Nr. 10, e1338237
    DOI (Open Access)
  • Franklin, Cindy; Livingstone, Elisabeth; Rösch, Alexander; Schilling, Bastian; Schadendorf, Dirk
    Immunotherapy in melanoma : Recent advances and future directions
    In: European Journal of Surgical Oncology , Jg. 43 2017, Nr. 3, S. 604 – 611
    DOI
  • Robertson, A. Gordon; Shih, Juliann; Yau, Christina; Gibb, Ewan A.; Oba, Junna; Mungall, Karen L.; Hess, Julian M.; Uzunangelov, Vladislav; Walter, Vonn; Danilova, Ludmila; Lichtenberg, Tara M.; Kucherlapati, Melanie; Kimes, Patrick K.; Tang, Ming; Penson, Alexander; Babur, Ozgun; Akbani, Rehan; Bristow, Christopher A.; Hoadley, Katherine A.; Iype, Lisa; Chang, Matthew T.; Abdel-Rahman, Mohamed H.; Ally, Adrian; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Benz, Christopher; Beroukhim, Rameen; Birol, Inanc; Bodenheimer, Tom; Bowen, Jay; Bowlby, Reanne; Brooks, Denise; Carlsen, Rebecca; Cebulla, Colleen M.; Cherniack, Andrew D.; Chin, Lynda; Cho, Juok; Chuah, Eric; Chudamani, Sudha; Cibulskis, Carrie; Cibulskis, Kristian; Cope, Leslie; Coupland, Sarah E.; Defreitas, Timothy; Demchok, John A.; Desjardins, Laurence; Dhalla, Noreen; Esmaeli, Bita; Felau, Ina; Ferguson, Martin L.; Frazer, Scott; Gabriel, Stacey B.; Gastier-Foster, Julie M.; Gehlenborg, Nils; Gerken, Mark; Gershenwald, Jeffrey E.; Getz, Gad; Griewank, Klaus; Grimm, Elizabeth A.; Hayes, D. Neil; Hegde, Apurva M.; Heiman, David I.; Helsel, Carmen; Hobensack, Shital; Holt, Robert A.; Hoyle, Alan P.; Hu, Xin; Hutter, Carolyn M.; Jager, Martine J.; Jefferys, Stuart R.; Jones, Corbin D.; Jones, Steven J.M.; Kandoth, Cyriac; Kasaian, Katayoon; Kim, Jaegil; Kucherlapati, Raju; Lander, Eric; Lawrence, Michael S.; Lazar, Alexander J.; Lee, Semin; Leraas, Kristen M.; Lin, Pei; Liu, Jia; Liu, Wenbin; Lolla, Laxmi; Lu, Yiling; Ma, Yussanne; Mahadeshwar, Harshad S.; Mariani, Odette; Marra, Marco A.; Mayo, Michael; Meier, Sam; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Mills, Gordon B.; Moore, Richard A.; Mose, Lisle E.; Mungall, Andrew J.; Murray, Bradley A.; Naresh, Rashi; Noble, Michael S.; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Perou, Charles M.; Pihl, Todd; Pilarski, Robert; Protopopov, Alexei; Radenbaugh, Amie; Rai, Karan; Ramirez, Nilsa C.; Ren, Xiaojia; Reynolds, Sheila M.; Roach, Jeffrey; Roman-Roman, Sergio; Roszik, Jason; Sadeghi, Sara; Saksena, Gordon; Sastre, Xavier; Schadendorf, Dirk; Schein, Jacqueline E.; Schoenfield, Lynn; Schumacher, Steven E.; Seidman, Jonathan; Seth, Sahil; Sethi, Geetika; Sheth, Margi; Shi, Yan; Shields, Carol; Shmulevich, Ilya; Simons, Janae V.; Singh, Arun D.; Sipahimalani, Payal; Skelly, Tara; Sofia, Heidi; Soloway, Matthew G.; Song, Xingzhi; Stern, Marc-Henri; Stuart, Joshua; Sun, Qiang; Sun, Huandong; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorsson, Vesteinn; Tse, Kane; Veluvolu, Umadevi; Verhaak, Roel G.W.; Voet, Doug; Wan, Yunhu; Wang, Zhining; Weinstein, John N.; Wilkerson, Matthew D.; Williams, Michelle D.; Wise, Lisa; Woodman, Scott E.; Wong, Tina; Wu, Ye; Yang, Liming; Yang, Lixing; Zenklusen, Jean C.; Zhang, Jiashan; Zhang, Hailei; Zmuda, Erik
    Integrative analysis identifies four molecular and clinical subsets in uveal melanoma
    In: Cancer Cell , Jg. 32 2017, Nr. 2, S. 204 – 220.e15
    DOI (Open Access)
  • Ascierto, Paolo A; Del Vecchio, Michele; Robert, Caroline; Mackiewicz, Andrzej; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Bastholt, Lars; Hamid, Omid; Rutkowski, Piotr; McNeil, Catriona; Garbe, Claus; Loquai, Carmen; Dreno, Brigitte; Thomas, Luc; Grob, Jean-Jacques; Liszkay, Gabriella; Nyakas, Marta; Gutzmer, Ralf; Pikiel, Joanna; Grange, Florent; Hoeller, Christoph; Ferraresi, Virginia; Smylie, Michael; Schadendorf, Dirk; Mortier, Laurent; Svane, Inge Marie; Hennicken, Delphine; Qureshi, Anila; Maio, Michele
    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma : a randomised, double-blind, multicentre, phase 3 trial
    In: The Lancet Oncology , Jg. 18 2017, Nr. 5, S. 611 – 622
    DOI
  • Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A.; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M.; Loquai, Carmen; Markovic, Svetomir N.; Joseph, Richard W.; Markey, Kelly; Utikal, Jochen S.; Weishaupt, Carsten; Goldinger, Simone M.; Sondak, Vernon K.; Zager, Jonathan S.; Schadendorf, Dirk; Khushalani, Nikhil I.
    Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 75 2017, S. 47 – 55
    DOI
  • Sekulic, Aleksandar; Migden, Michael R.; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher D.; Miller, Chris; Mortier, Laurent; Murrell, Dedee F.; Hamid, Omid; Quevedo, Jorge F.; Hou, Jeannie; McKenna, Edward; Dimier, Natalie; Williams, Sarah; Schadendorf, Dirk; Hauschild, Axel
    Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : final update of the pivotal ERIVANCE BCC study
    In: BMC Cancer , Jg. 17 2017, S. 332
    DOI (Open Access)
  • Reinhardt, Julia; Landsberg, Jennifer; Schmid-Burgk, Jonathan L.; Ramis, Bartomeu Bibiloni; Bald, Tobias; Glodde, Nicole; Lopez-Ramos, Dorys; Young, Arabella; Ngiow, Shin Foong; Nettersheim, Daniel; Schorle, Hubert; Quast, Thomas; Kolanus, Waldemar; Schadendorf, Dirk; Long, Georgina V.; Madore, Jason; Scolyer, Richard A.; Ribas, Antoni; Smyth, Mark J.; Tumeh, Paul C.; Tuting, Thomas; Holzel, Michael
    MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy
    In: Cancer Research , Jg. 77 2017, Nr. 17, S. 4697 – 4709
    DOI
  • Gerber, Tobias; Willscher, Edith; Loeffler-Wirth, Henry; Hopp, Lydia; Schadendorf, Dirk; Schartl, Manfred; Anderegg, Ulf; Camp, Gray; Treutlein, Barbara; Binder, Hans; Kunz, Manfred
    Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
    In: OncoTarget , Jg. 8 2017, Nr. 1, S. 846 – 862
    DOI (Open Access)
  • Delker, Sarah; Livingstone, Elisabeth; Schimming, Tobias; Schadendorf, Dirk; Griewank, Klaus
    Melanoma diagnosed in lesions previously treated by laser therapy
    In: The Journal of Dermatology , Jg. 44 2017, Nr. 1, S. 23 – 28
    DOI
  • Schadendorf, Dirk; Lebbé, Céleste; zur Hausen, Axel; Avril, Marie-Françoise; Hariharan, Subramanian; Bharmal, Murtuza; Becker, Jürgen
    Merkel cell carcinoma : Epidemiology, prognosis, therapy and unmet medical needs
    In: European Journal of Cancer (EJC) , Jg. 71 2017, S. 53 – 69
    DOI (Open Access)
  • Cosgarea, I.; Körber, Andreas; Dill, D.; Schadendorf, Dirk; Ugurel, Selma
    Metastatic recurrence of 17-year relapse-free melanoma during anti-TNFa therapy
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 31 2017, Nr. 8, S. e368 – e369
    DOI
  • Long, Georgina V.; Weber, Jeffrey S.; Larkin, James; Atkinson, Victoria; Grob, Jean-Jacques; Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Márquez-Rodas, Ivan; McNeil, Catriona; Schmidt, Henrik; Briscoe, Karen; Baurain, Jean-François; Hodi, F Stephen; Wolchok, Jedd D.
    Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression : Analysis of 2 Phase 3 Clinical Trials
    In: JAMA Oncology , Jg. 3 2017, Nr. 11, S. 1511 – 1519
    DOI (Open Access)
  • Wolchok, J.D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.-J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Schadendorf, Dirk; Ferrucci, P.F.; Smylie, M.; Dummer, R.; Hill, A.; Hogg, D.; Haanen, J.; Carlino, M.S.; Bechter, O.; Maio, M.; Marquez-Rodas, I.; Guidoboni, M.; McArthur, G.; Lebbé, C.; Ascierto, P.A.; Long, G.V.; Cebon, J.; Sosman, J.; Postow, M.A.; Callahan, M.K.; Walker, D.; Rollin, L.; Bhore, R.; Hodi, F.S.; Larkin, J.
    Overall survival with combined nivolumab and ipilimumab in advanced melanoma
    In: The New England Journal of Medicine , Jg. 377 2017, Nr. 14, S. 1345 – 1356
    DOI (Open Access)
  • Wistuba-Hamprecht, Kilian; Martens, Alexander; Heubach, Florian; Romano, Emanuela; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael; Wong, Phillip; Mallardo, Domenico; Schilling, Bastian; Di Giacomo, Anna Maria; Khammari, Amir; Dreno, Brigitte; Maio, Michele; Schadendorf, Dirk; Ascierto, Paolo A.; Wolchok, Jedd D.; Blank, Christian U.; Garbe, Claus; Pawelec, Graham; Weide, Benjamin
    Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
    In: European Journal of Cancer (EJC) , Jg. 73 2017, S. 61 – 70
    DOI (Open Access)
  • Brinker, Titus Josef; Schadendorf, Dirk; Klode, Joachim; Cosgarea, Ioana; Rösch, Alexander; Jansen, Philipp; Stoffels, Ingo; Izar, Benjamin
    Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study.
    In: JMIR mhealth and uhealth , Jg. 5 2017, Nr. 7, e101
    DOI (Open Access)
  • Brinker, Titus Josef; Brieske, Christian Martin; Schaefer, Christoph Matthias; Buslaff, Fabian; Gatzka, Martina; Petri, Maximilian Philip; Sondermann, Wiebke; Schadendorf, Dirk; Stoffels, Ingo; Klode, Joachim
    Photoaging mobile apps in school-based melanoma prevention: pilot study
    In: Journal of Medical Internet Research (JMIR) , Jg. 19 2017, Nr. 9, S. e319
    DOI (Open Access)
  • Brüggemann, C.; Kirchberger, Michael Constantin; Goldinger, Simone Maria; Weide, Benjamin M.; Konrad, Andreas; Erdmann, Michael K.; Schadendorf, Dirk; Croner, Roland Siegfried; Krähenbühl, Lukas; Kähler, Katharina Charlotte; Hafner, C.; Leisgang, Waltraud; Kiesewetter, Franklin F.; Dummer, Reinhard G.; Schuler, Gerold; Stürzl, Michael; Heinzerling, Lucie M.
    Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
    In: Journal of Cancer Research and Clinical Oncology , Jg. 143 2017, Nr. 10, S. 1977 – 1984
    DOI
  • Jacquelot, N; Roberti, M P; Enot, D P; Rusakiewicz, S; Ternès, N; Jegou, S; Woods, D M; Sodré, A L; Hansen, M; Meirow, Y; Sade-Feldman, M; Burra, A; Kwek, S S; Flament, C; Messaoudene, M; Duong, C P M; Chen, L; Kwon, B S; Anderson, A C; Kuchroo, V K; Weide, B; Aubin, F; Borg, C; Dalle, S; Beatrix, O; Ayyoub, M; Balme, B; Tomasic, G; Di Giacomo, A M; Maio, M; Schadendorf, Dirk; Melero, I; Dréno, B; Khammari, A; Dummer, R; Levesque, M; Koguchi, Y; Fong, L; Lotem, M; Baniyash, M; Schmidt, H; Svane, I M; Kroemer, G; Marabelle, A; Michiels, S; Cavalcanti, A; Smyth, M J; Weber, J S; Eggermont, A M; Zitvogel, L
    Predictors of responses to immune checkpoint blockade in advanced melanoma
    In: Nature Communications , Jg. 8 2017, S. 592
    DOI (Open Access)
  • Reinsch, Nico; Arendt, Marina; Geisel, Henrike; Schulze, Christina; Holzendorf, Volker; Warnke, Anna; Neumann, Till; Brockmeyer, Norbert H.; Schadendorf, Dirk; Eisele, Lewin; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Esser, Stefan
    Prolongation of the QTc interval in HIV-infected individuals compared to the general population
    In: Infection - A Journal of Infectious Disease , Jg. 45 2017, Nr. 5, S. 659 – 667
    DOI
  • Eigentler, Thomas K.; Mühlenbein, Corinna; Follmann, Markus; Schadendorf, Dirk; Garbe, Claus
    S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. 6, S. e1 – e41
    DOI
  • Griewank, Klaus; Müller, Hansgeorg; Jackett, Louise A.; Emberger, Michael; Möller, Inga; van de Nes, Johannes; Zimmer, Lisa; Livingstone, Elisabeth; Wiesner, Thomas; Scholz, Simone L.; Cosgarea, Ioana; Sucker, Antje; Schimming, Tobias; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Reis, Henning; Mentzel, Thomas; Kutzner, Heinz; Rütten, Arno; Murali, Rajmohan; Scolyer, Richard A.; Schadendorf, Dirk
    SF3B1 and BAP1 mutations in blue nevus-like melanoma
    In: Modern Pathology , Jg. 30 2017, Nr. 7, S. 928 – 939
    DOI (Open Access)
  • Weber, Jeffrey S.; Hodi, F. Stephen; Wolchok, Jedd D.; Topalian, Suzanne L.; Schadendorf, Dirk; Larkin, James; Sznol, Mario; Long, Georgina V.; Li, Hewei; Waxman, Ian M.; Jiang, Joel; Robert, Caroline
    Safety profile of nivolumab monotherapy : a pooled analysis of patients with advanced melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 35 2017, Nr. 7, S. 785 – 792
    DOI
  • Esser, Stefan; Krotzek, Judith; Dirks, Henrike; Scherbaum, Norbert; Schadendorf, Dirk
    Sexual risk behavior, sexually transmitted infections, and HIV transmission risks in HIV-positive men who have sex with men (MSM) – approaches for medical prevention
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. 4, S. 421 – 428
    DOI
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications , Jg. 8 2017, S. 14447
    DOI (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Flaherty, Keith T.; Grob, Jean Jacques; Hauschild, Axel; Larkin, James; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : the impact of novel therapies–update 2017
    In: European Journal of Cancer (EJC) , Jg. 83 2017, S. 247 – 257
    DOI
  • Wittig-Blaich, Stephanie; Wittig, Rainer; Schmidt, Steffen; Lyer, Stefan; Bewerunge-Hudler, Melanie; Gronert-Sum, Sabine; Strobel-Freidekind, Olga; Müller, Carolin; List, Markus; Jaskot, Aleksandra; Christiansen, Helle; Hafner, Mathias; Schadendorf, Dirk; Block, Ines; Mollenhauer, Jan
    Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma
    In: OncoTarget , Jg. 8 2017, Nr. 14, S. 23760 – 23774
    DOI (Open Access)
  • Cosgarea, Ioana; Ugurel, Selma; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Ziemer, Mirjana; Utikal, Jochen; Mohr, Peter; Pfeiffer, Christiane; Pföhler, Claudia; Hillen, Uwe; Horn, Susanne; Schadendorf, Dirk; Griewank, Klaus; Rösch, Alexander
    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
    In: OncoTarget , Jg. 8 2017, Nr. 25, S. 40683 – 40692
    DOI (Open Access)
  • Young, Arabella; Ngiow, Shin Foong; Madore, Jason; Reinhardt, Julia; Landsberg, Jennifer; Chitsazan, Arash; Rautela, Jai; Bald, Tobias; Barkauskas, Deborah S.; Ahern, Elizabeth; Huntington, Nicholas D.; Schadendorf, Dirk; Long, Georgina V.; Boyle, Glen M.; Hölzel, Michael; Scolyer, Richard A.; Smyth, Mark J.
    Targeting adenosine in BRAF-mutant melanoma reduces tumor growth and metastasis
    In: Cancer Research , Jg. 77 2017, Nr. 17, S. 4684 – 4696
    DOI
  • Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B. A. G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Piotr; Grob, Jean-Jacques; Nathan, Paul; Ribas, Antoni; Davies, Michael A.; Zhang, Ying; Kaper, Mathilde; Mookerjee, Bijoyesh; Legos, Jeffrey J.; Flaherty, Keith T.; Robert, Caroline
    Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
    In: European Journal of Cancer (EJC) , Jg. 82 2017, S. 45 – 55
    DOI
  • Dréno, Brigitte; Kunstfeld, Rainer; Hauschild, Axel; Fosko, Scott; Zloty, David; Labeille, Bruno; Grob, Jean-Jacques; Puig, Susana; Gilberg, Frank; Bergström, Daniel; Page, Damian R; Rogers, Gary; Schadendorf, Dirk
    Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE) : a randomised, regimen-controlled, double-blind, phase 2 trial
    In: The Lancet Oncology , Jg. 18 2017, Nr. 3, S. 404 – 412
    DOI
  • Hoge, Jennifer C.; Schadendorf, Dirk
    Update der S3-Leitlinie zum malignen Melanom : aktuelle Empfehlungen für das fortgeschrittene Melanom
    In: Best Practice Onkologie , Jg. 12 2017, Nr. 2, S. 110 – 118
    DOI
  • Cosgarea, Ioana; Ritter, Cathrin; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Update on the clinical use of kinase inhibitors in melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. 9, S. 887 – 893
    DOI
  • McArthur, Grant A.; Maio, Michele; Arance, Ana Maria; Nathan, Paul D.; Blank, Christian U.; Avril, Marie Françoise; Garbe, Claus; Hauschild, Axel; Schadendorf, Dirk; Hamid, Omid A.; Fluck, Michael; Thebeau, Melissa S.; Schachter, Jacob M.; Kefford, Rick F.; Chamberlain, Marc Charles; Makrutzki, Martina; Robson, Susan; Gonzalez, René C.; Margolin, Kim A.
    Vemurafenib in metastatic melanoma patients with brain metastases : An open-label, single-arm, phase 2, multicentre study
    In: Annals of Oncology , Jg. 28 2017, Nr. 3, S. 634 – 641
    DOI
  • Campigotto, F.; Schadendorf, Dirk; Nägeli, M.; Micaletto, S.; Schmid, H.; Goldinger, S.M.; Kriemler-Krahn, U.; Dummer, R.; Michielin, O.A.; Pedroncelli, A.
    A phase I, open-label study of pasireotide in patients with BRAF- and NRAS-wild type, unresectable and or metastatic melanoma
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6
    DOI
  • Eigentler, T K; Gutzmer, R; Hauschild, A; Heinzerling, L; Schadendorf, Dirk; Nashan, D; Hölzle, E; Kiecker, F; Becker, Jürgen; Sunderkötter, C; Moll, I; Richtig, E; Pönitzsch, I; Pehamberger, H; Kaufmann, R; Pföhler, C; Vogt, T; Berking, C; Praxmarer, M; Garbe, C
    Adjuvant treatment with pegylated interferon ?-2a versus low-dose interferon ?-2a in patients with high-risk melanoma : a randomized phase III DeCOG trial
    In: Annals of Oncology , Jg. 27 2016, Nr. 8, S. 1625 – 1632
    DOI (Open Access)
  • Gebhardt, C.; Sucker, A.; Schadendorf, Dirk; Haselmann, V.H.; Neumaier, M.; Duda, A.; Brechtel, I.; Utikal, J.
    Analysis of BRAF V600E mutation status – concordance of results from circulating tumor DNA and tissue-based testing and impact on prediction of the clinical course in patients undergoing BRAFi therapy
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1145P
    DOI
  • Robert, C.; Schadendorf, Dirk; Long, G.V.; Stroyakovskiy, D.; Levchenko, E.; Chiarion-Sileni, V.; Flaherty, K.; Nathan, P.; Ribas, A.; Davies, M.; Zhang, J.; Chen, L.; Mookerjee, B.; Redhu, S.; Grob, J.J.
    Analysis of patient-reported outcomes by disease progression status in patients (pts) with BRAF V600–mutant metastatic melanoma in the COMBI-d and COMBI-v trials
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1140P
    DOI
  • Weide, Benjamin; Martens, Alexander; Hassel, Jessica C; Berking, Carola; Postow, Michael A; Bisschop, Kees; Simeone, Ester; Mangana, Johanna; Schilling, Bastian; Di Giacomo, Anna Maria; Brenner, Nicole; Kähler, Katharina; Heinzerling, Lucie; Gutzmer, Ralf; Bender, Armin; Gebhardt, Christoffer; Romano, Emanuela; Meier, Friedegund; Martus, Peter; Maio, Michele; Blank, Christian; Schadendorf, Dirk; Dummer, Reinhard; Ascierto, Paolo A; Hospers, Geke; Garbe, Claus; Wolchok, Jedd D
    Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
    In: Clinical Cancer Research , Jg. 22 2016, Nr. 22, S. 5487 – 5496
    DOI (Open Access)
  • Martens, Alexander; Wistuba-Hamprecht, Kilian; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Romano, Emanuela; Khammari, Amir; Dreno, Brigitte; Capone, Mariaelena; Ascierto, Paolo A; Di Giacomo, Anna Maria; Maio, Michele; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Hassel, Jessica C; Eigentler, Thomas K; Martus, Peter; Wolchok, Jedd D; Blank, Christian; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
    In: Clinical Cancer Research , Jg. 22 2016, Nr. 12, S. 2908 – 2918
    DOI (Open Access)
  • Hauschild, Axel; Schadendorf, Dirk
    Checkpoint inhibitors : a new standard of care for advanced Merkel cell carcinoma?
    In: The Lancet Oncology , Jg. 17 2016, Nr. 10, S. 1337 – 1339
    DOI
  • Herz, Saskia; Höfer, Thomas; Papapanagiotou, Matina; Leyh, Julia Christina; Meyenburg, Sarah; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Livingstone, Elisabeth; Schilling, Bastian; Franklin, Cindy
    Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
    In: European Journal of Cancer (EJC) , Jg. 67 2016, S. 66 – 72
    DOI
  • McGranahan, Nicholas; Furness, Andrew J S; Rosenthal, Rachel; Ramskov, Sofie; Lyngaa, Rikke; Saini, Sunil Kumar; Jamal-Hanjani, Mariam; Wilson, Gareth A; Birkbak, Nicolai J; Hiley, Crispin T; Watkins, Thomas B K; Shafi, Seema; Murugaesu, Nirupa; Mitter, Richard; Akarca, Ayse U; Linares, Joseph; Marafioti, Teresa; Henry, Jake Y; Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Schadendorf, Dirk; Garraway, Levi A; Makarov, Vladimir; Rizvi, Naiyer A; Snyder, Alexandra; Hellmann, Matthew D; Merghoub, Taha; Wolchok, Jedd D; Shukla, Sachet A; Wu, Catherine J; Peggs, Karl S; Chan, Timothy A; Hadrup, Sine R; Quezada, Sergio A; Swanton, Charles
    Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
    In: Science , Jg. 351 2016, Nr. 6280, S. 1463 – 1469
    DOI
  • Santiago-Walker, Ademi; Gagnon, Robert; Mazumdar, Jolly; Casey, Michelle; Long, Georgina V.; Schadendorf, Dirk; Flaherty, Keith; Kefford, Richard; Hauschild, Axel; Hwu, Patrick; Haney, Patricia; O'Hagan, Anne; Carver, Jennifer; Goodman, Vicki; Legos, Jeffrey; Martin, Anne Marie
    Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
    In: Clinical Cancer Research , Jg. 22 2016, Nr. 3, S. 567 – 574
    DOI (Open Access)
  • Hofmann, Lars; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Thomas, Ioannis; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Ugurel, Selma; Zimmer, Lisa; Goldinger, Simone M.; Loquai, Carmen; Forschner, Andrea
    Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
    In: European Journal of Cancer (EJC) , Jg. 60 2016, S. 190 – 209
    DOI
  • van de Nes, Johannes; Wrede, Karsten; Ringelstein, Adrian; Stiller, Mathias; Horn, Susanne; Sucker, Antje; Möller, Inga; Scholz, Simone L; Murali, Rajmohan; Gessi, Marco; Schadendorf, Dirk; Griewank, Klaus
    Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature
    In: Journal of Investigative Dermatology , Jg. 136 2016, Nr. 7, S. 1526 – 1528
    DOI
  • Schadendorf, Dirk
    Eine Übersicht über Therapiefortschritte in den letzten 50 Jahren beim Metastasierten Melanom
    In: Drug Research , Jg. 66 2016, Nr. S 01, S. 31 – S34
    DOI
  • Schadendorf, Dirk
    Entscheidungsfindung für die klinische Praxis : Aktuelle Konzepte und Behandlungsalgorithmen mit Immun-Checkpoint-Inhibitoren beim Melanom
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 4, S. 8 – 12
    DOI
  • Schadendorf, Dirk; Hauschild, A.; Fosko, S.; Zloty, D.; Labeille, B.; Grob, J.J.; Puig, S.; Makrutzki, M.; Templeton, I.; Rogers, G.; Dreno, B.; Kunstfeld, R.
    Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1152P
    DOI
  • Ebstein, Frédéric; Keller, Martin; Paschen, Annette; Walden, Peter; Seeger, Michael; Bürger, Elke; Krüger, Elke; Schadendorf, Dirk; Kloetzel, Peter-M; Seifert, Ulrike
    Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)
    In: Scientific Reports , Jg. 6 2016, S. 25208
    DOI (Open Access)
  • Long, Georgina V; Grob, Jean-Jacques; Nathan, Paul; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Lane, Stephen R; Mak, Carmen; Legenne, Philippe; Flaherty, Keith T; Davies, Michael A
    Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment : a pooled analysis of individual patient data from randomised trials
    In: The Lancet Oncology , Jg. 17 2016, Nr. 12, S. 1743 – 1754
    DOI
  • Hamid, O.; Puzanov, I.; Dummer, R.; Schachter, J.; Daud, A.; Schadendorf, Dirk; Blank, C.; Cranmer, L.D.; Robert, C.; Pavlick, A.C.; Gonzalez, R.; Hodi, F.S.; Ascierto, P.A.; Salama, A.; Margolin, K.A.; Gangadhar, T.C.; Wei, Z.; Ebbinghaus, S.W.; Ibrahim, N.; Ribas, A.
    Final overall survival for KEYNOTE-002 : pembrolizumab (pembro) versus investigator-choice chemotherapy (chemo) for ipilimumab (ipi)-refractory melanoma
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1107O
    DOI
  • Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M; Hille, Darcy; Ebbinghaus, Scot; Kang, S Peter; Zhou, Wei; Ribas, Antoni
    Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
    In: European Journal of Cancer (EJC) , Jg. 67 2016, S. 46 – 54
    DOI (Open Access)
  • Nathan, P.; Levchenko, E.; Davies, M.; Chiarion-Sileni, V.; Grob, J.J.; Long, G.V.; Schadendorf, Dirk; Robert, C.; Chen, L.; Mookerjee, B.; Redhu, S.; Zhang, J.; Ribas, A.; Stroyakovskiy, D.; Flaherty, K.
    Health-related quality-of-life (HRQOL) impact of dabrafenib (D) and trametinib (T) vs BRAF inhibitor (BRAFi) monotherapy by lactate dehydrogenase (LDH) in patients (pts) with BRAF V600–mutant melanoma
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1137P
    DOI
  • Ekedahl, Henrik; Lauss, Martin; Olsson, Håkan; Griewank, Klaus; Schadendorf, Dirk; Ingvar, Christian; Jönsson, Göran
    High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma
    In: Pigment Cell and Melanoma Research , Jg. 29 2016, Nr. 5, S. 598 – 600
    DOI
  • Martens, Alexander; Wistuba-Hamprecht, Kilian; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Capone, Mariaelena; Madonna, Gabriele; Khammari, Amir; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Martus, Peter; Dreno, Brigitte; Ascierto, Paolo A; Wolchok, Jedd D; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
    In: Clinical Cancer Research , Jg. 22 2016, Nr. 19, S. 4848 – 4858
    DOI
  • Potrony, Miriam; Carreras, Esther; Aranda, Fernando; Zimmer, Lisa; Puig-Butille, Joan-Anton; Tell-Martí, Gemma; Armiger, Noelia; Sucker, Antje; Giménez-Xavier, Pol; Martínez-Florensa, Mario; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana; Lozano, Francisco
    Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival
    In: International Journal of Cancer , Jg. 139 2016, Nr. 6, S. 1297 – 1302
    DOI (Open Access)
  • Sondermann, Wiebke; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander; Klode, Joachim; Dissemond, Joachim
    Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
    In: Medicine , Jg. 95 2016, Nr. 29, S. e4332
    DOI (Open Access)
  • Weber, Jeffrey S; Postow, Michael; Lao, Christopher D; Schadendorf, Dirk
    Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
    In: The Oncologist , Jg. 21 2016, Nr. 10, S. 1230 – 1240
    DOI (Open Access)
  • Xie, Huaping; Sivaramakrishna, Rachakonda; Heidenreich, Barbara; Nagore, Eduardo; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Mapping of deletion breakpoints at the CDKN2A locus in melanoma : Detection of MTAP-ANRIL fusion transcripts
    In: OncoTarget , Jg. 7 2016, Nr. 13, S. 16490 – 16504
    DOI
  • Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Schilling, Bastian
    Medikamentöse Therapie des metastasierten malignen Melanoms
    In: Arzneimitteltherapie (AMT) , Jg. 34 2016, Nr. 1-2, S. 14 – 22
  • Zhao, Fang; Sucker, Antje; Horn, Susanne; Heeke, Christina; Bielefeld, Nicola; Schrörs, Barbara; Bicker, Anne; Lindemann, Monika; Rösch, Alexander; Gaudernack, Gustav; Stiller, Mathias; Becker, Jürgen; Lennerz, Volker; Wölfel, Thomas; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
    In: Cancer Research , Jg. 76 2016, Nr. 15, S. 4347 – 4358
    DOI
  • Schadendorf, Dirk; Schilling, Bastian
    Molecular features of response to anti-PD-1 therapy
    In: Chinese Clinical Oncology , Jg. 5 2016, Nr. 6, S. 74
    DOI (Open Access)
  • Zimmer, Lisa; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Forschner, Andrea; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Marian-Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Thomas, Ioannis; Ugurel, Selma; Loquai, Carmen; Hofmann, Lars; Goldinger, Simone M.
    Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
    In: European Journal of Cancer (EJC) , Jg. 60 2016, S. 210 – 225
    DOI
  • Hillen, Uwe; Grabellus, Florian; Franklin, Cindy; Sucker, Antje; Schadendorf, Dirk; Schilling, Bastian
    Oncogene Status of an Interdigitating Dendritic Cell Sarcoma : Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma
    In: The American Journal of Surgical Pathology , Jg. 40 2016, Nr. 12, S. 1721 – 1723
    DOI
  • Griewank, Klaus; Schilling, Bastian; Scholz, Simone L; Metz, Claudia H; Livingstone, Elisabeth; Sucker, Antje; Möller, Inga; Reis, Henning; Franklin, Cindy; Cosgarea, Ioana; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zimmer, Lisa
    Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
    In: European Journal of Cancer (EJC) , Jg. 57 2016, S. 112 – 117
    DOI
  • Wolchok, J.; Wagstaff, J.; Long, G.V.; Hodi, F.S.; Hassel, J.; Hoeller, C.; Larkin, J.; Ascierto, P.A.; Lebbe, C.; Haanen, J.B.A.G.; Schadendorf, Dirk; Hogg, D.; Horak, C.; Robert, C.; Dummer, R.; Sileni, V.; Pavlick, A.C.; Rutkowski, P.; Corrie, P.
    PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL) : A pooled analysis
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1112PD
    DOI
  • Wistuba-Hamprecht, Kilian; Di Benedetto, Svetlana; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Garbe, Claus; Weide, Benjamin; Pawelec, Graham
    Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma
    In: International Journal of Cancer , Jg. 138 2016, Nr. 3, S. 698 – 704
    DOI (Open Access)
  • Rösch, Alexander; Paschen, Annette; Landsberg, Jenny; Helfrich, Iris; Becker, Jürgen; Schadendorf, Dirk
    Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
    In: European Journal of Cancer (EJC) , Jg. 59 2016, S. 109 – 112
    DOI
  • Petri, M.; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim; Schulz, Andrea; Ley, Julia; Stoffels, Ingo; Jose, Jithin
    Photoacoustic imaging of real-time oxygen changes in chronic leg ulcers after topical application of a haemoglobin spray : a pilot study
    In: Journal of Wound Care , Jg. 25 2016, Nr. 2, S. 87 – 91
    DOI
  • Grob, J.J.; Schadendorf, Dirk; Mookerjee, B.; Flaherty, K.; Ribas, A.; Nathan, P.; Lane, S.; Robert, C.; Long, G.V.; Davies, M.; Legos, J.J.
    Pooled analysis of factors to predict durable clinical outcomes with combination dabrafenib (D) and trametinib (T) across registration trials
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 1134P
    DOI
  • Kaehler, Katharina C; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Haalck, Thomas; Heinzerling, Lucie; Kornek, Thomas; Livingstone, Elisabeth; Loquai, Carmen; Maul, Lara Valeska; Lang, Berenice M; Schadendorf, Dirk; Stade, Barbara; Terheyden, Patrick; Utikal, Jochen; Wagner, Tobias; Hauschild, Axel; Garbe, Claus; Augustin, Matthias
    Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
    In: Medicine , Jg. 95 2016, Nr. 46, S. e5375
    DOI (Open Access)
  • Wistuba-Hamprecht, Kilian; Martens, Alexander; Haehnel, Karin; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Romano, Emanuela; Khammari, Amir; Dreno, Brigitte; Capone, Mariaelena; Ascierto, Paolo A; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth; Larbi, Anis; Schilling, Bastian; Schadendorf, Dirk; Wolchok, Jedd D; Blank, Christian U; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
    In: European Journal of Cancer (EJC) , Jg. 64 2016, S. 116 – 126
    DOI (Open Access)
  • Ebstein, Frédéric; Textoris-Taube, Kathrin; Keller, Christin; Golnik, Richard; Vigneron, N.; Van den Eynde, Benoît J.; Schuler-Thurner, Beatrice; Schadendorf, Dirk; Lorenz, Felix K.M.; Uckert, Wolfgang A.; Urban, Sabrina; Lehmann, Andrea; Albrecht-Koepke, N.; Janek, Katharina; Henklein, Petra; Niewienda, Agathe; Kloetzel, Peter Michael; Mishto, Michele
    Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes
    In: Scientific Reports , Jg. 6 2016, S. 24032
    DOI (Open Access)
  • Willmes, Christoph; Ugurel, Selma; Sucker, Antje; Schadendorf, Dirk; Hesbacher, Sonja; Poppe, Lidia; Fried, Isabella; Becker, Jürgen; Kumar, Rajiv
    SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
    In: OncoTarget , Jg. 7 2016, Nr. 9, S. 10117 – 10132
    DOI (Open Access)
  • Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, P A; Demidov, L; Grob, J J; Ridolfi, R; Schadendorf, Dirk; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, T P; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, P M; Louahed, J; Brichard, V G; Lehmann, F F
    Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma : results of a phase I dose escalation study
    In: ESMO Open , Jg. 1 2016, Nr. 4, S. e000068
    DOI (Open Access)
  • Stiller, Mathias; Sucker, Antje; Griewank, Klaus; Aust, Daniela; Baretton, Gustavo Bruno; Schadendorf, Dirk; Horn, Susanne
    Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA
    In: OncoTarget , Jg. 7 2016, Nr. 37, S. 59115 – 59128
    DOI (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Flaherty, Keith T.; Grob, Jean Jacques; Hauschild, Axel; Larkin, James; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma: The impact of novel therapies
    In: European Journal of Cancer (EJC) , Jg. 53 2016, S. 125 – 134
    DOI
  • van de Nes, Johannes; Gessi, Marco; Sucker, Antje; Möller, Inga; Stiller, Mathias; Horn, Susanne; Scholz, Simone L.; Pischler, Carina; Stadtler, Nadine; Schilling, Bastian; Zimmer, Lisa; Hillen, Uwe; Scolyer, Richard A.; Buckland, Michael E.; Lauriola, Libero; Pietsch, Torsten; Waha, Andreas; Schadendorf, Dirk; Murali, Rajmohan; Griewank, Klaus
    Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system
    In: Journal of Neuro-Oncology , Jg. 127 2016, Nr. 3, S. 435 – 444
    DOI (Open Access)
  • Kandilarova, Snezhina Mihailova; Paschen, Annette; Mihaylova, Anastassia; Ivanova, Milena; Schadendorf, Dirk; Naumova, Elissaveta
    The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression
    In: Archivum Immunologiae et Therapiae Experimentalis , Jg. 64 2016, Nr. Suppl. 1, S. 73 – 81
    DOI
  • van Kempen, Léon C L; Redpath, Margaret; Elchebly, Mounib; Klein, Kathleen Oros; Papadakis, Andreas I; Wilmott, James S; Scolyer, Richard A; Edqvist, Per-Henrik; Pontén, Fredrik; Schadendorf, Dirk; van Rijk, Anke F; Michiels, Stefan; Dumay, Anne; Helbling-Leclerc, Anne; Dessen, Philippe; Wouters, Jasper; Stass, Marguerite; Greenwood, Celia M T; Ghanem, Ghanem E; van den Oord, Joost; Feunteun, Jean; Spatz, Alan
    The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene
    In: Science Translational Medicine , Jg. 8 2016, Nr. 369, S. 369ra177
    DOI
  • Robert, C.; Karaszewska, B.; Schachter, J.; Rutkowski, P.; Mackiewicz, A.; Stroyakovskiy, D.; Dummer, R.; Grange, F.; Mortier, L.; Chiarion-Sileni, V.; Drucis, K.; Krajsová, I.; Hauschild, A.; Mookerjee, B.; Legos, J.J.; Zhang, Y.; Lane, S.; Schadendorf, Dirk
    Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) + trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K–mutant cutaneous melanoma
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. LBA40
    DOI
  • Harries, Mark; Malvehy, Josep; Lebbe, Céleste; Heron, Louise; Amelio, Justyna; Szabo, Zsolt; Schadendorf, Dirk
    Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe
    In: European Journal of Cancer (EJC) , Jg. 60 2016, S. 179 – 189
    DOI
  • Kaur, Amanpreet; Schadendorf, Dirk; Schilling, Bastian; Lehrmann, Elin; Yin, Xiangfan; Tang, Hsin-Yao; Meeth, Katrina; Kossenkov, Andrew V.; Ferrucci, Luigi; McDonnell, Nazli B.; Morissette, Rachel; Valiga, Alexander A.; Cheng, Phil; O’Connell, Michael P.; Appleton, Jessica; Dang, Vanessa M.; Kugel, Curtis H.; Ndoye, Abibatou; Behera, Reeti; Marchbank, Katie; Webster, Marie R.
    sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
    In: Nature , Jg. 532 2016, Nr. 7598, S. 250 – 254
    DOI (Open Access)
  • Ugurel, Selma; Loquai, Carmen; Kähler, Katharina; Hassel, Jessica; Berking, Carola; Zimmer, Lisa; Haubitz, Imme; Satzger, Imke; Müller-Brenne, Tina; Mikhaimer, Nadia C.; Becker, Jürgen; Kilian, Katharina J.; Schadendorf, Dirk; Heinzerling, Lucie; Kaatz, Martin; Utikal, Jochen; Göppner, Daniela; Pföhler, Claudia; Pflugfelder, Annette; Mößner, Rotraut; Gutzmer, Ralf
    A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma : pretreatment impacts survival
    In: Annals of Oncology , Jg. 26 2015, Nr. 3, S. 573 – 582
    DOI (Open Access)
  • Johnson, Douglas B.; Schadendorf, Dirk; Egberts, Friederike; Berking, Carola; Becker, Jürgen; Gutzmer, Ralf; Gogask, Helen; Scolyer, Richard A.; Sucker, Antje; Rizos, Helen; Zhao, Shilin; Eroglu, Zeynep; Zimmer, Lisa; Menzies, Alexander M.
    Acquired BRAF inhibitor resistance : A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. 18, S. 2792 – 2799
    DOI (Open Access)
  • Livingstone, Elisabeth; Eigentler, Thomas Kurt; Windemuth-Kieselbach, Christine; Hauschild, Axel; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothée; Kilian, Katharina J.; Debus, Dirk; Kähler, Katharina Charlotte; Mauerer, Andreas; Möllenhof, Katrin; Dippel, Edgar; Schadendorf, Dirk
    Actual practice of melanoma follow-up and treatment in Germany : results of a prospective, longitudinal cohort study
    In: British Journal of Dermatology: BJD , Jg. 172 2015, Nr. 6, S. 1646 – 1650
    DOI
  • Scholz, Simone L.; Horn, Susanne; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Sondermann, Wiebke; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, Claudia H; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: OncoTarget , Jg. 6 2015, Nr. 28, S. 25868 – 25882
    DOI (Open Access)
  • Scholz, S.; Horn, S.; Murali, R.; Moeller, I.; Sucker, A.; Sondermann, W.; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, C.; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 13 2015, Nr. Suppl. 2, S. 11
    DOI
  • Sun, Vera; Zhou, Wen B.; Nosrati, Mehdi; Majid, Shahana; Thummala, Suresh; De Semir, David; Bezrookove, Vladimir; De Feraudy, Sébastien; Chun, Liane; Schadendorf, Dirk; Debs, Robert; Kashani-Sabet, Mohammed; Dar, Altaf A.
    Antitumor activity of miR-1280 in melanoma by regulation of Src
    In: Molecular Therapy , Jg. 23 2015, Nr. 1, S. 71 – 78
    DOI (Open Access)
  • Ahmad-Nejad, Parviz; Duda, Angelika; Sucker, Antje; Werner, Martin; Bronsert, Peter; Stickeler, Elmar; Reifenberger, Guido; Malzkorn, Bastian; Oberländer, Martina; Habermann, Jens K.; Bruch, Hans-Peter; Linnebacher, Michael; Schadendorf, Dirk; Neumaier, Michael
    Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks
    In: Clinical Chemistry and Laboratory Medicine , Jg. 53 2015, Nr. 12, S. 1927 – 1934
    DOI
  • Ullrich, Nico; Heinemann, Anja; Nilewski, Elena; Scheffrahn, Inka; Klode, Joachim; Scherag, Andre; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    CEACAM1-3S drives melanoma cells into NK cell-mediated cytolysis and enhances patient survival
    In: Cancer Research , Jg. 75 2015, Nr. 9, S. 1897 – 1907
    DOI (Open Access)
  • Löffek, Stefanie; Ullrich, Nico; Görgens, André; Murke, Florian; Eilebrecht, Mara; Menne, Christopher; Giebel, Bernd; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    CEACAM1-4L promotes anchorage-independent growth in melanoma
    In: Frontiers in Oncology , Jg. 5 2015, 234
    DOI (Open Access)
  • Stoffels, Ingo; Morscher, S.; Helfrich, Iris; Hillen, Uwe; Lehy, J.; Burton, N.; Pöppel, Thorsten; Gunzer, Matthias; Schadendorf, Dirk; Klode, Joachim
    Clinical application of noninvasive and nonradioactive determination of microscopic lymph node tumor status by multispectral optoacoustic imaging
    In: Journal of Nuclear Medicine (JNM) , Jg. 56 2015, Nr. Suppl. 3, S. 40
  • Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean Jacques; Cowey, C Lance; Lao, Christopher D; Schadendorf, Dirk; Dummer, Reinhard; Smylie, Michael; Rutkowski, Piotr; Ferrucci, Pier F; Hill, Andrew; Wagstaff, John; Carlino, Matteo S; Haanen, John B; Maio, Michele; Marquez-Rodas, Ivan; McArthur, Grant A; Ascierto, Paolo A; Long, Georgina V; Callahan, Margaret K; Postow, Michael A; Grossmann, Kenneth; Sznol, Mario; Dreno, Brigitte; Bastholt, Lars; Yang, Arvin; Rollin, Linda M; Horak, Christine; Hodi, F Stephen; Wolchok, Jedd D
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    In: The New England Journal of Medicine , Jg. 373 2015, Nr. 1, S. 23 – 34
    DOI (Open Access)
  • Livingstone, Elisabeth; Swann, Suzanne; Lilla, Carmen; Schadendorf, Dirk; Rösch, Alexander
    Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
    In: Experimental Dermatology , Jg. 24 2015, Nr. 9, S. 709 – 710
    DOI
  • Grob, Jean Jacques; Amonkar, Mayur M; Karaszewska, Boguslawa; Schachter, Jacob; Dummer, Reinhard; Mackiewicz, Andrzej; Stroyakovskiy, Daniil; Drucis, Kamil; Grange, Florent; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Lichinitser, Mikhail; Levchenko, Evgeny; Wolter, Pascal; Hauschild, Axel; Long, Georgina V; Nathan, Paul; Ribas, Antoni; Flaherty, Keith; Sun, Peng; Legos, Jeffrey J; McDowell, Diane Opatt; Mookerjee, Bijoyesh; Schadendorf, Dirk; Robert, Caroline
    Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v) : results of a phase 3, open-label, randomised trial
    In: The Lancet Oncology , Jg. 16 2015, Nr. 13, S. 1389 – 1398
    DOI
  • Sucker, A. Antje; Neumaier, M.; Jones, F.; Haselmann, V.; Schadendorf, Dirk
    Concordance of BRAF V600E mutation status in metastatic melanoma patients by comparison of results from circulating tumor DNA and tissue-based testing
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. Suppl. 3, S. S685
    DOI
  • Sondermann, Wiebke; Griewank, Klaus; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarae, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe
    Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
    In: PLoS ONE , Jg. 10 2015, Nr. 4, S. e0124590
    DOI (Open Access)
  • Long, Georgina V.; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; Braud, Filippo de; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B. A. G.; Hansson, Johan; Utikal, Jochen; Ferraresi, Virginia; Kovalenko, Nadezhda; Mohr, Peter; Probachai, Volodymr; Schadendorf, Dirk; Nathan, Paul; Robert, Caroline; Ribas, Antoni; DeMarini, Douglas J.; Irani, Jhangir G.; Swann, Suzanne; Legos, Jeffrey J.; Jin, Fan; Mookerjee, Bijoyesh; Flaherty, Keith
    Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma : a multicentre, double-blind, phase 3 randomised controlled trial
    In: Lancet , Jg. 386 2015, Nr. 9992, S. 444 – 451
    DOI
  • Stoffels, Ingo; Morscher, S.; Helfrich, Iris; Hillen, Uwe; Lehy, J.; Burton, N. C.; Poppel, T.; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joachim
    Die multispektraloptoakustische Tomographie (MSOT) zur nichtinvasiven Diagnostik des Schildwächterlymphknotens bei Patienten mit malignem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 13 2015, Nr. 12, S. 1323
    DOI
  • Grob, Jean Jacques; Long, Georgina V; Schadendorf, Dirk; Flaherty, Keith
    Disease kinetics for decision-making in advanced melanoma : a call for scenario-driven strategy trials
    In: The Lancet Oncology , Jg. 16 2015, Nr. 13, S. e522 – e526
    DOI
  • Hannani, Dalil; Vétizou, Marie; Enot, David; Rusakiewicz, Sylvie; Chaput, Nathalie; Klatzmann, David; Desbois, Melanie; Jacquelot, Nicolas; Vimond, Nadège; Chouaib, Salem; Mateus, Christine; Allison, James P.; Ribas, Antoni; Wolchok, Jedd D.; Yuan, Jianda; Wong, Philip; Postow, Michael; Mackiewicz, Andrzej; Mackiewicz, Jacek; Schadendorf, Dirk; Jaeger, Dirk; Zörnig, Inka; Hassel, Jessica; Korman, Alan J.; Bahjat, Keith; Maio, Michele; Calabro, Luana; Teng, Michele W.L.; Smyth, Mark J.; Eggermont, Alexander; Robert, Caroline; Kroemer, Guido; Zitvogel, Laurence
    Erratum : Anticancer immunotherapy by CTLA-4 blockade: Obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
    In: Cell Research , Jg. 25 2015, Nr. 3, S. 399 – 400
    DOI
  • Stoffels, Ingo; Leyh, Julia; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies : prospective randomized clinical trial to compare ICG-99mTc-nanocolloid hybrid tracer versus 99mTc-nanocolloid
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 42 2015, Nr. 11, S. 1631 – 1638
    DOI
  • Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K; Wolchok, Jedd D; Hudson, Andrew M
    Expanded access programmes : patient interests versus clinical trial integrity
    In: The Lancet Oncology , Jg. 16 2015, Nr. 1, S. 15 – 17
    DOI
  • Vits, Sabine; Dissemond, Joachim; Schadendorf, Dirk; Kriegler, Lisa; Körber, Andreas; Schedlowski, Manfred; Cesko, Elvir
    Expectation-induced placebo responses fail to accelerate wound healing in healthy volunteers : results from a prospective controlled experimental trial
    In: International Wound Journal (IWJ) , Jg. 12 2015, Nr. 6, S. 664 – 668
    DOI
  • Scholz, Simone L; Thomasen, Henning; Reis, Henning; Möller, Inga; Darawsha, Raid; Müller, Bettina; Dekowski, Dirk; Sucker, Antje; Schilling, Bastian; Schadendorf, Dirk; Steuhl, Klaus-Peter; Paschen, Annette; Westekemper, Henrike; Meller, Daniel; Griewank, Klaus
    Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia
    In: Investigative Ophthalmology & Visual Science, IOVS , Jg. 56 2015, Nr. 10, S. 5854 – 5861
    DOI (Open Access)
  • Ibarrola-Villava, Maider; Kumar, Rajiv; Nagore, Eduardo; Benfodda, Meriem; Guedj, Mickael; Gazal, Steven; Hu, Hui-Han; Guan, Jian; Rachkonda, P. Sivaramakishna; Descamps, Vincent; Basset-Seguin, Nicole; Bensussan, Armand; Bagot, Martine; Saiag, Philippe; Schadendorf, Dirk; Martin-Gonzalez, Manuel; Mayor, Matias; Grandchamp, Bernard; Ribas, Gloria; Soufir, Nadem
    Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition
    In: International Journal of Cancer , Jg. 136 2015, Nr. 9, S. 2109 – 2119
    DOI
  • Law, Matthew H.; Bishop, D. Timothy; Lee, Jeffrey E.; Brossard, Myriam; Martin, Nicholas G.; Moses, Eric K.; Song, Fengju; Barrett, Jennifer H.; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Taylor, John C.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Duffy, David L.; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Montgomery, Grant W.; Novaković, Srdjan; Olsson, Håkan; Puig, Susanne; Puig-Butille, Joan Anton; Qureshi, Abrar A.; Radford-Smith, Graham L.; van der Stoep, Nienke; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nick; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Hayward, Nicholas K.; Han, Jiali; Schulze, Hans-Joachim; Dunning, Alison M.; Newton Bishop, Julia A.; Demenais, Florence; Amos, Christopher I.; MacGregor, Stuart; Iles, Mark M.
    Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
    In: Nature Genetics , Jg. 47 2015, Nr. 9, S. 987 – 995
    DOI (Open Access)
  • The Cancer Genome Atlas Network; Schadendorf, Dirk; Klode, Joachim
    Genomic Classification of Cutaneous Melanoma
    In: Cell , Jg. 161 2015, Nr. 7, S. 1681 – 1696
    DOI (Open Access)
  • Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Shukla, Sachet A; Blank, Christian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Foppen, Marnix H Geukes; Goldinger, Simone M; Utikal, Jochen; Hassel, Jessica C; Weide, Benjamin; Kaehler, Katharina C; Loquai, Carmen; Mohr, Peter; Gutzmer, Ralf; Dummer, Reinhard; Gabriel, Stacey; Wu, Catherine J; Schadendorf, Dirk; Garraway, Levi A
    Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    In: Science , Jg. 350 2015, Nr. 6257, S. 207 – 211
    DOI (Open Access)
  • Schadendorf, Dirk; Amonkar, Mayur M.; Stroyakovskiy, Daniil; Levchenko, Evgeny; Gogas, Helen; Braud, Filippo de; Grob, Jean-Jacques; Bondarenko, Igor; Garbe, Claus; Lebbe, Celeste; Larkin, James; Chiarion-Sileni, Vanna; Millward, Michael; Arance, Ana; Mandalà, Mario; Flaherty, Keith T.; Nathan, Paul; Ribas, Antoni; Robert, Caroline; Casey, Michelle; DeMarini, Douglas J.; Irani, Jhangir G.; Aktan, Gursel; Long, Georgina
    Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. 7, S. 833 – 840
    DOI
  • Robert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D; Little, Shonda M; Schadendorf, Dirk
    Improved overall survival in melanoma with combined dabrafenib and trametinib
    In: The New England Journal of Medicine , Jg. 372 2015, Nr. 1, S. 30 – 39
    DOI (Open Access)
  • Nsengimana, Jérémie; Laye, Jon; Filia, Anastasia; Walker, Christy; Jewell, Rosalyn; Oord, Joost J. Van den; Wolter, Pascal; Patel, Poulam; Sucker, Antje; Schadendorf, Dirk; Jönsson, Göran B.; Bishop, D. Timothy; Newton- Bishop, Julia
    Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
    In: OncoTarget , Jg. 6 2015, Nr. 13, S. 11683 – 11693
    DOI (Open Access)
  • Dummer, Reinhard; Hauschild, Axel; Lebbé, Célèste; Larkin, James; Ascierto, Paolo A.; Schadendorf, Dirk
    Integrating first-line treatment options into clinical practice : What's new in advanced melanoma?
    In: Melanoma Research , Jg. 25 2015, Nr. 6, S. 461 – 469
    DOI
  • Mohr, Peter; Podda, Maurizio; Schadendorf, Dirk; Gogas, Helen; Loquai, Carmen; Weichenthal, Michael; Tilgen, Wolfgang; Enk, Alexander; Hauschild, Axel; Trefzer, Uwe
    Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma : Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 34, S. 4077 – 4084
    DOI
  • Stoffels, Ingo; Dissemond, Joachim; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection : Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes
    In: JAMA Surgery , Jg. 150 2015, Nr. 7, S. 617 – 623
    DOI (Open Access)
  • Ullrich, Nico; Löffek, Stefanie; Horn, Susanne; Ennen, Marie; Sánchez‐del‐Campo, Luis; Zhao, Fang; Breitenbücher, Frank; Davidson, Irwin; Singer, Bernhard B.; Schadendorf, Dirk; Goding, Colin R.; Helfrich, Iris
    MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
    In: Pigment Cell and Melanoma Research , Jg. 28 2015, Nr. 6, S. 736 – 740
    DOI
  • Schadendorf, Dirk; Fisher, David E; Garbe, Claus; Gershenwald, Jeffrey E; Grob, Jean-Jacques; Halpern, Allan; Herlyn, Meenhard; Marchetti, Michael A; McArthur, Grant; Ribas, Antoni; Rösch, Alexander; Hauschild, Axel
    Melanoma
    In: Nature Reviews Disease Primers , Jg. 1 2015, S. 15003
    DOI
  • Stoffels, Ingo; Morscher, Stefan; Helfrich, Iris; Hillen, Uwe; Leyh, Julia; Burton, Neal C.; Sardella, Thomas C.P.; Claussen, Jing; Pöppel, Thorsten; Bachmann, Hagen Sjard; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joachim
    Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
    In: Immunotherapy , Jg. 7 2015, Nr. 317, S. 317ra199
    DOI
  • Cierlitza, Monika; Chauvistré, Heike; Bogeski, Ivan; Zhang, Xin; Hauschild, Axel; Herlyn, Meenhard; Schadendorf, Dirk; Vogt, Thomas; Rösch, Alexander
    Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations
    In: Experimental Dermatology , Jg. 24 2015, Nr. 2, S. 155 – 157
    DOI (Open Access)
  • Gebhardt, Christoffer; Sevko, Alexandra; Jiang, Huanhuan; Lichtenberger, Ramtin; Reith, Maike; Tarnanidis, Kathrin; Holland-Letz, Tim; Umansky, Ludmila; Beckhove, Philipp; Sucker, Antje; Schadendorf, Dirk; Utikal, Jochen; Umansky, Viktor
    Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
    In: Clinical Cancer Research , Jg. 21 2015, Nr. 24, S. 5453 – 5459
    DOI (Open Access)
  • Wasserman, Ernesto; Yamazaki, Naoya; Wolter, Pascal; Demidov, Lev; Ford, James; Arenberger, Petr; Rangoni, Giovanni; Flaherty, Keith; Ascierto, Paolo; Giacomo, Anna Maria Di; Mandalà, Mario; Weill, Marine; Dummer, Reinhard; Long, Georgina; Schadendorf, Dirk
    NEMO : A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with advanced NRAS-mutant melanoma who are untreated or have progressed on or after immunotherapy
    In: Cancer Research , Jg. 75 2015, Nr. Suppl. 14, S. B16
    DOI
  • Hauschild, Axel; Schadendorf, Dirk
    Nachruf für Prof. Dr. med. Christiane Voit (Berlin)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 13 2015, Nr. 8, S. 851 – 852
    DOI
  • Robert, Caroline; Long, Georgina V.; Brady, Benjamin; Dutriaux, Caroline; Maio, Michele; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Arance, Ana; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Lundgren-Eriksson, Lotta; Horak, Christine; Sharkey, Brian; Waxman, Ian M.; Atkinson, Victoria; Ascierto, Paolo A.
    Nivolumab in previously untreated melanoma without BRAF mutation
    In: The New England Journal of Medicine , Jg. 372 2015, Nr. 4, S. 311 – 319
    DOI (Open Access)
  • Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus; Assi, Zeinab; Loquai, Carmen; Rompel, Rainer; Terheyden, Patrick; Fluck, Michael F Z; Hauschild, Axel; Stadler, Rudolf; Dippel, Edgar; Kämpgen, Eckhart; Berking, Carola; Mohr, Peter E.; Utikal, Jochen; Simon, Jan Christoph; Kiecker, Felix; Eigentler, Thomas Kurt
    Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
    In: Journal of Translational Medicine , Jg. 13 2015, Nr. 1, S. 351
    DOI (Open Access)
  • Griewank, Klaus; Schadendorf, Dirk
    Panel Sequencing Melanomas
    In: Journal of Investigative Dermatology , Jg. 135 2015, Nr. 2, S. 335 – 336
    DOI (Open Access)
  • Robert, Caroline; Schachter, Jacob; Long, Georgina V; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian U; Hamid, Omid; Mateus, Christine; Shapira-Frommer, Ronnie; Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot; Ribas, Antoni; Carlino, Matteo S; Cebon, Jonathan; Hersey, Peter; Long, Georgina; McNeil, Catriona; Millward, Michael; Walpole, Euan; Höller, Christoph; Kehrer, Helmut; Richtig, Erika; Schmuth, Matthias; Baurain, Jean-François; Neyns, Bart; Wolter, Pascal; Butler, Marcus; McWhirter, Elaine; Miller, Wilson; Petrella, Teresa; Acevedo, Alejandro; Caglevic, Christian; Morales, Luisa; Sanchez, Jesús; Yepes, Andres; Zambrano, Angela Regina; Avril, Marie-Francoise; Dutriaux, Caroline; Grob, Jean Jacques; Guilot, Bernard; Lacour, Jean-Phillippe; Leccia, Marie-Therese; Legoupil, Delphine; Lebbe, Celeste; Machet, Laurent; Mortier, Laurent; Robert, Caroline; Berking, Carola; Loquai, Carmen; Mohr, Peter; Schadendorf, Dirk; Utikal, Jochen; Bar-Sela, Gil; Lotem, Michal; Schachter, Jacob; Blank, Christian; Barrow, Catherine; Fitzharris, Bernie; Kersten, Christian; Nyakas, Marta; Straume, Oddbjørn; Arance, Ana; Berrocal, Alfonso; Cortes, Javier; Espinosa, Enrique; Lopez-Martin, Jose; Martin-Algarra, Salvador; Masucci, Giuseppe; Papworth, Karin; Ullenhag, Gustav; Brown, Ewan; Chao, David; Evans, Thomas; Larkin, James; Lorigan, Paul; Middleton, Mark; Skaria, Sunil; Steven, Neil; Agarwala, Sanjiv; Bhatia, Shailender; Daud, Adil; Gangadhar, Tara; Gonzalez, Rene; Hamid, Omid; Kumar, Pallavi; Kuzel, Timothy; Lutzky, Jose; O'Day, Steven; Perry, David; Pecora, Andrew; Puzanov, Igor; Ribas, Antoni; Slezak, Karen; Sznol, Mario; Tarhini, Ahmad; Weiss, Geoffrey
    Pembrolizumab versus Ipilimumab in Advanced Melanoma
    In: The New England Journal of Medicine , Jg. 372 2015, Nr. 26, S. 2521 – 2532
    DOI
  • Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F. Stephen; Schachter, Jacob; Pavlick, Anna C.; Lewis, Karl D.; Cranmer, Lee D.; Blank, Christian U.; O'Day, Steven J.; Ascierto, Paolo A.; Salama, April K. S.; Margolin, Kim A.; Loquai, Carmen; Eigentler, Thomas K.; Gangadhar, Tara C.; Carlino, Matteo S.; Agarwala, Sanjiv S.; Moschos, Stergios J.; Sosman, Jeffrey A.; Goldinger, Simone M.; Shapira-Frommer, Ronnie; Gonzalez, Rene; Kirkwood, John M.; Wolchok, Jedd D.; Eggermont, Alexander; Li, Xiaoyun Nicole; Zhou, Wei; Zernhelt, Adriane M.; Lis, Joy; Ebbinghaus, Scot; Kang, S. Peter; Daud, Adil
    Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial
    In: The Lancet Oncology , Jg. 16 2015, Nr. 8, S. 908 – 918
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kämpgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
    In: PLoS ONE , Jg. 10 2015, Nr. 3, S. e0118564
    DOI (Open Access)
  • Schadendorf, Dirk; Hodi, F Stephen; Robert, Caroline; Weber, Jeffrey S; Margolin, Kim; Hamid, Omid; Patt, Debra; Chen, Tai-Tsang; Berman, David M; Wolchok, Jedd D
    Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 17, S. 1889 – 1894
    DOI (Open Access)
  • Zörnig, Inka; Halama, Niels; Lorenzo-Bermejo, Justo; Ziegelmeier, Claudia; Dickes, Elke; Migdoll, Alexander; Kaiser, Iris; Waterboer, Tim; Pawlita, Michael; Grabe, Niles; Ugurel, Selma; Schadendorf, Dirk; Falk, Christine; Eichmüller, Stefan B.; Jäger, Dirk
    Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients
    In: International Journal of Cancer , Jg. 136 2015, Nr. 1, S. 138 – 151
    DOI
  • Esser, Stefan; Geisel, Henrike; Arendt, M.; Schulze, C.; Holzendorf, V.; Warnke, A.; Brockmeyer, N.H.; Hower, M.; Schadendorf, Dirk; Neumann, Till; Eisele, Lewin; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Reinsch, Nico
    Prolongation of QTc interval in HIV-infected individuals compared to the general population is not caused by antiretroviral therapy
    In: Journal of the International AIDS Society , Jg. 18 2015, Nr. Suppl. 4, S. 20479
    DOI (Open Access)
  • Livingstone, Elisabeth; Krajewski, C.; Eigentler, Thomas K.; Windemuth-Kieselbach, Christine; Benson, Sven; Elsenbruch, Sigrid; Hauschild, Axel; Rompel, Rainer; Meiss, Frank; Mauerer, Andreas; Kähler, Katharina C.; Dippel, Edgar; Möllenhoff, Katrin; Kilian, Katharina; Mohr, Mohr, Peter E.; Utikal, Jochen; Schadendorf, Dirk
    Prospective evaluation of follow-up in melanoma patients in Germany : results of a multicentre and longitudinal study
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. 5, S. 653 – 667
    DOI
  • Hecht, Markus; Zimmer, Lisa; Loquai, Carmen; Weishaupt, Carsten; Gutzmer, Ralf; Schuster, B.; Gleisner, S.; Schulze, Björn; Goldinger, S. M.; Berking, Carola; Forschner, Andrea; Clemens, P.; Grabenbauer, Gerhard; Müller-Brenne, Tina; Bauch, Julia; Eich, Hans T.; Grabbe, Stephan; Schadendorf, Dirk; Schuler, Gerold; Keikavoussi, Petra; Semrau, S.; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients
    In: Annals of Oncology , Jg. 26 2015, Nr. 6, S. 1238 – 1244
    DOI (Open Access)
  • Schilling, Bastian; Sondermann, Wiebke; Griewank, Klaus; Livingstone, Elisabeth; Zimmer, Lisa; Hillen, Uwe; Schadendorf, Dirk
    Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al.
    In: Annals of Oncology , Jg. 26 2015, Nr. 1, S. 250 – 251
    DOI
  • Griewank, Klaus; Murali, Rajmohan; Scherag, Andre; Schadendorf, Dirk
    Response
    In: Journal of the National Cancer Institute (JNCI) , Jg. 107 2015, Nr. 4, S. djv051
    DOI
  • Livingstone, Elisabeth; Hillen, Uwe; Hafner, Christian; Piel, Sarah; Groesser, Leopold; Schadendorf, Dirk; Happle, Rudolf
    Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman
    In: British Journal of Dermatology: BJD , Jg. 172 2015, Nr. 6, S. 1642 – 1645
    DOI
  • Ramanujam, Sangeetha; Long, Georgina V.; Schadendorf, Dirk
    Systemic therapies for melanoma brain metastases : which drug for whom and when?
    In: Chinese Clinical Oncology , Jg. 4 2015, Nr. 2, S. 25 – 29
    DOI
  • Murali, Rajmohan; Chandramohan, Raghu; Möller, Inga; Scholz, Simone L.; Berger, Michael; Huberman, Kety; Viale, Agnes; Pirun, Mono; Socci, Nicholas D.; Bouvier, Nancy; Bauer, Sebastian; Artl, Monika; Schilling, Bastian; Schimming, Tobias; Sucker, Antje; Schwindenhammer, Benjamin; Grabellus, Florian; Speicher, Michael R.; Schaller, Jörg; Hillen, Uwe; Schadendorf, Dirk; Mentzel, Thomas; Cheng, Donavan T.; Wiesner, Thomas; Griewank, Klaus
    Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
    In: OncoTarget , Jg. 6 2015, Nr. 34, S. 36041 – 36052
    DOI (Open Access)
  • Erfle, Holger; Pashayeva, K.; Harder, N.; Zhang, Lihua; Rohr, K.; Schadendorf, Dirk; Ugurel, Selma; Keese, Michael
    Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells : a live-cell RNAi screen displays differential nucleus-derived phenotypes
    In: Biotechnology Journal , Jg. 10 2015, Nr. 9, S. 1467 – 1477
    DOI
  • Wagner, T.; Terheyden, P.; Gutzmer, R.; Forschner, A.; Rudolph, B.; Schadendorf, Dirk; Kaehler, K.C.; Kornek, T.; Heinzerling, L.; Garbe, C.; Stade, B.; Gebhardt, C.; Augustin, M.; Maul, L.V.; Hauschild, A.; Loquai, C.; Blohme, C.; Livingstone, Elisabeth
    The GERMELATOX DeCOG-trial : The attitude of German melanoma patients towards toxicity during adjuvant interferon treatment - Differences between the patient's and the physician's perspective
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. Suppl. 3, S. S671 – S672
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Schilling, Bastian; Rösch, Alexander; Zimmer, Lisa
    Therapie des malignen Melanoms
    In: Der Onkologe , Jg. 21 2015, Nr. 10, S. 965 – 974
    DOI
  • Espinosa, Enrique; Grob, Jean Jacques R.; Dummer, Reinhard G.; Rutkowski, Piotr; Robert, Caroline; Gogas, Helen J.; Kefford, Richard F.; Eggermont, Alexander Mm. M.; Martín-Algarra, Salvador; Hauschild, Axel; Schadendorf, Dirk
    Treatment algorithms in stage IV melanoma
    In: American Journal of Therapeutics , Jg. 22 2015, Nr. 1, S. 61 – 67
    DOI (Open Access)
  • Legos, J.; Mortier, L.; Stroyakovskiy, D.; Karaszewska, B.; Grange, F.; Robert, C.; Mackiewicz, A.; Schadendorf, Dirk; Schachter, J.; Rutkowski, P.; Chiarion-Sileni, V.; Dummer, R.; Lichinitser, M.; Drucis, K.; Krajsova, I.; Mookerjee, B.; Hauschild, A.
    Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. Suppl. 3, S. S663
    DOI
  • Hauschild, Alexander; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment , Jg. 38 2015, Nr. Suppl. 3, S. 1
    DOI
  • Bhattacharya, Animesh; Schmitz, Ulf; Raatz, Yvonne; Schönherr, Madeleine; Kottek, Tina; Schauer, Marianne; Franz, Sandra; Saalbach, Anja; Anderegg, Ulf; Wolkenhauer, Olaf; Schadendorf, Dirk; Simon, Jan Christoph; Magin, Thomas Michael; Vera, Julio; Kunz, Manfred
    miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
    In: OncoTarget , Jg. 6 2015, Nr. 5, S. 2966 – 2980
    DOI (Open Access)
  • Davies, John R; Field, Sinead; Randerson-Moor, Juliette; Harland, Mark; Kumar, Rajiv; Anic, Gabriella M; Nagore, Eduardo; Hansson, Johan; Höiom, Veronica; Jönsson, Göran; Gruis, Nelleke A; Park, Jong Y; Guan, Jian; Sivaramakrishna Rachakonda, P; Wendt, Judith; Pjanova, Dace; Puig, Susana; Schadendorf, Dirk; Okamoto, Ichiro; Olsson, Håkan; Affleck, Paul; García-Casado, Zaida; Puig-Butille, Joan Anton; Stratigos, Alexander J; Kodela, Elizabeth; Donina, Simona; Sucker, Antje; Hosen, Ismail; Egan, Kathleen M; Barrett, Jennifer H; van Doorn, Remco; Bishop, D Timothy; Newton-Bishop, Julia
    An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma : a BioGenoMEL study
    In: Pigment Cell and Melanoma Research , Jg. 27 2014, Nr. 2, S. 234 – 243
    DOI (Open Access)
  • Schimming, Tobias T; Griewank, Klaus; Esser, Stefan; Schadendorf, Dirk; Hillen, Uwe
    Angioplasmacellular hyperplasia - a new histopathologic clue for anogenital herpes simplex recidivans in immunocompromised patients?
    In: American Journal of Dermatopathology , Jg. 36 2014, Nr. 10, S. 822 – 826
    DOI
  • Schadendorf, Dirk
    Arbeitsgemeinschaft Dermatologische Onkologie – eine dermatologische Erfolgsgeschichte
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 12 2014, Nr. Suppl. 4, S. 40 – 41
    DOI
  • Schadendorf, Dirk
    Behandlungsalgorithmus bei Patienten mit malignem Melanom
    In: Der Onkologe , Jg. 20 2014, Nr. 6, S. 533 – 534
    DOI
  • Matusiewicz, David; Körber, Andreas; Schadendorf, Dirk; Wasem, Jürgen; Neumann, Anja
    Childhood Psoriasis : An Analysis of German Health Insurance Data
    In: Pediatric Dermatology , Jg. 31 2014, Nr. 1, S. 8 – 13
    DOI
  • Zelba, Henning; Weide, Benjamin; Martens, Alexander; Derhovanessian, Evelyna; Bailur, Jithendra K.; Kyzirakos, Christina; Pflugfelder, Annette; Eigentler, Thomas K.; Di Giacomo, Anna M.; Maio, Michele; Aarntzen, Eric H. J. G.; Vries, Jolanda de; Sucker, Antje; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma
    In: Clinical Cancer Research , Jg. 20 2014, Nr. 16, S. 4390 – 4399
    DOI
  • Dreno, Brigitte; Basset-Seguin, Nicole; Caro, Ivor; Yue, Huibin; Schadendorf, Dirk
    Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma
    In: The Oncologist , Jg. 19 2014, Nr. 8, S. 790 – 796
    DOI (Open Access)
  • Malvehy, Josep; Hauschild, Axel; Curiel-Lewandrowski, C.; Mohr, Peter E.; Hofmann-Wellenhof, Rainer; Motley, Richard J.; Berking, Carola; Grossman, Douglas; Paoli, John; Loquai, Carmen; Oláh, Judit; Reinhold, Uwe; Wenger, H.; Dirschka, Thomas P.; Davis, Steven A.; Henderson, Catriona A.; Rabinovitz, Harold S.; Welzel, Julia; Schadendorf, Dirk; Birgersson, Ulrik
    Clinical performance of the Nevisense system in cutaneous melanoma detection : an international, multicentre, prospective and blinded clinical trial on efficacy and safety
    In: British Journal of Dermatology: BJD , Jg. 171 2014, Nr. 5, S. 1099 – 1107
    DOI (Open Access)
  • Long, Georgina V; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Braud, Filippo; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean Jacques; Chiarion Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B A G; Hansson, Johan; Utikal, Jochen; Ferraresi, Virginia; Kovalenko, Nadezhda; Mohr, Peter; Probachai, Volodymyr; Schadendorf, Dirk; Nathan, Paul; Robert, Caroline; Ribas, Antoni; DeMarini, Douglas J; Irani, Jhangir G; Casey, Michelle; Ouellet, Daniele; Martin, Anne-Marie; Le, Ngocdiep; Patel, Kiran; Flaherty, Keith
    Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
    In: The New England Journal of Medicine , Jg. 371 2014, Nr. 20, S. 1877 – 1888
    DOI (Open Access)
  • Stoffels, Ingo; Müller, Markus; Geisel, Henrike; Leyh, Julia; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 41 2014, Nr. 9, S. 1723 – 1731
    DOI
  • Stoffels, Ingo; Gunzer, Matthias; Leyh, J.; Hillen, Uwe; Helfrich, Iris; Schadendorf, Dirk; Klode, Joachim
    Die Photooptoakustische Tomographie zur nicht invasiven und nicht radioaktiven Bestimmung des Schildwachterlymphknotenstatus bei Melanompatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 12 2014, Nr. Suppl. 3, S. 5 – 6
    DOI
  • Schilling, Bastian; Sondermann, W.; Zhao, F.; Griewank, Klaus; Livingstone, Elisabeth; Sucker, A.; Zelba, H.; Weide, B.; Trefzer, U.; Wilhelm, T.; Loquai, C.; Berking, C.; Hassel, J.; Kähler, K. C.; Utikal, J.; Al~ghazal, P.; Gutzmer, R.; Goldinger, S. M.; Zimmer, Lisa; Paschen, Annette; Hillen, Uwe; Schadendorf, Dirk
    Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
    In: Annals of Oncology , Jg. 25 2014, Nr. 3, S. 747 – 753
    DOI
  • Paschen, Annette; Baingo, Jolanthe; Schadendorf, Dirk
    Expression of stress ligands of the immunoreceptor NKG2D in melanoma : regulation and clinical significance
    In: European Journal of Cell Biology (EJCB) , Jg. 93 2014, Nr. 1-2, S. 49 – 54
    DOI
  • Schadendorf, Dirk; Amonkar, M. M.; Milhem, M.; Grotzinger, K.; Demidov, L. V.; Rutkowski, P.; Garbe, C.; Dummer, R.; Hassel, J. C.; Wolter, P.; Mohr, P.; Trefzer, U.; Lefeuvre-Plesse, C.; Rutten, A.; Steven, N.; Ullenhag, G.; Sherman, L.; Wu, F. S.; Patel, K.; Casey, M.; Robert, C.
    Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma : Quality-of-life analyses of the METRIC study
    In: Annals of Oncology , Jg. 25 2014, Nr. 3, S. 700 – 706
    DOI
  • Griewank, Klaus; Scolyer, Richard A.; Thompson, John F.; Flaherty, K. T.; Schadendorf, Dirk; Murali, Rajmohan
    Genetic alterations and personalized medicine in melanoma: Progress and future prospects
    In: Journal of the National Cancer Institute (JNCI) , Jg. 106 2014, Nr. 2, S. djt435
    DOI
  • Griewank, Klaus; van de Nes, Johannes; Schilling, Bastian; Moll, Iris; Sucker, Antje; Kakavand, Hojabr; Haydu, Lauren E; Asher, Marina; Zimmer, Lisa; Hillen, Uwe; Thompson, John F; Scolyer, Richard A; Schadendorf, Dirk; Murali, Rajmohan
    Genetic and clinico-pathologic analysis of metastatic uveal melanoma
    In: Modern Pathology , Jg. 27 2014, Nr. 2, S. 175 – 183
    DOI
  • Sucker, Antje; Zhao, Fang; Real, Birgit; Heeke, Christina; Bielefeld, Nicola; Maßen, Stefan; Horn, Susanne; Moll, Iris; Maltaner, Raffaela; Horn, Peter; Schilling, Bastian; Sabbatino, Francesco; Lennerz, Volker; Kloor, Matthias; Ferrone, Soldano; Schadendorf, Dirk; Falk, Christine S; Griewank, Klaus; Paschen, Annette
    Genetic evolution of T-cell resistance in the course of melanoma progression
    In: Clinical Cancer Research , Jg. 20 2014, Nr. 24, S. 6593 – 6604
    DOI
  • Leyvraz, S.; Piperno-Neumann, S.; Suciu, S.; Baurain, J. F.; Zdzienicki, M.; Testori, A.; Marshall, E.; Scheulen, Max Ernst; Jouary, T.; Negrier, S.; Vermorken, J. B.; Kaempgen, E.; Durando, X.; Schadendorf, Dirk; Gurunath, R. K.; Keilholz, U.
    Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021) : A multicentric randomized trial
    In: Annals of Oncology , Jg. 25 2014, Nr. 3, S. 742 – 746
    DOI
  • Schadendorf, Dirk; Jäger, Dirk
    Immunonkologie "Coming of Age" : die nächste Generation der Immun-Checkpoint-Inhibitoren
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 4, S. 6 – 9
    DOI
  • Schadendorf, Dirk; Jäger, Dirk
    Immunonkologie «Coming of Age» - die nächste Generation der Immun-Checkpoint-Inhibitoren
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 4, S. 6 – 9
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Incidence of new primary melanomas after diagnosis of stage III and IV melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 8, S. 816 – 823
    DOI
  • Davies, J. R.; Jewell, R.; Affleck, P.; Anic, G. M.; Randerson-Moor, J.; Ozola, A.; Egan, K. M.; Elliott, F.; García-Casado, Z.; Hansson, J.; Harland, M.; Höiom, V.; Jian, G.; Jönsson, G.; Kumar, R.; Nagore, E.; Wendt, J.; Park, J. Y.; Patel, P.; Pjanova, D.; Puig, S.; Schadendorf, Dirk; Sivaramakrishna-Rachakonda, P.; Snowden, H.; Stratigos, A. J.; Bafaloukos, D.; Ogbah, Z.; Sucker, A.; Van Den Oord, J.J.; van Doorn, R.; Walker, C.; Okamoto, I.; Wolter, P.; Barrett, J. H.; Timothy Bishop, D.; Newton-Bishop, J.
    Inherited variation in the PARP1 gene and survival from melanoma
    In: International Journal of Cancer , Jg. 135 2014, Nr. 7, S. 1625 – 1633
    DOI (Open Access)
  • Ullrich, N.; Heinemann, A.; Nilewsk, E.; Scherag, Andre; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    Isoform-specific function of CEACAM1 during tumorigenesis : CEACAM1-3S, a novel prognostic biomarker in malignant melanoma
    In: Experimental Dermatology , Jg. 23 2014, Nr. 3, S. E45
    DOI
  • Kunstfeld, Rainer; Hauschild, Axel; Zloty, David; Rogers, Gary; Dreno, Brigitte; Mitchell, Lada; Starnawski, Michal; Schadendorf, Dirk
    MIKIE : A randomized, double-blind, regimen-controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. TPS9121
    DOI
  • Schadendorf, Dirk; Schlag, P. M.
    Malignes Melanom
    In: Der Onkologe , Jg. 20 2014, Nr. 6, S. 530 – 532
    DOI
  • Schadendorf, Dirk; Bernhard, H.
    Medikamentöse Systemtherapie des Melanoms
    In: Der Onkologe , Jg. 20 2014, Nr. 6, S. 568 – 576
    DOI
  • Schadendorf, Dirk; Hauschild, Axel
    Melanoma in 2013 : Melanoma - The run of success continues
    In: Nature Reviews Clinical Oncology , Jg. 11 2014, Nr. 2, S. 75 – 76
    DOI
  • McCusker, Margaret; Basset-Seguin, Nicole; Dummer, Reinhard; Lewis, Karl; Schadendorf, Dirk; Sekulic, Aleksandar; Hou, Jeannie; Wang, Lisa; Yue, Huibin; Hauschild, Axel
    Metastatic basal cell carcinoma : prognosis dependent on anatomic site and spread of disease
    In: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. 4, S. 774 – 783
    DOI (Open Access)
  • Weide, Benjamin; Martens, Alexander; Zelba, Henning; Stutz, Christina; Derhovanessian, Evelyna; Di Giacomo, Anna Maria; Maio, Michele; Sucker, Antje; Schilling, Bastian; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Myeloid-derived suppressor cells predict survival of patients with advanced melanoma : Comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells
    In: Clinical Cancer Research , Jg. 20 2014, Nr. 6, S. 1601 – 1609
    DOI
  • Ugurel, Selma; Mentzel, Thomas; Utikal, Jochen; Helmbold, Peter; Mohr, Peter; Pföhler, Claudia; Schiller, Meinhard; Hauschild; Hein, Rüdiger; Kämpgen, Eckhardt; Kellner, Ivonne; Leverkus, Martin; Becker, Jürgen; Ströbel, Philip; Schadendorf, Dirk
    Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans : A multicenter phase II DeCOG Trial with Long-Term Follow-Up
    In: Clinical Cancer Research , Jg. 20 2014, Nr. 2, S. 499 – 510
    DOI
  • Zelba, Henning; Derhovanessian, Evelyna; Weide, Benjamin; Vries, Jolanda de; Schadendorf, Dirk; Maio, Michele; Giacomo, Anna Maria Di; Martens, Alexander; Pawelec, Graham P.; Garbe, Claus
    Peripheral immune signatures and survival in stage IV melanoma
    In: Cancer Research , Jg. 74 2014, Nr. 19 Suppl., S. 2547
    DOI
  • Helfrich, Iris; Ullrich, Nico; Zigrino, Paola; Schadendorf, Dirk
    Primary tumor versus metastasis : new experimental models for studies on cancer cell homing and metastasis in melanoma
    In: Pigment Cell and Melanoma Research , Jg. 27 2014, Nr. 2, S. 309 – 316
    DOI
  • Follmann, Markus; Schadendorf, Dirk; Kochs, Corinna; Buchberger, Barbara; Winter, Anna; Wesselmann, Simone
    Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 12 2014, Nr. 2, S. 139 – 147
    DOI
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Reply to M. Perier-Muzet et al [Safety and Management of New Primary Melanomas During Receipt of BRAF Inhibitors ]
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 28, S. 3203 – 3204
    DOI
  • Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 28 2014, Nr. 12, S. 1685 – 1689
    DOI
  • Schrama, David; Ugurel, Selma; Sucker, Antje; Ritter, Cathrin; Zapatka, Marc; Schadendorf, Dirk; Becker, Jürgen
    STAT3 single nucleotide polymorphism rs4796793 SNP does not correlate with response to adjuvant IFNα therapy in stage III melanoma patients
    In: Frontiers in Medicine , Jg. 1 2014, Nr. 47
    DOI (Open Access)
  • McArthur, Grant A; Chapman, Paul B; Robert, Caroline; Larkin, James; Haanen, John B; Dummer, Reinhard; Ribas, Antoni; Hogg, David; Hamid, Omid; Ascierto, Paolo A; Garbe, Claus; Testori, Alessandro; Maio, Michele; Lorigan, Paul; Lebbé, Celeste; Jouary, Thomas; Schadendorf, Dirk; O'Day, Stephen J; Kirkwood, John M; Eggermont, Alexander M; Dréno, Brigitte; Sosman, Jeffrey A; Flaherty, Keith T; Yin, Ming; Caro, Ivor; Cheng, Suzanne; Trunzer, Kerstin; Hauschild, Axel
    Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3) : extended follow-up of a phase 3, randomised, open-label study
    In: The Lancet Oncology , Jg. 15 2014, Nr. 3, S. 323 – 332
    DOI (Open Access)
  • Kordelas, Lambros; Verheyen, Jens; Beelen, Dietrich; Horn, Peter; Heinold, Andreas; Kaiser, Rolf; Trenschel, Rudolf; Schadendorf, Dirk; Dittmer, Ulf; Esser, Stefan
    Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation
    In: The New England Journal of Medicine , Jg. 371 2014, Nr. 9, S. 880 – 882
    DOI
  • Livingstone, Elisabeth; Hollestein, Loes M; van Herk-Sukel, Myrthe P P; van de Poll-Franse, Lonneke; Joosse, Arjen; Schilling, Bastian; Nijsten, Tamar; Schadendorf, Dirk; de Vries, Esther
    Statin use and its effect on all-cause mortality of melanoma patients : a population-based Dutch cohort study
    In: Cancer Medicine , Jg. 3 2014, Nr. 5, S. 1284 – 1293
    DOI (Open Access)
  • Flaherty, Keith T.; Hennig, Michael; Lee, Sandra J.; Ascierto, Paolo A.; Dummer, Reinhard; Eggermont, Alexander M. M.; Hauschild, Axel; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant; O'Day, Steven; Patel, Poulam M.; Robert, Caroline; Schadendorf, Dirk
    Surrogate endpoints for overall survival in metastatic melanoma: A meta-analysis of randomised controlled trials
    In: The Lancet Oncology , Jg. 15 2014, Nr. 3, S. 297 – 304
    DOI
  • Griewank, Klaus; Murali, Rajmohan; Puig-Butille, Joan Anton; Schilling, Bastian; Livingstone, Elisabeth; Potrony, Miriam; Carrera, Cristina; Schimming, Tobias; Möller, Inga; Schwamborn, Marion; Sucker, Antje; Hillen, Uwe; Badenas, Celia; Malvehy, Josep; Zimmer, Lisa; Scherag, Andre; Puig, Susanne; Schadendorf, Dirk
    TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
    In: Journal of the National Cancer Institute (JNCI) , Jg. 106 2014, Nr. 9
    DOI
  • Griewank, Klaus; Schilling, Bastian; Murali, Rajmohan; Bielefeld, Nicola; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Hillen, Uwe; Schaller, Jörg; Brenn, Thomas; Schadendorf, Dirk; Mentzel, Thomas
    TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
    In: Modern Pathology , Jg. 27 2014, Nr. 4, S. 502 – 508
    DOI (Open Access)
  • Van Allen, Eliezer M; Wagle, Nikhil; Sucker, Antje; Treacy, Daniel J; Johannessen, Cory M; Goetz, Eva M; Place, Chelsea S; Taylor-Weiner, Amaro; Whittaker, Steven; Kryukov, Gregory V; Hodis, Eran; Rosenberg, Mara; McKenna, Aaron; Cibulskis, Kristian; Farlow, Deborah; Zimmer, Lisa; Hillen, Uwe; Gutzmer, Ralf; Goldinger, Simone M; Ugurel, Selma; Gogas, Helen J; Egberts, Friederike; Berking, Carola; Trefzer, Uwe; Loquai, Carmen; Weide, Benjamin; Hassel, Jessica C; Gabriel, Stacey B; Carter, Scott L; Getz, Gad; Garraway, Levi A; Schadendorf, Dirk; Dermatologic Cooperative Oncology Group of Germany (DeCOG)
    The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
    In: Cancer Discovery , Jg. 4 2014, Nr. 1, S. 94 – 109
    DOI
  • Stockmann, Christian; Schadendorf, Dirk; Klose, Ralph; Helfrich, Iris
    The impact of the immune system on tumor : angiogenesis and vascular remodeling
    In: Frontiers in Oncology , Jg. 4 2014, S. 69
    DOI (Open Access)
  • Jarry, J.; Schadendorf, Dirk; Greenwood, C.; Spatz, A.; van Kempen, L.C.
    The validity of circulating microRNAs in oncology : Five years of challenges and contradictions
    In: Molecular Oncology , Jg. 8 2014, Nr. 4, S. 819 – 829
    DOI (Open Access)
  • Bald, Tobias; Quast, Thomas; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hömig-Hölzel, Cornelia; Reuten, Raphael; Schadow, Benjamin; Weighardt, Heike; Wenzel, Daniela; Helfrich, Iris; Schadendorf, Dirk; Bloch, Wilhelm; Bianchi, Marco E; Lugassy, Claire; Barnhill, Raymond L; Koch, Manuel; Fleischmann, Bernd K; Förster, Irmgard; Kastenmüller, Wolfgang; Kolanus, Waldemar; Hölzel, Michael; Gaffal, Evelyn; Tüting, Thomas
    Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
    In: Nature , Jg. 507 2014, Nr. 7490, S. 109 – 113
    DOI
  • Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Jürgen; Hauschild, Axel; Dummer, Reinhard
    Upstream mitogen-activated protein kinase (MAPK) pathway inhibition : MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
    In: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. 2, S. 406 – 410
    DOI
  • Whittaker, Steven R.; Theurillat, Jean-Philippe; Van Allen, Eliezer; Wagle, Nikhil; Hsiao, Jessica; Cowley, Glenn S.; Schadendorf, Dirk; Root, David E.; Garraway, Levi A.
    A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
    In: Cancer Discovery , Jg. 3 2013, Nr. 3, S. 351 – 362
    DOI
  • Lacouture, Mario E.; Duvic, Madeleine; Hauschild, Axel; Prieto, Victor G.; Robert, Caroline; Schadendorf, Dirk; Kim, Caroline C.; McCormack, Christopher J.; Myskowski, Patricia L.; Spleiss, Olivia; Trunzer, Kerstin; Su, Fei; Nelson, Betty; Nolop, Keith B.; Grippo, Joseph F.; Lee, Richard J.; Klimek, Matthew J.; Troy, James L.; Joe, Andrew K.
    Analysis of dermatologic events in vemurafenib-treated patients with melanoma
    In: The Oncologist , Jg. 18 2013, Nr. 3, S. 314 – 322
    DOI (Open Access)
  • Hermes, I.; Tsiogka, Maria; Rompoti, N.; Suttorp, W.; Zimmer, Lisa; Schadendorf, Dirk
    Autoimmuno-hypophysitis, Autoimmuno-colitis and Autoimmuno-hepatitis in a Patient with metastatic Melanoma during Therapy with CTLA-4 Antibody Ipilimumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 9, S. 932
  • Esser, Stefan; Eisele, Lewin; Schwarz, B.; Neumann, Till; Schulze, C.; Warnke, A.; Holzendorf, V.; Potthoff, A.; Brockmeyer, N.; Hower, M.; Schadendorf, Dirk; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Reinsch, Nico
    B-type natriuretic peptide elevation is more frequent in HIV plus patients compared to the general population
    In: Antiviral Therapy , Jg. 18 2013, Nr. Suppl. 3, S. A41 – A42
  • Vits, Sabine; Cesko, Elvir; Benson, Sven; Rueckert, Annika; Hillen, Uwe; Schadendorf, Dirk; Schedlowski, Manfred
    Cognitive factors mediate placebo responses in patients with house dust mite allergy
    In: PLoS ONE , Jg. 8 2013, Nr. 11, S. e79576
    DOI (Open Access)
  • Rompoti, Natalia; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 30, S. 3844 – 3845
    DOI
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Sucker, Antje; Hillen, Uwe; Steuhl, Klaus-Peter; Zimmer, Lisa; Schadendorf, Dirk; Steuhl, Klaus-Peter
    Conjunctival Melanomas Harbor BRAF and NRAS Mutations—Response
    In: Clinical Cancer Research , Jg. 19 2013, Nr. 22, S. 6331 – 6332
    DOI
  • Griewank, Klaus; Westekemper, Henrike; Murali, Rajmohan; Mach, Monika; Schilling, Bastian; Wiesner, Thomas; Schimming, Tobias; Livingstone, Elisabeth; Sucker, Antje; Grabellus, Florian; Metz, Claudia; Süsskind, Daniela; Hillen, Uwe; Speicher, Michael R.; Woodman, Scott E.; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas
    In: Clinical Cancer Research , Jg. 19 2013, Nr. 12, S. 3143 – 3152
    DOI
  • Sevko, Alexandra; Sade-Feldman, Moshe; Kanterman, Julia; Michels, Tillmann; Falk, Christine S; Umansky, Ludmila; Ramacher, Marcel; Kato, Masashi; Schadendorf, Dirk; Baniyash, Michal; Umansky, Viktor
    Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    In: Journal of Investigative Dermatology , Jg. 133 2013, Nr. 6, S. 1610 – 1619
    DOI (Open Access)
  • Lacouture, Mario E; Schadendorf, Dirk; Chu, Chia-Yu; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Hauschild, Axel; O’Brien, Dennis
    Dermatologic adverse events associated with afatinib : An oral ErbB family blocker
    In: Expert Review of Anticancer Therapy , Jg. 13 2013, Nr. 6, S. 721 – 728
    DOI
  • Kochs, Dr. C.; Pflugfelder, A.; Garbe, C.; Schadendorf, Dirk
    Die neue S3-Leitlinie "melanom" : Das Wichtigste für die Praxis
    In: Best Practice Onkologie , Jg. 8 2013, Nr. 2, S. 40 – 48
    DOI
  • Kochs, Corinna; Pflugfelder, Annette; Garbe, Claus; Schadendorf, Dirk
    Die neue S3-leitlinie "Diagnostik, therapie und nachsorge des malignen melanoms" : Wie soll das staging durchgeführt werden?
    In: Haut: Dermatologie, Allergologie, Kosmetologie , Jg. 24 2013, Nr. 3, S. 124 – 128
  • Robert, Caroline; Schadendorf, Dirk; Messina, Marianne; Hodi, F. Stephen; O'Day, Steven
    Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control
    In: Clinical Cancer Research , Jg. 19 2013, Nr. 8, S. 2232 – 2239
    DOI
  • Reinsch, Nico; Esser, Stefan; Neumann, Till; Bokhof, B.; Eisele, Lewin; Schwarz, B.; Holzendorf, V.; Jöckel, Karl-Heinz; Schadendorf, Dirk; Erbel, Raimund; German Heart Failure Network
    Framingham risk score and cardiovascular risk profiles in HIV+ patients and HIV- controls differ by sex
    In: European Heart Journal , Jg. 34 2013, Nr. Suppl. 1, S. P5164
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Vaubel, Julia; Zimmer, Lisa
    Hautkrebsforschung reloaded : Paradigmenwechsel in der Dermatoonkologie
    In: Unikate: Berichte aus Forschung und Lehre 2013, Nr. 44: Medizin: 50 Jahre Universitätsklinikum Essen, S. 136 – 143
    DOI, Online Volltext (Open Access)
  • Miller, Dorothea; Zappala, Valeria; El Hindy, Nicolai; Livingstone, Elisabeth; Schadendorf, Dirk; Sure, Ulrich; Sandalcioglu, Ibrahim Erol
    Intracerebral metastases of malignant melanoma and their recurrences : a clinical analysis
    In: Clinical Neurology and Neurosurgery , Jg. 115 2013, Nr. 9, S. 1721 – 1728
    DOI
  • Gramsch, Carolin; Göricke, Sophia Luise; Behrens, Felix; Zimmer, Lisa; Schadendorf, Dirk; Krasny, Andrej; Forsting, Michael; Schlamann, Marc
    Isolated cerebral susceptibility artefacts in patients with malignant melanoma : Metastasis or not?
    In: European Radiology , Jg. 23 2013, Nr. 9, S. 2622 – 2627
    DOI
  • Rompoti, N.; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-Inhibitoren
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 9, S. 952 – 952
  • Schilling, Bastian; Bielefeld, Nicola; Sucker, Antje; Hillen, Uwe; Zimmer, Lisa; Schadendorf, Dirk; Zeschnigk, Michael; Griewank, Klaus
    Lack of SF3B1 R625 mutations in cutaneous melanoma
    In: Diagnostic Pathology , Jg. 8 2013, S. 87
    DOI (Open Access)
  • Hassel, Jessica C.; Amann, Philipp M.; Schadendorf, Dirk; Eichmüller, Stefan B.; Nagler, Markus; Bazhin, Alexandr V.
    Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma
    In: Experimental Dermatology , Jg. 22 2013, Nr. 11, S. 757 – 759
    DOI
  • Ascierto, Paolo A.; Schadendorf, Dirk; Berking, Carola; Agarwala, Sanjiv S.; van Herpen, Carla M.L.; Queirolo, Paola; Blank, Christian U.; Hauschild, Axel; Beck, J Thaddeus; St-Pierre, Annie; Niazi, Faiz; Wandel, Simon; Peters, Malte; Zubel, Angela; Dummer, Reinhard
    MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: A non-randomised, open-label phase 2 study
    In: The Lancet Oncology , Jg. 14 2013, Nr. 3, S. 249 – 256
    DOI
  • Pflugfelder, Annette; Kochs, Corinna; Blum, Andreas; Capellaro, Marcus; Czeschik, Christina; Dettenborn, Therese; Dill, Dorothee; Dippel, Edgar; Eigentler, Thomas; Feyer, Petra; Follmann, Markus; Frerich, Bernhard; Ganten, Maria-Katharina; Gärtner, Jan; Gutzmer, Ralf; Hassel, Jessica; Hauschild, Axel; Hohenberger, Peter; Hübner, Jutta; Kaatz, Martin; Kleeberg, Ulrich R.; Kölbl, Oliver; Kortmann, Rolf-Dieter; Krause-Bergmann, Albrecht; Kurschat, Peter; Leiter, Ulrike; Link, Hartmut; Loquai, Carmen; Löser, Christoph; Mackensen, Andreas; Meier, Friedegund; Mohr, Peter; Möhrle, Matthias; Nashan, Dorothee; Reske, Sven; Rose, Christian; Sander, Christian; Satzger, Imke; Schiller, Meinhard; Schlemmer, Heinz-Peter; Strittmatter, Gerhard; Sunderkötter, Cord; Swoboda, Lothar; Trefzer, Uwe; Voltz, Raymond; Vordermark, Dirk; Weichenthal, Michael; Werner, Andreas; Wesselmann, Simone; Weyergraf, Ansgar J.; Wick, Wolfgang; Garbe, Claus; Schadendorf, Dirk
    Malignes melanom S3-leitlinie "Diagnostik, Therapie und Nachsorge des Melanoms"
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. Suppl. 6 , S. 1 - 116; 1 - 126
    DOI (Open Access)
  • Luo, Chonglin; Merz, Patrick R.; Chen, Yiwei; Dickes, Elke; Pscherer, Armin; Schadendorf, Dirk; Eichmüller, Stefan B.
    MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2
    In: Cancer Letters , Jg. 341 2013, Nr. 2, S. 240 – 247
    DOI
  • Luo, Chonglin; Tetteh, Paul W.; Merz, Patrick R.; Dickes, Elke; Abukiwan, Alia; Hotz-Wagenblatt, Agnes; Holland-Cunz, Stefan; Sinnberg, Tobias; Schittek, Birgit; Schadendorf, Dirk; Diederichs, Sven; Eichmüller, Stefan B.
    MiR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes
    In: Journal of Investigative Dermatology , Jg. 133 2013, Nr. 3, S. 768 – 775
    DOI (Open Access)
  • Eberhardt, Wilfried; Gauler, Thomas; Schadendorf, Dirk
    Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, Melanom
    In: Der Onkologe , Jg. 19 2013, Nr. 10, S. 821 – 834
    DOI
  • Helfrich, Iris; Hansen, Wiebke; Hutzler, Marina; Sakaguchi, S.; Albert, J.; Stockmann, C.; Buer, Jan; Schadendorf, Dirk
    Neuropilin-1 Deficiency on CD4+Foxp3+Regulatory T Cells Modulates Tumor Angiogenesis and Impaires Tumor Growth in Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. Suppl. S7, S. 30
    DOI
  • Hutzler, Marina; Helfrich, Iris; Schadendorf, Dirk; Buer, Jan; Hansen, Wiebke
    Neuropilin-1 is a key mediator of VEGF-dependent Treg migration to tumors
    In: International Journal of Molecular Medicine , Jg. 32 2013, Nr. Suppl. 1, S. S36
  • Griewank, Klaus; Ugurel, Selma; Schadendorf, Dirk; Paschen, Annette
    New developments in biomarkers for melanoma
    In: Current Opinion in Oncology , Jg. 25 2013, Nr. 2, S. 145 – 151
    DOI
  • Ascierto, Paolo A.; Minor, David; Ribas, Antoni; Lebbe, Celeste; O'Hagan, Anne; Arya, Niki; Guckert, Mary; Schadendorf, Dirk; Kefford, Richard F.; Grob, Jean-Jacques; Hamid, Omid; Amaravadi, Ravi; Simeone, Ester; Wilhelm, Tabea; Kim, Kevin B.; Long, Georgina V.; Martin, Anne-Marie; Mazumdar, Jolly; Goodman, Vicki L.; Trefzer, Uwe
    Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 26, S. 3205 – 3211
    DOI
  • Esser, Stefan; Gelbrich, Götz; Brockmeyer, Norbert; Goehler, Alexander; Schadendorf, Dirk; Erbel, Raimund; Neumann, Till; Reinsch, Nico
    Prevalence of cardiovascular diseases in HIV-infected outpatients: Results from a prospective, multicenter cohort study
    In: Clinical Research in Cardiology , Jg. 102 2013, Nr. 3, S. 203 – 213
    DOI
  • Schwarz, B.; Eisele, Lewin; Neumann, Till; Reinsch, Nico; Schulze, C.; Warnke, A.; Holzendorf, V.; Potthoff, A.; Brockmeyer, N.; Hower, M.; Schadendorf, Dirk; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Esser, Stefan
    Psychotropic drugs are prescribed more frequently in HIV-positive patients compared to the general population. Data from two German prospective cohorts : Heinz Nixdorf Recall Study and HIV HEART Study
    In: Antiviral Therapy , Jg. 18 2013, Nr. Suppl. 3, S. A77 – A78
  • Löhr, J.-Matthias; Dinter, Dietmar; Diehl, Steffen J.; Haas, Stephan L.; Veeser, Mira; Pfützer, Roland; Retter, Jürgen; Schönberg, Stefan O.; Düber, Christoph; Keim, Volker; Schadendorf, Dirk; Witt, Heiko
    Rapid progression of a splenic aneurysm due to segmental arterial mediolysis: : a rare cause of acute pancreatitis
    In: Pancreatology , Jg. 13 2013, Nr. 5, S. 553 – 556
    DOI
  • Pechlivanis, Sonali; Mühleisen, Thomas W.; Möhlenkamp, Stefan; Schadendorf, Dirk; Erbel, Raimund; Jöckel, Karl-Heinz; Hoffmann, Per; Nöthen, Markus M.; Scherag, Andre; Moebus, Susanne
    Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study
    In: BMC Medical Genetics , Jg. 14 2013, Nr. 1, S. 23
    DOI (Open Access)
  • Pflugfelder, Annette; Kochs, Corinna; Blum, Andreas; Capellaro, Marcus; Czeschik, Christina; Dettenborn, Therese; Dill, Dorothee; Dippel, Edgar; Eigentler, Thomas; Feyer, Petra; Follmann, Markus; Frerich, Bernhard; Ganten, Maria-Katharina; Gärtner, Jan; Gutzmer, Ralf; Hassel, Jessica; Hauschild, Axel; Hohenberger, Peter; Hübner, Jutta; Kaatz, Martin; Kleeberg, Ulrich R.; Kölbl, Oliver; Kortmann, Rolf-Dieter; Krause-Bergmann, Albrecht; Kurschat, Peter; Leiter, Ulrike; Link, Hartmut; Loquai, Carmen; Löser, Christoph; MacKensen, Andreas; Meier, Friedegund; Mohr, Peter; Möhrle, Matthias; Nashan, Dorothee; Reske, Sven; Rose, Christian; Sander, Christian; Satzger, Imke; Schiller, Meinhard; Schlemmer, Heinz-Peter; Strittmatter, Gerhard; Sunderkötter, Cord; Swoboda, Lothar; Trefzer, Uwe; Voltz, Raymond; Vordermark, Dirk; Weichenthal, Michael; Werner, Andreas; Wesselmann, Simone; Weyergraf, Ansgar J.; Wick, Wolfgang; Garbe, Claus; Schadendorf, Dirk
    S3-Guideline "diagnosis, therapy and follow-up of melanoma" - short version
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 6, S. 593 – 602
    DOI
  • Robert, Caroline; Dummer, Reinhard; Gutzmer, Ralf; Lorigan, Paul; Kim, Kevin B.; Nyakas, Marta; Arance, Ana; Liszkay, Gabriella; Schadendorf, Dirk; Cantarini, Mireille; Spencer, Stuart; Middleton, Mark R.
    Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma : A phase 2 double-blind randomised study
    In: The Lancet Oncology , Jg. 14 2013, Nr. 8, S. 733 – 740
    DOI
  • Griewank, Klaus; Murali, Rajmohan; Schilling, Bastian; Schimming, Tobias; Möller, Inga; Moll, Iris; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Schadendorf, Dirk; Hillen, Uwe
    TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma
    In: PLoS ONE , Jg. 8 2013, Nr. 11, S. e80354
    DOI (Open Access)
  • Rachakonda, P. Sivaramakrishna; Hosen, Ismail; De Verdier, Petra J.; Fallah, Mahdi; Heidenreich, Barbara; Ryk, Charlotta; Wiklund, N. Peter; Steineck, Gunnar; Schadendorf, Dirk; Hemminki, Kari; Kumar, Rajiv
    TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 110 2013, Nr. 43, S. 17426 – 17431
    DOI
  • Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Fischer, Christine; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    TERT promoter mutations in familial and sporadic melanoma
    In: Science , Jg. 339 2013, Nr. 6122, S. 959 – 961
    DOI
  • Griewank, Klaus; Murali, R.; Schilling, Bastian; Scholz, S.; Sucker, A.; Song, M.; Süsskind, D.; Grabellus, Florian; Zimmer, Lisa; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zeschnigk, Michael
    TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
    In: British Journal of Cancer (BJC) , Jg. 109 2013, Nr. 2, S. 497 – 501
    DOI (Open Access)
  • Aarntzen, Erik H. J. G.; De Vries, I. Jolanda M.; Lesterhuis, W. Joost; Schuurhuis, Danita; Jacobs, Joannes F. M.; Bol, Kalijn; Schreibelt, Gerty; Mus, Roel; De Wilt, Johannes H. W.; Haanen, John B. A. G.; Schadendorf, Dirk; Croockewit, Alexandra; Blokx, Willeke A. M.; Van Rossum, Michelle M.; Kwok, William W.; Adema, Gosse J.; Punt, Cornelis J. A.; Figdor, Carl G.
    Targeting CD4+ T-helper cells improves the induction of antitumor responses in dendritic cell -based vaccination
    In: Cancer Research , Jg. 73 2013, Nr. 1, S. 19 – 29
    DOI
  • Niessner, Heike; Forschner, Andrea; Klumpp, Bernhard; Honegger, Jürgen B; Witte, Maria; Bornemann, Antje; Dummer, Reinhard; Adam, Annemarie; Bauer, Jürgen; Tabatabai, Ghazaleh; Flaherty, Keith; Sinnberg, Tobias; Beck, Daniela; Leiter, Ulrike; Mauch, Cornelia; Rösch, Alexander; Weide, Benjamin; Eigentler, Thomas; Schadendorf, Dirk; Garbe, Claus; Kulms, Dagmar; Quintanilla-Martinez, Leticia; Meier, Friedegund
    Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
    In: Cancer Medicine , Jg. 2 2013, Nr. 1, S. 76 – 85
    DOI (Open Access)
  • Voskens, Caroline J.; Goldinger, Simone M.; Loquai, Carmen; Robert, Caroline; Kaehler, Katharina C.; Berking, Carola; Bergmann, Tanja; Bockmeyer, Clemens L.; Eigentler, Thomas; Fluck, Michael; Garbe, Claus; Gutzmer, Ralf; Grabbe, Stephan; Hauschild, Axel; Hein, Rüdiger; Hundorfean, Gheorghe; Justich, Armin; Keller, Ullrich; Klein, Christina; Mateus, Christine; Mohr, Peter; Paetzold, Sylvie; Satzger, Imke; Schadendorf, Dirk; Schlaeppi, Marc; Schuler, Gerold; Schuler-Thurner, Beatrice; Trefzer, Uwe; Ulrich, Jens; Vaubel, Julia Marianne; Moos, Roger von; Weder, Patrik; Wilhelm, Tabea; Göppner, Daniela; Dummer, Reinhard; Heinzerling, Lucie M.
    The price of tumor control : an analysis of rare side effects of Anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
    In: PLoS ONE , Jg. 8 2013, Nr. 1, S. e53745
    DOI (Open Access)
  • Hillen, Uwe; Griewank, Klaus; Sommerwerck, Urte; Baba, Hideo Andreas; Schadendorf, Dirk
    Tumor regression and sirolimus-based therapy in lung transplantation
    In: The Journal of Heart and Lung Transplantation , Jg. 32 2013, Nr. 9, S. 938 – 939
    DOI
  • Reinsch, Nico; Esser, Stefan; Gelbrich, Götz; Brockmeyer, Norbert; Potthoff, Anja; Schadendorf, Dirk; Erbel, Raimund; Neumann, Till
    Valvular manifestations of human immunodeficiency virus infection - Results from the prospective, multicenter HIV-HEART study
    In: Journal of Cardiovascular Medicine , Jg. 14 2013, Nr. 10, S. 733 – 739
    DOI
  • Beck, Daniela; Niessner, Heike; Smalley, Keiran S.M.; Flaherty, Keith; Paraiso, Kim H.T.; Busch, Christian; Sinnberg, Tobias; Vasseur, Sophie; Iovanna, Juan Lucio; Drießen, Stefan; Stork, Björn; Wesselborg, Sebastian; Schaller, Martin; Biedermann, Tilo; Bauer, Jürgen; Lasithiotakis, Konstantinos; Weide, Benjamin; Eberle, Jürgen; Schittek, Birgit; Schadendorf, Dirk; Garbe, Claus; Kulms, Dagmar; Meier, Friedegund
    Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells
    In: Science Signaling , Jg. 6 2013, Nr. 260
    DOI
  • Schilling, Bastian; Sucker, Antje; Griewank, Klaus; Zhao, Fang; Weide, Benjamin; Görgens, André; Giebel, Bernd; Schadendorf, Dirk; Paschen, Annette
    Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
    In: International Journal of Cancer , Jg. 133 2013, Nr. 7, S. 1653 – 1663
    DOI
  • Weide, Benjamin; Schilling, Bastian; Paschen, Annette; Görgens, Andre; Sucker, Antje; Zhao, Fang; Giebel, Bernd; Griewank, Klaus; Schadendorf, Dirk
    Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
    In: Cancer Research , Jg. 73 2013, Nr. 8 Suppl., S. 4714
    DOI
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 4, S. 1
    DOI
  • Livingstone, Elisabeth; Hollestein, L. M.; Herk-Sukel, M. P. P. van; Poll-Franse, L. van de; Nijsten, T.; Schadendorf, Dirk; Vries, E. de
    β-Blocker use and all-cause mortality of melanoma patients : results from a population-based Dutch cohort study
    In: European Journal of Cancer (EJC) , Jg. 49 2013, Nr. 18, S. 3863 – 3871
    DOI
  • Hodis, Eran; Watson, Ian R.; Kryukov, Gregory V.; Arold, Stefan T.; Imielinski, Marcin; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; Li, Liren; Place, Chelsea; Dicara, Daniel; Ramos, Alex H.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey; Voet, Douglas; Saksena, Gordon; Stransky, Nicolas; Onofrio, Robert C.; Winckler, Wendy; Ardlie, Kristin; Wagle, Nikhil; Wargo, Jennifer; Chong, Kelly; Morton, Donald L.; Stemke-Hale, Katherine; Chen, Guo; Noble, Michael; Meyerson, Matthew; Ladbury, John E.; Davies, Michael A.; Gershenwald, Jeffrey E.; Wagner, Stephan N.; Hoon, Dave S.B.; Schadendorf, Dirk; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Garraway, Levi A.; Chin, Lynda
    A Landscape of Driver Mutations in Melanoma
    In: Cell , Jg. 150 2012, Nr. 2, S. 251 – 263
    DOI
  • Schadendorf, Dirk; Vaubel, Julia Marianne; Livingstone, Elisabeth; Zimmer, Lisa
    Advances and perspectives in immunotherapy of melanoma
    In: Annals of Oncology , Jg. 23 2012, Nr. Suppl. 10, S. x104 – x108
    DOI
  • Stoffels, Ingo; Dissemond, Joachim; Pöppel, Thorsten; Klötgen, K.; Hillen, Uwe; Körber, Andreas; Schadendorf, Dirk; Klode, Joachim
    Advantages of preoperative ultrasound in conjunction with lymphoscintigraphy in detecting malignant melanoma metastases in sentinel lymph nodes : a retrospective analysis in 221 patients with malignant melanoma AJCC Stages i and II
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 26 2012, Nr. 1, S. 79 – 85
    DOI
  • Stoffels, Ingo; Boy, Christian; Pöppel, Thorsten; Kuhn, Jasna; Klötgen, Kerstin; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim
    Association Between Sentinel Lymph Node Excision With or Without Preoperative SPECT/CT and Metastatic Node Detection and Disease-Free Survival in Melanoma
    In: JAMA: Journal of the American Medical Association , Jg. 308 2012, Nr. 10, S. 1007 – 1014
    DOI
  • Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E.; Busam, Klaus; Carvajal, Richard D.; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M.; Dummer, Reinhard; Long, Georgina V.; McArthur, Grant; Scherag, Andre; Sucker, Antje; Schadendorf, Dirk
    Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 19, S. 2375 – 2383
    DOI
  • Preusser, Matthias; Berghoff, Anna S.; Schadendorf, Dirk; Lin, Nancy U.; Stupp, Roger
    Brain metastasis : Opportunity for drug development?
    In: Current Opinion in Neurology , Jg. 25 2012, Nr. 6, S. 786 – 794
    DOI
  • Reinsch, N.; Kloetgen, H. W.; Jablonka, Robert; Storim, J.; Warnke, A.; Gelbrich, G.; Erbel, Raimund; Neumann, Till; Schadendorf, Dirk; Esser, Stefan; German Competence Network
    Brain natriuretic peptide (BNP) : A general mortality predictor in HIV-infected patients? - Results from the 5 year follow-up of the HIV-HEART trial
    In: European Heart Journal , Jg. 33 2012, Nr. Suppl. 1, S. 337
  • Livingstone, Elisabeth; Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Current advances and perspectives in the treatment of advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 10 2012, Nr. 5, S. 319 – 325
    DOI
  • Long, Georgina V.; Trefzer, Uwe; Davies, Michael A.; Kefford, Richard F.; Ascierto, Paolo A.; Chapman, Paul B.; Puzanov, Igor; Hauschild, Axel; Robert, Caroline; Algazi, Alain; Mortier, Laurent; Tawbi, Hussein; Wilhelm, Tabea; Zimmer, Lisa; Switzky, Julie; Swann, Suzanne; Martin, Anne-Marie; Guckert, Mary; Goodman, Vicki; Streit, Michael; Kirkwood, John M.; Schadendorf, Dirk
    Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB) : A multicentre, open-label, phase 2 trial
    In: The Lancet Oncology , Jg. 13 2012, Nr. 11, S. 1087 – 1095
    DOI
  • Esser, Stefan; Jablonka, Robert; Heinemann, Falko M.; Reuter, Stefan; Jaeger, Hans; von Krosigk, Ariane; Schenk-Westkamp, Pia; Schadendorf, Dirk; Horn, Peter; Lindemann, Monika
    Detection of abacavir hypersensitivity by ELISpot method
    In: Inflammation & Allergy - Drug Targets , Jg. 11 2012, Nr. 3, S. 227 – 234
    DOI
  • Testori, Alessandro; Suciu, Stefan; Akkooi, Alexander C. J. van; Cook, Martin; Ghanem, Ghanem; Karra Gurunath, R.; Keilholz, Ulrich; Kempen, Leon van; Leyvraz, Serge; Mihm, Martin; Newton-Bishop, Julia; Patel, Poulam; Robert, Caroline; Schadendorf, Dirk; Schaetzen, Gaetan de; Spatz, Alan; Vries, Esther de; Eggermont, Alexander M. M.
    EORTC Melanoma Group achievements
    In: European Journal of Cancer / EJC Supplements , Jg. 10 2012, Nr. 1, S. 112 – 119
    DOI
  • Stoffels, Ingo; Von Der Stück, Hannah; Boy, Christian; Pöppel, Thorsten; Körber, Nina; Weindorf, Maren; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim
    Fluoreszenz-Markierung mittels Indocyanin-Grün bei der Sentinel-Lymphknoten-Exstirpation in der Dermatoonkologie
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 10 2012, Nr. 1, S. 51 – 58
    DOI
  • Weide, Benjamin; Zelba, Henning; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Di Giacomo, Anna Maria; Maio, Michele; Aarntzen, Erik H.J.G.; De Vries, I. Jolanda M.; Sucker, Antje; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 15, S. 1835 – 1841
    DOI
  • Paschen, Annette; Schadendorf, Dirk; Schilling, Bastian
    Gegen den Hautkrebs : Forschung zur Überwindung immuntherapeutischer Hürden beim malignen Melanom
    In: Unikate: Berichte aus Forschung und Lehre 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 32 – 41
    DOI, Online Volltext (Open Access)
  • Kamphausen, Thomas; Schadendorf, Dirk; Von Wurmb-Schwark, Nicole; Bajanowski, Thomas; Poetsch, Micaela
    Good shedder or bad shedder : the influence of skin diseases on forensic DNA analysis from epithelial abrasions
    In: International Journal of Legal Medicine , Jg. 126 2012, Nr. 1, S. 179 – 183
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Hautarzt , Jg. 63 2012, Nr. 12, S. 952 – 960
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Onkologe , Jg. 18 2012, Nr. 9, S. 801 – 807
    DOI
  • Flaherty, Keith T.; Robert, Caroline; Hersey, Peter; Nathan, Paul; Garbe, Claus; Milhem, Mohammed; Demidov, Lev V.; Hassel, Jessica C.; Rutkowski, Piotr; Mohr, Peter; Dummer, Reinhard; Trefzer, Uwe; Larkin, James M.G.; Utikal, Jochen; Dreno, Brigitte; Nyakas, Marta; Middleton, Mark R.; Becker, Jürgen; Casey, Michelle; Sherman, Laurie J.; Wu, Frank S.; Ouellet, Daniele; Martin, Anne-Marie; Patel, Kiran; Schadendorf, Dirk
    Improved survival with MEK inhibition in BRAF-mutated melanoma
    In: The New England Journal of Medicine , Jg. 367 2012, Nr. 2, S. 107 – 114
    DOI
  • Lenci, Romina Elizabeth; Bevier, Melanie; Brandt, Andreas; Bermejo, Justo Lorenzo; Sucker, Antje; Moll, Iris; Planelles, Dolores; Requena, Celia; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
    In: PLoS ONE , Jg. 7 2012, Nr. 11, S. 0050692
    DOI (Open Access)
  • Davies, John R.; Randerson-Moor, Juliette; Kukalizch, Kairen; Harland, Mark; Kumar, Rajiv; Madhusudan, Srinivasan; Nagore, Eduardo; Hansson, Johan; Höiom, Veronica; Ghiorzo, Paola; Gruis, Nelleke A.; Kanetsky, Peter A.; Wendt, Judith; Pjanova, Dace; Puig, Susana; Saiag, Philippe; Schadendorf, Dirk; Soufir, Nadem; Okamoto, Ichiro; Affleck, Paul; García-Casado, Zaida; Ogbah, Zighereda; Ozola, Aija; Queirolo, Paola; Sucker, Antje; Barrett, Jennifer H.; van Doorn, Remco; Bishop, D. Timothy; Newton-Bishop, Julia
    Inherited variants in the MC1R gene and survival from cutaneous melanoma : A BioGenoMEL study
    In: Pigment Cell and Melanoma Research , Jg. 25 2012, Nr. 3, S. 384 – 394
    DOI
  • Lenci, Romina E.; Rachakonda, P. Sivaramakrishna; Kubarenko, Andriy V.; Weber, Alexander; Brandt, Andreas; Gast, Andreas; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Integrin genes and susceptibility to human melanoma
    In: Mutagenesis , Jg. 27 2012, Nr. 3, S. 367 – 373
    DOI
  • Ren, Guangxu; Esser, Stefan; Jochum, Christoph; Schlaak, Jörg Friedrich; Gerken, Guido; Schadendorf, Dirk; Dittmer, Ulf; Wu, Gang; Yuan, Zhenghong; Timm, Jörg
    Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1
    In: AIDS , Jg. 26 2012, Nr. 17, S. 2145 – 2153
    DOI
  • Eggermont, Alexander M. M.; Suciu, Stefan; Testori, Alessandro; Santinami, Mario; Kruit, Wim H. J.; Marsden, Jeremy; Punt, Cornelis J.A.; Salès, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam M.; De Schaetzen, Gaetan; Spatz, Alan; Keilholz, Ulrich
    Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 31, S. 3810 – 3818
    DOI
  • Flaherty, Keith T.; Robert, Caroline; Schadendorf, Dirk
    MEK inhibition in BRAF-mutated melanoma
    In: The New England Journal of Medicine , Jg. 367 2012, Nr. 14, S. 1365
    DOI
  • Berger, Michael F.; Hodis, Eran; Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Lawrence, Michael S.; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Nickerson, Elizabeth; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Cibulskis, Kristian; Sivachenko, Andrey Y.; Wagle, Nikhil; Sucker, Antje; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Drier, Yotam; Stojanov, Petar; Singer, Meredith A.; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Wargo, Jennifer; Schadendorf, Dirk; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Wagner, Stephan N.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.
    Melanoma genome sequencing reveals frequent PREX2 mutations
    In: Nature , Jg. 485 2012, Nr. 7399, S. 502 – 506
    DOI
  • Hansen, Wiebke; Hutzler, Marina; Abel, Simone; Alter, Christina; Stockmann, Christian; Kliche, Stefanie; Albert, Juliane; Sparwasser, Tim; Sakaguchi, Shimon; Westendorf, Astrid; Schadendorf, Dirk; Buer, Jan; Helfrich, Iris
    Neuropilin 1 deficiency on CD4⁺Foxp3⁺ regulatory T cells impairs mouse melanoma growth
    In: Journal of Experimental Medicine (JEM) , Jg. 209 2012, Nr. 11, S. 2001 – 2016
    DOI (Open Access)
  • Schimming, Tobias T.; Grabellus, Florian; Roßner, Mathias; Pechlivanis, Sonali; Sucker, Antje; Bielefeld, Nicola; Moll, Iris; Schadendorf, Dirk; Hillen, Uwe
    PHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas
    In: American Journal of Dermatopathology , Jg. 34 2012, Nr. 3, S. 266 – 269
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Hillen, Uwe; Dom̈kes, Stephanie; Becker, Arne; Schadendorf, Dirk
    Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its Management
    In: Archives of Dermatology , Jg. 148 2012, Nr. 3, S. 357 – 361
    DOI
  • Matusiewicz, David; Körber, Andreas; Schadendorf, Dirk; Wasem, Jürgen; Neumann, Anja
    Psoriasis im Kindes- und Jugendalter : Eine bundesweite Ärztebefragung zur Versorgungssituation in Deutschland
    In: Der Hautarzt , Jg. 63 2012, Nr. 10, S. 801 – 807
    DOI
  • Oberholzer, Patrick A.; Kee, Damien; Dziunycz, Piotr; Sucker, Antje; Kamsukom, Nyam; Jones, Robert; Roden, Christine; Chalk, Clinton J.; Ardlie, Kristin; Palescandolo, Emanuele; Piris, Adriano; MacConaill, Laura E.; Robert, Caroline; Hofbauer, Günther F. L.; McArthur, Grant A.; Schadendorf, Dirk; Garraway, Levi A.
    RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 3, S. 316 – 321
    DOI
  • Stoffels, Ingo; Pöppel, Thorsten; Boy, Christian; Müller, Stefan; Wichmann, F.; Dissemond, Joachim; Schadendorf, Dirk; Rosenbaum-Krumme, Sandra; Klode, Joachim
    Radio-guided surgery : Advantages of a new portable γ-camera (Sentinella®) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 26 2012, Nr. 3, S. 308 – 313
    DOI
  • Leyvraz, S.; Suciu, S.; Piperno-Neumann, S.; Baurain, J. F.; Zdzienicki, M.; Testori, A.; Marshall, E.; Scheulen, Max Ernst; Jouary, T.; Negrier, S.; Vermorken, J. B.; Kaempgen, E.; Durando, X.; Schadendorf, Dirk; Gurunath, R. K.; Polders, L.; De Schaetzen, G.; Vanderschaeghe, S.; Gauthier, M. P.; Keilholz, U.
    Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma : Final results of the EORTC 18021 study
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. Suppl. 15, S. 8532
  • Stoffels, Ingo; Dissemond, Joachim; Schulz, Andrea; Hillen, Uwe; Schadendorf, Dirk; Klode, Joachim
    Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia : A retrospective analysis in patients with malignant melanoma AJCC stage III
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 26 2012, Nr. 2, S. 200 – 206
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk
    Side effects of systemic oncological therapies in dermatology
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 10 2012, Nr. 7, S. 475 – 486
    DOI
  • Kasparian, N. A.; Bränström, R.; Chang, Y. M.; Affleck, P.; Aspinwall, L. G.; Tibben, A.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leachman, S.; Bergman, W.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, Dirk; Gruis, N. A.; Newton-Bishop, J.; Brandberg, Y.; Melanoma Genetics Consortium (GenoMEL)
    Skin Examination Behavior : The Role of Melanoma History, Skin Type, Psychosocial Factors, and Region of Residence in Determining Clinical and Self-conducted Skin Examination
    In: Archives of Dermatology , Jg. 148 2012, Nr. 10, S. 1142 – 1151
    DOI
  • Dirks, Henrike; Esser, Stefan; Borgmann, R.; Wolter, M.; Fischer, E.; Potthoff, Anja Verena; Jablonka, Robert; Schadendorf, Dirk; Brockmeyer, Norbert Hermann; Scherbaum, Norbert
    Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics
    In: HIV Medicine , Jg. 13 2012, Nr. 9, S. 533 – 540
    DOI
  • Abschuetz, Oliver; Osen, Wolfram; Frank, Kathrin; Kato, Masashi; Schadendorf, Dirk; Umansky, Viktor
    T-cell mediated immune responses induced in ret transgenic mouse model of malignant melanoma
    In: Cancers , Jg. 4 2012, Nr. 2, S. 490 – 503
    DOI
  • Urban, Sabrina; Textoris-Taube, Kathrin; Reimann, Barbara; Janek, Katharina; Dannenberg, Tanja; Ebstein, Frédéric; Seifert, Christin; Zhao, Fang; Kessler, Jan H.; Halenius, Anne; Henklein, Petra; Paschke, Julia; Cadel, Sandrine; Bernhard, Helga; Ossendorp, Ferry; Foulon, Thierry; Schadendorf, Dirk; Paschen, Annette; Seifert, Ulrike
    The efficiency of human cytomegalovirus pp65₄₉₅₋₅₀₃ CD8 ⁺T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases
    In: The Journal of Immunology (JI) , Jg. 189 2012, Nr. 2, S. 529 – 538
    DOI
  • Brokalaki, E.I.; Voshege, Nadine; Witzke, Oliver; Kribben, Andreas; Schadendorf, Dirk; Hillen, Uwe
    Treatment of Severe Psoriasis With Etanercept in a Pancreas-Kidney Transplant Recipient
    In: Transplantation Proceedings , Jg. 44 2012, Nr. 9, S. 2776 – 2777
    DOI
  • Preusser, Matthias; Winkler, Frank; Collette, Laurence; Haller, Sven; Marreaud, Sandrine; Soffietti, Riccardo; Klein, Martin; Reijneveld, Jaap C.; Tonn, Jörg-Christian; Baumert, Brigitta G.; Mulvenna, Paula; Schadendorf, Dirk; Duchnowska, Renata; Berghoff, Anna Sophie; Lin, Nancy; Cameron, David A.; Belkacemi, Yazid; Jassem, Jacek; Weber, Damien C.
    Trial design on prophylaxis and treatment of brain metastases : Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
    In: European Journal of Cancer (EJC) , Jg. 48 2012, Nr. 18, S. 3439 – 3447
    DOI
  • Heinemann, Anja; Zhao, Fang; Pechlivanis, Sonali; Eberle, Jürgen; Steinle, Alexander; Diederichs, Sven; Schadendorf, Dirk; Paschen, Annette
    Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
    In: Cancer Research , Jg. 72 2012, Nr. 2, S. 460 – 471
    DOI
  • Eggermont, Alexander M.M.; Suciu, Stefan; Testori, Alessandro; Kruit, Wim H.; Marsden, Jeremy; Punt, Cornelis J.; Santinami, Mario; Sals, Franois; Schadendorf, Dirk; Patel, Poulam; Dummer, Reinhard; Robert, Caroline; Keilholz, Ulrich; Yver, Antoine; Spatz, Alan
    Ulceration and stage are predictive of interferon efficacy in melanoma : results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
    In: European Journal of Cancer (EJC) , Jg. 48 2012, Nr. 2, S. 218 – 225
    DOI
  • Amann, Philipp M.; Luo, Chonglin; Owen, Robert W.; Hofmann, Claudia; Freudenberger, Muriel; Schadendorf, Dirk; Eichmüller, Stefan B.; Bazhin, Alexandr V.
    Vitamin A metabolism in benign and malignant melanocytic skin cells : Importance of lecithin/retinol acyltransferase and RPE65
    In: Journal of Cellular Physiology , Jg. 227 2012, Nr. 2, S. 718 – 728
    DOI
  • Livingstone, Elisabeth; Windemuth-Kieselbach, Christine; Eigentler, Thomas K.; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothee; Rotterdam, Sebastian; Ugurel, Selma; Schadendorf, Dirk
    A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up
    In: European Journal of Cancer (EJC) , Jg. 47 2011, Nr. 13, S. 1977 – 1989
    DOI
  • O'Day, S.; Pavlick, A.; Loquai, C.; Lawson, D.; Gutzmer, R.; Richards, J.; Schadendorf, Dirk; Thompson, J.A.; Gonzalez, R.; Trefzer, U.; Mohr, P.; Chao, D.; Zhong, B.; De Boer, C.J.; Uhlar, C.; Marshall, D.; Gore, M.E.; Lang, Z.; Hait, W.; Ho, P.; Ottensmeier, C
    A randomised, phase II study of intetumumab, an anti-α v-integrin mAb, alone and with dacarbazine in stage IV melanoma
    In: British Journal of Cancer (BJC) , Jg. 105 2011, Nr. 3, S. 346 – 352
    DOI (Open Access)
  • Klode, Joachim; Pöppel, Thorsten; Boy, Christian; Müller, Stefan; Schadendorf, Dirk; Körber, Andreas; Stoffels, Ingo; Dissemond, Joachim
    Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 25 2011, Nr. 10, S. 1213 – 1221
    DOI
  • Schadendorf, Dirk
    Arbeitsgemeinschaft Dermatologische Onkologie (ADO) : Gezielte Blockade des mutierten BRAF führt zu Überlebensvorteil bei Patienten mit metastasiertem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. 4, S. 340
    DOI
  • Gast, Andreas; Bermejo, Justo Lorenzo; Claus, Rainer; Brandt, Andreas; Weires, Marianne; Weber, Alexander; Plass, Christoph; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
    In: PLoS ONE , Jg. 6 2011, Nr. 9
    DOI (Open Access)
  • Vits, Sabine; Cesko, Elvir; Enck, Paul; Hillen, Uwe; Schadendorf, Dirk; Schedlowski, Manfred
    Behavioural conditioning as the mediator of placebo responses in the immune system
    In: Philosophical Transactions of the Royal Society B: Biological Sciences , Jg. 366 2011, Nr. 1572, S. 1799 – 1807
    DOI
  • Helfrich, Iris; Schadendorf, Dirk
    Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma : One step forward for overcoming anti-angiogenic drug resistance?
    In: Molecular Oncology , Jg. 5 2011, Nr. 2, S. 137 – 149
    DOI
  • Meyera, Christiane; Sevko, Alexandra; Ramacher, Marcel; Bazhin, Alexandr V.; Falk, Christine S.; Osena, Wolfram; Borrello, Ivan; Kato, Masashi; Schadendorf, Dirk; Baniyash, Michal; Umanskya, Viktor
    Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 108 2011, Nr. 41, S. 17111 – 17116
    DOI
  • Leong, Stanley P.L.; Gershenwald, Jeffrey E.; Soong, Seng-Jaw; Schadendorf, Dirk; Tarhini, Ahmad A.; Agarwala, Sanjiv; Hauschild, Axel; Soon, Christopher W.M.; Daud, Adil; Kashani-Sabet, Mohammed
    Cutaneous melanoma : A model to study cancer metastasis
    In: Journal of Surgical Oncology , Jg. 103 2011, Nr. 6, S. 538 – 549
    DOI
  • Kirkwood, J. M.; Dreno, B.; Hauschild, A.; Schadendorf, Dirk; Testori, A.; Hersey, P.; Jamoul, C.; Peeters, O.; Therasse, P.
    DERMA phase III trial of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in patients with MAGE-A3-positive resected stage III melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. TPS232
    DOI
  • Klode, Joachim; Klotgen, K.; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Die Sklerotherapie mit Polidocanolschaum ist eine neue und effektive Behandlung von postoperativen Lymphozelen und Lymphorrhoe
    In: Vasomed: Die Fachzeitschrift für Gefäßerkrankungen , Jg. 23 2011, Nr. 5, S. 252
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW , Jg. 136 2011, Nr. 1-2, S. 39 – 44
    DOI
  • Schrama, David; Scherer, Dominique; Schneider, Michael; Zapatka, Marc; Bröcker, Eva-Bettina; Schadendorf, Dirk; Ugurel, Selma; Kumar, Rajiv; Becker, Jürgen
    ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma
    In: Journal of Investigative Dermatology , Jg. 131 2011, Nr. 6, S. 1280 – 1290
    DOI (Open Access)
  • Boehncke, Sandra; Hardt, Katja; Schadendorf, Dirk; Henschler, Reinhard; Boehncke, Wolf-Henning; Duthey, Beatrice
    Endogenous μ-opioid peptides modulate immune response towards malignant melanoma
    In: Experimental Dermatology , Jg. 20 2011, Nr. 1, S. 24 – 28
    DOI
  • Arab, Khelifa; Smith, Laura T.; Gast, Andreas; Weichenhan, Dieter; Huang, Joseph Po-Hsien; Claus, Rainer; Hielscher, Thomas; Espinosa, Allan V.; Ringel, Matthew D.; Morrison, Carl D.; Schadendorf, Dirk; Kumar, Rajiv; Plass, Christoph
    Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma
    In: Carcinogenesis , Jg. 32 2011, Nr. 10, S. 1467 – 1473
    DOI
  • Körber, Andreas; Klode, Joachim; Al-Benna, Samy; Wax, Caroline; Schadendorf, Dirk; Steinstraesser, Lars; Dissemond, Joachim
    Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. 2, S. 116 – 121
    DOI
  • Cesko, Elvir; Vits, S.; Körber, Andreas; Schadendorf, Dirk; Schedlowski, Manfred; Dissemond, Joachim
    Expectation-induced Placebo effects in Wound healing processes : First results from a prospective clinical Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. 11, S. 984 – 984
  • Patel, Poulam M.; Suciu, Stefan; Mortier, Laurent; Kruit, Wim H.; Robert, Caroline; Schadendorf, Dirk; Trefzer, Uwe; Punt, Cornelis J.A.; Dummer, Reinhard; Davidson, Neville; Becker, Jürgen; Conry, Robert; Thompson, John A.; Hwu, Wen-Jen; Engelen, Kristel; Agarwala, Sanjiv S.; Keilholz, Ulrich; Eggermont, Alexander M.M.; Spatz, Alain
    Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma : Final results of a randomised phase III study (EORTC 18032)
    In: European Journal of Cancer (EJC) , Jg. 47 2011, Nr. 10, S. 1476 – 1483
    DOI
  • Schneider, Thomas; Kimpfler, Silvia; Warth, Arne; Schnabel, Philipp A.; Dienemann, Hendrik; Schadendorf, Dirk; Hoffmann, Hans; Umansky, Viktor
    Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma
    In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 3, S. 432 – 438
    DOI (Open Access)
  • Chapman, Paul B.; Hauschild, Axel; Robert, Caroline; Haanen, John B.; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Garbe, Claus; Testori, Alessandro; Maio, Michele; Hogg, David; Lorigan, Paul; Lebbe, Celeste; Jouary, Thomas; Schadendorf, Dirk; Ribas, Antoni; O'Day, Steven J.; Sosman, Jeffrey A.; Kirkwood, John M.; Eggermont, Alexander M. M.; Dreno, Brigitte; Nolop, Keith; Li, Jiang; Nelson, Betty; Hou, Jeannie; Lee, Richard J.; Flaherty, Keith T.; McArthur, Grant A.
    Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    In: The New England Journal of Medicine , Jg. 364 2011, Nr. 26, S. 2507 – 2516
    DOI
  • Meier, F. E.; Beck, D.; Niessner, H.; Flaherty, K. T.; Iovanna, J.; Kulms, D.; Schadendorf, Dirk; Garbe, C.
    Induction of apoptosis by the BRAFV600E kinase inhibitor PLX4032 in BRAFV600E melanoma cells through regulation of endoplasmic reticulum stress-related genes
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. 8518
    DOI
  • Klode, Joachim; Schöttler, Larissa; Stoffels, Ingo; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Investigation of adhesion of modern wound dressings : a comparative analysis of 56 different wound dressings
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 25 2011, Nr. 8, S. 933 – 939
    DOI
  • Vaubel, Julia Marianne; Schadendorf, Dirk
    Moderne Pharmakotherapie des malignen Melanoms
    In: Der Internist , Jg. 52 2011, Nr. 6, S. 756 – 764
    DOI
  • Papaspyrou, Giorgios; Garbe, Claus; Schadendorf, Dirk; Werner, Jochen A.; Hauschild, Axel; Egberts, Friederike
    Mucosal melanomas of the head and neck : New aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors
    In: Melanoma Research , Jg. 21 2011, Nr. 6, S. 475 – 482
    DOI
  • Czeschik, Johanna Christina; Huptas, Lisa; Schadendorf, Dirk; Hillen, Uwe
    Nodular scabies: Hypersensitivity reaction or infection?
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. 10, S. 840 – 841
    DOI
  • Eigentler, Thomas K.; Figl, Adina; Krex, Dietmar; Mohr, Peter; Mauch, Cornelia; Rass, Knut; Bostroem, Azize; Heese, Oliver; Koelbl, Oliver; Garbe, Claus; Schadendorf, Dirk
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
    In: Cancer , Jg. 117 2011, Nr. 8, S. 1697 – 1703
    DOI
  • Cesko, Elvir; Vits, S.; Körber, Andreas; Schadendorf, Dirk; Schedlowski, Manfred; Dissemond, Joachim
    P4 Vorschlag für Posterpreis Medizin : Beeinflussung der Wundheilung durch Placeboeffekte: Erste Resultate einer prospektiven klinischen Untersuchung
    In: Zeitschrift für Wundheilung , Jg. 16 2011, Nr. Suppl. B, S. 92
  • Lacouture, M. E.; Chapman, P. B.; Ribas, A.; Sosman, J. A.; McArthur, G. A.; Flaherty, K. T.; Kim, K. B.; Puzanov, I.; Nolop, K. B.; Joe, A. K.; Spleiss, O.; Koehler, A.; Wu, W.; Robert, C.; Hauschild, A.; Schadendorf, Dirk; Troy, J. L.; Duvic, M.; Trunzer, K.
    Presence of frequent underlying RAS mutations in cutaneous squamous cell carcinomas and keratoacanthomas (cuSCC/KA) that develop in patients during vemurafenib therapy
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. 8520
    DOI
  • Hofmann, Maja A.; Hauschild, Axel; Mohr, Peter; Garbe, Claus; Weichenthal, Michael; Trefzer, Uwe; Drecoll, Ulrike; Tilgen, Wolfgang; Schadendorf, Dirk; Kaatz, Martin; Ulrich, Jens
    Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice : A multicentre Dermatologic Cooperative Oncology Group trial
    In: Melanoma Research , Jg. 21 2011, Nr. 6, S. 516 – 523
    DOI
  • Voshege, Nadine; Brokalaki, E.; Witzke, Oliver; Kribben, Andreas; Schadendorf, Dirk; Hillen, Uwe
    Psoriasis therapy with Rtanercept in a Kidney and Pancreas transplant Patients
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. Suppl. 1, S. 213
    DOI
  • Stoffels, Ingo; Dissemond, Joachim; Körber, Andreas; Hillen, Uwe; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma : A retrospective analysis in 300 patients with malignant melanoma AJCC Stages i and II
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 25 2011, Nr. 3, S. 306 – 310
    DOI
  • Amann, Philipp M.; Schadendorf, Dirk; Owen, Robert W.; Korn, Bernhard; Eichmüller, Stefan B.; Bazhin, Alexandr V.
    Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT
    In: Experimental Dermatology , Jg. 20 2011, Nr. 4, S. 373 – 375
    DOI (Open Access)
  • Huptas, L.; Rompoti, N.; Herbig, S.; Körber, Andreas; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim
    Schmerzreduktion bei Patienten mit chronischem Ulcus cruris durch ein neu entwickeltes Morphingel : Erste Resultate einer klinischen Untersuchung
    In: Der Hautarzt , Jg. 62 2011, Nr. 4, S. 280 – 286
    DOI
  • Egberts, F.; Gutzmer, R.; Ugurel, Selma; Becker, J.C.; Trefzer, U.; Degen, A.; Schenck, F.; Frey, L.; Wilhelm, T.; Hassel, J.C.; Schadendorf, Dirk; Livingstone, Elisabeth; Mauch, C.; Garbe, C.; Berking, C.; Rass, K.; Mohr, P.; Kaehler, K.C.; Weichenthal, M.; Hauschild, A.
    Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma : A multicenter phase II DeCOG trial
    In: Annals of Oncology , Jg. 22 2011, Nr. 7, S. 1667 – 1674
    DOI
  • Niessner, Heike; Beck, Daniela; Sinnberg, Tobias; Lasithiotakis, Konstantinos; MacZey, Evelyn; Gogel, Jeannette; Venturelli, Sascha; Berger, Alexander; Mauthe, Mario; Toulany, Mahmoud; Flaherty, Keith; Schaller, Martin; Schadendorf, Dirk; Proikas-Cezanne, Tassula; Schittek, Birgit; Garbe, Claus; Kulms, Dagmar; Meier, Friedegund
    The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells
    In: Journal of Investigative Dermatology , Jg. 131 2011, Nr. 2, S. 468 – 479
    DOI (Open Access)
  • Liang, Ruixia; Wallace, Andrea R; Schadendorf, Dirk; Rubin, Brian P
    The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma
    In: Pigment Cell and Melanoma Research , Jg. 24 2011, Nr. 4, S. 714 – 723
    DOI
  • Schilling, Bastian; Vaubel, Julia Marianne; Schadendorf, Dirk
    Adjuvant pegylated interferon α-2b therapy for melanoma
    In: Oncology Letters , Jg. 1 2010, Nr. 2, S. 237 – 241
    DOI
  • Scherer, D.; Rachakonda, P. S.; Angelini, S.; Mehnert, F.; Sucker, A.; Egberts, F.; Hauschild, A.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors
    In: Journal of Investigative Dermatology , Jg. 130 2010, Nr. 12, S. 2844 – 2848
    DOI
  • Körber, Andreas; Schmid, E. N.; Buer, Jan; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim
    Bacterial colonization of chronic leg ulcers : current results compared with data 5 years ago in a specialized dermatology department
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 24 2010, Nr. 9, S. 1017 – 1025
    DOI
  • Dangoor, A.; Lorigan, P.; Keilholz, U.; Schadendorf, Dirk; Harris, A.; Ottensmeier, C.; Smyth, J.; Hoffmann, K.; Anderson, R.; Cripps, M.; Schneider, J.; Hawkins, R.
    Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
    In: Cancer Immunology, Immunotherapy , Jg. 59 2010, Nr. 6, S. 863 – 873
    DOI
  • Czeschik, J. C.; Hillen, Uwe; Schadendorf, Dirk
    Diagnostik des malignen Melanoms
    In: Der Onkologe , Jg. 16 2010, Nr. 12, S. 1121 – 1130
    DOI
  • Bazhin, A. V.; Kahnert, S.; Kimpfler, S.; Schadendorf, Dirk; Umansky, V.
    Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells
    In: Molecular Immunology , Jg. 47 2010, Nr. 4, S. 678 – 684
    DOI
  • Meier, F. E.; Beck, D.; Niessner, H.; Flaherty, K. T.; Sinnberg, T.; Schadendorf, Dirk; Kulms, D.; Garbe, C.
    Effect of mTOR inhibitors on sorafenib-induced endoplasmic reticulum stress and apoptosis in melanoma cells
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. e19027
    DOI
  • Hauschild, A.; Weichenthal, M.; Rass, K.; Linse, R.; Berking, C.; Böttjer, J.; Vogt, T.; Spieth, K.; Eigentler, T.; Brockmeyer, N. H.; Stein, A.; Näher, H.; Schadendorf, Dirk; Mohr, P.; Kaatz, M.; Tronnier, M.; Hein, R.; Schuler, G.; Egberts, F.; Garbe, C.
    Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness : Results of a Randomized Phase III DeCOG Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. 5, S. 841 – 846
    DOI
  • Peccerella, T.; Lukan, N.; Hofheinz, R.; Schadendorf, Dirk; Kostrezewa, M.; Neumaier, M.; Findeisen, P.
    Endoprotease Profiling with Double-Tagged Peptide Substrates : A New Diagnostic Approach in Oncology
    In: Clinical Chemistry , Jg. 56 2010, Nr. 2, S. 272 – 280
    DOI
  • Jansen, Thomas; Denisjuk, Natalja; Romiti, Ricardo; Schadendorf, Dirk
    Facial variant of eruptive vellus hair cysts : A case report and brief review of the literature
    In: Kosmetische Medizin , Jg. 31 2010, Nr. 4, S. 200 – 203
  • Godet, Y.; Desfrançois, J.; Vignard, V.; Schadendorf, Dirk; Khammari, A.; Dreno, B.; Jotereau, F.; Labarrière, N.
    Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy
    In: European Journal of Immunology , Jg. 40 2010, Nr. 6, S. 1786 – 1794
    DOI
  • Broekaert, S. M.; Roy, R.; Okamoto, I.; van den Oord, J.; Bauer, J.; Garbe, C.; Barnhill, R. L.; Busam, K. J.; Cochran, A. J.; Cook, M. G.; Elder, D. E.; McCarthy, S. W.; Mihm, M. C.; Schadendorf, Dirk; Scolyer, R. A.; Spatz, A.; Bastian, B. C.
    Genetic and morphologic features for melanoma classification
    In: Pigment Cell and Melanoma Research , Jg. 23 2010, Nr. 6, S. 763 – 770
    DOI
  • Hodi, F. S.; O'Day, S. J.; McDermott, D. F.; Weber, R. W.; Sosman, J. A.; Haanen, J. B.; Gonzalez, R.; Robert, C.; Schadendorf, Dirk; Hassel, J. C.; Akerley, W.; van den Eertwegh, A. J.; Lutzky, J.; Lorigan, P.; Vaubel, Julia Marianne; Linette, G. P.; Hogg, D.; Ottensmeier, C. H.; Lebbé, C.; Peschel, C.; Quirt, I.; Clark, J. I.; Wolchok, J. D.; Weber, J. S.; Tian, J.; Yellin, M. J.; Nichol, G. M.; Hoos, A.; Urba, W. J.
    Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    In: The New England Journal of Medicine , Jg. 363 2010, Nr. 8, S. 711 – 723
    DOI
  • Wolchok, Jedd D.; Weber, Jeffrey S.; Hamid, Omid; Lebbé, Celeste; Maio, Michele; Schadendorf, Dirk; Pril, Veerle de; Heller, Kevin; Chen, Tai-Tsang; Ibrahim, Ramy; Hoos, Axel; O'Day, Steven J.
    Ipilimumab efficacy and safety in patients with advanced melanoma : a retrospective analysis of HLA subtype from four trials
    In: Cancer Immunology: a Journal of the Academy of Cancer Immunology , Jg. 10 2010, Nr. 1, S. 9
    (Open Access)
  • Wolchok, J. D.; Neyns, B.; Linette, G.; Negrier, S.; Lutzky, J.; Thomas, L.; Waterfield, W.; Schadendorf, Dirk; Smylie, M.; Guthrie, T.; Grob, J. J.; Chesney, J.; Chin, K.; Chen, K.; Hoos, A.; O'Day, S. J.; Lebbé, C.
    Ipilimumab monotherapy in patients with pretreated advanced melanoma : a randomised, double-blind, multicentre, phase 2, dose-ranging study
    In: The Lancet Oncology , Jg. 11 2010, Nr. 2, S. 155 – 164
    DOI
  • Weindorf, Maren; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Klippel-Trénaunay-Syndrom : eine seltene Ursache eines chronischen Ulcus cruris
    In: Medizinische Klinik , Jg. 105 2010, Nr. 11, S. 841 – 844
    DOI
  • Hassel, J. C.; Sucker, A.; Edler, L.; Kurzen, H.; Moll, I.; Stresemann, C.; Spieth, K.; Mauch, C.; Rass, K.; Dummer, R.; Schadendorf, Dirk
    MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
    In: British Journal of Cancer (BJC) , Jg. 103 2010, Nr. 6, S. 820 – 826
    DOI (Open Access)
  • Bränström, R.; Chang, Y. M.; Kasparian, N.; Affleck, P.; Tibben, A.; Aspinwall, L. G.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertma?ski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leaf, S. L.; van Nieuwpoort, F. A.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Ruffin, A. D.; Schadendorf, Dirk; Gruis, N. A.; Brandberg, Y.; Newton-Bishop, J.
    Melanoma risk factors, perceived threat and intentional tanning : an international online survey
    In: European Journal of Cancer Prevention , Jg. 19 2010, Nr. 3, S. 216 – 226
    DOI
  • Browne, William J.; Dryden, Ian L.; Handley, Kelly; Mian, Shahid; Schadendorf, Dirk
    Mixed effect modelling of proteomic mass spectrometry data by using Gaussian mixtures
    In: Journal of the Royal Statistical Society / Series C (Applied Statistics) , Jg. 59 2010, S. 617 – 633
    DOI
  • Eberle, J.; Spangler, B.; Becker, J. C.; Heinemann, S. H.; Klein, C. A.; Kunz, M.; Kuphal, S.; Langer, P.; Mauch, C.; Meierjohann, S.; Paschen, Annette; Schadendorf, Dirk; Schartl, M.; Schittek, B.; Schönherr, R.; Tüting, T.; Zigrino, P.; Bosserhoff, A. K.
    Multicentre study on standardisation of melanoma cell culture : An initiative of the German Melanoma Research Network
    In: Pigment Cell and Melanoma Research , Jg. 23 2010, Nr. 2, S. 296 – 298
    DOI
  • Muthuswamy, R.; Mueller-Berghaus, J.; Haberkorn, U.; Reinhart, T. A.; Schadendorf, Dirk; Kalinski, P.
    PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
    In: Blood , Jg. 116 2010, Nr. 9, S. 1454 – 1459
    DOI
  • Muthuswamy, Ravikumar; Kalinski, Pawel; Reinhart, Todd; Schadendorf, Dirk
    PGE2 Transiently Enhances DC Expression of CCR7 but Inhibits the Ability of DCs to Produce CCL19 and Attract Naïve T cells
    In: Clinical Immunology , Jg. 135 2010, S. S100
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Piel, S.; Schadendorf, Dirk
    PLX4032 : does it keep its promise for metastatic melanoma treatment?
    In: Expert Opinion on Investigational Drugs , Jg. 19 2010, Nr. 11, S. 1439 – 1449
    DOI
  • Kaehler, K. C.; Sondak, V. K.; Schadendorf, Dirk; Hauschild, A.
    Pegylated interferons : Prospects for the use in the adjuvant and palliative therapy of metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 46 2010, Nr. 1, S. 41 – 46
    DOI
  • Riehemann, A. C.; Körber, Andreas; Voshege, Nadine; Schadendorf, Dirk; Dissemond, Joachim
    Perianale Ulzerationen durch Kaliumpermanganatbäder
    In: Der Hautarzt , Jg. 61 2010, Nr. 5, S. 435 – 438
    DOI
  • Hillen, Uwe; Meyer, Sabine; Schadendorf, Dirk; Kremens, Bernhard
    Photopheresis in pediatric patients with low-body weight using the UVAR XTS system
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 8 2010, Nr. 1, S. 32 – 37
    DOI
  • Klode, Joachim; Klötgen, K.; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 24 2010, Nr. 8, S. 904 – 909
    DOI
  • Bouwhuis, M. G.; Gast, A.; Figl, A.; Eggermont, A. M. M.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Polymorphisms in the CD28/CTLA4/ICOS genes : role in malignant melanoma susceptibility and prognosis?
    In: Cancer Immunology, Immunotherapy , Jg. 59 2010, Nr. 2, S. 303
    DOI
  • Bränström, R.; Kasparian, N. A.; Chang, Y. M.; Affleck, P.; Tibben, A.; Aspinwall, L. G.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bergman, W.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leachman, S. A.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, Dirk; Gruis, N. A.; Newton-Bishop, J.; Brandberg, Y.
    Predictors of Sun Protection Behaviors and Severe Sunburn in an International Online Study
    In: Cancer Epidemiology, Biomarkers & Prevention , Jg. 19 2010, Nr. 9, S. 2199 – 2210
    DOI
  • Helfrich, Iris; Scheffrahn, Inka; Bartling, Soenke; Weis, Joachim; von Felbert, Verena; Middleton, Mark; Kato, Masahi; Ergün, Süleyman; Schadendorf, Dirk
    Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
    In: Journal of Experimental Medicine (JEM) , Jg. 207 2010, Nr. 3, S. 491 – 503
    DOI (Open Access)
  • Osen, W.; Soltek, S.; Song, M.; Leuchs, B.; Steitz, J.; Tüting, T.; Eichmüller, S. B.; Nguyen, X. D.; Schadendorf, Dirk; Paschen, Annette
    Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries
    In: PLoS ONE , Jg. 5 2010, Nr. 11, S. e14137
    DOI (Open Access)
  • Figl, A.; Scherer, D.; Nagore, E.; Bermejo, J. L.; Botella-Estrada, R.; Gast, A.; Thirumaran, R. K.; Planelles, D.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma
    In: Mutation Research / Genetic Toxicology and Environmental Mutagenesis , Jg. 702 2010, Nr. 1, S. 8 – 16
    DOI
  • Gast, Andreas; Scherer, Dominique; Chen, Bowang; Bloethner, Sandra; Melchert, Stephanie; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Somatic alterations in the melanoma genome : a high-resolution array-based comparative genomic hybridization study
    In: Genes, Chromosomes and Cancer , Jg. 49 2010, Nr. 8, S. 733 – 745
    DOI
  • Hauschild, A.; Gutzmer, R.; Ugurel, Selma; Trefzer, U.; Egberts, F.; Hassel, J.; Schadendorf, Dirk; Mauch, C.; Garbe, C.; Weichenthal, M.
    Sorafenib and pegylated interferon-alpha-2b in advanced metastatic melanoma : A multicenter phase II DeCOG trial
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. 8526
    DOI
  • Jansen, Thomas; Melnik, B. C.; Schadendorf, Dirk
    Steroid-induced Periorificial Dermatitis in Children—Clinical Features and Response to Azelaic Acid
    In: Pediatric Dermatology , Jg. 27 2010, Nr. 2, S. 137 – 142
    DOI
  • Waltermann, K.; Geier, J.; Diessenbacher, P.; Schadendorf, Dirk; Hillen, Uwe
    Systemic allergic contact dermatitis from intravenous piritramide
    In: Allergy , Jg. 65 2010, Nr. 9, S. 1203 – 1204
    DOI
  • Kaehler, K. C.; Piel, S.; Livingstone, Elisabeth; Schilling, Bastian; Hauschild, A.; Schadendorf, Dirk
    Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma : Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
    In: Seminars in Oncology , Jg. 37 2010, Nr. 5, S. 485 – 498
    DOI

    • Aufsätze

  • Sondermann, Wiebke; Utikal, Jochen Sven; Enk, Alexander H.; Schadendorf, Dirk; Klode, Joachim; Hauschild, Axel; Weichenthal, Michael; French, Lars E.; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Fröhling, Stefan; Kalle, Christof von; Brinker, Titus J.
    Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’
    In: European Journal of Cancer (EJC) , Jg. 123 2019, S. 171
    DOI (Open Access)

    • Vorworte / Nachworte

  • Hahn, Andrew W.; Menk, Ashley V.; Rivadeneira, Dayana B.; Augustin, Ryan C.; Xu, Mingchu; Li, Jun; Wu, Xiaogang; Mishra, Aditya K.; Gide, Tuba N.; Quek, Camelia; Zang, Yan; Spencer, Christine N.; Menzies, Alexander M.; Daniel, Carrie R.; Hudgens, Courtney W.; Nowicki, Theodore; Haydu, Lauren E.; Khan, M A Wadud; Gopalakrishnan, Vancheswaran; Burton, Elizabeth M.; Malke, Jared; Simon, Julie M.; Bernatchez, Chantale; Putluri, Nagireddy; Woodman, Scott E.; Vashisht Gopal, Y.N.; Guerrieri, Renato; Fischer, Grant M.; Wang, Jian; Wani, Khalida M.; Thompson, John F.; Lee, Jeffrey E.; Hwu, Patrick; Ajami, Nadim; Gershenwald, Jeffrey E.; Long, Georgina V.; Scolyer, Richard A.; Tetzlaff, Michael T.; Lazar, Alexander J.; Schadendorf, Dirk; Wargo, Jennifer A.; Kirkwood, John M.; DeBerardinis, Ralph J.; Liang, Han; Futreal, Andrew; Zhang, Jianhua; Wilmott, James S.; Peng, Weiyi; Davies, Michael A.; Delgoffe, Greg M.; Najjar, Yana G.; McQuade, Jennifer L.
    Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
    In: Clinical Cancer Research , Jg. 29 2023, Nr. 1, S. 154 – 164
    DOI (Open Access)
  • Brochez, Lieve; Kruse, Vibeke; Schadendorf, Dirk; Muller, Alexander J.; Prendergast, George C.
    Editorial : Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
    In: Frontiers in Immunology , Jg. 12 2021, 789473
    DOI (Open Access)
  • Schilling, Bastian; Schadendorf, Dirk
    Editorial
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 14 2016, Nr. 1, S. 1 – 2
    DOI
  • Hauschild, Axel; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 4, S. 1
    DOI
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment , Jg. 37 2014, S. 1
    DOI (Open Access)
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 2, S. 1
    DOI (Open Access)
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 2, S. 1
    DOI (Open Access)

    • Abstracts

  • Larkin, J.; Chiarion Sileni, V.; Gaudy Marqueste, C.; Rutkowski, P.; Medina, T.M.; Lao, C.D.; Cowey, C.L.; Schadendorf, Dirk; Wagstaff, J.; Dummer, R.; Queirolo, P.; Walker, J.; Butler, M.O.; Hill, A.G.; Marquez-Rodas, I.; Haanen, J.B.A.G.; Nassar, A.; Askelson, M.; Hodi, F.S.; Wolchok, J.D.
    10-y survival outcomes from the phase III CheckMate 067 trial of nivolumab plus ipilimumab in advanced melanoma
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S1234 – S1235
    DOI
  • Koyfman, S. A.; Silk, A. W.; Davar, D.; Schadendorf, Dirk
    A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)
    In: International Journal of Radiation Oncology, Biology, Physics , Jg. 118 2024, Nr. 5, S. E86
  • Long, Georgina V.; Atkinson, Victoria; Ascierto, Paolo Antonio; Davar, Diwakar; Hamid, Omid; Robert, Caroline; Butler, Marcus O.; Dummer, Reinhard; Hafner, Christine; Khattak, Muhammad Adnan; Larkin, James; Lorigan, Paul; McKean, Meredith; Seedor, Rino S.; Shaw, Heather May; Stephenson, Joe; Yuan, Yuan; Patel, Roma; Thiyagarajah, Piruntha; Schadendorf, Dirk
    A phase 3 trial of IMC-F106C (PRAME x CD3) plus nivolumab versus standard nivolumab regimens in HLA-A*02:01+ patients with previously untreated advanced melanoma (PRISM-MEL-301)
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, TPS9602
    DOI (Open Access)
  • Long, Georgina V.; Haddad, Robert I.; Robert, Caroline; Mortier, Laurent; Schadendorf, Dirk; Uppaluri, Ravindra; Svane, Inge Marie; Saiag, Philippe; Lim, Annette May Ling; Soria Rivas, Ainara; Scolyer, Richard A; Chaney, Marya F.; Abildgaard, Cecilie; Ahmad, Qasim; Ringeisen, Francois Philippe; McDowell, Diane Opatt; Burtness, Barbara
    A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, TPS2701
    DOI (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk
    Adjuvant Treatment of Real World Melanoma Patients with Nivolumab : 3-year Results of the German, prospective, non-interventional NICO Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 19 – 20
    DOI
  • Livingstone, Elisabeth; Forschner, A.; Hassel, J.C.; von Wasielewski, I.; Meier, F.; Mohr, P.; Kähler, K.C.; Schilling, B.; Erdmann, M.; Berking, C.; Huning, S.; Stege, H.; Gutzmer, R.; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Hauschild, A.; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Adjuvant treatment of patients with stage III melanoma : 4-year follow-up time of multicenter real-world study
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S740
    DOI
  • Leven, A. S.; Peters, T.; Rajcsanyi, L.S.; Tasdogan, Alpaslan; Placke, Jan-Malte; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Rösch, Alexander; Hinney, Anke; Ugurel, Selma
    Analysis of gender-specific Differences in Response to First-line Treatment with Immunotherapy or targeted Therapy in Melanoma Patients with metastatic Stage IV Melanoma : An ADO/DeCOG Study of 2032 Patients from the prospective, multicenter Skin Cancer Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 16 – 17
    DOI
  • Mohr, P.; Debus, D.; von Wasielewski, I.; Tüting, T.; Gebhardt, C.; Heppt, M.V.; Hassel, J.C.; Ziller, F.; Weichenthal, M.; Aoun, M.; Schley, G.; Ulrich, J.; Utikal, J.; Meier, F.; Terheyden, P.; Gutzmer, R.; Schadendorf, Dirk
    COMBI-EU : Adverse event management of adjuvant dabrafenib plus trametinib (D+T) in patients with BRAF V600-mutant melanoma
    In: Annals of Oncology ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain , Jg. 35 2024, Nr. Suppl. 2, S. S728 – S729
    DOI
  • Hassel, J.C.; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kähler, K.C.; Holst, I.; Stege, H.; Franklin, C.; Sindrilaru, A.; Zimmer, Lisa; Heinzerling, L.; Utikal, J.; Meier, F.; Berking, C.; Garbe, C.; Weichenthal, M.; Schadendorf, Dirk; Hauschild, A.; Mohr, P.
    Characteristics and quality of life of nine-year survivors from 312 patients with metastatic melanoma treated with pembrolizumab
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S733 – S734
    DOI
  • Becker, Jürgen; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma
    Clinical Characteristics and Survival Data of Patients with advanced Merkel Cell Carcinoma (MCC) treated with Avelumab : Analysis of a prospective German MCC Registry (MCC TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 11 – 12
    DOI
  • Amaral, Teresa; Forchhammer, Stephan; Chatziioannou, Eftychia; Johansson, Iva; Nagore, Eduardo; Manrique-Silva, Esperanza; Través-Zapata, Víctor; Van Leeuwen, Barbara; Jansen, Marnix R.; Bañuls, José; Jara, Noelia; Niveiro de Jaime, María; Bohne, Ann-Sophie; Teras, Jyri; Ross, Merrick I.; van Akkooi, Alexander Christopher Jonathan; Weber, Jeffrey S.; Schadendorf, Dirk; Olofsson Bagge, Roger; Hauschild, Axel
    Clinical validation of a prognostic 7-marker IHC assay (7-IHC) in 382 patients (pts) with stage IB/IIA cutaneous melanoma (CM; MELARISK-001)
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 9572
    DOI (Open Access)
  • Lodde, Georg; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Zaremba-Montenari, Anne; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Correlation of Laboratory Parameters at the Start of adjuvant Treatment of Stage III Melanoma Patients with clinical Outcome : A multicenter Real World Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 8 – 9
    DOI
  • Tarantino, G.; Zaremba-Montenari, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Hadaschik, Eva; Pelletier, R.; Shi, Y.; Lopez Leon, M.; Makhzami, S.; Lian, C.; Murphy, G.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Deciphering unresectable in-transit metastasis in melanoma : Multi-modal and longitudinal insights
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S736
    DOI
  • Schadendorf, Dirk; Gogas, H.; Kandolf Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel-Becker, Selma; Gutzmer, R.; Grob, J.J.; Zimmer, Lisa; Livingstone, Elisabeth
    Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma : Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S1235 – S1236
    DOI
  • Wong, Michael K.K.; Sacco, Joseph J; Robert, Caroline; Michels, Judith; Bowles, Tawnya Lynn; In, Gino Kim; Tsai, Katy K.; Lebbe, Celeste; Gaudy-Marqueste, Caroline; Muñoz Couselo, Eva; Middleton, Mark R.; Samson, Adel; Schadendorf, Dirk; Beasley, Georgia; Niu, Jiaxin; Chmielowski, Bartosz; Wise-Draper, Trisha M.; Zhu, Junhong; Viana, Marcus; Milhem, Mohammed M.
    Efficacy and safety of RP1 combined with nivolumab in patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 9517
    DOI (Open Access)
  • Schadendorf, Dirk; Tawbi, Hussein A.; Lipson, Evan J.; Hodi, F. Stephen; Ascierto, Paolo Antonio; Larkin, James; Lao, Christopher D.; Grob, Jean-Jacques; Ejzykowicz, Flavia; Moshyk, Andriy; Horton, Viviana Garcia; Zhou, Jenny; Xin, Yiqiao; Palaia, Jennell; McDonald, Laura; Keidel, Sarah; Salvatore, Anthony; Sakkal, Leon A.; Long, Georgina V.
    Efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO + RELA) versus NIVO plus ipilimumab (NIVO + IPI) in advanced melanoma : An indirect treatment comparison (ITC) using patient-level data (PLD)
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2024, Nr. Suppl. 16, 9552
    DOI (Open Access)
  • Ladwa, R.; Davar, D.; Lee, J.; Silk, A.W.; Popovtzer, A.; Asher, N.; Khattak, M.A.; Meehan, R.; Posadas, T.; Wang, A.; Yuan, J.; Gross, N.; Koyfman, S.; Schadendorf, Dirk
    INTerpath-007 : A phase II/III, adaptive, randomized study of neoadjuvant and adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) for treatment of resectable locally advanced (LA) cutaneous squamous cell carcinoma (cSCC)
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S652 – S653
    DOI
  • Schadendorf, Dirk
    Interim Analysis of German Data from the multinational Safety Study NISSO to Evaluate the long-term Safety of Sonidegib in Patients with locally advanced Basal Cell Carcinoma : Time to adverse Events
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 10 – 11
    DOI
  • Asher, Nethanel; Mohr, Peter; Ellebaek, Eva; Bender, Marc; Mangana, Joanna; Kandolf, Lidija; Gavrilova, Iva; Ascierto, Paolo Antonio; Gogas, Helen; Rutkowski, Piotr; Schadendorf, Dirk; Bastholt, Lars; Weichenthal, Michael
    Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma : An EUMelaReg real world study
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 9531
    DOI (Open Access)
  • Hauschild, Axel; Dummer, Reinhard; Santinami, Mario; Atkinson, Victoria; Mandala, Mario; Merelli, Barbara; Chiarion-Sileni, Vanna; Haydon, Andrew Mark; Schachter, Jacob; Schadendorf, Dirk; Lesimple, Thierry; Plummer, Elizabeth Ruth; Larkin, James; Tan, Monique; Adnaik, Sachin Bajirao; Burgess, Paul; Jandoo, Tarveen; Long, Georgina V.
    Long-term follow up for adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma : Final results of the COMBI-AD study
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 9500
    DOI (Open Access)
  • Tawbi, Hussein A.; Hodi, F. Stephen; Lipson, Evan J.; Schadendorf, Dirk; Ascierto, Paolo Antonio; Matamala, Luis; Gutiérrez, Erika Castillo; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Menezes, Juliana; Dalle, Stéphane; Arance, Ana Maria; Grob, Jean-Jacques; Ratto, Barbara; Rodriguez, Saima; Mazzei, Antonella; Dolfi, Sonia; Long, Georgina V.
    Nivolumab (NIVO) plus relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma (RELATIVITY-047) : Overall survival (OS) and melanoma-specific survival (MSS) outcomes at 3 years
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 9524
    DOI (Open Access)
  • Schadendorf, Dirk; Tawbi, H.A.; Hodi, F.S.; Lipson, E.J.; Ascierto, P.A.; Medina Soto, F.A.; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Mujika Eizmendi, M.K.; Atkinson, V.G.; Hassel, J.C.; Cinat, G.; Keidel, S.; Rodriguez, S.; Wang, P.T.; Dolfi, S.; Long, G.V.
    Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma : 3-year subgroup analyses from RELATIVITY-047
    In: Annals of Oncology ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain , Jg. 35 2024, Nr. Suppl. 2, S. S723 – S724
    DOI
  • Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Lodde, Georg; Tasdogan, Alpaslan; Becker, Jürgen; Griewank, Klaus; Hadaschik, Boris; Schadendorf, Dirk; Ugurel, Selma
    PD-L1 Expression in Lymph Node Metastases as a Predictor of adjuvant Immunotherapy Success in Stage III Melanoma Patients: An Analysis of the prospective ADOREG Study TRIM-ADJUVANT
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 15 – 16
    DOI
  • Hauschild, Axel; Hassel, Jessica Cecile; Ziemer, Mirjana; Rutkowski, Piotr; Meier, Friedegund Elke; Flatz, Lukas; Gaudy-Marqueste, Caroline; Santinami, Mario; Russano, Francesco; von Wasielewski, Imke; Eigentler, Thomas; Maio, Michele; Zalaudek, Iris; Haferkamp, Sebastian; Quaglino, Pietro; Ascierto, Paolo Antonio; Garbe, Claus; Robert, Caroline; Schadendorf, Dirk; Kähler, Katharina C.
    Phase 3 study (PIVOTAL) of neoadjuvant intralesional daromun vs. immediate surgery in fully resectable melanoma with regional skin and/or nodal metastases
    2024 ASCO Annual Meeting, May 31 - June 4, 2024, Chicago, Ill., USA and online,
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 17, Supplement, LBA9501
    DOI
  • Ascierto, P.A.; Rodon, J.; De Vos, F.Y.F.L.; Gambardella, V.; De Miguel, M.; Marquez-Rodas, I.; Gil Martín, M.; Robert, C.; Del Vecchio, M.; Moreno Garcia, V.; Schadendorf, Dirk; Jamal, R.; Sloan, S.; Mclaughlin, M.; Murray, S.; Gomez-Carrillo Ruiz, B.; Hsiue, E.; Moody, S.; Arance, A.M.
    Phase I study of WNT974 in combination with spartalizumab in patients with cutaneous melanoma
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S716 – S717
    DOI
  • Kuper, A.; Krämer, Nicole; Livingstone, Elisabeth; Schadendorf, Dirk; Lodde, Georg
    Psychological Characteristics and their Impact on Trust in AI in dermatological Decision Making
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 34 – 35
    DOI
  • Rodriguez, S. Egea; Varaljai, R.; Philip, M.; Rambow, F.; Rösch, Alexander; Zhao, F.; Paschen, Annette; Schadendorf, Dirk
    RECQL4-mediated Downregulation of MHC Class II promotes Immune Evasion and reduced Anti-PD-1 Response in Melanoma Patients
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 6
    DOI
  • Schaper-Gerhardt, K.; Gutzmer, R.; Angela, Y.; Zimmer, Lisa; Schadendorf, Dirk; Hassel, J. C.; Weishaupt, C.; Remes, B.; Kubat, Linda; Becker, Jürgen C.
    A low interventional trial addressing the immunological effects of the RANKL-inhibitor Denosumab in combination with dual checkpoint blockade in melanoma patients with bone involvement reveals upregulation of CXCL-13
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 17
    DOI (Open Access)
  • Schadendorf, Dirk
    Adjuvant Pembrolizumab in Stage II Melanoma : Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
    In: Annals of Surgical Oncology , Jg. 30 2023, Nr. Suppl. 1, S. S34 – S35
    DOI (Open Access)
  • Zillikens, H.; Scheib, C.; Peller, V.; Müller, C.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Guntrum, F.; Baum, S.H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Außergewöhnlicher Therapiebenefit von Imatinib bei cKIT-mutiertem Schleimhautmelanom mit nachfolgendem KIT-Mutationsverlust
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21 – 22
    DOI (Open Access)
  • Placke, Jan-Malte; Kimmig, M.; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Welzel, J.; Engel, Daniel Robert; Kreft, S.; Sucker, A.; Krefting, F.; Lodde, Georg C.; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen C.; Weichenthal, M.; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 – 28
    DOI (Open Access)
  • Anker, K.; Sammet, S.; Schadendorf, Dirk; Rath, Peter-Michael; Esser, Stefan
    Efficacy of current antimicrobial treatment for gonorrhoea: A retrospective data analysis from 2016-2022 in the Ruhr area
    DÖAK 2023 / German-Austrian AIDS Conference, Bonn, Germany, 23-25 March 2023,
    In: HIV Medicine , Jg. 24 2023, Nr. 1, S. 43 – 44
  • Jansen, P.; Otero Baguer, D.; Duschner, N.; Le ́Clerc Arrastia, J.; Schmidt, M.; Landsberg, J.; Wenzel, J.; Schadendorf, Dirk; Hadaschik, Eva; Maass, P.; Schaller, J.; Griewank, Klaus
    Etablierung eines Mustererkennungsalgorithmus zur histologischen Detektion von Melanommetastasen im Schildwächterlymphknoten
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 20 – 21
    DOI (Open Access)
  • Rünger, A.; Schadendorf, Dirk; Hauschild, A.; Gebhardt, C.
    Immune-Checkpoint Blockade for Organ-Transplant Recipients with Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 25
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, W.; Lodde, Georg C.; Zaremba, Anne; Standl, F.; Landsberg, J.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Placke, Jan-Malte; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Möller, I.; Sucker, A.; Paschen, Annette; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Molekulare und klinische Charakterisierung von BRAF/NRAS/NF1-wt Melanomen
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21
    DOI (Open Access)
  • Luke, Jason J.; Ascierto, Paolo Antonio; Khattak, Muhammad Adnan; de la Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M. M.; Robert, Caroline; Grob, Jean-Jacques; de Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo S.; Wu, Larry; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M.; Long, Georgina V.
    Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma : Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 17_suppl., LBA9505
    DOI
  • Placke, Jan-Malte; Mohr, Peter; Bluhm, Leonie; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Predictors of long-term survival of Stage IV melanoma patients: a multicenter DeCOG study on 395 patients from the prospective skin cancer registry ADOREG
    52. Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e. V., 26.-29.04.2023, Berlin,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S1, Special Issue: Abstractband anlässlich der 52. Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e. V. 26. bis 29. April 2023, Berlin, S. 9 – 27
    DOI (Open Access)
  • Fink, M.; Schmidt, K.; Tewes, Mitra; Schuler, Martin; Müller, B. W.; Schadendorf, Dirk; Scherbaum, Norbert; Kowalski, A.; Skoda, E.-M.; Teufel, Martin
    RCT to Test the Efficacy of an EEG Neurofeedback Intervention in Cancer Patients and Cancer Survivors
    Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, 03.-05.05.2023, Berlin,
    In: Zeitschrift für Psychosomatische Medizin und Psychotherapie , Jg. 69 2023, Nr. 2, S. 148 – 149
    DOI
  • Gutzmer, R.; Ugurel, Selma; Eigentler, T.; Mohr, P.; Weichenthal, M.; Gebhardt, C.; Göppner, D.; Haferkamp, S.; Herbst, R.; Kähler, K. C.; Kreuter, A.; Meier, F.; Pföhler, C.; Sachse, M. M.; Herber, M.; Terheyden, P.; Ulrich, J.; Utikal, J. S.; von Wasielewski, I.; Schadendorf, Dirk
    Relationship between baseline health-related quality of life (HRQoL) measures and clinical outcomes of nivolumab (NIVO) or nivolumab plus ipilimumab (NIVO+IPI) in patients (pts) with unresectable or metastatic melanoma using real-world data from the non-interventional study (NIS) NICO in Germany
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 6 – 8
    DOI (Open Access)
  • Rohner, Maxi; Sammet, Stefanie; Maischack, Felix; Schadendorf, Dirk; Esser, Stefan
    Therapeutic outcomes of human papilloma virus (HPV)-associated anal lesions in HIV-positive and negative patients
    DÖAK 2023 / German-Austrian AIDS Conference, Bonn, Germany, 23-25 March 2023,
    In: HIV Medicine , Jg. 24 2023, Nr. S1, S. 36 – 37
  • Galetzka, W.; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Kowall, Bernd; Stang, Andreas
    Treatment decision for melanoma patients : Identification of similar patients at point of care
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 5 – 6
    DOI (Open Access)
  • Lodde, Georg C.; Zhao, F.; Galetzka, W.; Placke, Jan-Malte; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Sucker, A.; Paschen, Annette; Horn, S.; Jansen, Philipp; Becker, Jürgen C.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Untersuchung des klinischen Verlaufs von Melanompatienten mit einer Super-Response (CR/PR innerhalb von 3 Monaten) unter PD-1-basierter Immuncheckpoint-Inhibition : eine Subgruppen-Analyse der prospektiven multizentrischen Studie ADOREG
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 8 – 9
    DOI (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Mandalà, Mario; Kirkwood, John M.; Robert, Caroline; Grob, Jean-Jacques; Nathan, Paul D.; Davies, Michael A.; Banerjee, Hiya; Shah, Rohan; Lau, Mike R.; Dummer, Reinhard; Long, Georgina V.
    Adjuvant dabrafenib plus trametinib (D + T) versus placebo in patients with resected stage III BRAFᵛ⁶⁰⁰-mutant melanoma : Updated 5-year distant metastases-free survival (DMFS) analysis of COMBI-AD.
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9563
    DOI (Open Access)
  • Becker, Jürgen C.; Ugurel, Selma; Leiter-Stoppke, U.; Meier, F.; Gutzmer, R.; Haferkamp, S.; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, T.; Hauschild, A.; Kiecker, F.; Hassel, J.C.; Mohr, P.; Fluck, M.; Thomas, I.; Garzarolli, M.; Grimmelmann, I.; Drexler, K.; Eckhardt, S.; Schadendorf, Dirk
    Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC) : Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S903
    DOI (Open Access)
  • Schadendorf, Dirk; Hassel, J.C.; Fluck, M.; Eigentler, T.; Loquai, C.; Haferkamp, S.; Gutzmer, R.; Meier, F.; Mohr, P.; Hauschild, A.; Menzer, C.; Kiecker, F.; Dippel, E.; Simon, J-C.; Conrad, B.; Garbe, C.; Körner, S.; Becker, Jürgen C.; Zimmer, Lisa; Livingstone, Elisabeth
    Adjuvant nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma with no evidence of disease (NED) : Overall survival (OS) results of IMMUNED, a randomized, double-blind multi-center phase II DeCOG trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S900
    DOI (Open Access)
  • Dummer, Reinhard; Farberg, Aaron S.; Gutzmer, Ralf; Spencer, James; Kiecker, Felix; Guminski, Alexander; Gebauer, Kurt; Loquai, Carmen; Robert, Caroline; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Migden, Michael
    Analysis of efficacy outcomes using ERIVANCE-like methodology in patients with locally advanced basal cell carcinoma
    Australasian College of Dermatologists 54th Annual Scientific Meeting, Discover Connect Collaborate; 30 April to 3 May 2022; online,
    In: Australasian Journal of Dermatology , Jg. 63 2022, Nr. 1, SI, S. 112
    DOI (Open Access)
  • Dolfi, Sonia; Tang, Tracy; Long AO, Georgina; Ascierto, Paolo; Hodi, F. Stephen; Lipson, Evan; Schadendorf, Dirk; Wojcik, John; Postelnek, Jennifer; Wang, Yu; Sobiesk, Anne Marie; Mishra, Kaushal; Keidel, Sarah; Miller-Moslin, Karen; Tawbi, Hussein; Garnett-Benson, Charlie
    Biomarker analyses of baseline tumor specimens and on-treatment changes in sera samples of patients enrolled in the RELATIVITY-047 trial to characterize LAG-3 biology
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. Suppl. 2, S. A636 – A637
    DOI (Open Access)
  • Koch, F.; Salva, K.; Wirtz, M.; Hadaschik, Eva; Varaljai, R.; Schadendorf, Dirk; Kehrmann, Jan; Rösch, Alexander
    Cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses
    In: Experimental Dermatology , Jg. 31 2022, Nr. 2, S. e24 – e24
  • Placke, Jan-Malte; Bottek, J.; Váraljai, R.; Shannan, B.; Krisp, C.; Spangenberg, P.; Soun, C.; Hoffmann, F.; Zhao, F.; Paschen, Annette; Schlüter, H.; von Eggeling, F.; Helfrich, Iris; Rambow, F.; Schadendorf, Dirk; Engel, Daniel Robert; Rösch, Alexander
    Compartment-based proteomics of CD8high vs. CD8low melanoma regions reveals differential regulation of TOR signaling
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 12
    DOI
  • Albrecht, L. J.; Varaljai, R.; Hoewner, A.; Lueong, S. S.; von Neuhof, N.; Sucker, A.; Sondermann, Wiebke; Schadendorf, Dirk; Rösch, Alexander
    Context Sensitive Links 9 of 29 Circulating tumor derived cell-free RNA (cfRNA) as a potential biomarker in melanoma
    In: Experimental Dermatology , Jg. 31 2022, Nr. 2, S. e26 – e27
  • Franklin, Cindy; Mohr, P.; Meier, F.; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Schadendorf, Dirk; Ugurel, Selma; et al.
    Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 13 – 14
    DOI
  • Weichenthal, Michael; Svane, Inge Marie; Kandolf Sekulovic, Lidija; Mangana, Joanna; Mohr, Peter; Marquez-Rodas, Ivan; Schmidt, Henrik; Ziogas, Dimitrios C.; Bender, Marc; Ellebaek, Eva; Urch, Kristina; Shalamanova-Deleva, Gergana; Gavrilova, Iva; Espinosa, Enrique; Dummer, Reinhard; Rutkowski, Piotr; Ascierto, Paolo Antonio; Gogas, Helen; Schadendorf, Dirk; Bastholt, Lars
    EMRseq : Registry-based outcome analysis on 1,000 patients with BRAF V600–mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9540
    DOI (Open Access)
  • Gutzmer, R.; Weichenthal, M.; Eigentler, T.; Grimmelmann, I.; Sickmann, T.; Zimmer, Lisa; Livingstone, Elisabeth; Ugurel, Selma; Utikal, J. S.; Müller, V.; Göppner, D.; Herbst, R.; Kreuter, A.; Pföhler, C.; Hollburg, W.; Loquai, C.; Kähler, K.; Mohr, P.; Schadendorf, Dirk
    Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 18 – 19
    DOI
  • Schadendorf, Dirk; Gogas, Helen; Kandolf Sekulovic, Lidija; Meier, Friedegund Elke; Eigentler, Thomas; Simon, Jan-Christoph; Terheyden, Patrick Andres Maximilian; Gesierich, Anja Heike; Herbst, Rudolf Alexander; Kähler, Katharina C.; Ziogas, Dimitrios C.; Mijuskovic, Zeljko; Garzarolli, Marlene; Garbe, Claus; Rösch, Alexander; Ugurel, Selma; Gutzmer, Ralf; Grob, Jean-Jacques; Zimmer, Lisa; Livingstone, Elisabeth
    Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAFV600-positive melanoma : Interim analysis of the ImmunoCobiVem study
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9548
    DOI
  • Richtig, Erika; Loquai, Carmen; Forschner, Andrea; Gutzmer, Ralf; Hassel, Jessica Cecile; Utikal, Jochen; Haferkamp, Sebastian; Meier, Friedegund Elke; Debus, Dirk; Dummer, Reinhard; Von Moos, Roger Anton Fredy; Thompson, Jan; Gengenbacher, Laura; Michielin, Olivier; Hoeller, Christoph; Schadendorf, Dirk
    Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAFᵛ⁶⁰⁰-mutant melanoma : Updated data from the multicenter, multinational, prospective, non-interventional longitudinal study BERINGᴹᴱᴸᴬᴺᴼᴹᴬ
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9526
    DOI (Open Access)
  • Egetemaier, S.; Chauvistré, H.; Shannan, B.; Váraljai, R.; Lueong, S. S.; Ullrich, V.; Srinivas, N.; Becker, Jürgen C.; Schadendorf, Dirk; Rösch, Alexander
    Epigenetisch-metabolische Vulnerabilität von medikamententoleranten Persisterzellen im Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 24
    DOI
  • Jansen, P.; Otero Baguer, D.; Duschner, N.; Schaller, Jörg; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus; Maass, P.
    Etablierung eines Deep-Learning-Algorithmus zur Differenzierung von Morbus Bowen und seborrhoischen Keratosen
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 15
    DOI
  • Albrecht, L. J.; Höwner, A.; Griewank, Klaus; Lueong, S. S.; von Neuhoff, N.; Horn, Peter A.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, S.; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, R.; Rösch, Alexander
    Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 12 – 13
    DOI
  • Placke, Jan-Malte; Dick, J.; Soun, C.; Spangenberg, P.; Shannan, B.; Varaljai, R.; Krisp, C.; Schlueter, H.; Urbanek, A.; von Eggeling, F.; Schadendorf, Dirk; Engel, Daniel Robert; Rösch, Alexander
    Inhibition of the mTOR inhibitory protein sirtuin 1 leads to faster tumor growth under PD1-based immune checkpoint blockade
    In: Experimental Dermatology , Jg. 31 2022, Nr. 2, S. e92
  • Shannan, B.; Matschke, Johann; Larafa, S.; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander
    KDM5B's role in creating radiation synthetic vulnerabilities and its effects on sequential therapy combinations
    48th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF): Virtual, Innsbruck, 23-26 February 2022,
    In: Experimental Dermatology , Jg. 31 2022, Nr. 2, S. e9 – e10
    DOI
  • Zaremba, Anne; Meier, F.; Schlein, C.; Jansen, Philipp; Lodde, Georg; Song, M.; Kretz, J.; Möller, I.; Stadtler, N.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, A.; Schadendorf, Dirk; Griewank, Klaus
    Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 6
    DOI
  • Livingstone, Elisabeth; Forschner, Andrea; Hassel, Jessica Cecile; Wulfken, Lena M.; Meier, Friedegund Elke; Mohr, Peter; Kähler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Kowall, Bernd; Galetzka, Wolfgang; Hauschild, Axel; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9570
    DOI (Open Access)
  • Wong, Michael K.K.; Burgess, Melissa Amber; Chandra, Sunandana; Schadendorf, Dirk; Silk, Ann W.; Olszanski, Anthony J.; Grob, Jean-Jacques; Jang, Sekwon; Grewal, Jaspreet Singh; Lewis, Karl D.; Fecher, Leslie Anne; Rabinowits, Guilherme; Lebbe, Celeste; Shen, Annalise; Chan, Tiffanie; McGreivy, Jesse S.; Rothbaum, Wayne P.; Hanna, Glenn J.; Kelly, Ciara Marie
    Navtemadlin (KRT-232) activity after failure of anti-PD-1/L1 therapy in patients (pts) with TP53ᵂᵀ Merkel cell carcinoma (MCC)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9506
    DOI (Open Access)
  • Lebbe, C.; Long, G.V.; Robert, C.; Hamid, O.; Atkinson, V.G.; Shoushtari, A.N.; Daud, A.; Bechter, O.E.; Schadendorf, Dirk; Sullivan, R.J.; Dummer, R.; Grob, J.J.; Lewis, N.; Fan, L.; Basu, S.; Caponigro, G.; Cooke, V.G.; Lau, A.; Amaria, R.
    Phase II study of multiple LXH254 drug combinations in patients (pts) with unresectable/metastatic, BRAF V600- or NRAS-mutant melanoma
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1407
    DOI (Open Access)
  • Long, Georgina; Tang, Tracy; Apfel, Abraham; Paulucci, David; Chasalow, Scott; Tenney, Daniel; Fusaro, Gina; Schadendorf, Dirk; Tawbi, Hussein; Stephen Hodi, F; Thakkar, Pratik; Larkin, James; Wolchok, Jedd; Wind-Rotolo, Megan; Huang, Shu-Pang; Mohr, Peter; Robert, Caroline; Hoeller, Christoph; Grob, Jean-Jacque; Gogas, Helen; Weber, Jeffrey; Chang, Han; Moss, Rebecca
    Predicting primary resistance and exploring mechanisms in patients with advanced melanoma treated with immune checkpoint inhibitors (ICIs)
    37th Annual Meeting of the Society for Immunotherapy of Cancer, SITC 2022 ; November 8 - 12, 2022, Boston, Mass., USA,
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. Supplement 2, S. A639 – A640
    DOI (Open Access)
  • Placke, Jan-Malte; Mohr, P.; Bluhm, L.; Engel, Daniel Robert; Franklin, Cindy; Zaremba, Anne; Krefting, F.; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen C.; Tasdogan, Alpaslan; Rösch, Alexander; Schadendorf, Dirk; Ugurel, Selma; et al.
    Predictors of long-term survival of stage IV melanoma patients : a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 16 – 17
    DOI
  • Glutsch, V.; Kneitz, H.; Gesierich, A.; Goebeler, M.; Posch, C.; Gebhardt, C.; Haferkamp, S.; Zimmer, Lisa; Becker, Jürgen C.; Leiter-Stöppke, U.; Weichenthal, M.; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian
    REINA - Retrospective Multicenter ADOReg Evaluation of Ipilimumab plus Nivolumab in Avelumab-refractory Merkel cell carcinoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 21
    DOI
  • Mohr, P.; Scherrer, E.; Alar, V.; Schadendorf, Dirk; Ugurel, Selma; Weichenthal, M.
    Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 18
    DOI
  • Lodde, Georg; Forschner, A.; Hassel, J. C.; Wulfken, L. M.; Meier, F.; Mohr, P.; Kähler, K.; Schilling, Bastian; Loquai, C.; Berking, C.; Hüning, S.; Eckardt, J.; Gutzmer, R.; Reinhardt, L.; Glutsch, V.; Nikfarjam, U.; Erdmann, M.; Kowall, Bernd; Galetzka, W.; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapiemanagement des ersten Rezidivs nach adjuvanter Therapie im Stadium III : multizentrische real-world Daten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 3
    DOI
  • Dummer, R.; Pathan, N.; Deng, S.; Robert, C.; Arance Fernandez, A.M.; de Groot, J.W.B.; Garbe, C.; Gogas, H.J.; Gutzmer, R.; Krajsova, I.; Liszkay, G.; Loquai, C.; Mandala, M.; Schadendorf, Dirk; Yamazaki, N.; di Pietro, A.; Xie, T.; Ascierto, P.A.; Flaherty, K.
    Tumor biomarker analysis from COLUMBUS part 1 : Encorafenib + binimetinib for BRAF V600E/K-mutant advanced or metastatic melanoma
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S902
    DOI (Open Access)
  • Schadendorf, Dirk
    5-Year Overall Survival in COLUMBUS : A randomized Phase 3 Study of Encorafenib plus Binimetinib versus Vemurafenib or Encorafenib in Patients with BRAF(V600)-mutated Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 56
  • Schadendorf, Dirk
    Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915)
    AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,
    In: Cancer Research , Jg. 81 2021, Nr. Suppl. 13, CT004
  • Schadendorf, Dirk; Ugurel, Selma
    Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 16 – 17
  • Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, Charles Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O.; Hill, Andrew Graham; Marquez-Rodas, Ivan; Haanen, John B. A. G.; Bas, Tuba; van Dijck, Wim; Larkin, James; Hodi, F. Stephen
    CheckMate 067 : 6.5-year outcomes in patients (pts) with advanced melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9506 – 9506
    DOI (Open Access)
  • Maischack, Felix; Reinsch, Nico; Albayrak-Rena, Sarah; Kaiser, Franziska; Dolff, Sebastian; Schadendorf, Dirk; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    Comparing 5-year body-mass-index gain of people living with HIV (PLH) with the general population
    In: Infection - A Journal of Infectious Disease , Jg. 49 2021, Nr. Suppl. 1, S. 23
    DOI (Open Access)
  • Mavarani, Laven; Maischack, Felix; Reinsch, Nico; Albayrak-Rena, Sarah; Kaiser, Franziska; Potthoff, Anja; Hower, Martin; Dolff, Sebastian; Brockmeyer, Norbert; Schadendorf, Dirk; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    Comparing 5-year body-mass-index gain of people living with HIV (PLH) with the general population
    In: Infection - A Journal of Infectious Disease , Jg. 49 2021, Nr. Suppl. 1, S. 23
    DOI (Open Access)
  • Gambichler, T.; Rohrmoser, E. M.; Horny, K.; Sucker, A. Antje; Schadendorf, Dirk; Skrygan, M.; Susok, L.; Stücker, M.; Abu Rached, N.; Becker, Jürgen
    Comparison of Mutation Profiles in primary Melanomas and nodal Nevi using next Generation Sequencing
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 80 – 81
  • Gutzmer, R.; Eigentler, T.; Mohr, P.; Weichenthal, M.; Dücker, P.; Gebhardt, C.; Göppner, D.; Grimmelmann, I.; Haferkamp, S.; Kähler, K.C.; Meier, F.; Pföhler, C.; Sickmann, T.; Sindrilaru, A.; Terheyden, P.; Ugurel, Selma; Ulrich, J.; Utikal, J.; Weishaupt, C.; Schadendorf, Dirk
    Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naïve and pretreated patients with advanced melanoma within the German noninterventional study NICO
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 894 – S895
    DOI (Open Access)
  • Esser, Stefan; Kreuter, Alexander; Potthoff, Anja; Oette, Mark; Bilbilis, Konstantinos; Lax, Hildegard; Wiehler, Heidi; Yavuz, Aylin; Brockmeyer, Norbert; Jöckel, Karl-Heinz; Schadendorf, Dirk; Wieland, Ulrike
    Efficacy of trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia marker lesions in HIV-positive patients
    In: Infection - A Journal of Infectious Disease , Jg. 49 2021, Nr. Suppl. 1, S. 24 – S25
    DOI (Open Access)
  • Esser, Stefan; Kreuter, Alexander; Potthoff, Anja; Oette, Mark; Bilbilis, Konstantinos; Lax, Hildegard; Wiehler, Heidi; Yavuz, Aylin; Brockmeyer, Norbert H.; Jöckel, Karl-Heinz; Schadendorf, Dirk; Wieland, Ulrike
    Efficacy of trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia marker lesions in HIV-positive patients
    In: Infection - A Journal of Infectious Disease , Jg. 49 2021, Nr. Suppl. 1, S. 24 – S25
    DOI (Open Access)
  • Schadendorf, Dirk
    Encorafenib plus Binimetinib in Patients with locally advanced, non-resectable or metastatic BRAF(V600) mutated Melanoma : First Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERING(MELANOMA)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 53
  • Richtig, Erika; Gutzmer, Ralf; Loquai, Carmen; Utikal, Jochen; Hoeller, Christoph; Stadler, Rudolf; Forschner, Andrea; Hassel, Jessica Cecile; Goeppner, Daniela; Fluck, Michael; Haferkamp, Sebastian; Kaatz, Martin; Welslau, Manfred; Dummer, Reinhard; Von Moos, Roger Anton Fredy; Schmidt, Andrea; Milde, Laura; Michielin, Olivier; Schadendorf, Dirk
    Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutant melanoma : First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERINGMELANOMA
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9555 – 9555
    DOI (Open Access)
  • Egetemaier, S.; Chauvistre, H.; Shannan, B.; Varaljai, R.; Lueong, S.; Ullrich, V.; Schadendorf, Dirk; Rösch, Alexander
    Epigenetic-metabolic Vulnerability of drug-tolerant Persister Cells in Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 36
  • Esser, Stefan; Kreuter, A.; Potthoff, A.; Bilbilis, K.; Lax, H.; Oette, M.; Wiesel, P.; Sprinzl, M.; Brockmeyer, N. H.; Schadendorf, Dirk; Wieland, U.
    Evaluation der Detektion von analen intraepitheliale Neoplasien (AIN) bei HIV‐positiven Menschen durch zytologische Abstriche und HPV Typisierungen beim Screening auf anale HPV‐assoziierte Läsionen
    51. Tagung der Deutschen Dermatologischen Gesellschaft ; 14.‐17. April 2021, Virtuell,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 2, S. 22
    DOI (Open Access)
  • Rischin, D.; Hughes, B.G.M.; Basset-Séguin, N.; Schadendorf, Dirk; Bowyer, S.; Trabelsi, S.; Meier, F.; Eigentler, T.; Casado Echarren, V.; Migden, M.R.; Hauschild, A.; Schmults, C.D.; Yoo, S-Y.; Paccaly, A.; Jankovic, V.; Seebach, F.; Drutman, S.; Booth, J.; Fury, M.G.; Guminski, A.
    Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) : Primary analysis of phase II results
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 886 – S887
    DOI (Open Access)
  • Zaremba, Anne; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint-Inhibition in Patients with NRAS-mutated Melanoma compared to Patients with NRAS Wild-type Melanoma : Results of a Study on 702 Patients from the prospective, multicenter Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 59 – 60
  • Thier, B.; Such, L.; Peller, V.; Schwamborn, M.; Sucker, A.; Coch, C.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette
    Interferon-independent enhancement of melanoma cell immunogenicity by RIG-I activation
    47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,
    In: Experimental Dermatology , Jg. 30 2021, Nr. 3, S. E78
  • Thier, B.; Zhao, F.; Horn, S.; Coch, C.; Hartmann, G.; Schadendorf, Dirk; Paschen, Annette
    Intratumoral Immunotherapy : RIG-I Agonists induce a dedifferentiated yet T-Cell-sensitive Melanoma Cell Phantotype
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 34
  • Mavarani, L.; Reinsch, N.; Albayrak-Rena, S.; Kaiser, F.; Brockmeyer, N.H.; Potthoff, A.; Hower, M.; Schadendorf, Dirk; Erbel, R.; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    No difference in changes of the body mass index categories over 5 years in people living with HIV and the general population from the German Ruhr-area
    18th European AIDS Conference (EACS 2021), Online & London, United Kingdom, October 27-30, 2021,
    In: HIV Medicine , Jg. 22 2021, Nr. S3, S. 140
    DOI
  • Ugurel, Selma; Griewank, Klaus; Horn, S.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pfoehler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Sucker, A.; Placke, Jan-Malte; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Becker, Jürgen; Weichenthal, M.; Schadendorf, Dirk
    PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 19
  • Robert, C.; Schadendorf, Dirk; Long, G.V.; Ascierto, P.; Intagliata, S.; Meier, F.; van der Veldt, A.A.M.; Ribas, A.; Weber, J.S.; Stenson, L.; Solovieff, N.; Louveau, A-L.; Boran, A.D.; Grob, J.J.; Dummer, R.
    PLATForM : Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanoma
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 898
    DOI (Open Access)
  • Albrecht, L. J.; Grünwald, Viktor; Becker, Jürgen; Gutzmer, R.; Asan, L.; Uslar, E.; Olischewsky, A.; Mueseler, A. C.; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    PTHrP-induced hypercalcemia Psychosyndrome under Immune Checkpoint Blockade in Patients with penile Squamous Cell Carcinoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 23
    DOI (Open Access)
  • Lodde, Georg; Ugurel, Selma; Placke, Jan-Malte; Griewank, Klaus; Sucker, A.; Jansen, Philipp; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk
    Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 6 – 7
  • Robbrecht, Debbie; Grob, Jean-Jacques; Bechter, Oliver; Santoro, Armando; Doger, Bernard; Borbath, Ivan; Butler, Marcus; Cheng, Tina; Martin, Patricia; Bennouna, Jaafar; Di Nicola, Massimo; Curigliano, Giuseppe; Ryu, Min-Hee; Vida, Alejo Rodriguez; Schadendorf, Dirk; Garralda, Elena; Abbadessa, Giovanni; Demers, Brigitte; Amrate, Amele; Lin, Tun Tun; Brahmachary, Manisha; Lee, Joon Sange; Theilhaber, Joachim; Pomponio, Rob; Wang, Rui
    Preliminary biomarker and pharmacodynamic (PD) activity of the TGFβ inhibitor SAR439459, alone or in combination with cemiplimab, in a phase 1 clinical study in patients with advanced solid tumors
    SITC 36th Anniversary Annual Meeting (SITC 2021), 10-14 November 2021, Washington & virtually,
    In: Journal for ImmunoTherapy of Cancer , Jg. 9 2021, Nr. Suppl. 2, S. A550 – A550
    DOI (Open Access)
  • Zhao, F.; Peller, V.; Schwamborn, M.; Kwapik, S.; Sucker, A.; Ugurel, Selma; Schadendorf, Dirk; Paschen, Annette
    Profiling of tumor-infiltrating T cells for guidance of melanoma salvage therapy in immune-checkpoint-blockade resistant patients
    47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,
    In: Experimental Dermatology , Jg. 30 2021, Nr. 3, S. E52
    DOI
  • Ascierto, Paolo Antonio; Robert, Caroline; Nathan, Paul D.; Dummer, Reinhard; Tawbi, Hussein Abdul-Hassan; Flaherty, Keith T.; Ribas, Antoni; Schadendorf, Dirk; Green, Steven; Sandalic, Lali; Lau, Mike R.; Romero, Tonatiuh; Long, Georgina V.
    Pyrexia-related outcomes upon application of an adapted pyrexia management algorithm in patients (pts) with BRAF V600 : Mutant unresectable or metastatic melanoma treated with dabrafenib plus trametinib (DabTram) in the COMBI-i trial
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9560 – 9560
    DOI (Open Access)
  • Lipson, Evan J.; Tawbi, Hussein Abdul-Hassan; Schadendorf, Dirk; Ascierto, Paolo Antonio; Matamala, Luis; Gutiérrez, Erika Castillo; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Janoski de Menezes, Juliana; Dalle, Stéphane; Arance, Ana Maria; Grob, Jean-Jacques; Srivastava, Shivani; Abaskharoun, Mena; Simonsen, Katy L.; Li, Bin; Long, Georgina V.; Hodi, F. Stephen
    Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma : Primary phase III results from RELATIVITY-047 (CA224-047)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9503 – 9503
    DOI (Open Access)
  • Hassel, Jessica Cecile; Berking, Carola; Schlaak, Max; Eigentler, Thomas; Gutzmer, Ralf; Ascierto, Paolo Antonio; Schilling, Bastian; Hamm, Svetlana; Hermann, F.; Reimann, Philip Gero; Schadendorf, Dirk
    Results from the phase Ib of the SENSITIZE trial combining domatinostat with pembrolizumab in advanced melanoma patients refractory to prior checkpoint inhibitor therapy
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9545 – 9545
    DOI (Open Access)
  • Vehring, J.; Sammet, S.; Maischack, F.; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    S7/1 Behandlungsergebnisse der Therapie einer Syphilis-Infektion
    65. Deutschen STI-Kongresses – virtuell – vom 5./6. Februar 2021,
    In: Der Hautarzt , Jg. 72 2021, Nr. Supplement 1, S. S5 – S6
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, J.; Zaremba, Anne; Chorti, E.; Lodde, Georg; Jansen, Philipp; Kretz, J.; Möller, I.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus
    TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK Therapy
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 31
  • Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa
    Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications : A retrospective, multicenter ADOReg Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 15 – 16
  • Ugurel, Selma; Schadendorf, Dirk
    The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 5 – 6
  • Weichenthal, Michael; Scherrer, Emilie; Chandwani, Sheenu; Mohr, Peter; Leiter, Ulrike; Ugurel, Selma; Kähler, Katharina C.; Gutzmer, Ralf; Pföhler, Claudia; Hassel, Jessica; Terheyden, Patrick; Schell, Beatrice; Utikal, Jochen; Kreuter, Alexander; Haferkamp, Sebastian; Sindrilaru, Anca; Hassel, Jessica; Nashan, Dorothee; Kaune, Kjell M.; Berking, Carola; Debus, Dirk; Ulrich, Jens; Dabrowski, Evelyn; Eigentler, Thomas; Herbst, Rudolf; Welzel, Julia; Loquai, Carmen; Meier, Friedegund; Schadendorf, Dirk
    The impact of brain involvement in metastatic melanoma patients treated with pembrolizumab
    Immunotherapy Bridge and Melanoma Bridge 2020, 02.-03.12.2020, Virtual Meeting,
    In: Journal of Translational Medicine , Jg. 19 2021, Nr. Suppl. 1, S. 17
    DOI (Open Access)
  • Tawbi, Hussein Abdul-Hassan; Long, Georgina V.; Meyer, Nicolas; Breznen, Boris; Vyas, Charmy; Leung, Lisa; Moshyk, Andriy; Pushkarna, Divya; Thakkar, Pratik K.; Fazeli, Mir Sohail; Schadendorf, Dirk
    Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy : A systematic literature review (SLR) and meta-analysis.
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9561 – 9561
    DOI (Open Access)
  • Long, G.V.; Tawbi, H.A.; Meyer, N.; Breznen, B.; Vyas, C.; Leung, L.; Moshyk, A.; Pushkarna, D.; Thakkar, P.; Fazeli, M.S.; Kotapati, S.; Schadendorf, Dirk
    Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy : A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 892 – S893
    DOI (Open Access)
  • Zimmer, Lisa; Krackhardt, Angela; Schultz, Erwin S.; Goeppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Livingstone, Elisabeth; Schadendorf, Dirk
    Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma : Final results from the dose-finding phase I part of the IMMU-Target trial
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9532 – 9532
    DOI (Open Access)
  • Ugurel, Selma; Griewank, Klaus; Horn, Susanne; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund Elke; Dippel, Edgar; Sucker, Antje; Placke, Jan-Malte; Hadaschik, Eva; Becker, Jürgen; Weichenthal, Michael; Schadendorf, Dirk
    Tumor PD-L1 expression and gene panel mutational profile as outcome predictors of PD-1-based checkpoint inhibition therapy in metastatic melanoma : A prospective multicenter DeCOG study
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9568 – 9568
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, C.; Bottek, J.; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, A.; Griewank, Klaus; Horn, S.; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 58 – 59
  • Robert, Caroline; Long, G.V.; Larkin, J.; Wolchok, Jedd D.; Hassel, J.C.; Schadendorf, Dirk; Hodi, F. Stephen; Lebbé, C.; Grob, Jean-Jacquez; Grossmann, Kenneth F.; Wagstaff, J.; Chesney, Jason A.; Butler, Marcus; Bechter, O.; Márquez-Rodas, I.; Pavlick, A.C.; Re, S.; van Dijck, W.; Postow, Michael A.; Ascierto, P.A.
    5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO plus IPI) or NIVO alone
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S734 – S735
    DOI (Open Access)
  • Zaremba, Anne; Martaki, Anna; Salzmann, Martin; Baroudjian, Barouyr; Sachse, Michael M.; Gesierich, A.; Reinhardt, Lydia; Meier, F.; Hassel, Jessica C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Broeckelmann, Paul; Kramer, R.; Heinzerling, L.; Zimmer, Lisa
    Agranulozytose unter Immuncheckpoint‐Blockade : Eine retrospektive, multizentrische Auswertung
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV28
    DOI (Open Access)
  • Robert, Caroline; Flaherty, K.T.; Gogas, Helen; Fernandez, A.M. Arance; Mandala, Mario; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Gutzmer, Ralf; de Groot, Jan Willem B.; Dutriaux, Caroline; Loquai, Carmen; Harney, A.; Kiprilov, E.; Pickard, Michael D.; Cantey-Kiser, J.; Dummer, Reinhard; Ascierto, Paolo A.
    Correlation of BRAF mutation status in circulating tumour DNA (ctDNA) with tumour biopsy and clinical outcomes in COLUMBUS
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S757 – S758
    DOI (Open Access)
  • Placke, Jan-Malte; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Funke-Lorenz, Carolin
    Die Extracorporale Photopherese verbessert therapierefraktäre autoimmune Nebenwirkungen nach Immuncheckpointblockade
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV06
    DOI (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Cosgarea, Ioana; Mauch, Cornelia; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma
    Die diagnostische Bedeutung der CT-gesteuerten Punktion bei Hauttumorpatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV49
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pfoehler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Constance M.; Mohr, Peter; Gutzmer, Ralf; Meier, F.; Dippel, Edgar; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Engel, Daniel Robert; Schadendorf, Dirk; Ugurel, Selma
    Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36
    DOI (Open Access)
  • Zhao, F.; Harbers, Franziska; Thier, Beatrice; Stupia, Simone; Zhu, S.; Schwamborn, Marion; Peller, Vladimir; Chauvistre, Heike; Rösch, Alexander; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette
    Distinct melanoma differentiation trajectories driven by MAPKi associate with activation of CD8+tumor-infiltrating lymphocytes
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV17
    DOI (Open Access)
  • Dummer, Reinhard; Biette, Kelly; Gusenleitner, Daniel; Ramesh, Radha; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Gasal, Eduard; Brase, Jan C.; Long, Georgina V.
    Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10034
    DOI (Open Access)
  • Berking, Carola; Schadendorf, Dirk; Weichenthal, Michael; Eigentler, Thomas K.; Schober, Karola; Mohr, Peter; Kiecker, Felix; Loquai, Carmen; Debus, Dirk; Gutzmer, Ralf; Leiter-Stoeppke, Ulrike
    Effektivität von Dabrafenib plus Trametinib bei der Behandlung von Melanompatienten mit BRAFV600‐mutierten Hirnmetastasen
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P128
    DOI (Open Access)
  • Lodde, Georg; Ruebben, Albert; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Placke, Jan-Malte; Griewank, Klaus; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter Cemiplimab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08
    DOI (Open Access)
  • Gilde, Christian; Ugurel, Selma; Mohr, Peter; Weichenthal, Michael; Terheyden, Patrick; Meier, F.; Pfoehler, Claudia; Leiter-Stoeppke, Ulrike; Kaatz, Miriam; Haferkamp, Sebastian; Ulrich, Jens; Kochanek, Chris; Schadendorf, Dirk; Gutzmer, Ralf
    Einfluss des BRAF‐V600 Mutationsstatus auf die Effizienz einer Immun‐Checkpoint‐Blockade : Eine Auswertung des ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV33
    DOI (Open Access)
  • Richtig, Erika; Debus, Dirk; Stadler, Rudolf; Holler, Christoph; Utikal, Jochen; Dummer, Reinhard; Haferkamp, Sebastian; von Moos, Rover; Michielin, Olivier; Schadendorf, Dirk
    Encorafenib plus Binimetinib bei Patienten mit lokal fortgeschrittenem, inoperablem oder metastasiertem BRAFV600‐mutierten Melanom : Erste Daten der multizentrischen, multinationalen, prospektiven, nicht‐interventionellen Längsschnittstudie BERINGMELANOM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P130
    DOI (Open Access)
  • Weichenthal, Michael; Stadler, Rudolf; Schley, Gaston; Duecker, Pia; Mohr, Peter; Terheyden, Patrick; Debus, Dirk; Utikal, Jochen S.; Schlaak, M.; Gutzmer, Ralf; Susok, Laura; Klemke, Claus-Detlev; Ulrich, Jens; Lang, C.; Schadendorf, Dirk
    E‐Health trifft auf „Real‐World“ : App‐basierte Unterstützung in der adjuvanten Therapie von Melanompatienten im Stadium III mit Dabrafenib und Trametinib (Combi‐EU)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV45
    DOI (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Terheyden, Patrick; Andtback, H. B.; Villabona, Luis; Leiter-Stoeppke, Ulrike; Eigentler, Thomas K.; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, L.; Horny, Kai; Habermann, Dirk; Hoffmann, D.; Becker, Jürgen
    Immun‐Checkpoint‐Blockade beim Merkelzellkarzinom : Klinische und molekulare Biomarker‐Analyse
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV22
    DOI (Open Access)
  • Weber, Jeffrey; Ascierto, Paolo; Middleton, Mark; Hennicken, Delphine; Zoffoli, Roberto; Pieters, Anne; Amadi, Adenike; Kupas, Katrin; Kotapati, Srividya; Moshyk, Andriy; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. Suppl. 3, S. A308
    DOI (Open Access)
  • Hauschild, Axel; Dummer, Reinhard; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Kirkwood, John M.; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Dasgupta, Kohinoor; Gasal, Eduard; Tan, Monique; Long, Georgina V.; Schadendorf, Dirk
    Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600–mutant melanoma : Five-year analysis of COMBI-AD
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10001
    DOI (Open Access)
  • Olischewsky, Alexandra; Schneider, M.; Koch, Fiona; Lodde, Georg; Alt, Clemens; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Neoadjuvante Immun‐ und zielgerichtete Therapie bei Melanompatienten im Stadium III B
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV44
    DOI (Open Access)
  • Gutzmer, Ralf; Eigentler, T.; Mohr, P.; Weichenthal, M.; Dücker, P.; Gebhardt, Christoffer; Göppner, D.; Haferkamp, S.; Kähler, Katharina C.; Meier, Friedegund; Pföhler, Claudia; Satzger, Imke; Sickmann, T.; Sindrilaru, Anca; Terheyden, P.; Ugurel, Selma; Ulrich, J.; Utikal, Jens; Weishaupt, C.; Schadendorf, Dirk
    Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO+IPI) in advanced melanoma patients with brain metastases : Real-world evidence from the German non-interventional study NICO
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. 746 – S747
    DOI (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I.; Schmults, Chrysalyne D.; Guminski, Alexander David; Chang, Anne Lynn S.; Lewis, Karl D.; Lim, Annette May Ling; Hernandez-Aya, Leonel Fernando; Hughes, Brett Gordon Maxwell; Schadendorf, Dirk; Hauschild, Axel; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Chen, Zhen; Okoye, Emmanuel; Lowy, Israel; Fury, Matthew G.; Migden, Michael Robert
    Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) : Longer follow-up
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl.
    DOI (Open Access)
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, Raluca I.; Helfrich, Iris; Korste, S; Mrotzek, Simone; Rischpler, C; Herrmann, Ken; Ugurel, Selma; Zimmer, Lisa; Coman, C; Ahrends, R; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3260
    DOI (Open Access)
  • Thier, B.; Such, L.; Schwamborn, M.; Sucker, A.; Coch, C.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette
    RIG-I activation enhances melanoma immunogenicity and improves anti-tumor T cell responses in combination with anti-PD-1 immune checkpoint blocking antibodies
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. Suppl. 2, S. A3
    DOI (Open Access)
  • Ugurel, Selma; Satzger, Imke; Eigentler, Thomas K.; Mohr, Peter; Goeppner, Daniela; Herber, Matthew P.; Herbst, Rudolf; Meier, F.; Meiss, Frank; Pfohler, C.; Sachse, Michael Max; Schneider, Stefan W.; Terheyden, Patrick; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Schadendorf, Dirk; Gutzmer, Ralf
    Real World‐ Daten zur Anwendung von Nivolumab (Nivo) als Monotherapie oder in Kombination mit Ipilimumab (Nivo+Ipi) in der Behandlung des fortgeschrittenen Melanoms : Zwischenergebnisse der nicht‐interventionellen Studie NICO
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P101
    DOI (Open Access)
  • Kirkwood, J.M.; Dummer, Reinhard; Hauschild, Axel; Santinami, M.; Atkinson, Victoria; Sileni, Vanna Chiarion; Larkin, J.; Nyakas, M.S.; Haydon, Andrew M.; Dutriaux, Caroline; Schachter, Jacob; Robert, Caroline; Mortier, Laurent; Banerjee, Haimanti; Haas, T.; Tan, M.; Lau, M.; Schadendorf, Dirk; Long, G.V.; Mandala, Mario
    Restricted mean survival time (RMST) and cure-rate modeling in estimating survival benefit with adjuvant dabrafenib (D) plus trametinib (T) treatment in melanoma
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. 743 – S744
    DOI (Open Access)
  • Nathan, Paul D.; Dummer, Reinhard; Long, G.V.; Ascierto, Paolo A.; Tawbi, Hussein A.; Robert, Caroline; Rutkowski, P.; Leonov, O.; Dutriaux, C.; Mandala, Mario; Lorigan, P.; Ferrucci, Pier Francesco; Flaherty, K.T.; Brase, Jan C.; Green, S.; Haas, T.; Masood, A.; Gasal, Eduard; Ribas, A.; Schadendorf, Dirk
    Spartalizumab plus dabrafenib and trametinib (Sparta-DabTram) in patients (pts) with previously untreated BRAF V600–mutant unresectable or metastatic melanoma : Results from the randomized part 3 of the phase III COMBI-i trial
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S1172
    DOI (Open Access)
  • Long, Georgina V.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Pakhle, Neha; Masood, Aisha; Gasal, Eduard; Dummer, Reinhard
    The anti–PD-1 antibody spartalizumab in combination with dabrafenib and trametinib in advanced BRAF V600–mutant melanoma : Efficacy and safety findings from parts 1 and 2 of the Phase III COMBI-i trial
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10028
    DOI (Open Access)
  • Lodde, Georg; Forschner, Andrea; Wulfken, Lena M.; Meier, F.; Mohr, Peter; Kaehler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Gebhardt, C.; Huening, Svea; Schatton, Kerstin; Eckardt, Josephine; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapieentscheidung bei Indikation zur adjuvanten Therapie des Melanoms : Multizentrische Real World Data
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV43
    DOI (Open Access)
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, Raluca I.; Helfrich, Iris; Korste, S; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3250
    DOI (Open Access)
  • Thier, Beatrice; Such, Lina; Sucker, Antje; Coch, Carla; Hartmann, G.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette
    Tumorzell‐intrinsiche Aktivierung des Immunrezeptors RIG‐I in Kombination mit Immun‐Checkpoint‐Blockade verbessert anti‐Tumor T‐Zellantworten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV18
    DOI (Open Access)
  • Schadendorf, Dirk; Garbe, Carolina; Gutzmer, Ralf; Loquai, Carmen; Fluck, Michael; Kiecker, Felix; Mohr, Peter; Terheyden, Patrick; Gogas, Helen; Ascierto, Paolo A.; Flaherty, Keith T.; Arance, Antonio; Mandala, Marco; Liszkay, Gabriella; Krajsova, Ivana; de Groot, Jan Willem B.; Dutriaux, Caroline; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Chrissy; Dummer, Reinhard
    Update zum Gesamtüberleben in der COLUMBUS‐Studie : Eine randomisierte Phase 3‐Studie mit Encorafenib (ENCO) plus Binimetinib (BINI) vs Vemurafenib (VEM) oder ENCO bei Patienten mit BRAF V600–mutiertem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P127
    DOI (Open Access)
  • Robert, Caroline; Dummer, Reinhard; Arance, Ana; Ribas, Antoni; Weber, Jeffrey; Long, Georgina V.; Haanen, John; Nathan, Paul; Ascierto, Paolo A.; Gasal, Eduard; D'Amelio, Anthony; Bettinger, Severine; Boran, Aislyn D.; Schadendorf, Dirk
    A randomized, open-label, open-platform, Phase II study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATforM)
    In: Cancer Research , Jg. 79 2019, Nr. Suppl. 13
    DOI (Open Access)
  • Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M.G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Ortmann, Christine-Elke; De Jong, Egbert; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Association between baseline disease characteristics and relapse-free survival (RFS) in patients (pts) with BRAF V600-mutant resected stage III melanoma treated with adjuvant dabrafenib (D) + trametinib (T) or placebo (PBO)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9582 – 9582
    DOI (Open Access)
  • Jansen, Philipp; Petri, Maximilian; Merz, S.; Brinker, T. J.; Schadendorf, Dirk; Stang, Andreas; Stoffels, Ingo; Klode, Joachim
    Der Stellenwert der Schildwächterlymphknotenentnahme auf das metastasenfreie Überleben von Patienten mit Hochrisiko-Plattenepithelkarzinomen
    29. Deutscher Hautkrebskongress (ADO–Jahrestagung) ; 11.–14. September 2019, Ludwigshafen,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 17 2019, Nr. Supplement 5: Abstractband anlässlich des 29. Deutschen Hautkrebskongresses (ADO–Jahrestagung) 11.–14. September 2019, Ludwigshafen, S. 23 – 23
    DOI (Open Access)
  • Izar, Benjamin; Jerby-Arnon, Livnat; Tirosh, Itay; Shah, Parin; Cuoco, Michael C.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Lin, Jia-Ren; Boland, Genevieve M.; Zhang, Gao; Hodi, F. Stephen; Sorger, Peter K.; Wucherpfennig, Kai W.; Allen, Eli M. Van; Schadendorf, Dirk; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Rotem, Asaf; Yoon, Charles H.; Regev, Aviv
    Development of therapeutic strategies by resolving the tumor ecosystem
    In: Cancer Research , Jg. 79 2019, Nr. Suppl. 13
    DOI (Open Access)
  • Nathan, Paul D.; Robert, Caroline; Grob, Jean Jacques; Stroyakovskiy, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Eugeny; Chiarion Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Bondarenko, Igor; Davies, Michael A.; Ribas, Antoni; Flaherty, Keith; Burgess, Paul; Tan, Monique; Gasal, Eduard; Schadendorf, Dirk; Long, Georgina V.
    Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9507 – 9507
    DOI (Open Access)
  • Hodi, F. Stephen; Wolchok, Jedd D.; Schadendorf, Dirk; Larkin, James; Qian, Max; Saci, Abdel; Young, Tina C.; Srinivasan, Sujaya; Chang, Han; Wind-Rotolo, Megan; Rizzo, Jasmine I.; Jackson, Donald G.; Ascierto, Paolo A.
    Genomic analyses and immunotherapy in advanced melanoma
    In: Cancer Research , Jg. 79 2019, Nr. Suppl. 13
    DOI (Open Access)
  • Schadendorf, Dirk; Larkin, James M.G.; Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Taylor, Fiona; Lawrance, Rachael; Moreno-Koehler, Alejandro; Lord-Bessen, Jennifer; Rizzo, Jasmine I.; Moshyk, Andriy; Kotapati, Serividya; Hodi, F. Stephen
    Patient-reported quality of life (QoL) of advanced melanoma patients in a Phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI : CheckMate 067 4-year data
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9551 – 9551
    DOI (Open Access)
  • Migden, Michael Robert; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Rischin, Danny; Schmults, Chrysalyne D.; Hernandez-Aya, Leonel Fernando; Meier, Friedegund Elke; Schadendorf, Dirk; Guminski, Alexander David; Hauschild, Axel; Wong, Deborah J.L.; Daniels, Gregory A.; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Lewis, Karl D.
    Primary analysis of phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 6015 – 6015
    DOI (Open Access)
  • Jerby, Livnat; Shah, Parin; Cuoco, Michael S.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes M.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Rabasha, Bokang; Liu, David; Zhang, Gao; Margolais, Claire; Ashenberg, Orr; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Riz; Hodi, Stephen; Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie; Miao, Benchun; Moll, Tabea; Flaherty, Keith; Herlyn, Meenhard; Jenkins, Russell S.; Thummalapalli, Rohit; Kowalczyk, Monika S.; Canadas, Israel; Schilling, Bastian; Cartwright, Adam N.R; Luoma, Adrienne M.; Malu, Shruti; Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andree; Barbie, David A.; Shalek, Alex K.; Tirosh, Itay; Sorger, Peter K.; Wucherpfennig, Kai W.; Allen, Eliezer M. Van; Schadendorf, Dirk; Johnson, Bruce E.; Rotem, Asaf; Rosenblatt-Rozen, Orit; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin; Regev, Aviv
    Single-cell RNA-sequencing of metastatic melanoma identifies a cancer cell-intrinsic program associated with immune checkpoint inhibitor resistance
    4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, September 30 - October 3, 2018, New York, NY,
    In: Cancer Immunology Research , Jg. 7 2019, Nr. 2, Supplement, S. A082
    DOI (Open Access)
  • Long, Georgina V.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance Fernandez, Ana Maria; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Lee, Dung-Yang; Masood, Aisha; Gasal, Eduard; Dummer, Reinhard
    The anti–PD-1 antibody spartalizumab (S) in combination with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF V600–mutant melanoma : Updated efficacy and safety from parts 1 and 2 of COMBI-i
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9531 – 9531
    DOI (Open Access)
  • Dummer, Reinhard; Gusenleitner, Daniel; Campbell, Catarina D.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Gasal, Eduard; Brase, Jan C.; Long, Georgina V.
    Tumor microenvironment (TME), longitudinal biomarker changes, and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma treated with first-line spartalizumab (S) + dabrafenib (D) + trametinib (T)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9515 – 9515
    DOI (Open Access)
  • Liszkay, Gabriella; Gogas, Helen; Mandalà, Mario; Arance Fernandez, Ana Maria; Garbe, Claus; Schadendorf, Dirk; Dummer, Reinhard; Ascierto, Paolo Antonio; Robert, Caroline; Pickard, Michael D.; Sandor, Victor; Gollerkeri, Ashwin; Flaherty, Keith
    Update on overall survival in COLUMBUS : A randomized phase III trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in patients with BRAF V600–mutant melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 9512 – 9512
    DOI (Open Access)
  • Puig-Butille, J. A.; Potrony, M.; Gimenez-Xavier, P.; Tell-Marti, G.; Rebollo-Morell, A.; Zimmer, Lisa; Carreras, E.; Aranda, F.; Sucker, A.; Schadendorf, Dirk
    Variants in CD5 and IRF4 impact into melanoma survival
    In: European Journal of Human Genetics , Jg. 26 2019, Nr. Suppl., S. 688 – 689
    DOI (Open Access)
  • Gogas, H.; Samoylenko, I.; Schadendorf, Dirk; Gutzmer, Ralf; Grob, J.J.; Sacco, Joseph J.; Gorski, Kevin S.; Anderson, Abraham A.; Liu, C.; Malvehy, Rovira, J.
    1246PD - Talimogene laherparepvec (T-VEC) treatment increases intratumoral effector T-cell and natural killer (NK) cell density in noninjected tumors in patients (pts) with stage IIIB–IVM1c melanoma: : Evidence for systemic effects in a phase II, single-arm study
    In: Annals of Oncology , Jg. 29 2018, Nr. 8, S. viii443
    DOI (Open Access)
  • Lipson, Evan J.; Long, Georgina V.; Tawbi, Hussein; Schadendorf, Dirk; Atkinson, Victoria G.; Maurer, M.; Simonsen, Katy L.; Harbison, Christopher T.; Hodi, Frank S.
    A randomized, double-blind, phase II/III study of relatlimab (anti-LAG-3) in combination with nivolumab (anti-PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii464 – viii465
    DOI (Open Access)
  • Weber, Jeffrey S.; Long, Georgina V.; Haanen, John B.; Arance, Ana M.; Dummer, Reinhard G.; Nathan, Paul; Ribas, Antoni; Ascierto, Paolo A.; Robert, Caroline; Gasal, Eduard; D'Amelio, A.; Bettinger, Severine; Boran, A. D.; Schadendorf, Dirk
    A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM)
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii465 – viii466
    DOI (Open Access)
  • Becker, Jürgen; Hassel, Jessica Cecile; Menzer, Christian; Kahler, Katharina C.; Eigentler, Thomas K.; Meier, Friedegund Elke; Berking, Carola; Gutzmer, Ralf; Mohr, Peter; Kiecker, Felix; Kaatz, Martin; Windemuth-Kieselbach, Christiane; Lorenz-Schlüter, Claudia; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk
    Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC) : A randomized, multicenter DeCOG/ADO study
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9527
    DOI (Open Access)
  • Becker, Jürgen; Hassel, J.; Menzer, C.; Hauschild, A.; Eigentler, T.; Meier, F.; Berking, C.; Gutzmer, R.; Mohr, P.; Kiecker, F.; Kaatz, M.; Windemuth‐Kieselbach, C.; Lorenz‐Schlüter, C.; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; German Dermatooncology Group (DeCOG/ADO)
    Adjuvante Therapie des Merkelzellkarzinoms mit Ipilimumab im Vergleich zur Beobachtung (ADMEC) : eine randomisierte, multizentrische ADO‐Studie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 6
    DOI (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo Antonio; Arance, Ana M.; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem; Yamazaki, Naoya; Loquai, Carmen; de Parseval, Laure A.; Pickard, Michael D.; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith
    Adverse events of special interest in the phase 3 COLUMBUS study
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9567 – 9567
    DOI (Open Access)
  • Albrecht, M.; Hadaschik, Eva; Zimmer, L.; Livingstone, Elisabeth; Hamacher, R.; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Angiosarkom im Bereich des Capillitium mit der Symptomatik eines Quincke‐Ödems
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. Suppl. 6, S. 34
    DOI (Open Access)
  • Varaljai, R.; Neuhoff, N.; Sucker, A.; Newton-Bishop, J.; Schadendorf, Dirk; Rösch, Alexander
    Application of circulating cell-free tumor DNA (ctDNA) profiles for monitoring metastatic melanoma progression under therapy
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology , Jg. 27 2018, Nr. 3, S. e22 – e23
    DOI (Open Access)
  • Kanaki, T.; Knispel, Sarah; Chorti, E.; Albrecht, M.; Martaki, A.; Zaremba, Anne; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Auswirkungen der überarbeiteten AJCC‐Klassifikation (8. Edition) auf das Essener Melanomkollektiv
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 61 – 62
    DOI (Open Access)
  • Placke, Jan-Malte; Knispel, Sarah; Chorti, E.; Albrecht, M.; Kanaki, T.; Jockenhöfer, Finja; Martaki, A.; Zaremba, Anne; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Autoimmunbedingte Gastritis nach Immuncheckpoint‐Blockade : eine Fallserie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 26 – 27
    DOI (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Kubat, L.; Terheyden, P.; Hassel, J.; Schadendorf, Dirk; Becker, Jürgen
    Biomarkers of response to PD‐1 inhibition in Merkel cell carcinoma
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 5
    DOI (Open Access)
  • Kubat, L.; Schrama, D.; Melior, Anita; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Schilling, Bastian; Sucker, A.; Meier, F.; Dippel, E.; Kaatz, M.; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen
    CCR5 Δ32 Polymorphismus als prädiktiver Marker für die Therapie mit Immuncheckpoint‐Inhibitoren beim Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 49 – 50
    DOI (Open Access)
  • Herrera-Rios, D.; Schmitt, V.; Herz, Josephine; Hinze, D.; Pierscianek, Daniela; Kato, M.; Felsberg, J.; Singer, Bernhard B.; Sure, Ulrich; Reifenberger, Guido; Schadendorf, Dirk; Holzel, M.; Helfrich, Iris
    Catch me if you can! : Novel immune escape mechanisms in melanoma metastases of the brain
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology , Jg. 27 2018, Nr. 3, S. e15
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, A.; Schimming, Tobias; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Clear Cell Sarcoma - a rare Differential Diagnosis of malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. Suppl. 6, S. 3
  • Ugurel, Selma; Horn, S.; Griewank, Klaus; Sucker, A.; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Weyandt, G.; Meier, F.; Dippel, E.; Kaatz, M.; Weichenthal, M.; Schilling, Bastian; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Rebmann, Vera; Schadendorf, Dirk
    Die Anzahl mutierter Melanom‐assoziierter Gene und die Expression von PD‐L1 sind unabhängige Prädiktoren der anti‐PD1 Immuntherapie ‐ eine prospektive Registerstudie der ADO (ADOREG/TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 7 – 8
    DOI (Open Access)
  • Weichenthal, Michael; Akkooi, Alexander van; Mohr, Peter; Ellebaek, Eva; Svane, Inge Marie; Ugurel-Becker, Selma; Leiter, Ulrike; Hoejberg, Lise; Haanen, John B. A. G.; Schmidt, Henrik; Oellegaard, T. H.; Wouters, Michel W. J. M.; Schadendorf, Dirk; Bastholt, Lars
    EUMelaReg : A European platform for outcome research on real world treatment data of patients with advanced melanoma
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii459
    DOI (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Ji, Ran; Aimone, Paola; Manson, Stephanie; Kefford, Richard; Dummer, Reinhard; Kirkwood, John M.; Long, Georgina V.
    Effect on health-related quality of life (HRQOL) of adjuvant treatment (tx) with dabrafenib plus trametinib (D + T) in patients (pts) with resected stage III BRAF-mutant melanoma.
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9590 – 9590
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Gutzmer, R.; Heinzerling, L.; Weishaupt, C.; Pföhler, C.; Gesierich, A.; Herbst, R.; Kähler, K.; Weide, B.; Schlaak, M.; Loquai, C.; Utikal, J.; Terheyden, P.; Kaatz, M.; Berking, C.; Kreuter, A.; Ulrich, J.; Mohr, P.; Dippel, E.; Weichenthal, M.; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Einfluss einer vorangegangenen Radiatio auf den Erfolg einer immunonkologischen Therapie beim metastasierten Melanom – eine retrospektive multizentrische Studie der ADO
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 28 – 29
    DOI (Open Access)
  • Pieper, N.; Zaremba, Anne; Harbers, F. N.; Schwamborn, M.; Lübcke, S.; Schrörs, B.; Sucker, A.; Lennerz, V.; Wölfel, T.; Schadendorf, Dirk; Paschen, Annette; Zhao, F.
    Evolution of cross‐resistance to CD8+ T cells in the course of BRAF and MEK inhibitor treatment in BRAFV600E melanoma
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. 6, S. 53
    DOI (Open Access)
  • Schaarschmidt, B. M.; Grueneisen, J.; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, P.; Antoch, G.; Pöppel, Thorsten
    F-18-FDG PET/MR including DWI in initial N-Staging in patients with malignant melanoma : Is it a possible replacement for sentinel lymph node biopsy?
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 45 2018, Nr. Suppl. 1, S. 38
    DOI
  • Vokes, Natalie; Miao, Diana; Margolis, Claire; Liu, David; Wankowicz, Stephanie; Schilling, Bastian; Sholl, Lynette M.; Getz, Gad; Janne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David Allen; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter S.; Van Allen, Eliezer Mendel
    Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 3036
    DOI (Open Access)
  • Dummer, R.; Ascierto, P. A.; Gogas, H. J.; Arance, A.; Mandala, M.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Gutzmer, R.; Chiarion‐Sileni, V.; Dutriaux, C.; de Groot, J. W.; Yamazaki, N.; Loquai, C.; Moutouh‐de Parseval, L. A.; Pickard, M. D.; Sandor, V.; Robert, C.; Flaherty, K. T.
    Gesamtüberleben (OS) in COLUMBUS: eine Phase‐III‐Studie mit Encorafenib (ENCO) plus Binimetinib (BINI) vs. Vemurafenib (VEM) oder ENCO beim BRAF‐mutierten Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 41
    DOI (Open Access)
  • Brinker, T. J.; Klode, Joachim; Esser, Stefan; Schadendorf, Dirk
    Gesichtsalterungs‐Apps in Warteräumen : Eine neue Möglichkeit für die Hautkrebsprävention?
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 66 – 67
    DOI (Open Access)
  • Brinker, T. J.; Esser, Stefan; Klode, Joachim; Schadendorf, Dirk
    Gesichtsalterungs‐Apps in Warteräumen von HIV‐positiven Patienten zur Tabakentwöhnung : Führt die öffentliche Selfiebearbeitung zum Aufhörversuch? – eine Interventionsstudie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 65 – 66
    DOI (Open Access)
  • Brinker, T. J.; Klode, Joachim; Schadendorf, Dirk
    Gesichtsalterungs‐Apps in der schulischen Melanomprävention: : erste Ergebnisse aus Deutschland und Brasilen – Perspektiven für großflächige Implementation
    Konferenz 28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 67
    DOI (Open Access)
  • Coens, Corneel; Bottomley, Andrew; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M. M.; Lichinitser, Mikhail R.; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen K.; Larkin, James M. G.; Puig Sarda, Susana; Ascierto, Paolo A.; Schadendorf, Dirk; Ibrahim, Nageatte; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M.M.
    Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial : An international randomized double-blind phase III trial
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii456
    DOI (Open Access)
  • Brunßen, A.; Hübner, J.; Schadendorf, Dirk; Terheyden, P.; Katalinic, Alexander
    Impact of skin cancer screening on the incidence of advanced melanoma and melanoma mortality : A pilot project for a case-control study in the setting of the German nationwide skin cancer screening (PiKoM)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 159
    DOI (Open Access)
  • Wendlinger, S. A.; Wohlfarth, J.; Kerstan, A.; Schwamborn, M.; Sucker, A.; Siedel, C.; Schadendorf, Dirk; Goebeler, Matthias; Schilling, B.
    Interaction of neutrophils and melanoma in the context of MAP kinase inhibition
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology , Jg. 27 2018, Nr. 3, S. e85 – e86
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Schimming, T.; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 3
    DOI (Open Access)
  • Brinker, T. J.; Enk, A.; Schadendorf, Dirk; Berking, C.; von Kalle, C.
    Künstliche Intelligenz in der dermatologischen Diagnostik : Das Skin‐Classification‐Projekt
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 7
    DOI (Open Access)
  • Kirchberger, M. C.; Ugurel, Selma; Mangana, J.; Heppt, M.; Eigentler, T.; Berking, C.; Schadendorf, Dirk; Schuler, G.; Dummer, R.; Heinzerling, L.
    MEK‐Inhibitoren könnten das Überleben von NRAS‐mutierten Melanompatienten unter Checkpoint‐Inhibitoren verbessern : Ergebnisse einer retrospektiven, multizentrischen Analyse von 364 Patienten
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 4
    DOI (Open Access)
  • Chorti, E.; Keyvani, Kathy; Umutlu, Lale; Kanaki, T.; Zaremba, Anne; Jockenhöfer, Finja; Knispel, Sarah; Placke, Jan-Malte; Albrecht, M.; Martaki, A.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Glas, M.; Zimmer, Lisa
    Meningeosis melanomatosa : Schlechte Prognose trotz neuer Systemtherapeutika
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 11 – 12
    DOI (Open Access)
  • Dummer, Reinhard; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Robert, Caroline; Schadendorf, Dirk; Aimone, Paola; Mookerjee, Bijoyesh; Campbell, Catarina D.; Garrett, James; Brase, Jan C.; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Mutational and immune gene expression profiling at relapse in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (pbo) in the COMBI-AD trial
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9574 – 9574
    DOI (Open Access)
  • Gutzmer, R.; Eigentler, T.; Mohr, P.; Becker, S.; Haferkamp, S.; Meiß, F.; Pföhler, C.; Satzger, I.; Schneider, S. W.; Terheyden, P.; Ulrich, J.; Utikal, J.; Weichenthal, M.; Weishaupt, C.; Zimmer, Lisa; Schadendorf, Dirk
    NICO ‐ eine nationale, prospektive, nicht‐interventionelle Studie (NIS) mit Nivolumab als Monotherapie oder in Kombination mit Ipilimumab bei Patienten mit fortgeschrittenem (inoperablem oder metastasiertem) Melanom zur Erhebung von real‐world data
    Konferenz 28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 79
    DOI (Open Access)
  • Dummer, Reinhard; Ascierto, Paolo Antonio; Gogas, Helen; Arance, Ana M.; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem; Yamazaki, Naoya; Loquai, Carmen; De Parseval, Laure A.; Pickard, Michael D.; Sandor, Victor; Robert, Caroline; Flaherty, Keith
    Overall survival in COLUMBUS : A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9504 – 9504
    DOI (Open Access)
  • Brütting, J.; Bergmann, M.; Schadendorf, Dirk; Berking, C.; Tilgen, W.; Weber, C.; Meier, F.
    PAKOME‐RCT: Projektskizze für die Evaluation des Einsatzes einer evidenzbasierten Patienteninformation (EBPI) zum Melanom in der Praxis
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 60
    DOI (Open Access)
  • Ribas, Antoni; Robert, Caroline; Squires, Matthew; Schadendorf, Dirk; Davies, Michael A.; Nathan, Paul D.; Tan, Puay; Powell, William; Jaeger, Savina; Grob, Jean Jacques; Flaherty, Keith; Long, Georgina V.
    PD-L1 and CD8 expression and association with outcomes in patients (pts) with BRAF V600E/K–mutant metastatic melanoma (MM) who received dabrafenib + trametinib (D+T) in the randomized phase 3 COMBI-v study.
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 5 Suppl., S. 183
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Schadendorf, Dirk; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission eines fortgeschrittenen Melanoms durch eine Kombinationstherapie mit Nivolumab und Trametinib nach Therapieversagen unter Ipilimumab + Nivolumab
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 38
    DOI (Open Access)
  • Eggermont, Alexander M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Eertwegh, Alfonsus J. van den; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Rivas, Veronica; Ibrahim, Nageatte; Marreaud, Sandrine; Janssen, Sven; Akkooi, Alexander van; Suciu, Stefan; Robert, Caroline
    Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma : Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
    In: Cancer Research , Jg. 78 2018, Nr. Suppl. 13
    DOI (Open Access)
  • Khattak, A.; Robert, C.; Blank, C. U.; Mandala, M.; Long, G. V.; Atkinson, V.; Dalle, S.; Haydon, A.; Lichinitser, M.; Carlino, M. S.; Sandhu, S.; Larkin, J.; Puig, S.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, Dirk; Lorigan, P.; Ibrahim, N.; Suciu, S.; Eggermont, A. M. M.
    Phase 3 Randomized Eortc 1325‐Mg/Keynote‐054 Study Results: Pembrolizumab Versus Placebo after Complete Resection in Patients with High‐Risk Stage III Melanoma
    Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, New Directions in Personalised Cancer Therapy; 1–3 August 2018; Adelaide, Australia,
    In: Asia-Pacific Journal of Clinical Oncology , Jg. 14 2018, Nr. Supplement 3, S. 48
    DOI
  • Löffek, S.; Horn, S.; Dujardin, P.; Hölzel, M.; Schadendorf, Dirk; Helfrich, Iris
    Potential role of TGF-beta signaling in immune-checkpoint-therapy-induced resistance in malignant melanoma
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology , Jg. 27 2018, Nr. 3, S. e63 – e64
    DOI (Open Access)
  • Rischin, Danny; Migden, Michael Robert; Chang, Anne; Chung, Christine H.; Dunn, Lara; Guminski, Alexander; Hauschild, Axel; Hernandez-Aya, Leonel; Hughes, Brett Gordon Maxwell; Lewis, Karl D.; Lim, Annette May Ling; Modi, Badri; Schadendorf, Dirk; Schmults, Chrysalyne; Booth, Jocelyn; Li, Siyu; Mohan, Kosalai Kal; Stankevich, Elizabeth; Lowy, Israel; Fury, Matthew G.
    Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9519 – 9519
    DOI (Open Access)
  • Schadendorf, Dirk; Lewis, Karl; Maio, Michele; Demidov, Lev; Mandalà, Mario; Bondarenko, Igor; Ascierto, Paolo A.; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant; Simmons, Brian; Ye, Chenglin; Hooper, Gregory; Wongchenk, Matthew J.; Yan, Yibing
    Prognostic impact of baseline tumor immune infiltrate on disease-free survival (DFS) in patients with completely resected, BRAF(V600) mutation-positive (BRAF(V600+)) melanoma receiving adjuvant vemurafenib
    Immunotherapy Bridge 2017 and Melanoma Bridge 2017 ; 29 November–2 December 2017. Naples, Italy,
    In: Journal of Translational Medicine , Jg. 16 2018, Nr. Suppl. 1, S. O20
    DOI (Open Access)
  • Jansen, Philipp; Petri, Maximilian; Schedlowski, Manfred; Schadendorf, Dirk; Stoffels, Ingo; Engler, Harald; Klode, Joachim
    Prospektive Studie zur Evaluation der perioperativen Angst und des Speichelkortisollevels bei Melanompatienten mit Schildwächterlymphknotenexstirpationen in Tumeszenz‐ vs. Vollnarkose
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 62
    DOI (Open Access)
  • Eigentler, T.; Gutzmer, R.; Mohr, P.; Kaatz, M.; Pföhler, C.; Terheyden, P.; Ulrich, J.; Utikal, J.; Zimmer, Lisa; Schadendorf, Dirk
    Real-world evidence in melanoma : A national, prospective, non-interventional study (NIS) of nivolumab monotherapy or in combination with ipilimumab in patients with advanced (unresected or metastatic) melanoma (NICO)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 159
    DOI (Open Access)
  • Izar, Benjamin; Jerby-Arnon, Livnat; Rotem, Asaf; Shah, Parin; Liu, David; Zhang, Gao; Schilling, Bastian; Rozenblatt-Rosen, Orit; Boland, Genevieve Marie; Hodi, F. Stephen; Flaherty, Keith; Van Allen, Eliezer Mendel; Johnson, Bruce E.; Schadendorf, Dirk; Yoon, Charles; Garraway, Levi A.; Regev, Aviv
    Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 3074 – 3074
    DOI (Open Access)
  • Dummer, Reinhard; Schadendorf, Dirk; Nathan, Paul; Tawbi, Hussein; Robert, Caroline; Ascierto, Paolo A.; Ribas, Antoni; Lebbé, Celeste; Mandala, Mario; Yamazaki, Naoya; Richtig, Erika; Miller, Wilson H.; Gasal, Eduard; Kaper, Mathilde; Brase, Jan C.; Mookerjee, Bijoyesh; Long, Georgina V.
    The anti-PD-1 antibody spartalizumab (PDR001) in combination with dabrafenib and trametinib in previously untreated patients with advancedBRAFV600-mutant melanoma : First efficacy, safety, and biomarker findings from the part 2 biomarker cohort of COMBi-i
    In: Cancer Research , Jg. 78 2018, Nr. Suppl. 13
    DOI (Open Access)
  • Bischof, L.; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Hadaschik, Eva; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Therapieversagen der Immuncheckpoint‐Blockade mit PD1‐Antikörpern bei Patienten mit metastasierten Hauttumorerkrankungen und gleichzeitiger Immunsuppression durch eine Chronisch Lymphatische Leukämie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 28
    DOI (Open Access)
  • Gutzmer, R.; Gogas, H. J.; Dummer, R.; Ascierto, P. A.; Arance, A.; Mandala, M.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Chiarion‐Sileni, V.; Dutriaux, C.; de Groot, J. W. B.; Yamazaki, N.; Loquai, C.; Moutouh‐de Parseval, L. A.; Pickard, M. D.; Gollerkeri, A.; Robert, C.; Flaherty, K. T.
    Unerwünschte Ereignisse von besonderem Interesse in der Phase‐3‐COLUMBUS‐Studie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 42
    DOI (Open Access)
  • Chorti, E.; Tiedje, Vera; Zaremba, Anne; Jockenhöfer, Finja; Hoge, J.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Führer, Dagmar; Livingstone, Elisabeth; Zimmer, Lisa
    Diagnostik und Therapie der immunvermittelten Thyreoiditis unter Therapie mit Ipilimumab und Nivolumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. Suppl. 3, S. 26 – 27
    DOI
  • Dreesen, J.; Schilling, Bastian; Koldehoff, Michael; Schadendorf, Dirk; Singer, Bernhard B.
    Mechanistic analysis of CD3-driven T cell functions reveals a CD32a polymorphism associated with melanoma emergence
    In: Experimental Dermatology , Jg. 24 2015, Nr. 3, 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), March 05-07, 2015, Ulm, Germany, S. E18 – E18
    DOI
  • Shannan, B.; Matschke, Johann; Hoewner, A.; Jendrossek, Verena; Schadendorf, Dirk; Rösch, Alexander
    Senescence-like responses in irradiated melanoma cells
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 13 2015, Nr. Suppl.2, S. 34
    DOI
  • Eigentler, Thomas K.; Gutzmer, Ralf; Hauschild, Axel; Kämpgen, Eckhart; Schadendorf, Dirk; Nashan, Dorothee; Hölzle, Erhard; Trefzer, Uwe; Becker, Jürgen C.; Sunderkötter, Cord; Moll, Ingrid; Richtig, Erika; Pönitzsch, Iris; Pehamberger, Hubert; Kaufmann, Roland; Pfoehler, Claudia; Vogt, Thomas; Berking, Carola; Praxmarer, Michael; Garbe, Claus
    Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002) : Decog-trial
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. 9071
    DOI
  • Lewis, Karl D.; Maio, Michele; Mandalà, Mario; Nelson, Betty J.; Goodman, Grant R.; Schadendorf, Dirk
    BRIM8 : A phase III, randomized, double-blind, placebo-controlled study of vemurafenib adjuvant therapy in patients with surgically resected, cutaneous BRAF-mutant melanoma at high risk for recurrence (NCT01667419)
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. TPS9118
    DOI
  • Reinsch, Nico; Eisele, Lewin; Schwarz, B.; Neumann, Till; Schulze, C.; Holzendorf, V.; Brockmeyer, N.; Schadendorf, Dirk; Erbel, Raimund; Esser, Stefan; HIV-HEART Study Grp
    Brain natriuretic peptide (BNP) as a prognostic parameter for cardiovascular events and death in HV-infected patients
    ESC Congress 2014, Barcelona, Spain, 30 August – 3 September 2014,
    In: European Heart Journal , Jg. 35 2014, Nr. Suppl. 1, S. 231
    DOI
  • Meier, Friedegund Elke; Garbe, Claus; Smalley, Keiran; Flaherty, Keith; Schadendorf, Dirk; Beissert, Stefan; Kulms, Dagmar; Niessner, Heike
    Effect of the BRAF inhibitor LGX818 on endoplasmic reticulum stress and sensitivity of NRAS-mutant melanoma cells to the MEK inhibitor binimetinib
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. 9062
    DOI
  • Reinsch, Nico; Eisele, Lewin; Schwarz, B.; Neumann, Till; Lunschken, F.; Holzendorf, V.; Brockmeyer, N.; Schadendorf, Dirk; Erbel, Raimund; Esser, Stefan
    Left ventricular ejection fraction as a prognostic marker for all-cause mortality in HIV-infected patients
    ESC Congress 2016, 27 - 31 August, Rome, Italy,
    In: European Heart Journal , Jg. 35 2014, Nr. Suppl. 1, S. 3
    DOI
  • Sekulic, Aleksandar; Migden, Michael Robert; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher; Miller, Chris; Mortier, Laurent; Murrell, Dedee F.; Hamid, Omid; Quevedo, Fernando; Hou, Jeannie; Tripathi, Mukta; Schadendorf, Dirk
    Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : Final update (30-month) of the pivotal ERIVANCE BCC study
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. 9013
    DOI
  • Ascierto, Paolo Antonio; Minor, David R.; Ribas, Antoni; Lebbe, Celeste; O'Hagan, Anne; Swann, R. Suzanne; Scheuber, Anita; Schadendorf, Dirk; Kefford, Richard; Grob, Jean Jacques; Hamid, Omid; Schuchter, Lynn Mara; Simeone, Ester; Wilhelm, Tabea; Kim, Kevin; Aktan, Gursel; Trefzer, Uwe
    Long-term safety and overall survival update for BREAK-2, a phase 2, single-arm, open-label study of dabrafenib in previously treated metastatic melanoma (NCT01153763)
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. 9034
    DOI
  • Flaherty, Keith; Arenberger, Petr; Ascierto, Paolo Antonio; De Groot, Jan Willem; Hallmeyer, Sigrun; Long, Georgina V.; Lotem, Michal; Marples, Maria; Schadendorf, Dirk; Starodub, Alexander; Taylor, Matthew Hiram; Wolter, Pascal; Yamazaki, Naoya; Wasserman, Ernesto; Ford, James; Weill, Marine; Dummer, Reinhard
    NEMO : A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with untreated or progressed after first-line immunotherapy unresectable or metastatic NRAS-mutant cutaneous melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. TPS9102 – TPS9102
    DOI
  • Zimmer, Lisa; Eigentler, Thomas K.; Vaubel, Julia Marianne; Mohr, Peter; Jradi, Zeinab; Kiecker, Felix; Utikal, Jochen; Berking, Carola; Kämpgen, Eckhart; Hauschild, Axel; Dippel, Edgar; Rompel, Rainer; Fluck, Michael; Stadler, Rudolf; Herbst, Rudolf; Terheyden, Patrick; Garbe, Claus; Loquai, Carmen; Schadendorf, Dirk
    Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. 9031
    DOI
  • Storim, J.; Verheyen, Jens; Wolff, E.; Wohlschläger, Jeremias; Jablonka, Robert; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    Proktitiden mit N. gonorrhoeae/C. trachomatis führen zur Rekrutierung von HIV-Zielzellen aber nicht zu einer gesteigerten HIV-Sekretion
    Leopoldina-Symposium und STI-Kongress, 18. und 19.–21. Juni 2014, Berlin,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 12 2014, Nr. 10, S. 952 – 953
    DOI
  • Kordelas, L.; Verheyen, Jens; Beelen, Dietrich; Horn, Peter; Heinold, Andreas; Kaiser, R.; Trenschel, Rudolf; Schadendorf, Dirk; Dittmer, Ulf; Esser, Stefan
    Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 38
    DOI
  • Kähler, Katharina C.; Kornek, Thomas; Blome, Christine; Wagner, Tobias; Utikal, Jochen; Gebhardt, Christoffer; Gutzmer, Ralf; Schenck, Florian; Livingstone, Elisabeth; Schadendorf, Dirk; Loquai, Carmen; Rudolph, Berenice M.; Mohr, Peter; Forschner, Andrea; Garbe, Claus; Terheyden, Patrick; Angün, Ozan; Stade, Barbara; Augustin, Matthias; Hauschild, Axel
    The GERMELATOX DeCOG-trial : German melanoma patients and their attitude toward toxicity during adjuvant interferon treatment
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. TPS9113
    DOI
  • Gogas, Helen; Schadendorf, Dirk; Dummer, Reinhard; Garbe, Claus; Lebbe, Celeste; Nathan, Paul D.; Larkin, James M. G.; Haydon, Andrew Mark; Bafaloukos, Dimitris; Robert, Caroline
    Vemurafenib treatment in patients with BRAF-mutated melanoma failing MEK inhibition with trametinib
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. 9061
    DOI
  • Buer, Jan; Hutzler, Marina; Helfrich, Iris; Schadendorf, Dirk; Hansen, Wiebke
    Neuropilin-1 mediates infiltration of regulatory T cells into tumors favoring immune escape
    In: European Journal of Immunology , Jg. 190 2013, S. P2063
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Mach, M.; Murali, R.; Wiesner, T.; Schimming, T.; Grabellus, Florian; Metz, C.; Sucker, A.; Hillen, Uwe; Speicher, M.; Woodman, S.; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Oncogene and copy number analysis of a larger cohort of conjunctival melanoma
    In: Experimental Dermatology , Jg. 22 2013, Nr. 3, S. E43
  • Warnke, A; Esser, Stefan; Neumann, Till; Schadendorf, Dirk; Potthoff, A; Brockmeyer, N; Reinsch, Nico; Becker-Boost, I; Erbel, Raimund; Hower, M
    A five-year observance of changes in the cardiovascular risk profile in 505 HIV-positive individuals
    In: Journal of the International AIDS Society , Jg. 15 2012, Nr. S4, S. P211
    DOI (Open Access)
  • Hodis, Eran; Watson, Ian; Theurillat, Jean-Philippe; Zou, Lihua; Place, Chelsea; Nickerson, Elizabeth; Auclair, Daniel; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory; Stransky, Nicolas; Ramos, Alex H.; Voet, Douglas; Lawrence, Michael S.; Stojanov, Petar; Saksena, Gordon; McKenna, Aaron; Carter, Scott L.; Pugh, Trevor; Noble, Michael; Lin, Pei; Lichtenstein, Lee; Zupko, Robert; Sougnez, Carrie; Guiducci, Candace; Onofrio, Robert C.; Ambrogio, Lauren; Fennell, Timothy; Chong, Kelly; Winckler, Wendy; Ardlie, Kristin; Lander, Eric S.; Golub, Todd; Meyerson, Matthew; Gabriel, Stacey B.; Getz, Gad; Wagner, Stefan; Schadendorf, Dirk; Hoon, Dave S. B.; Chin, Lynda; Garraway, Levi A.
    A glimpse into the somatic mutation landscape of melanoma through exome sequencing of 121 tumor-normal pairs
    In: Cancer Research , Jg. 72 2012, Nr. 8, Suppl., S. 5056
    DOI
  • Storim, J; Jochum, Christoph; Timm, Jörg; Schadendorf, Dirk; Esser, Stefan
    HIV-infection during treatment of a chronic hepatitis B virus infection : implications for PrEP?
    In: Journal of the International AIDS Society , Jg. 15 2012, Nr. S4, S. P234
    DOI
  • Robert, Caroline; Flaherty, Keith T.; Hersey, Peter; Nathan, Paul D.; Garbe, Claus; Milhem, Mohammed M.; Demidov, Lev V.; Hassel, Jessica C.; Rutkowski, Piotr; Mohr, Peter; Dummer, Reinhard; Trefzer, Uwe; Larkin, James M. G.; Utikal, Jochen; Casey, Michelle; Sherman, Laurie Jill; Crist, Wendy A.; Wu, Frank S.; Patel, Kiran; Schadendorf, Dirk
    METRIC phase III study : Efficacy of trametinib (T), a potent and selective MEK inhibitor (MEKi), in progression-free survival (PFS) and overall survival (OS), compared with chemotherapy (C) in patients (pts) with BRAFV600E/K mutant advanced or metastatic melanoma (MM)
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 18, Suppl., S. LBA8509
    DOI
  • Voshege, Nadine; Moebus, Susanne; Mohlenkamp, S.; Erbel, Raimund; Jöckel, Karl-Heinz; Körber, Andreas; Schadendorf, Dirk
    Cardiovascular Risk factors of Psoriasis : Results from the Heinz Nixdorf Recall Study
    46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V., 30. März bis 2. April 2011, Dresden,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. S1, Abstraktband anläßlich der 46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V. in Dresden vom 30. März bis 2. April 2011, S. 147 – 148
    DOI
  • Spatz, Alan; van Kempen, Leon C.; Job, Bastien; Richon, Catherine; Barrois, Michiel; Dessen, Philipe; Lazar, Vladimir; Michiels, Stefan; Helbling-Leclerc, Anne; Dumay, Anne; Petrella, Teresa; Batist, Gerald; Stas, Marguerite; Schadendorf, Dirk; van den Oord, Joost; Feunteun, Jean
    Gonosome-linked expression of PPP2R3B in cutaneous melanoma correlates with distant metastasis free survival
    In: Cancer Research , Jg. 71 2011, Nr. 8, Suppl., S. 4835
    DOI

    • Preprints

  • Egetemaier, Stefanie; Chauvistré, Heike; Váraljai, Renáta; Hua, Yichao; Lueong, Smiths; Makhzami, Samira; Srinivas, Nalini; Forster, Jan; Ullrich, Vivien; Stupia, Simone; Schroeder, Valéria; Scharfenberg, Sarah; Hoewner, Anna; Shannan, Batool; Siveke, Jens; Baietti, Maria Francesca; Leucci, Eleonora; Marine, Jean-Christophe; Paschen, Annette; Scheffler, Björn; Engel, Daniel R.; Becker, Lisa; Nensa, Felix; Köster, Johannes; Grünwald, Barbara; Poepsel, Simon; Ninck, Sabrina; Kaschani, Farnusch; Schadendorf, Dirk; Becker, Jürgen; Tasdogan, Alpaslan; Rambow, Florian; Rösch, Alexander
    Redirecting resistance evolution in BRAFV600 melanoma by inhibition of the peroxiredoxin-thioredoxin system
    2025
    DOI (Open Access)

    • Beiträge in Sammelwerken und Tagungsbänden

  • Rassaf, Tienush; Schadendorf, Dirk
    Cutaneous melanoma
    In: Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease / Herrmann, Joerg (Hrsg.) 2023, S. 370 – 375
    DOI
  • Beckmann, Catharina Lena; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, Britta
    Guideline-Based Context-Sensitive Decision Modeling for Melanoma Patients
    In: German Medical Data Sciences 2022 – Future Medicine: More Precise, More Integrative, More Sustainable! / Joint Conference of the 67th Annual Meeting of the German Association of Medical Informatics, Biometry, and Epidemiology e.V. (gmds) and the 14th Annual Meeting of the TMF – Technology, Methods, and Infrastructure for Networked Medical Research e.V.; 21–25 August 2022; Kiel, Germany / Röhrig, Rainer; Grabe, Niels; Hoffmann, Verena S.; Hübner, Ursula; König, Jochem; Sax, Ulrich; Schreiweis, Björn; Sedlmayr, Martin (Hrsg.) 2022, S. 50 – 57
    DOI (Open Access)
  • Schadendorf, Dirk; Flaherty, Keith T.; Duncan, Lyn M.; Kashani-Sabet, Mohammed; Ugurel, Selma
    Biomarkers for Melanoma
    In: Cutaneous Melanoma / Balch, Charles M.; Atkins, Michael B.; Garbe, Claus; Gershenwald, Jeffrey E.; Halpern, Allan C.; Kirkwood, John M.; McArthur, Grant A.; Thompson, John F.; Sober, Arthur J. (Hrsg.) 2020, S. 73 – 104
    DOI
  • Paschen, Annette; Schadendorf, Dirk
    The era of checkpoint inhibition : Lessons learned from melanoma
    In: Current Immunotherapeutic Strategies in Cancer / Theobald, Matthias (Hrsg.) 2020, S. 169 – 187
    DOI
  • Eggermont, Alexander M.M.; Schadendorf, Dirk; Robert, Caroline
    Immune checkpoint inhibitors in melanoma define a new era in immunotherapy aiming for cure
    In: Melanoma Development: Molecular Biology, Genetics and Clinical Application / Bosserhoff, Anja K. (Hrsg.) 2017, S. 427 – 436
    DOI
  • Fink, Wolfram; Schadendorf, Dirk
    The common and the unusual presentation of skin metastases in cancer patients
    In: Handbook of Skin Care in Cancer Patients / Awada, Ahmad; Vereecken, Pierre (Hrsg.) 2012, S. 95 – 115

    • Forschungsberichte

  • Merz, Simon F.; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    High-resolution 3-D imaging for precise staging in malignant melanoma
    New York 2020
    DOI, Online Volltext (Open Access)

    • Working Paper

  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Supporting Dermatologists with Explainable Ai : Exploring the Effects of Consistency and Explanation Approaches
    2024
    DOI

    • Poster / Posterbeiträge

  • Pires da Silva, I.; Li, I.; Ugurel-Becker, Selma; Serra-Bellver, P.; Andhale, A.; Burnette, H.; Aya, F.; Conway, J.; Carlino, M.; Menzies, A.M.; Weichenthal, M.; Mohr, P.; Gutzmer, R.; Arance Fernandez, A.M.; Johnson, D.; Lorigan, P.; Schadendorf, Dirk; Lo, S.; Long, G.V.
    Anti-PD-1 (PD1) monotherapy or in combination with anti-CTLA-4 for metastatic melanoma (MM) patients (pts) with liver metastases (mets)
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S666 – S667
    DOI (Open Access)
  • Albrecht, L. J.; Dimitriou, F.; Grover, P.; Hassel, J. C.; Erdmann, M.; Forschner, A.; Johnson, D.; Livingstone, Elisabeth; Rösch, Alexander; Ugurel, Selma; Schulz, C.; Berking, C.; Menzies, A. M.; Long, G. V.; Dummer, R.; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD1 plus BRAF/MEK inhibitors (triplet therapy) after failure of standard therapy in patients (pts) with advanced melanoma
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 44
    DOI (Open Access)
  • Scheib, C.; Zillikens, H.; Peller, V.; Müller, C.; Rudolph, V.; Leven, A. S.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Ausgedehntes Rezidiv eines atypischen Fibroxanthoms
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 99
    DOI (Open Access)
  • Becker, Jürgen C.; Mahmoudpour, S.; Schadendorf, Dirk; Leiter-Stoppke, U.; Meier, F.; Herbst, R.; Sachse, M.; Grabbe, S.; Gebhardt, C.; Ziller, F.; Pfoehler, C.; Mohr, P.; Zimmer, Lisa; Boutmy, E.; Hoff, S.; Verpillat, P.; Fernandez Milano, A.; Shlaen, M.; Fu, C.; Ugurel-Becker, Selma
    Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab : Analysis of a prospective German MCC registry (MCC TRIM)
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S685 – S686
    DOI
  • Weichenthal, M.; Schadendorf, Dirk; Bastholt, L.; Gavrilova, I.; Haanen, J.B.A.G.; Mangana, J.; Espinosa, E.; Svane, I-M.; Wouters, M.; Ellebæk, E.; Mohr, P.; Marques Rodas, I.; Asher, N.; Dummer, R.; Gaudy Marqueste, C.; Aya, F.; Gogas, H.; Lebbe, C.; Rutkowski, P.; Ascierto, P.A.
    Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment : A EUMelareg real-world evidence study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S665 – S666
    DOI
  • Borys, K.; Bloch, L.; Galetzka, W.; Livingstone, Elisabeth; Lodde, Georg C.; Schadendorf, Dirk; Friedrich, C. M.; Nensa, Felix
    Identifizierung von nachteiligen Datensamples zur verbesserten KI-gestützten Klassifizierung von Hautläsionen unter Verwendung von Radiomics
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 95 – 96
    DOI (Open Access)
  • Schadendorf, Dirk; Chmielowski, B.; Milhem, M. M.; Sacco, J. J.; Bowles, T. L.; Tsai, K. K.; In, G. K.; Muñoz-Couselo, E.; VanderWalde, A. M.; Chesney, J. A.; Michels, J.; Samson, A.; Beasley, G. M.; Mahmoud, F.; Wong, M. K.; Wise-Draper, T. M.; Zhu, J.; Bommareddy, P. K.; Hong, W.; Hou, J. W.; Middleton, M. R.
    Initial efficacy and safety of RP1+ nivolumab in patients with anti–PD-1–failed melanoma from the ongoing phase 1/2 IGNYTE study
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September, 2023 Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 119 – 120
    DOI (Open Access)
  • Rudolph, V.; Leven, A. S.; Peller, V.; Müller, C.; Scheib, C.; Zillikens, H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Langfristiger Therapieerfolg von sequentieller Immun- und zielgerichteter Therapie beim metastasierten malignen Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 47 – 48
    DOI (Open Access)
  • Lodde, Georg C.; Dollani, J.; Galetzka, W.; Stang, Andreas; Ugurel, Selma; Rösch, Alexander; Zaremba, Anne; Sucker, A.; Zimmer, Lisa; Schadendorf, Dirk; Griewank, Klaus; Livingstone, Elisabeth
    Melanom mit unbekanntem Primarius (MUP) - eine monozentrische Auswertung
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 76 – 77
    DOI (Open Access)
  • Tarantino, G.; Zaremba, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Pelletier, R.; Makhzami, S.; Murphy, G.; Lian, C.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Multi-modal and longitudinal characterization of the tumor and immune microenvironment from primary melanoma to in-transit and distant metastasis
    ESMO Congress 2023 ; 20 - 24 October 2023 Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S694
    DOI (Open Access)
  • Long, G.V.; Hodi, F.S.; Lipson, E.J.; Schadendorf, Dirk; Ascierto, P.A.; Medina Soto, F.A.; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Mujika Eizmendi, M.K.; Atkinson, V.G.; Hassel, J.C.; Cinat, G.; Ratto, B.; Rodriguez, S.; Wang, P.T.; Dolfi, S.; Tawbi, H.A.
    Nivolumab (NIVO) plus relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma : 2-year subgroup analyses from RELATIVITY-047
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S664 – S665
    DOI (Open Access)
  • Hartmann, E. M.; Nensa, Felix; Lodde, Georg C.; Livingstone, Elisabeth; Schadendorf, Dirk; Sachweh, S.
    Pain points in software interaction in the treatment of melanoma patients
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 125 – 126
    DOI (Open Access)
  • Idrissi-Yaghir, A.; Schäfer, H.; Lodde, Georg C.; Livingstone, Elisabeth; Schadendorf, Dirk; Friedrich, C.M.
    Preliminary Examination of Cited Literature in International Melanoma Guidelines
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 126
    DOI (Open Access)
  • Schadendorf, Dirk; Dummer, R.; Ribas, A.; Robert, C.; Sullivan, R.J.; King, A.; Polli, A.; di Pietro, A.; Ascierto, P.A.
    Randomized phase II trial (PORTSIDE) evaluating encorafenib (enco) and binimetinib (bini) plus pembrolizumab (pembro) versus nivolumab (nivo) and ipilimumab (ipi) for the treatment of advanced BRAF-mutant melanoma
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S700
    DOI (Open Access)
  • Zhao, F.; Thier, B.; Kwapik, S.; Laudage, M.; Griewank, Klaus; Nalbant, Perihan; Rambow, F.; Sucker, A.; Schadendorf, Dirk; Paschen, Annette
    Role of IFNγ-induced tumor-T cell equilibrium in melanoma latency
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 34
    DOI (Open Access)
  • Müller, C.; Scheib, C.; Peller, V.; Zillikens, H.; Rudolph, V.; Leven, A. S.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Therapieansprechen auf Sunitinib bei Imatinib-resistentem Rezidiv eines Dermatofibrosarkoma protuberans am Capillitium
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 99 – 100
    DOI (Open Access)
  • Peller, V.; Müller, C.; Zillikens, H.; Scheib, C.; Viktoria, R.; Rösch, Alexander; Ugurel, Selma; Becker, Jürgen C.; Gutzmer, R.; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Therapieoption beim lokal fortgeschrittenen kutanen Plattenepithelkarzinom nach Cemiplimab-Resistenz
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 72
    DOI (Open Access)
  • Placke, Jan-Malte; Kimmig, M.; Griewank, Klaus; Hadaschik, Eva; Herbst, R.; Terheyden, P.; Utikal, J.; Pfoehler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Welzel, J.; Becker, Jürgen C.; Weichenthal, M.; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel-Becker, Selma
    Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S695
    DOI
  • Beckmann, C. L.; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, B.
    Context-Sensitive Modeling of a Standard Operating Procedure for Melanoma Patient Treatment
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 67
    DOI
  • Long, G. V.; Luke, J.; Khattak, M. A.; Schadendorf, Dirk; Ascierto, P. A.; et al.
    Distant metastasis-free survival with pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: the phase 3 KEYNOTE-716 study
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 95
    DOI
  • Nathan, P.; Grob, J.J.; Dummer, R.; Ascierto, P.A.; Ribas, A.; Robert, C.; Schadendorf, Dirk; Flaherty, K.T.; Tawbi, H.A.; Hauschild, A.; Mandala, M.; Shah, R.; Banerjee, H.; Sarkar, R.P.; Lau, M.R.; Long, G.V.
    Efficacy of dabrafenib (D) trametinib (T) plus spartalizumab (S) by baseline site of metastases in patients (pts) with previously untreated BRAF V600-mutant unresectable or metastatic melanoma : Post hoc analysis of phase III COMBI-i trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7, S. S921 – S922
    DOI (Open Access)
  • Richtig, E.; Loquai, C.; Forschner, A.; Gutzmer, R.; Hassel, J. C.; Utikal, J. S.; Haferkamp, S.; Meier, F.; Debus, D.; Dummer, R.; von Moos, R. A. F.; Thompson, J.; Gengenbacher, L.; Michielin, O.; Höller, C.; Schadendorf, Dirk
    Encorafenib plus Binimetinib bei Patienten mit lokal fortgeschrittenem, nicht-resezierbarem oder metastasiertem BRAFV600-mutiertem Melanom : Aktualisierte Daten der multizentrischen, multinationalen, prospektiven, nicht-interventionellen Längsschnittstudie BERING MELANOMA
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 96 – 97
    DOI
  • Borys, K.; Livingstone, Elisabeth; Lodde, Georg; Seifert, Christin; Krämer, Nicole; Umutlu, Lale; Schadendorf, Dirk; Friedrich, C. M.; Nensa, Felix
    Explainable Radiomics by the example of malignant melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 65 – 66
    DOI
  • Zaremba, Anne; Jansen, Philipp; Murali, R.; Mayakonda, A.; Riedel, A.; Krahl, D.; Burkhardt, H.; John, S.; Géraud, C.; Philip, M.; Kretz, J.; Möller, I.; Stadtler, N.; Sucker, A.; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Plass, C.; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, P.; Griewank, Klaus
    Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 84
    DOI
  • Franklin, Cindy; Mohr, P.; Bluhm, L.; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, S.; Ugurel, Selma; et al.
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 29 – 30
    DOI
  • Sauter, D.; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, M.
    Konzept-basierte Erklärung neuronaler Netze für die Dermatohistopathologie
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 68
    DOI
  • Kreft, S.; Glutsch, V.; Zaremba, Anne; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian; et al.
    MAPKinase Inhibition nach Versagen einer PD-1 basierten Immuncheckpoint Blockade in Patienten:innen mit fortgeschrittenem Melanom : eine Auswertung des multizentrischen prospektiven Hautkrebsregisters ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 28
    DOI
  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Mitigating Cognitive Bias with Decision Support Systems
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 64
    DOI
  • Jansen, P.; Zaremba, Anne; Philip, M.; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Paschen, Annette; Sucker, A.; Möller, I.; Landsberg, J.; Rose, C.; Emberger, M.; Schaller, J.; Plass, C.; Hadaschik, Eva; Schadendorf, Dirk; Mentzel, T.; Lutsik, P.; Griewank, Klaus
    Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 88
    DOI
  • Placke, Jan-Malte; Mertens, D.; Tasdogan, A.; Chorti, E.; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Stoffels, Ingo; Klode, Joachim
    Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 105
    DOI
  • Hodi, F.S.; Tawbi, H.A.; Lipson, E.J.; Schadendorf, Dirk; Ascierto, P.A.; Matamala, L.A.; Salman, P.; Gutierrez, E.C.; Rutkowski, P.; Gogas, H.J.; Lao, C.D.; Menezes, J.; Dalle, S.; Arance Fernandez, A.M.; Grob, J.J.; Keidel, S.; Rodriguez, S.; Wang, P.; Dolfi, S.; Long, G.V.
    Nivolumab (NIVO) + relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma : Additional response outcomes from RELATIVITY-047
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S920 – S921
    DOI (Open Access)
  • Weichenthal, M.; Svane, I-M.; Kandolf Sekulovic, L.; Mangana, J.; Lugowska, I.; Mohr, P.; Espinosa, E.; Gogas, H.J.; Bender, M.; Ellebæk, E.; Gavrilova, I.; Herceg, D.; Muñoz Couselo, E.; Schmidt, H.; Stulhofer Buzina, D.; Rutkowski, P.; Ascierto, P.A.; Dummer, R.; Schadendorf, Dirk; Bastholt, L.
    Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S931
    DOI (Open Access)
  • Kreft, S.; Richter, L.; Peller, V.; Rieß, V.; Albrecht, L. J.; Müseler, A. C.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission auf Cemiplimab eines beidseitig Orbitae-infiltrierenden Basalzellkarzinoms des Mittelgesichts
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 44 – 45
    DOI
  • Chauvistre, H.; Shannan, B.; Daignault-Mill, S. M.; Ju, R. J.; Picard, D.; Egetemaier, S.; Váraljai, R.; Gibhardt, C. S.; Keminer, O.; Horn, S.; Remke, M.; Paschen, Annette; Becker, Jürgen C.; Helfrich, Iris; Gul, S.; Herlyn, M.; Bogeski, I.; Rodríguez-López, J. N.; Haass, N. K.; Schadendorf, Dirk; Rösch, Alexander
    Persister state-directed transitioning and vulnerability in melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 35 – 36
    DOI
  • Migden, M.R.; Schmults, C.; Khushanlani, N.; Guminski, A.; Chang, A.L.; Lewis, K.; Ansstas, G.; Bowyer, S.E.; Hughes, B.G.M.; Schadendorf, Dirk; Modi, B.; Dunn, L.; Flatz, L.; Hauschild, A.; Yoo, S-Y.; Booth, J.; Seebach, F.; Lowy, I.; Fury, M.G.; Rischin, D.
    Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) : Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S918 – S919
    DOI (Open Access)
  • Schadendorf, Dirk; Flaherty, K.T.; Tawbi, H.A.; Robert, C.; Nathan, P.; Dummer, R.; Long, G.V.; Ascierto, P.A.; Mandala, M.; Hauschild, A.; Grob, J.J.; Shah, R.; Gopal Sahoo, B.; Lau, M.R.; Ribas, A.
    Predictive role of neutrophil-lymphocyte ratio (NLR) in patients (pts) with metastatic melanoma : A post hoc exploratory analysis from phase III COMBI-i trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S947 – S948
    DOI (Open Access)
  • Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 75 – 76
    DOI (Open Access)
  • Vehring, Justus; Sammet, Stefanie; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    Efficacy of syphilis treatment in HIV-infected patients
    In: Infection - A Journal of Infectious Disease , Jg. 49 2021, Nr. Suppl. 1, S. 40
    DOI (Open Access)
  • Michielin, O.; Richtig, E.; Grimmelmann, I.; Loquai, C.; Forschner, A.; Hoeller, C.; Utikal, J.; Gutzmer, R.; Haferkamp, S.; Hassel, J. C.; Debus, D.; Fluck, M.; Goeppner, D.; Kehrer, H.; Dummer, R.; von Moos, R.; Thompson, J.; Milde, L.; Schadendorf, Dirk
    Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600) mutated melanoma : first data from a multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERINGMELANOMA
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 249 – 250
    DOI (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I.; Schmults, Chrysalyne D.; Guminski, Alexander; Chang, Anne Lynn S.; Lewis, Karl D.; Lim, Annette M.; Hernandez-Aya, Leonel; Hughes, Brett G. M.; Schadendorf, Dirk; Hauschild, Axel; Stankevich, Elizabeth; Booth, Jocelyn; Yoo, Suk-Young; Okoye, Emmanuel; Lowy, Israel; Fury, Matthew G.; Migden, Michael R.
    Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) : follow-up at 43 months
    48th Annual Scientific Meeting Cancer care and research: Learning from the past and improving the future, 16-18 November 2021,
    In: Asia-Pacific Journal of Clinical Oncology , Jg. 17 2021, Nr. 9, SI, S. 166
    DOI (Open Access)
  • Jansen, Thomas; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Rosacea in Children - A Case Report
    46. Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e. V., 30. März bis 2. April 2011, Dresden, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 9 2011, Nr. Suppl. 1, S. 240 – 240
    DOI

    • Forschungsdaten

  • Merz, Simon; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    3D data related to : Identification and quantification of hidden melanoma metastases in human sentinel lymph nodes using light sheet fluorescence microscopy
    2020
    DOI (Open Access)